patents and designs journal - nevo.co.il · government publications, 29 b-street, ... matan digital...

2/2007 ז"התשס/'ח

רשומותISRAEL STATE RECORDS

June 3, 2007 ז"התשס בסיוןז"י

יומן הפטנטים והמדגמים

PATENTS AND DESIGNS JOURNAL

PATENTS עמוד פטנטים Page

Applications filed 448 בקשות שהוגשו Applications accepted 593 בקשות שקובלו Patents granted 803 פטנטים שניתנו Patents renewed 804 פטנטים שחודשו

Patents not in force 805 פטנטים שתוקפם פקעו Patents renewed for 20 years 806 פטנטים שחודשו לעשרים שנה

Notices 807 עותהוד Corrigenda 810 תיקוני טעויות Country codes 811 קודים למדינות

i Indices of applications accepted מפתחות לבקשות שקובלו

DESIGNS מדגמים Designs registered 813 מדגמים שנרשמו Designs renewed 825 מדגמים שחודשו Designs void 826 מדגמים שבוטלו

June 3, 2007 446– ז" התשס בסיוןז"י

עות כלליותידי

:בענייני פטנטים ומדגמים יש לשלוח אל' וכו, מסמכים, מכתבים ירושלים, 4הסדנא ' רח, רשם הפטנטים והמדגמים

ירושלים והיא פתוחה לציבור בימי חול , תלפיות, 4הסדנא ' לשכת הפטנטים נמצאת ברח .12:30 - ו8:30שאינם ערבי שבת או מועד בין השעות

שקלים בעד כל 2.50 תצלומים של פירוטים ושרטוטים במחיר של לשכת הפטנטים מספקת .עמוד או חלק ממנו

' אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מסיש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה . 0-24145-2

.שולמה

GENERAL INFORMATION Letters, documents, etc. concerning Patents and Designs should be addressed to: The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs. The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50 per page or part thereof. Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together with the application for the action for which the fee has been paid.

זכות היוצרים בתקצירים אלה שמורה

אין להעתיק מת, למדינת ישראל קצירים

.אלה אלא ברשות לשכת הפטנטים

Copyright by the State of Israel. No Extracts may be published except with the permission of the Patent Office.

. 96₪.) מ.ע.כולל מ(לכל חוברת בודדת : מחיר

Price per single issue (incl. VAT) : NIS 96.

. 1,152₪.) מ.ע.כולל מ(דמי חתימה לשנה

Annual subscription (incl. VAT): NIS 1,152.

:אפשר להשיג אצל' רחוב ב, שרות ההפצה של פרסומי הממשלה

.אביב-תל, הקריה, 29' מס

Available at the Distribution Service of Government Publications, 29 B-Street, Hakirya, Tel-Aviv.

June 3, 2007– ז" בסיון התשסז"י

447

לחוק הפטנטים 16הודעה לפי סעיף 1967 -ז "תשכ

NOTICE UNDER SECTION 16 OF THE PATENTS LAW, 5727-1967

להלן רשימת בקשות חדשות

הממלאות אחר הדרישות שנקבעו ,לתקנות הפטנטים) א(32בתקנה :1968–ח"תשכ

In the following there are listed new Applications complying with the Provisions of rule 32(a) of the Patent Regulations, 5728-1968

פרטי הבקשות מובאים לפי :סדר זה

Particulars of the applications are given in the following order:

ותאריך הגשתה– מספר הבקשה וארבעה הסמנים הראשונים של

הסיווג הבינלאומי

Number and date of application And the first four symbols of the International Classification

י"כפי שהוצע ע (שם האמצאה )המבקש

Title of invention (as proposed by applicant)

המבקש

Applicant

–מדינת האיגוד : דין קדימה תאריך ומספר בקשת החוץ

Priority right: Convention country – Number and date of Foreign application

מספר בקשה בינלאומית

International Application Number

International Publication Number בינלאומיפרסום ' מס


B09B 169309 21/06/2005

MEFHOD FOR COLLECLION OF שיטת איסוף מוצרים מוחזריםRETURNED ARTICLES

ROZENTAL SHUNIA רוזנטל שוניה

G01S 174737 03/04/2006

–ם פס"שיטה והתקן לתצוגת תמונה במכ רחב אולטרה

SYSTEM AND METHOD FOR IMAGE DISPLAY IN ULTRA-WIDEBAND RADAR

.CAMERO-TECH LTD מ"טק בע-קמרו

F41H 175929 25/05/2006

מערכת לסילוק חום ממקור חום המותקן בקסדה

SYSTEM FOR TRANSFERRING HEAT AWAY FROM A HELMET MOUNTED HEAT EMITTER

.ELBIT SYSTEMS LTD מ"אלביט מערכות בע

B60K 176245 12/06/2006

MANUAL DRIVEN CONTROLS םמנגנון סוכן הפעלה לבקרי נהוג ידנייACTUATION AGENT MACHANISM

YEFIM KERETH יפים קרת

G06K 176369 18/06/2006

A SYSTEM & METHOD FOR מערכת ושיטה למניעת צילומיםPREVENTING PHOTOGRAPHY

PHOTO FREE LTD מ"פוטו פרי בע


449

F41H 176454 21/06/2006

EXPLOSIVE MATERIAL SENSITIVITY נפץבקרת רגישות לחומר CONTROL

ל רשות לפיתוח אמצעי לחימה "רפא מ"בע

RAFAEL ARMAMENT DEVELOPMENT AUTHORITY LTD.

A23L 179473 24/05/2005

תכשירים רפואיים לטיפול בגידולים ודלקות

PHARMACEUTICAL PRODUCTS FOR TREATING NEOPLASTIC DISEASE AND INFLAMMATION

KGK SYNERGIZE INC. 26/05/2004 60/574487 US PCT/IB/2005/001420 WO/2005/115376

G01B 180051 13/12/2006

מד טווח אופטי קוהרנטיCOHERENT OPTICAL RANGE FINDER USING TRANSMITTED PULSE AS LOCAL OSCILLATOR

ל רשות לפיתוח אמצעי לחימה "רפא מ"בע

RAFAEL ARMAMENT DEVELOPMENT AUTHORITY LTD.

F03G 180052 14/12/2006

DEVICE FOR GENERATING ENERGY מתקן לאנרגיה מגלי יםFROM SEA WAVES

ELAZAR TAGANSKY אלעזר טגנסקי

B41J 180111 17/12/2006

DUAL MODE PRINTER מדפסת בעלת שתי מצבים .MATAN DIGITAL PRINTERS LTD מ"בע ) 2001(מתן מדפסות דיגיטליות


C07D 180112 14/07/2005

תרכובות בנזאמיד דחוסות ותכשירי רוקחות המכילים אותן

CONDENSED BENZAMIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

JAPAN TOBACCO INC.

15/07/2004 2004-208334

JP

22/07/2004 60/590180 US 28/12/2004 2004-379551 JP 06/01/2005 60/641874 US 28/04/2005 2005-133724 JP 12/05/2005 60/680072 US PCT/JP/2005/013446 WO/2006/006741

G06F 180113 16/06/2005

שיטה לעידכון גוש תוכנית מאובטח אבטחההטעון בתוך מודול

METHOD FOR SECURELY UPDATING A PROGRAM BLOCK LOADED IN A SECURITY MODULE

NAGRACARD S.A. 17/06/2004 04102768.1 EP PCT/EP/2005/052797 WO/2005/124502

A61B 180114 23/06/2005

SYSTEMS AND METHODS FOR SPINE מערכות ושיטות לייצוב עמוד שידרהSTABILIZATION

YALE UNIVERSITY 23/06/2004 60/581716 US 31/12/2004 11/027270 US 31/12/2004 11/027246 US 31/12/2004 11/027073 US 31/12/2004 11/027082 US 31/12/2004 11/027245 US 31/12/2004 11/027269 US 31/12/2004 11/027247 US PCT/US/2005/022346 WO/2006/002333


451

A61K 180115 30/06/2005

, ופולימרIXצמדים של קבוצה של גורם תכשירים המכילים אותם ושיטות

להכנתם

A CONJUGATE OF A FACTOR IX MOIETY AND A POLYMER, COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF

NEKTAR THERAPEUTICS AL, CORPORATION

30/06/2004 60/584505 US PCT/US/2005/023745 WO/2006/005058

H04B 180116 02/06/2005

שיטה לאספקת חללים בספקטרום בשידור אותות על גבי רשת אלקטרונית

METHOD OF OBTAINING SPECTRAL VOIDS IN THE TRANSMISSION OF SIGNALS OVER THE ELECTRIC NETWORK

DISENO DE SISTEMAS EN SILICIO, S.A.

18/06/2004 P200401502 ES PCT/ES/2005/000315 WO/2006/000602

H04Q 180117 21/06/2005

איתות אסינכרוני והעברת מידע במערכת תקשורת אלחוטית

ASYNCHRONOUS SIGNALING AND DATA DELIVERY IN A WIRELESS COMMUNICATION SYSTEM

QUALCOMM INCORPORATED 21/06/2004 60/581970 US 31/05/2005 60/686132 US 17/06/2005 11/156176 US PCT/US/2005/022022 WO/2006/002214


A61K 180118 05/04/2000

מיימניים וממיסי –חד, נתרניים–מלחים דו אתנול להעברת נשאים פעילים

DISODIUM SALTS, MONOHYDRATES, AND ETHANOL SOLVATES FOR DELIVERING ACTIVE AGENTS

EMISPHERE TECHNOLOGIES, INC. 05/04/1999 60/127754 US 01/03/2000 60/186143 US 01/03/2000 60/186142 US 21/03/2000 60/191286 US PCT/US/2000/009390 WO/2000/059863

C01B 180119 15/06/2005

CHEMICALLY ASSISTED MILLING סיליקות בסיוע כימיטחינתOF SILICAS

W.R. GRACE & CO. CONN 15/06/2004 60/579694 US PCT/US/2005/021156 WO/2006/002085

H04L 180120 07/06/2005

גילוי מחיקות אמין ובקרת כוח של לולאה סגורה מבוססת קצב מחיקה

ROBUST ERASURE DETECTION AND ERASURE-RATE-BASED CLOSED LOOP POWER CONTROL

QUALCOMM INCORPORATED 18/06/2004 60/580819 US 13/07/2004 10/890717 US PCT/US/2005/020087 WO/2006/007317


453

H04L 180121 14/06/2005

סנכרון זמן בעזרת אומדן ספקטרלי במערכת תקשורת

TIME SYNCHRONIZATION USING SPECTRAL ESTIMATION IN A COMMUNICATION SYSTEM


H04L 180122 29/04/2005

פרוטוקול תקשורת רדיו עבור מערכת ת אלחוטיתתקשור

RADIO LINK PROTOCOLS FOR A WIRELESS COMMUNICATION SYSTEM


H04L 180123 14/06/2005

ריבוב שדרים עבור מערכת תקשורת ת אותותסלולרית מרוב

MULTIPLEXING FOR A MULTI-CARRIER CELLULAR COMMUNICATION SYSTEM



H04B 180124 07/06/2005

בקרת כוח במערכת תקשורת אלחוטית על ידי ריבוב אורתוגונלי

POWER CONTROL FOR A WIRELESS COMMUNICATION SYSTEM UTILIZING ORTHOGONAL MULTIPLEXING


C07C 180125 15/06/2005

METHODS FOR PRODUCING טות ליצור ביודיזלשיBIODIESEL

CARNEGIE MELLON UNIVERSITY 15/06/2004 10/867627 US PCT/US/2005/021173 WO/2006/002087

A61B 180126 16/06/2005

METHOD AND APPARATUS FOR שיטה והתקן לשימור ברגים בפלטהRETAINING SCREWS IN A PLATE

WARSAW ORTHOPEDIC, INC. 17/06/2004 10/870026 US PCT/US/2005/021358 WO/2006/009795

A61F 180127 15/06/2005

טמפון היגייני ושיטה ליצור טמפון היגייניA HYGIENIC TAMPON AND A METHOD OF MANUFACTURING A HYGIENIC TAMPON

JOHNSON & JOHNSON INDUSTRIAL LTDA

17/06/2004 PI0402403-6

BR

PCT/BR/2005/000109 WO/2005/122986


455

A61K 180128 17/06/2005

METHODS AND COMPOSITIONS FOR שיטות ותכשירים להלחמת פצעיםWOUND HEALING

THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION

18/06/2004 10/871158 US PCT/US/2005/021477 WO/2006/009853

C12Q 180129 07/06/2005

זיהוי של חריגות כרומוזומליות בתאים שהתקבלו מנוזל זקיקי

IDENTIFYING CHROMOSOMAL ABNORMALITIES IN CELLS OBTAINED FROM FOLLICULAR FLUID

RELIANCE LIFE SCIENCES PVT. LTD. 11/06/2004 642/MUM/2004 IN PCT/IN/2005/000185 WO/2005/121365

E04H 180130 17/06/2005

A PREFABRICATED SHELTER מחסה טרומי

CRAWFORD BREWIN LTD 17/06/2004 04253627.6 EP PCT/GB/2005/002406 WO/2005/124063

A01G 180131 17/06/2005

תרביות משותפות הניתנות לניהול שלאורגניזמים בעלי השפעה במניעת מחלות

ושיפור בריאות

MANAGED CO-CULTURES OF ORGANISMS HAVING PROPHYLACTIC AND HEALTH-PROMOTING EFFECTS

VEGA, GABRIEL, CHAVEZ 17/06/2004 60/580983 US PCT/US/2005/021807 WO/2006/002093


H01L 180133 17/12/2006

לבחינת מעגלים חשמליים ומערכת שיטה לבחינת מעגלים חשמליים

METHOD FOR INSPECTING ELECTRICAL CIRCUITS AND A SYSTEM FOR INSPECTING ELECTRICAL CIRCUITS

.CAMTEK LTD מ"קמטק בע 17/12/2005 60/749052 US

C07D 180136 07/07/2005

מותמרים שלוש –6,4,2פירימידינים (PI(ם כמעכבי פוספוטידילאינוסיטול פעמי

קינאז והשימוש בהם בטיפול בסרטן–3

2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER

ASTRAZENECA AB 09/07/2004 0415365.6 GB PCT/GB/2005/002664 WO/2006/005914

C07D 180137 07/07/2005

מותמרים שלוש פעמים –6,4,2פירימידינים –PI) 3(כמעכבי פוספוטידילאינוסיטול

קינאז והשימוש בהם בטיפול בסרטן

2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER


C07D 180138 07/07/2005

מותמרים שלוש פעמים –6,4,2פירימידינים –PI) 3(כמעכבי פוספוטידילאינוסיטול

קינאז והשימוש בהם בטיפול בסרטן

2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER



457

B02C 180139 18/12/2006

מכונה ושיטה לצורך גריסת פולימרים וחומרי גומי מגופר

MACHINE AND METHOD FOR COMMINUTING OF POLYMER AND CURED ELASTOMER MATERIALS

INNOVERT INVESTMENTS A.L. LTD מ"בע. ל.אינוברט השקעות א

G06F 180140 28/06/2005

אבטחת ומיכון , מערכת ושיטה לאיחוד של גישה מחוץ לפס לנודות ברשת נתונים

SYSTEM AND METHOD FOR CONSOLIDATING, SECURING AND AUTOMATING OUT-OF-BAND ACCESS TO NODES IN A DATA NETWORK

AVOCENT FREMONT CORP. 29/06/2004 10/881211 US PCT/US/2005/023719 WO/2006/005047

B31B 180141 22/06/2005

SHEET MATERIAL AND METHOD חומר יריעה ושיטה ELOPAK SYSTEMS AG 23/06/2004 0414029.9 GB PCT/IB/2005/001759 WO/2006/000881

C07D 180142 06/07/2005

טריאזולופירימידנים –אמינו–7–פניל–6שימוש בהם , שיטה ליצורם, מותמרים

לבקרה על פטריות פתוגניות וגורמים המכילים תרכובות אלו

SUBSTITUTED 6-PHENYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI, AND AGENTS CONTAINING THESE COMPOUNDS

BASF AKTIENGESELLSCHAFT 08/07/2004 102004033239.8 DE PCT/EP/2005/007277 WO/2006/005492


C07D 180143 12/07/2005

שיטה , 2רימידינים מותמרים בעמדה פילהכנתם ושימוש בהם לבקרה על

פטריות פתוגניות

2-SUBSTITUTED PYRIMIDINES, METHOD FOR THEIR PRODUCTION AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGI


A61P 180144 24/06/2005

Dתכשירים המכילים סטרונטיום וויטמין ושימושיהם

COMPOSITIONS COMPRISING STRONTIUM AND VITAMIN D AND USES THEREOF

STRONTIN APS 25/06/2004 PA200400991 DK 10/11/2004 PA200401733 DK PCT/DK/2005/000425 WO/2006/000224

B65D 180145 11/04/2006

IDENTIFICATION PANEL FOR PALLET לוח זיהוי עבור מיכלCONTAINER

MAUSER-WERKE GMBH 20/04/2005 202005006351.7 DE PCT/EP/2006/003325 WO/2006/111303

H01M 180146 18/12/2006

וציוד ציוד ושיטות להכנסת מצבר , מצבר כאלו למצב אחסון

A BATTERY, EQUIPMENT, AND METHODS OF PUTTING SUCH A BATTERY AND SUCH EQUIPMENT INTO A STORAGE CONDITION

SAGEM DEFENSE SECURITE 19/12/2005 0512880 FR


459

C07D 180147 20/06/2005

– פניל – 4 – בנזיל – N (1 – (1 –תולדות 1H –2,2 –) יל– 2 –אזול אימיד –

בנזאמיד ותרכובות ) דימתילפרופיל לטיפול בסרטןKSPקשורות כמעכבות

N - (1 - (1 - BENZYL - 4 - PHENYL - 1H-IMIDAZOL - 2 - YL) - 2,2 - DYMETHYLPROPYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPIDLE PROTEIN (KSP) INHIBITORS FOR THE TREATMENT OF CANCER

CHIRON CORPORATION 18/06/2004 60/580927 US PCT/US/2005/022062 WO/2006/002236

G09F 180149 18/12/2006

שיטה לפרסום על ידי שימוש ביחידות מוניטור רב מסכים של מחשב

ADVERTISING METHOD WITH USE OF MULTI-SCREENED COMPUTER MONITOR UNITS

D. SIT TRADE L.T.D מ"סיט סחר בע.ד

B67D 180150 18/12/2006

כלי קיבול להפקדת פריטים אישיים של סועד בשולחן אוכל

RECEPTACLE FOR DEPOSITING PERSONAL ITEMS OF A DINER AT DINING TABLE

ZIV BEN ZVI לירון חלבוני

C07D 180151 05/07/2005

–2,1טה לייצור תרכובת של שי און–2–דיהידרופירידין

METHOD FOR PRODUCING 1,2-DIHYDROPYRIDINE-2-ONE COMPOUND

EISAI R&D MANAGEMENT CO. LTD.

06/07/2004 2004-198709

JP

PCT/JP/2005/012364 WO/2006/004100


C07K 180152 30/06/2005

יים נוגדנים מונוקלונאליים כימר 13–ומותאמים לבני אדם נגד אינטלאוקין

CHIMERIC AND HUMANISED MONOCLONAL ANTIBODIES AGAINST INTELEUKIN-13

GLAXO GROUP LIMITED 01/07/2004 0414799.7 GB 25/10/2004 0423675.8 GB PCT/GB/2005/002581 WO/2006/003407

A61B 180153 06/07/2005

COLORECTAL CELL SAMPLING לדגימת תא קולורקטלימכשירDEVICE

COLONIX LIMITED 07/07/2004 0415277.3 GB PCT/GB/2005/002641 WO/2006/003447

H04N 180154 22/04/2005

REAL-TIME STABILIZATION ייצוב בזמן אמת

INTERGRAPH SOFTWARE TECHNOLOGIES COMPANY

21/06/2004 10/872767 US PCT/US/2005/013899 WO/2006/007006

H04Q 180155 21/06/2005

שיטה להבחנה בסוגים שונים של תכני מידע בתוך פקטות דטה במערכת

תקשורת אלחוטית

METHOD FOR DISTINGUISHING DIFFERENT TYPES OF DATA CONTENT IN DATA PACKETS IN A WIRELESS COMMUNICATION SYSTEM

QUALCOMM INCORPORATED 21/06/2004 60/581790 US 31/05/2005 60/686131 US 17/06/2005 11/156179 US PCT/US/2005/022025


461

WO/2006/002217

H04Q 180157 21/06/2005

מערכת תקשורת אלחוטית המשתמשת בערך מתמיד עבור בקשות תקשורת

צורך קיצור זמן אחזורקבוצתיות ל

WIRELESS COMMUNICATION SYSTEM UTILIZING A PERSISTENCE VALUE FOR GROUP COMMUNICATION REQUESTS TO REDUCE LATENCY


H04Q 180158 20/06/2005

שיטה לשימוש בערוץ איתות לצורך PUSH TOיצירת בקשה לשיחה בתקשורת

TALKבמערכת תקשורת אלחוטית

METHOD FOR USING A SIGNALING CHANNEL TO SET UP A CALL REQUEST FOR A PUSH TO TALK (PTT) COMMUNICATION ON A WIRELESS COMMUNICATION NETWORK

QUALCOMM INCORPORATED 21/06/2004 60/581968 US 31/05/2005 60/686147 US 16/06/2005 Unknown

yet US

PCT/US/2005/022118 WO/2006/002266

H04L 180160 11/07/2005

מגבר עבור אותות של זוג מוליכים מפותל בלתי מסוכך

AMPLIFIER FOR UNSHIELDED TWISTED PAIR WIRE SIGNALS

PHYLOGY, INC. 12/07/2004 10/889090 US PCT/US/2005/024576 WO/2006/017236


F03G 180163 23/06/2005

שיטה לפיתוח וייצור של מאגרים גיאותרמיים עמוקים

METHOD OF DEVELOPING AND PRODUCING DEEP GEOTHERMAL RESERVOIRS

CURLETT, HARRY, B. 23/06/2004 60/582626 US 07/02/2005 60/650667 US PCT/US/2005/022305 WO/2006/002325

E06B 180164 18/12/2006

WINDOW OR DOOR SHUTTER AND תריס לחלון או דלת ושלב עבורוSLAT THEREFOR

.PROFILE GLASS LTD מ"פרופיל גלס בע

H02J 180165 21/04/2005

BI-DIRECTIONAL ENERGY כוונית–מערכת המרת אנרגיה דוCONVERSION SYSTEM

.LV POWER (2003) LTD מ"בע ) 2003(פאוור .וי.אל 08/07/2004 60/585830 US PCT/IL/2005/000438 WO/2006/006142

E04B 180166 29/03/2005

טון מבודדת עם קשרי מערכת תבנית ב קיר באורכים משתנים

INSULATED CONCRETE FORM SYSTEM WITH VARIABLE LENGTH WALL TIES

PJER-MISE VELICKOVIC 21/06/2004 P20040578A HR PCT/HR/2005/000021 WO/2005/124046


463

C12N 180167 19/07/2005

–דנא המקודד פוליפפטיד המשתתף בביופוליפפטידים , ינתזה של פלאדיאינולידס

המקודדים הימנו ושיטות להכנת פלאדיאינוליד המשתמשות בהם

DNA CODING FOR POLYPEPTIDE PARTICIPATING IN BIOSYNTHESIS OF PLADIENOLIDE, POLYPEPTIDES ENCODED THEREBY AND A METHOD FOR PRODUCING PLADIENOLIDE UTILIZING THE SAME

EISAI R&D MANAGEMENT CO, LTD.

20/07/2004 2004-211279

JP

PCT/JP/2005/013541 WO/2006/009276

G09F 180168 19/12/2006

חבילות פרסום נייד להצגת פרסומות על מכשירים סלולרים אישיים

MOBILE ADVERTISING PACKAGES FOR DISPLAYING ADVERTISEMENT DISPLAY MESSAGES ON PERSONAL CELLULAR TELECOMMUNICATIONS DEVICES

.CELLTICK TECHNOLOGIES LTD מ"סלטיק טכנולוגיות בע

G01N 180169 20/07/2005

פרוצדורה לאפיון מבני של חלבון רקומביננטי רב שבטי או שורת תאים רב

שבטית

A PROCEDURE FOR STRUCTURAL CHARACTERIZATION OF A RECOMBINANT POLYCLONAL PROTEIN OR A POLYCLONAL CELL LINE

SYMPHOGEN A/S 20/07/2004 PA200401133 DK 22/12/2004 PA200401991 DK PCT/DK/2005/000504 WO/2006/007853


A61F 180170 16/06/2005

FLOW REGULATING IMPLANTS שתלים המווסתים זרם .OPTONOL LTD מ"אופטונול בע

25/06/2004 10/875571 US PCT/US/2005/021123 WO/2006/012009

C07J 180171 04/07/2005

D–טריאנים –)10(5, 3, 1–אסטרה– הומו כמעכבים 2חדשים המותמרים בעמדה

הידרוקסיסטינואיד –בתא–17של 1דהידרוגנאז מסוג

NOVEL 2-SUBSTITUTED D-HOMO-ESTRA-1,3,5(10)-TRIENES AS INHIBITORS OF 17?- HYDROXYSTEROID DEHYDROGENASE TYPE 1

SCHERING AKTIENGESELLSCHAFT 02/07/2004 102004032673.8 DE PCT/EP/2005/007314 WO/2006/003012

A61K 180172 01/07/2005

TOPICAL ANTIVIRAL הרכבים מקומיים אנטי וירלייםFORMULATIONS

GILEAD SCIENCES, INC. 09/07/2004 60/586839 US PCT/US/2005/023492 WO/2006/017044

B01D 180173 21/06/2005

שימוש בסדרת סינוני עומק משולבים עם צנטריפוגה מתמשכת להבהרת תרביות

תאי יונקים

USE OF DEPTH FILTRATION IN SERIES WITH CONTINUOUS CENTRIFUGATION TO CLARIFY MAMMALIAN CELL CULTURES

Biogen Idec MA Inc.


465

21/06/2004 10/871261 US PCT/US/2005/021781 WO/2006/007459

G06K 180174 24/06/2005

שיטה והתקן לקביעת מיקום הקשור עם דמות

METHOD AND APPARATUS FOR DETERMINING A LOCATION ASSOCIATED WITH AN IMAGE

DIGITALGLOBE, INC. 25/06/2004 60/521729 US PCT/US/2005/022961 WO/2006/078310

B02C 180175 05/07/2005

שיטה לטחינת חומרים מינרליים בנוכחות מקשרים לקבלת סוספנסיות מיימיות

והשימוש בהן

METHOD FOR GRINDING MINERAL MATERIALS IN THE PRESENCE OF BINDERS, RESULTING AQUEOUS SUSPENSIONS AND USE THEREOF

COATEX S.A.S. 13/07/2004 0407805 FR PCT/FR/2005/001715 WO/2006/016036

B02C 180176 05/07/2005

שיטה לטחינה של חומרים מינרליים בנוכחות גורמים מסמיכים לקבלת

ש בהןסוספנסות מיימיות והשימו

METHOD FOR GRINDING MINERAL MATERIALS IN THE PRESENCE OF THICKENING AGENTS, RESULTING AQUEOUS SUSPENSIONS AND USES THEREOF


C07D 180177 24/06/2005


ימידין ושימוש תרכובות טריאזולופיר בהן לבקרה על פטריות פתוגניות

TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGI


A01N 180178 16/06/2005

קרה על פטריות חומר מגן לב פייטופתוגניות

PROTECTANT FOR CONTROLLING PHYTOPATHOGENIC FUNGI

BAYER CROPSCIENCE AG 21/06/2004 102004029972.2 DE PCT/EP/2005/006483 WO/2005/122770

G01N 180179 19/07/2005

שיטה לקביעת נוכחות של תרכובת ת כימית המפוזרת בצורה הומוגני

במדיום באמצעים של קורלציה מצולבת של מדידת ספקטרום עם

רפרנס ספקטרום

METHOD FOR DETERMINING THE PRESENCE OF A CHEMICAL COMPOUND WHICH IS HOMOGENEOUSLY DISTRIBUTED IN A MEDIUM BY MEANS OF CROSS-CORRELATING A MEASURING SPECTRUM WITH REFERENCE SPECTRA


C07D 180180 13/07/2005

אורקילים ) תיאו( פניל– 3שיטה לייצור ודיתיאורקילים

METHOD FOR THE PRODUCTION OF 3 -PHENYL (THIO) URACILS AND DITHIOURACILS



467

E05B 180181 19/12/2006

A LOCK PROTECTION SYSTEM מערכת להגנה על מנעול

ITZHAK COHEN-NEHEMIA יצחק כהן נחמיה

A43B 180182 19/12/2006

BOOTS מגפיים

DORON MORADI דורון מורדי

F41G 180183 19/12/2006

שיטה המאפשרת ניווט קליע לעבר מטרה והתקן

A PROCESS ENABLING A PROJECTILE TO BE NAVIGATED AND/OR GUIDED AND/OR STEERED TOWARDS A TARGET AND THE DEVICE THEREOF

GIAT INDUSTRIES 19/12/2005 05.13205 FR

F42B 180186 24/06/2005

המצויד עם מגן , כדוגמת פגז, מגן וקליע אחד מסוג זה

SHIELD AND A PROJECTILE, SUCH AS A SHELL, WHICH IS EQUIPPED WITH ONE SUCH SHIELD

TDA ARMEMENTS S.A.S. 25/06/2004 0407009 FR PCT/EP/2005/052968 WO/2006/000575

C07K 180187 29/06/2005

תרכובות ושיטות עבור הטיפול בהפרעות דלקתיות

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS


DOMANTIS LIMITED 30/06/2004 2004/002829 GB 24/08/2004 10/925366 US 04/04/2005 11/098758 US PCT/GB/2005/002553 WO/2006/003388

G01R 180188 05/07/2005

ראש מכשיר בדיקה בעל ממברנה מושהית של מכשיר בדיקה

PROBE HEAD HAVING A MEMBRANE SUSPENDED PROBE

CASCADE MICROTECH, INC. 07/07/2004 60/586299 US PCT/US/2005/023806 WO/2006/017078

C07C 180189 23/06/2005

–1–פאניל–Z)–1(הליך עבור ייצור –2–ילאמינוקרבוניל'דיאת

ילציקלופרופאן'הידרוקסימת

PROCESS FOR PRODUCING (Z)-1-PHENYL-1-DIETHYLAMINOCARBONYL-2-HYDROXYMETHYLCYCLOPROPANE

SUMITOMO CHEMICAL COMPANY, LIMITED.

25/06/2004 2004-188901

JP

PCT/JP/2005/012020 WO/2006/001498

B41J 180190 29/07/2005

תשתית ושיטה עבור יצירת תשתית עבור מתקן פליטת נוזל

SUBSTRATE AND METHOD OF FORMING SUBSTRATE FOR FLUID EJECTION DEVICE

HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.

31/08/2004 60/606086 US 07/12/2004 11/007103 US PCT/US/2005/027213 WO/2006/026023


469

C07D 180192 28/06/2005

, מלח מזה, תולדות ארילאמידין חדשות פטרייתי המכיל אותן–ואנטי

NOVEL ARYLAMIDINE DERIVATIVE, SALT THEREOF, AND ANTIFUNGAL CONTAINING THESE

TOYAMA CHEMICAL CO., LTD.

30/06/2004 2004-193386

JP

PCT/JP/2005/011809 WO/2006/003881

C22C 180193 23/06/2005

DIE CAST MAGNESIUM ALLOY יציקת סגסוגת מגנזיום

CAST CENTRE PTY., LTD. 24/06/2004 2004903446 AU 25/11/2004 2004906768 AU PCT/AU/2005/000903 WO/2006/000022

A61K 180195 21/06/2005

תכשירים מכילי אקוורין ושיטות לשימוש בהם

AEQUORIN-CONTAINING COMPOSITIONS AND METHODS OF USING SAME

QUINCY BIOSCIENCE, LLC 21/06/2004 10/872795 US PCT/US/2005/021770 WO/2006/010004


C07D 180197 22/06/2005

ים מלחים בעלי מבנה רבעוני כאנטגוניסט CCR2 –ל

QUATERNARY SALT CCR2 ANTAGONISTS

JANSSEN PHARMACEUTICA, N.V. 25/06/2004 60/582929 US PCT/US/2005/022034 WO/2006/012135

C07D 180198 21/06/2005

מטבוליטים של אינדולילאלקילאמין 6 – הידרוקסיטריפטאמין – 5כליגנדים של

INDOLYLALKYLAMINE METABOLITES AS 5 - HYDROXYTRYPTAMINE - 6 LIGANDS

WYETH 23/06/2004 60/582290 US PCT/US/2005/021852 WO/2006/002125

C07F 180288 18/07/2005

ANTIVIRAL COMPOUNDS חומרים אנטיויראליים

GILEAD SCIENCES, INC. 16/07/2004 60/588633 US 27/07/2004 60/591635 US PCT/US/2005/025503 WO/2006/020276

H04Q 180289 06/07/2005

שיטה לתקשורת אלחוטית ומערכת WLAN–להעברת הודעה ב

WIRELESS COMMUNICATION METHOD AND SYSTEM FOR ESTABLISHING A MULTIMEDIA MESSAGE SERVICE OVER A WLAN

INTERDIGITAL TECHNOLOGY CORPORATION

30/07/2004 60/592856 US 15/06/2005 11/153207 US PCT/US/2005/023793 WO/2006/023108


471

C07D 180290 07/07/2005

תהליך להכנת נגזרות אזולן וחומרי ביניים להכנתם

PROCESS FOR PRODUCTION OF AZULENE DERIVATIVES AND INTERMEDIATES FOR THE SYNTHESIS OF THE SAME

KOTOBUKI PHARMAEUTICAL CO. LTD.

08/07/2004 2004-202437

JP

PCT/JP/2005/012577 WO/2006/006496

A61F 180291 30/06/2005

INTRAVAGINAL DEVICE WITH מכשיר ואגינלי הניתן לניפוחCONTROLLED EXPANSION

MCNEIL-PPC, INC. 30/06/2004 60/584772 US PCT/US/2005/023812 WO/2006/005069

A61M 180293 27/06/2005

A CREDIT CARD SIZED INJECTION מכשיר הזרקה בגודל כרטיס אשראיDEVICE

NOVO NORDISK A/S 05/07/2004 04015740.6 EP PCT/EP/2005/053001 WO/2006/003130


A61K 180295 11/07/2005

י שימוש בגורמים "שיטות לטיפול בסרטן ע WNT16המעכבים סיגנל

METHODS FOR TREATING CANCER USING AGENTS THAT INHIBIT WNT16 SIGNALING

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

09/07/2004 60/586564 US 20/01/2005 60/645709 US PCT/US/2005/024759 WO/2006/017318

A61F 180296 28/07/2005

HIGHLY DEFORMABLE TAMPON טמפון משנה צורה

THE PROCTER & GAMBLE COMPANY

28/07/2004 10/900950 US PCT/US/2005/026832 WO/2006/015139

A61F 180297 06/07/2005

מיוצב בגז ובעל מספר רב , טמפון דחוס קפליםשל

A COMPRESSED, GAS-STABILIZED TAMPON HAVING MULTIPLE FOLDS


09/07/2004 10/887645 US PCT/US/2005/023975 WO/2006/017098

A61F 180298 28/07/2005

טמפון משנה צורה המכיל מארז פנימי ומארז חיצוני

DEFORMABLE TAMPON COMPRISING AN INNER WRAP AND OUTER WRAP


28/07/2004 10/900821 US PCT/US/2005/026833 WO/2006/015140


473

F24J 180299 16/06/2005

SOLAR ENERGY COLLECTION מערכות קליטת אנרגיה שמשיתSYSTEMS

HELIODYNAMICS LIMITED 24/06/2004 0414184.2 GB 24/06/2004 0414183.4 GB PCT/GB/2005/050090 WO/2006/000834

B23B 180302 25/12/2006

CUTTING TOOL INSERT תותבת כלי חיתוך

SANDVIK INTELLECTUAL PROPERTY AB

30/12/2005 0502958-2 SE

C07D 180303 29/06/2005

ול ותכשירי רוקחות תולדות אזאאינד המכילים אותן

AZAINDOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

VERTEX PHARMACEUTICALS INCORPORATED

30/06/2004 60/584383 US 01/07/2004 60/584721 US 04/04/2005 11/098751 US 04/04/2005 PCT/US05/11358 US PCT/US/2005/023429 WO/2006/004984

G01N 180304 19/10/2001

התוית פגמי מסה עבור קביעת רצפי אוליגומרים

MASS DEFECT LABELING FOR THE DETERMINATION OF OLIGOMER SEQUENCES

TARGET DISCOVERY, INC. 19/10/2000 60/242165 US


19/10/2000 60/242398 US PCT/US/2001/049951 WO/2002/066952

A61M 180305 25/12/2006

ADMINISTRATION SET WITH TWO סט אינפוזיה עם שני מפתחותKEYS

CAESAREA MEDICAL ELECTRONICS מ"קיסריה אלקטרוניקה רפואית בעLTD.

A61B 180306 25/12/2006

A DEVICE TO SHARE FEELINGS התקן לשיתוף רגשות בין אנשיםAMONG PEOPLE

ISHAY PEREZ ישי פרץ

A61H 180307 25/12/2006

INDIVIDUALLY ADAPTIVE החיאה מותאמת אישיתRESUSCITATION

R. A. EREZ SYSTEMS LTD מ"ארז מערכות בע.א.ר

A23L 180308 25/12/2006

NATURAL SALT SUBSTITUTE תחליף טבעי למלח

GAN SHMUEL FOODS LTD מ" שמואל מזון בעגן

C07D 180309 13/07/2005

–2–)אוקסי–הטרואריל(–3נגזרות של ביציקלואלקיל כליגנדים –אזא–1–אלקיל

לטיפול במחלות NACHR–7של אלפא של מערכת העצבים המרכזית

3-(HETEROARYL-OXY)-2-ALKYL-1-AZA-BICYCLOALKYL DERIVATIVES AS ALPHA.7-NACHR LIGANDS FOR THE TREATMENT OF CNS DISEASES

NOVARTIS AG 14/07/2004 0415746.7 GB PCT/EP/2005/007630 WO/2006/005608


475

C02F 180310 18/07/2005

שכבתי קומפקטי מוצק לטיהור –מוצר דו מים

DOUBLE-LAYERED COMPACTED SOLID WATER-PURIFICATION PRODUCT

EUROTAB 19/07/2004 0407968 FR PCT/FR/2005/001834 WO/2006/016073

C07C 180311 13/07/2005

–4,4תהליך להכנת אסטרים של חומצה אוקסובוטנואית–3–דיפלואורו

PROCESS FOR THE PREPARATION OF 4,4-DIFLUORO-3-OXOBUTANOIC ACID ESTERS

SYNGENTA PARTICIPATIONS AG 14/07/2004 0415764.0 GB PCT/EP/2005/007635 WO/2006/005612

C07D 180312 28/06/2005

תהליך להכנת נגזרות של קרבוקסאמיד פירידין לשימוש כחומרי ביניים בסינתזה

NK–1של אנטגוניסטים של רצפטור

PROCESS FOR PREPARING CARBOXAMIDE PYRIDINE DERIVATIVES USED AS INTERMEDIATES IN THE SYNTHESIS OF NK-1 RECEPOR ANTAGONISTS

F. HOFFMANN-LA ROCHE AG 06/07/2004 60/585779 US 23/02/2005 60/655731 US PCT/EP/2005/006919 WO/2006/002860

C07D 180313 23/06/2005

THIAZOLINONE UNSUBSTITUTED מותמרים של תיאזולינון–קוינולינים בלתיQUINOLINES

F. HOFFMANN-LA ROCHE AG


01/07/2004 60/584746 US 19/11/2004 60/629495 US PCT/EP/2005/006807 WO/2006/002829

C07D 180314 11/08/2005

נגזרות של חומצת ציקליק אמינו בנזואיק חדשה

NOVEL CYCLIC AMINO BENZOIC ACID DERIVATIVE

KYORIN PHARMACEUTICAL CO., LTD.

11/08/2004 2004-234603

JP

PCT/JP/2005/014718 WO/2006/016637

B65D 180315 28/06/2005

FLOATING MULTI-CHAMBERED תוספת רב תאית צפה עבור מיכלי נוזלINSERT FOR LIQUID CONTAINERS

BALL PACKAGING EUROPE GMBH 09/07/2004 04016274.5 EP PCT/EP/2005/006955 WO/2006/005440

C07D 180317 11/11/2005

AZAINDOLE CARBOXAMIDES קארבוקסאמידים אזאיינדולים

SCHWARZ PHARMA AG 12/11/2004 102004054634.7 DE PCT/EP/2005/012127 WO/2006/050976


477

A01K 180318 28/06/2005

מערכת כימרית לסריקה המבוססת על עופות והכוללת שתלים ממקור יונקי

CHIMERIC AVIAN- BASED SCREENING SYSTEM CONTAINING MAMMALIAN GRAFTS

קרן מחקרים ופיתוח תשתיות שליד המרכז ש סוראסקי"הרפואי תל אביב ע

THE MEDICAL RESEARCH FUND AT THE TEL-AVIV SOURASKY MEDICAL CENTER

28/06/2004 60/582807 US PCT/IL/2005/000687 WO/2006/001021

A61K 180319 13/07/2005

תכשירים ושיטות עבור ריפוי פצעים דרמטולוגיים

COMPOSITIONS AND METHODS FOR DERMATOLOGICAL WOUND HEALING

MEDIWOUND LTD מ"מדיוונד בע 13/07/2004 60/587057 US PCT/IL/2005/000744 WO/2006/006167

F41G 180343 26/12/2006

מערכת בדיקה לבדיקת אפשרות הפעלה של מערכת אזהרה מהתקרבות טילים

מונחים

TEST APPARATUS FOR TESTING THE OPERABILITY OF A WARNING SYSTEM FOR APPROACHING GUIDED MISSILES

RUAG AEROSPACE 12/01/2004 06075083.3 EP

H04L 180344 11/05/2001

שיטה והתקן להתאמת קצב מהירה במעגל סגור בשידור נתונים בעל קצב

גבוה של מארזים

METHOD AND APPARATUS FOR FAST CLOSED-LOOP RATE ADAPTATION IN A HIGH RATE PACKET DATA TRANSMISSION

QUALCOMM INCORPORATED 12/05/2000 09/570210 US PCT/US/2001/015381


WO/2001/089162

C07D 180345 19/07/2005

IMPROVED PROCESS FOR THE שיטה משופרת לייצור מירטאזאפיןMANUFACTURE OF MIRTAZAPINE

MEDICHEM, S.A. 22/07/2004 200401804 ES PCT/EP/2005/053493 WO/2006/008302

F03G 180346 30/06/2004

TORQUE MULTIPLIER מכפל מומנט סיבובי

GIL ALDRETE 28/06/2004 PA/a/2004/006381 MX PCT/MX/2004/000041 WO/2006/001686

A45D 180348 26/12/2006

מערכת מרכזית לייבוש שיער עבור מספרות

CENTRAL HAIR DRYING SYSTEM FOR HAIR SALONS

ELIYAHU SUISSA אליהו סוויסה

C07D 180349 15/07/2005

אריל –טטראהידרואיסוקוינולינים מוחלפיוהטרואריל והשימוש בהם כדי למנוע

דופאמין , קליטה מחודשת של נוראפינפרין וסרוטנין

ARYL-AND HETEROARYL - SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE AND SEROTONIN

BRISTOL-MYERS SQUIBB COMPANY 15/07/2004 60/588448 US PCT/US/2005/025193 WO/2006/020049


479

A61K 180350 12/07/2005

תכשירים לאספקת תרופות בעלי מסיסות גבוהה במים

COMPOSITIONS FOR DELIVERING HIGHLY WATER SOLUBLE DRUGS

SD PHARMACEUTICALS, INC. 12/07/2004 10/889226 US PCT/US/2005/024594 WO/2006/017246

C07D 180351 30/06/2004

תהליך להפחתת אלכוהולים שאריתים בוולציקלוויר הידרוכלוריד קריסטליני

METHOD FOR REDUCING RESIDUAL ALCOHOLS IN CRYSTALLINE VALACYCLOVER HYDROCHLORIDE

TEVA PHARMACEUTICAL מ"טבע תעשיות פרמצבטיות בעINDUSTRIES LTD.

PCT/US/2004/020903 WO/2006/011874

C07C 180352 01/07/2005

– S) 1,24(צורות קריסטליניות של 2Dדיהידרוקסי ויטמין

CRYSTALLINE FORMS OF 1,24(S) - DIHYDROXY VITAMIN D2


01/07/2004 60/584844 US 23/09/2004 60/612914 US PCT/US/2005/023547 WO/2006/025939

C07C 180353 28/06/2005

PROCESSES FOR THE PREPARATION תהליכים להכנת טומוקסטיןOF TOMOXETINE

TEVA PHARMACEUTICAL FINE CHEMICALS S.R.L.

28/06/2004 60/583641 US 28/06/2004 60/583644 US


28/06/2004 60/583643 US 14/09/2004 60/609716 US 25/10/2004 60/622065 US 11/02/2005 60/652330 US 11/02/2005 60/652331 US 11/02/2005 60/652332 US 30/03/2005 60/666666 US 26/04/2005 60/675369 US 09/06/2005 60/689778 US 14/06/2005 60/690738 US PCT/US/2005/023412 WO/2006/068662

C07C 180354 28/06/2005

תהליך להכנת אטומוקסטין הידרוכלורידPROCESS FOR THE PREPARATION OF ATOMOXETINE HYDROCHLORIDE


28/06/2004 60/583641 US 28/06/2004 60/583644 US 28/06/2004 60/583643 US 14/09/2004 60/609716 US 25/10/2004 60/622065 US 11/02/2005 60/652330 US 11/02/2005 60/652331 US 11/02/2005 60/652332 US 30/03/2005 60/666666 US 26/04/2005 60/675369 US 09/06/2005 60/689778 US 14/06/2005 60/690738 US PCT/US/2005/023419 WO/2006/004976

C07C 180355 28/06/2005

תהליך לרזולוציה אופטית ומיחזור של טומוקסטין

PROCESS FOR THE OPTICAL RESOLUTION AND RECYCLING OF TOMOXETINE


28/06/2004 60/583641 US 28/06/2004 60/583644 US


481

28/06/2004 60/583643 US 14/09/2004 60/609716 US 25/10/2004 60/622065 US 11/02/2005 60/652330 US 11/02/2005 60/652331 US 11/02/2005 60/652332 US 26/04/2005 60/675369 US 30/05/2005 60/666666 US 09/06/2005 60/689778 US 14/06/2005 60/690738 US PCT/US/2005/023421 WO/2006/004977

C07C 180356 28/06/2005

אטומוקסטין וטומוקסטין מנדלאט נקיים אננטיומרית

ENANTIOMERICALLY PURE ATOMOXETINE AND TOMOXETINE MANDELATE



C07C 180357 28/06/2005

, נקיון מבודד של אטומוקסטין–אינקיונות של –תהליכים להכנת אי

ושימושם כסטנדרט, אטומוקסטין

AN ISOLATED ATOMOXETINE IMPURITY, PROCESSES FOR THE PREPARATION OF ATOMOXETINE IMPURITIES AND THEIR USE AS REFERENCE STANDARDS




C07D 180358 29/06/2005

CRYSTALLINE FORM IV OF של לינזולידV Iצורה קריסטלינית LINEZOLID


29/06/2004 60/584371 US 30/06/2004 60/584283 US 12/08/2004 60/601086 US 17/08/2004 60/602227 US 07/12/2004 60/633887 US 24/02/2005 60/656646 US 24/02/2005 60/656778 US 05/05/2005 60/678440 US 24/05/2005 60/684410 US PCT/US/2005/023272 WO/2006/004922

C07D 180359 29/06/2005

צורות מוצקות של לינזוליד ותהליכים להכנתן

SOLID FORMS OF LINEZOLID AND PROCESSES FOR PREPARATION THEREOF


29/06/2004 60/584371 US 30/06/2004 60/584283 US 12/08/2004 60/601086 US 17/08/2004 60/606227 US 07/12/2004 60/633887 US 05/05/2005 60/678440 US


483

24/05/2005 60/684410 US PCT/US/2005/023066 WO/2006/110155

C09C 180360 07/07/2005

שיטה לקביעת העתק כמעט זהה של יעד מידע

A METHOD FOR DETERMINING NEAR DUPLICATE DATA OBJECTS

EQUIVIO LTD מ"אקויויו בע 21/07/2004 60/589596 US PCT/IL/2005/000726 WO/2006/008733

A61K 180361 27/06/2005

תכשירים ושיטות למניעה ושליטה בהיפוגליקמיה מושפעת אינסולין

COMPOSITIONS AND METHODS FOR THE PREVENTION AND CONTROL OF INSULIN-INDUCED HYPOGLYCEMIA

DIOBEX, INC. 29/06/2004 60/584449 US PCT/US/2005/022812 WO/2006/004696

A61K 180363 08/07/2005

קולונוסקופיה וירטואלית עם אנלוגים של פוספוליפידים אתרים המסומנים באופן

רדיואקטיבי

VIRTUAL COLONOSCOPY WITH RADIOLABELLED PHOSPHOLIPID ETHER ANALOGS

CELLECTAR, LLC 08/07/2004 60/521831 US PCT/US/2005/024259 WO/2006/014589

C07K 180364 01/08/2005

נוגדנים המכוונים נגד בתא פפטיד המכיל עמילן ושיטות לשימוש בהם

ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE AND METHODS USING SAME


RINAT NEUROSCIENCE CORPORATION

30/07/2004 60/592494 US 14/02/2005 60/653197 US 29/04/2005 60/676093 US PCT/US/2005/027295 WO/2006/036291

A61B 180365 22/06/2005

CARBORANYLPORPHYRINS AND קרבורנילפורפרינים ושימושיהםUSES THEREOF

BROOKHAVEN SCIENCE ASSOCIATES

28/06/2004 10/878138 US PCT/US/2005/022061 WO/2006/012140

A61M 180366 28/06/2005

NASAL DILATOR AND USES מרחיב נחירי ושימושיוTHEREOF

ALEXANDRE YAZDI 28/06/2004 0407085 FR PCT/FR/2005/001634 WO/2006/010848

A61K 180367 29/06/2005

ל טרשת נפוצה שיטה לטיפול ומניעה ש באמצעות טיפול בזיהום לפטוספירה

METHOD FOR MULTIPLE SCLEROSIS TREATMENT AND PROPHYLAXIS BY TREATMENT OF LEPTOSPIRA INFECTION

KOBENHAVNS UNIVERSITET 01/07/2004 PA200401042 DK PCT/DK/2005/000444


485

WO/2006/002631

A61B 180369 05/07/2005

מכשיר ושיטה לעיצוב בעזרת מכונה של גוף צווארי חולייתי

INSTRUMENTS AND METHOD FOR MACHINING A CERVICAL VERTEBRAL BODY

CERVITECH, INC. 23/07/2004 10/897404 US 12/11/2004 10/897404 US PCT/EP/2005/007253 WO/2006/010444

C07K 180370 13/07/2005

IMPROVED APROTININ VARIANTS וריאנטים משופרים של אפרוטינין

BAYER PHARMACEUTICALS CORPORATION

13/07/2004 60/587655 US PCT/US/2005/024951 WO/2006/017355

C07K 180371 21/07/2005

METHOD OF TREATING SJOGREN'S ורגן'שיטה לטיפול בסינדרום סגSYNDROME

GENENTECH, INC. 22/07/2004 60/590302 US PCT/US/2005/026027 WO/2006/012508

C03B 180372 23/06/2005

חומר אופטי מנחה גלים וכן שיטה והתקן לייצורו

OPTICAL WAVEGUIDE MATERIAL AS WELL AS METHOD AND DEVICE FOR PRODUCING IT

LIEKKI OY 02/07/2004 20045264 FI PCT/FI/2005/050239


WO/2006/003253

C07C 180373 27/06/2005

–R 1 ,R 2 )–3–(3(–)–(צורות גבישיות –)מתילפרופיל–2–אתיל–1–דימתילאמינו

פנול הידרו כלוריד

CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE

GRUNENTHAL GMBH 28/06/2004 04015091.4 EP PCT/EP/2005/006884 WO/2006/000441

B65C 180374 26/12/2006

תאי לאחסון גזים בלחצים –המיכל רב שונים

MULTICHAMBER TANK FOR GAS STORAGE UNDER DIFFERENT PRESSURE

ANGSTORE TECHNOLOGIES LTD מ" אגנסטור טכנולוגי בע

A23L 180375 26/12/2006

קקטוס ממין אופונטיה שצריכתו גורמת לוויסות התיאבון והפחתת משקל

ומפחיתה את החשק לקופאין ולניקוטין

THE OPUNTIA SPECIES OF THE CACTUS FAMILY WHICH ITS CONSUMPTION CAUSES A REDUCTION OF THE APPETITE AND THE EAGERNESS FOR CAFFEINE AND NICOTINE

MOTI SHEFER מוטי שפר

B65D 180376 26/12/2006

מיכל לנוזל לניקוי כלים שבחלקו העליון יש שקערורית להנחת הספוג

A TANK FOR LIQUID SOAP FOR CLEANING DISHES WHICH ON TOP OF IT THERE IS A CRATER FOR LEAVING THE SPONGE

MOSHE ABARO משה אברו


487

B65B 180377 30/06/2005

VACUUM PACKAGE SYSTEM AND מערכת ושיטה לאריזה בריקMETHOD

WEST PHARMACEUTICAL SERVICES, INC.

01/07/2004 60/584826 US PCT/US/2005/023138 WO/2006/028562

A61M 180378 12/07/2005

ומערכת ,משאף למתן תרופות אבקתיות לאחסון האבקה לשימוש עם משאף זה

INHALER FOR THE ADMINISTRATION OF POWDERED PHARMACEUTICALS, AND A POWDER CARTRIDGE SYSTEM FOR USE WITH THIS INHALER

LABORATORIOS ALMIRALL, S.A. 16/07/2004 60/588382 US PCT/EP/2005/007525 WO/2006/008027

A61K 180379 13/07/2005

גורם לקידום ההבראה מדיספונקציה לאחר התקפה של מחלה נוירולוגית

מרכזית

AGENT FOR PROMOTING THE RECOVERY FROM DYSFUNCTION AFTER THE ONSET OF CENTRAL NEUROLOGICAL DISEASE

ASTELLAS PHARMA INC.

14/07/2004 2004-207234

JP

PCT/JP/2005/012895 WO/2006/006617


A61K 180380 06/07/2005

תכשיר רוקחות המכיל בוטולינום ניורוטוקסין

PHARMACEUTICAL COMPOSITION CONTAINING BOTULINUM NEUROTOXIN

IPSEN LIMITED 12/07/2004 0415491.0 GB PCT/GB/2005/002653 WO/2006/005910

C07J 180381 01/08/2005

תהליך להכנת תולדות של אסטרון 2ואסטראדיאול המותמרים בעמדה

PROCESS FOR THE PREPARATION 2-SUBSTITUTED-DERIVATIVES OF ESTRONE AND ESTRADIOL

N.V. ORGANON 04/08/2004 04103742.5 EP PCT/EP/2005/053732 WO/2006/013196

C07D 180382 28/06/2005

אלקיל קווינאזולינון מותמרים –2תולדות PARPכמעכבי

SUBSTITUTED 2-ALKYL QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS

JANSSEN PHARMACEUTICA N.V. 30/06/2004 04076887.1 EP PCT/EP/2005/053034 WO/2006/003150

B65D 180383 20/06/2005


489

גשת משקה בוצי ומוצר שיטה לה לשימוש בשיטה זו

METHOD OF SERVING A SLUSHY DRINK AND A PRODUCT FOR USE IN SUCH

UNILEVER PLC 19/07/2004 04254314.0 EP PCT/EP/2005/006697 WO/2006/007921

B23K 180388 14/06/2005

REDUCING PLASMA IGNITION צמצום בלחץ של הצתת פלאזמהPRESSURE

LAM RESEARCH CORPORATION 30/06/2004 10/883583 US PCT/US/2005/021098 WO/2006/012003

H04B 180389 30/06/2005

METHOD OF VIDEO DATA שיטה לשידור של נתוני וידיאוTRANSMITTING

COMET VIDEO TECHNOLOGY 30/06/2004 60/584364 US PCT/US/2005/023109 WO/2006/004837

G06K 180390 30/06/2005

שיטת דחיסת וידיאו כולל דחיסה של נתוני וידיאו

METHOD OF DATA COMPRESSION INCLUDING COMPRESSION OF VIDEO DATA

COMET VIDEO TECHNOLOGY 30/06/2004 60/584102 US PCT/US/2005/023133 WO/2006/004847

B65D 180391 28/06/2005


פעמית העשויה בצורה של –אריזה חדמצויד בפתח יציאה עבור , כלי אוכל

ריחות

READY-MADE DISH DISPOSABLE PACKAGING, EQUIPPED OF VENT DEVICE FOR INNER VAPORS

DEVELPACK S.R.L. 28/06/2004 CS2004A000006 IT 27/06/2005 CZ2005A000011 IT PCT/IT/2005/000371 WO/2006/001048

G06Q 180392 27/12/2006

שיטה ומערכת למכירה חוזרת של נכסים דרך רשת תקשורת

METHOD AND SYSTEM FOR RESELLING OF ASSETS THROUGH COMMUNICATION NETWORK

YACOV KORMAN שמואל וייסמן 12/12/2006 11/609366 US

G06F 180393 16/06/2005

A METHOD FOR DETECTING OF שיטה לזיהוי אקסקיוטבלים לא רצוייםUNWANTED EXECUTABLES

ALADDIN KNOWLEDGE SYSTEMS מ"אלדין מערכות מידע בעLTD.

14/07/2004 10/890170 US PCT/IL/2005/000648 WO/2006/006144

A61C 180394 06/02/2006

, עצמיים מסוג מקבל הברגה–שתלים תוךמושחל חיצונית בחתיכה אחת ורכיבים

כיסויי נוחות ומשענות הקשורים , להעברה להם

ONE-PIECE, SCREW-RECEIVING, EXTERNALLY-THREADED ENDOSSEOUS DENTAL IMPLANTS AND RELATED TRANSFER COMPONENTS, COMFORT CAPS AND ABUTMENTS

GERALD A. NIZNICK 11/02/2005 11/056578 US PCT/US/2006/004052 WO/2006/088680


491

G01N 180396 01/06/2005

METHOD FOR DETECTING GLUTEN שיטה לזיהוי גלוטן ACADEMISCH ZIEKENHUIS LEIDEN 30/06/2004 04076902.8 EP PCT/NL/2005/000400 WO/2006/004394

C07C 180397 19/07/2005

תכשירים קוטלי פטריות , תולדות דיאמין המכילים אותן ותהליכים להכנתן

DIAMINE DERIVATIVES, FUNGICIDAL COMPOSITIONS CONTAINING THE SAME, AND PROCESSES FOR THE PREPARATION THEREOF

MITSUI CHEMICALS, INC.

21/07/2004 2004-213208

JP

27/01/2005 2005-019032 JP PCT/JP/2005/013233 WO/2006/009134

C09D 180399 07/07/2005

תכשיר ציפוי לבקרת קורוזיה בעובדים ועובדים , שיטות להכנתו, מתכתיים

מתכתיים מצופים איתו

CORROSION CONTROL COATING COMPOSITION FOR METAL WORKPIECES, METHODS FOR THE PRODUCTION THEREOF AND METAL WORKPIECES COATED THEREWITH

EWALD DORKEN AG 16/07/2004 102004034645.3 DE PCT/EP/2005/007360


WO/2006/007985

H01M 180400 28/12/2006

שיטה לייצר חשמל בביתMETHOD FOR PRODUCING ELECTRICITY IN HOME FROM WASTE

SARAH MOGRABI מוגרבישרה

E05C 180401 28/12/2006

מנגנון הגנה לאצבעות ידיים בין דלתות ומשקופים

MECHANISM, ELEMENT FOR PROTECTION OF FINGERS IN DOORS AND GATES

VICTOR BEN DAVID YOSSEF ויקטור בן דוד יוסף

H04L 180402 22/07/2005

שה מרוחקת שיטה ומערכות לאבטחת גי לרשתות פרטיות

A METHOD AND SYSTEMS FOR SECURING REMOTE ACCESS TO PRIVATE NETWORKS

CITRIX SYSTEMS, INC. 23/07/2004 60/590837 US 13/08/2004 60/601431 US 03/09/2004 60/607420 US 07/12/2004 60/634379 US PCT/US/2005/026300 WO/2006/012612

H04L 180403 22/07/2005

שיטה ומערכות לאבטחת גישה מרוחקת לרשתות פרטיות


CITRIX SYSTEMS, INC. 23/07/2004 60/590837 US 13/08/2004 60/601431 US 03/09/2004 60/607420 US 07/12/2004 60/634379 US


493

PCT/US/2005/026300 WO/2006/012612

H04L 180404 22/07/2005




H04L 180405 22/07/2005




E02D 180406 28/12/2006

SCREW-PILE SYSTEMS בורגי–מערכות כלונס

) 1975(שירותים הנדסיים ' ליפסקר ושות מ"בע

LIPSKER & PARTNERS ENGINEERING SERVICES (1975) LTD.

B25G 180407 19/10/2004


מערכת של ידית קבוע עבור מכשיר או כלי ידני

HANDLE-FIXING SYSTEM FOR HAND TOOL OR UTENSIL

PEDRO JOSE ZUBIAURRE ALBERDI 01/10/2004 200402342 ES 01/10/2004 200402343 ES PCT/ES/2004/000449 WO/2006/045855

B65D 180408 27/07/2005

WATER STORAGE EVAPORATION בקרה על נידוף מים מאוחסניםCONTROL

WATER INNOVATIONS PTY LTD. 28/07/2004 2004904178 AU 02/08/2004 2004904282 AU 04/11/2004 2004906329 AU 23/03/2005 2005901415 AU PCT/AU/2005/001094 WO/2006/010204

C07D 180409 28/06/2005

PARP QUINAZOLINEDIONE DERIVATES ASתולדות קווינאזולינדיאון כמעכבות PARP INHIBITORS


C07D 180410 28/06/2005

PARP PHTHALAZINE DERIVATIVES ASתולדות פטאלזין כמעכבי PARP INHIBITORS


C07D 180411 28/06/2005


495

PARP QUINAZOLINONE DERIVATIVES ASתולדות קווינאזולינון כמעכבי PARP INHIBITORS


A47G 180412 28/12/2006

DREAM SHEET סדין וסדינית חלומית ANAT BEN-DOV TZABARI דוב צברי-בןענת

C07C 180413 13/07/2005

METHOD OF CRYSTALLIZATION OF תהליך התגבשות של ביקאלוטאמידBICALUTAMIDE

SUMITOMO CHEMICAL COMPANY, LIMITED.

14/07/2004 2004-207709

JP

PCT/JP/2005/013346 WO/2006/006736

B32B 180415 29/06/2005

מעטפות בניה מבודדות יעילות מבחינה אנרגית

ENERGY EFFICIENT AND INSULATED BUILDING ENVELOPES

ASPEN AEROGELS, INC 29/06/2004 60/583940 US 07/10/2004 60/616887 US PCT/US/2005/023677 WO/2006/002440


A61J 180417 29/06/2005

TEAT פטמה JACKEL INTERNATIONAL LIMITED 29/06/2004 0414560.3 GB 08/02/2005 0502599.4 GB PCT/GB/2005/002532 WO/2006/000816

C12Q 180418 30/06/2005

שיטות וערכות לחיזוי קצב הצטלקות הכבד בחולים כרוניים בדלקת הכבד מסוג

C

METHODS AND KITS FOR PREDICTING LIVER FIBROSIS PROGRESSION RATE IN CHRONIC HEPATITIS C PATIENTS



01/07/2004 60/584179 US PCT/IL/2005/000700 WO/2006/003654

C07K 180419 06/07/2005

CYCLIC PEPTIDES FOR TREATMENT פפטידים ציקליים לטיפול בהתנוונותOF CACHEXIA

PALATIN TECHNOLOGIES, INC. 06/07/2004 60/585971 US 05/07/2005 11/174845 US PCT/US/2005/024125 WO/2006/014552

C07K 180420 06/07/2005

CYCLIC PEPTIDES FOR TREATMENT פפטידים ציקליים לטיפול בהתנוונותOF CACHEXIA



497

C07F 180421 04/07/2005

בעלי קישור דיפוספינופרוצנים –'1,1לרדיקלים אכיראלים או ' 2, 2בעמדה כיראלים

1,1'- DIPHOSPHINOFERROCENES HAVING 2, 2' - BOUND ACHIRALS OR CHIRAL RADICALS

SOLVIAS AG 05/07/2004 1126/04 CH 26/10/2004 1773/04 CH 10/11/2004 1853/04 CH PCT/EP/2005/053171 WO/2006/003196

C07C 180424 19/07/2005

סינתזה של תרכובות הלומתיל פוליהלוגנטיות ארומטיות

SYNTHESIS OF AROMATIC POLYHALOGENATED HALOMETHYL COMPOUNDS

.BROMINE COMPOUNDS LTD מ"תרכובות ברום בע 19/07/2004 163101 IL PCT/IL/2005/000768 WO/2006/008738

C07D 180426 17/06/2005

תרכובות מותמרות של הטרואריל ופנילסולפמואיל

SUBSTITUTED HETEROARYL - AND PHENYLSULFAMOYL COMPOUNDS

PFIZER PRODUCTS, INC. 29/06/2004 60/583721 US PCT/IB/2005/002007 WO/2006/003495

B60R 180427 28/12/2006

SYSTEM FOR ENCOURAGING USING גורת בטיחותמערכת לעידוד השימוש בחA SEATBELT

YOSSEF COHEN ליאור פרידמן

C08J 180428 19/07/2005


NOVEL FLAME-RETARDANT בעירה חדשים–פוליסטירינים מונעי POLYSTYRENES

.BROMINE COMPOUNDS LTD מ"תרכובות ברום בע 19/07/2004 163100 IL PCT/IL/2005/000767 WO/2006/013554

C07F 180429 04/07/2005

ליגנדים של טטרהדנטאט פרוצין ושימושם

TETRADENTATE FERROCENE LIGANDS AND THEIR USE

SOLVIAS AG 05/07/2004 1126/04 CH 26/10/2004 1773/04 CH 10/11/2004 1853/04 CH PCT/EP/2005/053170 WO/2006/003195

C07D 180430 12/07/2005

PYRIDINE DERIVATIVES נגזרות של פירידין

PFIZER INC. 23/07/2004 0416524.7 GB 21/01/2005 60/646077 US PCT/IB/2005/002214 WO/2006/011050

C07F 180431 01/07/2005

תהליך להכנת חומצות אמינו המשמשות ודולטורים לרצפטור של פפטידבהכנת מ

PROCESS FOR THE PREPARATION OF AMINO ACIDS USEFUL IN THE PREPARATION OF PEPTIDE RECEPTOR MODULATORS

BRISTOL-MYERS SQUIBB COMPANY 02/07/2004 60/584968 US PCT/US/2005/023363 WO/2006/014324


499

C07D 180432 01/07/2005

CETP CETP INHIBITORSבי מעכ

MERCK & CO., INC. 02/07/2004 60/585274 US 21/01/2005 60/646103 US PCT/US/2005/023546 WO/2006/014357

C07F 180433 29/06/2005

HIV PRODRUGS OF HIV PROTEASEפרודרגים של מעכבי פרוטאזת INHIBITORS

ABBOTT LABORATORIES 06/07/2004 60/585710 US PCT/US/2005/023047 WO/2006/014282

C07K 180434 30/06/2005

דמוי גלוקאגון 1 –מודולטורים של פפטיד אנושי ושימושיהם בטיפול בסכרת ומצבים

קשורים

HUMAN GLUCAGON - LIKE - PEPTIDE - 1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS

BRISTOL-MYERS SQUIBB COMPANY 02/07/2004 60/585358 US 26/05/2005 60/684805 US PCT/US/2005/023076 WO/2006/014287

H04M 180435 28/02/2001

שיטה לגילוי שימוש לא מאומת בחשמל מועבר דרך קווי כח

METHOD OF DETECTING UNAUTHORIZED USAGE OF ELECTRICITY TRANSMITTED OVER POWER LINES


QUADLOGIC CONTROLS CORPORATION

29/02/2000 60/185832 US PCT/US/2001/006573 WO/2001/065823

G06K 180436 30/06/2005

עזר – בעל סוללת RFID משיב –משדר עם פיזור אחורי

BATTERY-ASSISTED BACKSCATTER RFID TRANSPONDER

POWERID LTD מ"פאואראיידי בע 01/07/2004 60/584141 US 18/08/2004 60/602342 US 09/09/2004 60/608118 US 01/10/2004 60/614552 US 04/02/2005 60/649561 US PCT/IL/2005/000694 WO/2006/003648

A61L 180437 30/06/2005

ניהול צורה ומימדי שתל רקמה רכה באמצעות תאי גזע

SHAPE AND DIMENSION MAINTENANCE OF SOFT TISSUE GRAFTS BY STEM CELLS

THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS

30/06/2004 60/584657 US PCT/US/2005/023318 WO/2006/004951

A47K 180438 28/12/2006

AMENITIES CASE מארז נוחות

BR-GO INTERNATIONAL TRADE גו סחר בינלאומי שותפות מוגבלת-ברLIMITED PARTNERSHIP


501

B65H 180439 30/06/2005

מערכות ושיטות לשליטה בליפוף של חומר לינארי

SYSTEMS AND METHODS FOR CONTROLLING SPOOLING OF LINEAR MATERIAL

GREAT STUFF, INC. 01/07/2004 60/584797 US 02/07/2004 60/585042 US PCT/US/2005/023652 WO/2006/007582

G21K 180440 28/12/2006

COMPACT SOURCE WITH VERY בהירהXמקור דחוס עם קרן BRIGHT X - RAY BEAM

ALCATEL LUCENT 03/01/2006 0650007 FR

C07D 180441 22/07/2005

פירימידינים –) איל– 2–פירידין (– 2ושימוש בהם לבקרה על פטריות

פתוגניות

2 - (PYRIDIN - 2 - YL) - PYRIMIDINES AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGI


C09D 180442 14/07/2005

דיו להזרקה הניתנים לריפוי באמצעות שיטה לייצור ושיטות לשימוש , קרינה בהם

RADIATION CURABLE INKJET INKS, METHOD OF MANUFACTURE, AND METHODS OF USE THEREOF

HEXION SPECIALTY CHEMICALS, INC.


16/07/2004 60/588921 US 04/10/2004 60/615756 US 02/06/2005 60/686768 US PCT/US/2005/025074 WO/2006/085992

H04L 180443 01/07/2005

MIMO ADVANCED MIMO INTERLEAVINGאינטרליבינג מתקדם ל


H04N 180444 01/07/2005

שיטה ומתקן לשימוש בטכניקות של קצב מסגרת המרה למעלה בהצפנות וידיאו

לפי סקלה

METHOD AND APPARATUS FOR USING FRAME RATE UP CONVERSION TECHNIQUES IN SCALABLE VIDEO CODING


B29D 180445 16/07/2004

STRETCH FILM פילים אלסטי

MEGAPLAST S.A. PCT/EP/2004/007965 WO/2006/018028


503

G06F 180446 23/06/2005

מציג של אפליקציית גרף לתהליך –בקר אובייקט

OBJECT PROCESS GRAPH APPLICATION CONTROLLER-VIEWER

GRAPHLOGIC INC. 16/07/2004 60/588465 US 20/05/2005 10/908653 US PCT/US/2005/022192 WO/2006/019506

C12N 180447 13/07/2005

MEDIUM FOR GROWING HUMAN מצע לגידול תאי גזע של עובר בן אדםEMBRYONIC STEM CELLS

GERON CORPORATION 13/07/2004 60/587843 US 01/03/2005 60/657990 US PCT/US/2005/025179 WO/2006/017370

B23B 180448 28/12/2006

CLAMPING APPARATUS םמתקן מלחציי

F-TOOL INTERNATIONAL AG 30/01/2006 00151/06 CH

C07K 180449 11/12/1997

נוסחאות פרמצבטיות המכילות תרכובות שאינה מסיסה במים להעברת תרופות

מתמשכת

PHARMACEUTICAL FORMULATIONS COMPRISING A WATERINSOLUBLE COMPLEX FOR SUSTAINED DRUG DELIVERY

PRAECIS PHARMACEUTICALS INCORPORATED

11/12/1996 08/762747 US PCT/US/1997/022881 WO/1998/025642


C07K 180450 11/12/1997

נוסחאות פרמצבטיות המכילות תרכובות שאינה מסיסה במים להעברת תרופות

מתמשכת

PHARMACEUTICAL FORMULATIONS COMPRISING A WATERINSOLUBLE COMPLEX FOR SUSTAINED DRUG DELIVERY

PRAECIS PHARMACEUTICALS INCORPORATED

11/12/1996 08/762747 US PCT/US/1997/022881 WO/1998/025642

A61L 180451 07/07/2005

שיטה ותכשיר לחיטוי ברמה גבוהה וניבשימוש הרכבי אמוניום רביע

METHOD AND COMPOSITION FOR HIGH LEVEL DISINFECTION EMPLOYING QUATERNARY AMMONIUM COMPOUNDS

NANOSONICS PTY LIMITED 09/07/2004 2004903796 AU PCT/AU/2005/000997 WO/2006/005108

B60H 180452 31/12/2006

ACTIVE VENTILATING SYSTEM FOR מערכת אוורור פעיל עבור רכבVEHICLE

GIL AVRAHAM גיל אברהם

B60H 180453 31/12/2006

A BATHTUB אמבטיה

LIAV DAVID ליאב רונלי דויד

G06Q 180454 31/12/2006

METHOD & SYSTEM FOR שיטה ומערכת לניתוב תשלום אלקטרוניELECTRONIC PAYMENT ROUTING


505

EHUD ZIEGELMAN אהוד ציגלמן

A47G 180455 05/04/2002

מציין גודל הניתן להסרה עבר קולב לדברי לבוש

REMOVABLE SIZE INDICATOR FOR A GARMENT HANGER

SPOTLESS PLASTICS PTY. LTD. 05/04/2001 827072 US PCT/US/2002/010750 WO/2002/080741

A61M 180456 30/06/2005

SYRINGE DEVICE HAVING VENTING ם מערכת אוורורהתקן הזרקה עSYSTEM

WEST PHARMACEUTICAL SERVICES, INC.

01/07/2004 60/584893 US PCT/US/2005/023754 WO/2006/007592

C07K 180458 01/07/2005

PEPTIDE ANTIBIOTICS AND אנטיביוטיקה מפפטיד ושיטות להכנתהMETHODS FOR MAKING SAME

BIOSOURCE PHARM, INC. 01/07/2004 10/881160 US PCT/US/2005/023343 WO/2006/083317

C07K 180459 01/07/2005

TREATMENT OF BACTERIAL טיפול בזיהומים בקטרייאליםINFECTIONS

NEUTEC PHARMA PLC 02/07/2004 0414886.2 GB PCT/GB/2005/002607 WO/2006/003426


A61K 180460 30/06/2005

TREATMENT OF CANCER טיפול בסרטן NEUTEC PHARMA PLC 02/07/2004 0414885.4 GB 20/09/2004 0420845.0 GB 30/09/2004 60/614423 US 21/02/2005 0503566.2 GB 22/02/2005 60/654458 US PCT/GB/2005/002545 WO/2006/003384

A61L 180461 25/06/2005

תרסיס פורמולציות תרחיף המכילות EA 277 TG או A 134 TGכחומר מניע

AEROSOL SUSPENSION FORMULATIONS CONTAINING TG 227 EA OR TG 134 A AS A PROPELLANT

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

02/07/2004 102004032322.4 DE 17/05/2005 102005023334.1 DE PCT/EP/2005/006865 WO/2006/002840

A47C 180462 31/12/2006

INTELLIGENT CHILD SAFETY SEAT כסא חכם לבטיחות הילד

ASHER S. SABAN סבן. אשר ש 30/03/2006 174634 IL

A45D 180463 06/07/2004

עם חימום מקדים של מכשיר גילוח SHAVER WITH HAIR PREHEATING השיער

RADIANCY INC. PCT/IL/2004/000603 WO/2006/003642


507

A45D 180464 06/07/2004

מכשיר גילוח חשמלי עם אלמנט להרחקת פסולת

ELECTRIC SHAVER WITH DEBRIS REMOVAL ELEMENT

RADIANCY INC. PCT/IL/2004/000602 WO/2006/003641

A45D 180465 06/07/2004

IMPROVED ELECTRIC SHAVER מכשיר גילוח חשמלי משופר RADIANCY INC. PCT/IL/2004/000604 WO/2006/003643

B64C 180467 24/06/2005

HYBRID AIRCRAFT מטוס היברידי

SIMICON AS 02/07/2004 20042823 NO PCT/NO/2005/000228 WO/2006/004416

A01H 180468 01/07/2005

WATERMELON WITH IMPROVED אבטיח בעל תכונות עיבוד משופרותPROCESSING QUALITIES

SEMINIS VEGETABLE SEEDS, INC. 02/07/2004 60/584964 US 22/10/2004 10/972190 US 31/03/2005 2005201372 AU PCT/US/2005/023902


WO/2006/014463

A61F 180469 31/12/2006

VASCULAR ACCESS SYSTEM AND מערכת ושיטה לחדירה לוורידMETHOD

OFER SELA עופר סלע

A61K 180470 29/06/2005

צורת מינון פומית מוגנת נגד שימוש לרעה

ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSE

GRUNENTHAL GMBH 01/07/2004 102004032049.7 DE 14/07/2004 10/890763 US PCT/EP/2005/006984 WO/2006/002884

A61K 180471 26/06/2005

צורת מינון פומית מוגנת נגד שימוש –R 1 , R 2 )–3–(3(לרעה הכוללת –מתיל–2–אתיל–1–דימתילאמינו

פניל–)פרופיל

ORAL DOSAGE FORM SAFEGUARDED AGAINST ABUSE CONTAINING (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL

GRUNENTHAL GMBH 01/07/2004 102004032103.5 DE 14/07/2004 10/890707 US PCT/EP/2005/006990 WO/2006/002886

H01L 180472 01/01/2007

מערכת הידראולית ליצירת חשמל באמצעות שינויי נפח

A SYSTEM FOR ELECTRICITY CREATION BY HYDRAULIC VOLUMETRIC REPLACEMENT


509

KLUGERMAN VLADIMIR קלוגרמן רומן

A61M 180473 21/07/2005

שיטה ומערכות לאספקת ממשק להתקן אינפוזיה

METHOD AND SYSTEMS FOR PROVIDING AN INFUSION DEVICE INTERFACE

ANIMAS CORPORATION 21/07/2004 60/589623 US PCT/US/2005/025931 WO/2006/012446

H05K 180475 01/01/2007

שיטה לקיבוע חלקי של סיב אופטי בלוח מעגלים מודפס

METHOD OF PARTIALLY EMBEDDING OPTICAL FIBER IN MULTILAYER PRINTED CIRCUIT BOARD

.ELTEK LTD מ"אלטק בע

H05K 180476 01/01/2007

דרך ישירה לשידור אותות אופטיים דרך לוח מעגלים מודפס

STRAIGHTFORWARD OPTICAL VIA FOR SIGNAL TRANSMISSION THROUGH A PRINTED CIRCUIT BOARD

.ELTEK LTD מ"אלטק בע

G09B 180477 01/01/2007

מערכת ושיטה להגהה ותיקון דיגיטלי צדדי בתוך פגישה–ורב

SYSTEM AND METHOD FOR DIGITAL MULTI-LATERAL PROOFREADING DURING A MEETING

D. SIT TRADE LTD מ"סיט סחר בע.די


C07C 180479 30/09/2005

IMPROVED SYNTHESIS SCHEME FOR סכימת סינתזה משופרת ללקוסאמידLACOSAMIDE

SCHWARZ PHARMA AG 02/10/2004 04023556.6 EP PCT/EP/2005/010603 WO/2006/037574

D01F 180480 14/07/2005

תהליך לעשיית סיב מרוכב מננוטובים של פוליאתילן בעל מסה מולרית /פחמן

אולטרה גבוהה

PROCESS FOR MAKING A CARBON NANOTUBES/ ULTRA-HIGH MOLAR MASS POLYETHYLENE COMPOSITE FIBRE

DSM IP ASSETS B.V. 27/07/2004 04077162.8 EP PCT/EP/2005/007816 WO/2006/010521

C07D 180481 20/07/2005

ARYL-PYRIDINE DERIVATIVES פירידין–נגזרות של אריל

F. HOFFMANN-LA ROCHE AG 28/07/2004 04103639.3 EP PCT/EP/2005/007894 WO/2006/010546

G01N 180482 01/01/2007

בדיקה של תווים קטנים באמצעות פלואורסצנזיה של קרני רנטגן

INSPECTION OF SMALL FEATURES USING X - RAY FLUORESCENCE

JORDAN VALLEY מ"ורדן ואלי סמיקונדקטורס בע'גSEMICONDUCTORS LTD.


511

G11C 180483 01/07/2005

מערכת ושיטה לשיפור ריענון דינמי על ידי מדידת טמפרטורה בהתקן זיכרון

מוליך למחצה

APPARATUS AND METHOD FOR IMPROVING DYNAMIC REFRESH IN A SEMICONDUCTOR MEMORY DEVICE BY TEMPERATURE MEASUREMENT


C07D 180484 20/07/2005

הכנתן , און3–ארילמורפולינ–4תולדות ושימושן הרפואי

4-ARYLMORPHOLIN-3-ONE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

SANOFI-AVENTIS 23/07/2004 0408222 FR PCT/FR/2005/001852 WO/2006/021654

H01S 180485 03/08/2005

SOLID-STATE SUSPENSION LASER לייזר סוספנסיה מוצקה

RAYTHEON COMPANY 10/08/2004 10/915229 US PCT/US/2005/027472 WO/2006/026037

C07D 180486 05/08/2005

מלחים של תולדת בנזימידאזול עם אמינים ותהליך לייצרה

SALTS OF BENZIMIDAZOLE DERIVATIVE WITH AMINES AND PROCESS FOR PRODUCTION THEREOF

EISAI R&D MANAGEMENT CO. LTD.

06/08/2004 2004-230094

JP

PCT/JP/2005/014400


WO/2006/013960

A61K 180487 08/07/2005

MEDICAMENT תרופה

AIMSCO LIMITED 08/07/2004 0415359.9 GB 21/10/2004 0423386.2 GB PCT/GB/2005/050108 WO/2006/021814

C07D 180488 25/07/2005

, תולדות אוריאה ציקליות מותמרותהכנתן והשימוש הפרמצבטי שלהן

כמעכבי קינאז

SUBSTITUTED CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF OF KINASE INHIBITORS

AVENTIS PHARMA S.A. 27/07/2004 04291903.5 EP PCT/EP/2005/008722 WO/2006/010643

H04Q 180489 04/07/2005

שיטה ומערכת לאיתור גאופרפי של התקן סלולרי

SYSTEM AND METHOD FOR GEOGRAPHICALLY LOCATING A CELLULAR DEVICE

ITIS UK LIMITED 09/07/2004 10/888631 US PCT/GB/2005/002637 WO/2006/005906

C07K 180490 06/07/2005

CYCLIC PEPTIDES פפטידים ציקליים PALATIN TECHNOLOGIES, INC. 06/07/2004 60/585971 US 05/07/2005 11/174851 US PCT/US/2005/024125 WO/2006/014552


513

C07K 180491 06/07/2005

CYCLIC PEPTIDES פפטידים ציקליים


B65D 180492 15/06/2005

התקן ושיטה להנפקת חומרים עם דרגת נקיון גבוהה

APPARATUS AND METHOD FOR DISPENSING HIGH PURITY MATERIALS

MALLINCKRODT BAKER, INC. 06/07/2004 60/585663 US 21/10/2004 60/621030 US PCT/US/2005/021234 WO/2006/014225

C07D 180493 30/06/2005

–5,5–מתוקסימתיל–1תהליך להכנת חומצה ברביטורית–דיפניל

A PROCESS FOR PREPARING 1-METHOXYMETHYL-5,5-DIPHENYLBARBITURIC ACID

TARO PHARMACEUTICAL מ"תרו תעשיה רוקחית בעINDUSTRIES LTD.

02/07/2004 60/584955 US PCT/IL/2005/000697 WO/2006/003651

C07D 180495 20/07/2005

תרכובות טריאזולון כמעכבי רברס טרנסקריפטאז שאינם נוקלאוטידים

BENZYLTRIAZOLONE COMPOUNDS AS NIN-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

F. HOFFMANN-LA ROCHE AG


27/07/2004 60/591311 US PCT/EP/2005/007893 WO/2006/010545

G01N 180496 07/07/2005

או מדידת ריכוז מטענים /חיישן לגילוי ו חשמליים

שימושים בו והשיטה לייצורו, אטמוספירם

SENSOR FOR DETECTING AND/OR MEASURING CONCENTRATION OF ELECTRIC CHARGES CONTAINED IN AN ATMOSPHERE, CORRESPONDING USES AND METHOD FOR MAKING SAME

UNIVERSITE DE RENNES 1 07/07/2004 0407583 FR PCT/FR/2005/001761 WO/2006/013289

A61B 180497 30/06/2005

BIOLOGICAL TISSUE CLOSURE התקן ושיטה לסגירה של רקמה ביולוגיתDEVICE AND METHOD

BRUCE D. MODESITT 10/07/2004 10/888682 US PCT/US/2005/023107 WO/2006/017023

C07J 180498 12/07/2005

PROCESS FOR PRODUCTION OF תהליך ליצירת סטרואידיםSTEROIDS

MITSUBISHI CHEMICAL CORPORATION

13/07/2004 2004-205515

JP


515

23/07/2004 2004-215304 JP PCT/JP/2005/013216 WO/2006/006718

C09D 180499 05/07/2005

שימוש בקופולימרים אקריליים מסיסי מים בתמיסות מים צבעוניות ותמיסות

USE OF WATER-SOLUBLE ACRYLIC COPOLYMERS IN OPTIONALLY PIGMENTED AQUEOUS FORMULATIONS AND RESULTING FORMULATIONS


A01G 180500 02/01/2007

הריסת מנהרות באמצעות מערכת השקיה בטפטוף

TUNNEL DISTRACTION WITH DRIP IRRIGATION SYSTEM

RONI BEN AVRAHAM )לידי משפחת ספורטס(רוני בן אברהם

A47G 180501 02/07/2005

CROWN SIZER ודלכותרת ממינת ג

MAINETTI S.P.A.

09/07/2004 VI 2004 A 000168

IT

14/01/2005 VI 2005 A 000007 IT

PCT/EP/2005/007172 WO/2006/005467

C12Q 180502 13/12/2004

חומרים בפזה מוצקה ללכידת חומצות גרעין

SOLID PHASE MATERIALS FOR BINDING NUCLEIC ACIDS

LUMIGEN, INC.


15/07/2004 10/891880 US PCT/US/2004/039762 WO/2006/019388

C12Q 180503 30/06/2005

שיטות לשחרור חומצות גרעין מחומרים מלכדים בפזה מוצקה

METHODS FOR RELEASING NUCLEIC ACIDS FROM SOLID PHASE BINDING MATERIALS

LUMIGEN, INC. 15/07/2004 10/891880 US PCT/US/2005/023916 WO/2006/019568

C12Q 180504 13/12/2004

שיטות לבידוד חומצות גרעין מפזות מוצקות שניתנות לביקוע

METHODS FOR ISOLATING NUCLEIC ACIDS FROM CLEAVABLE SOLID PHASES

LUMIGEN, INC. 15/07/2004 10/891880 US PCT/US/2004/039761 WO/2006/019387

B65H 180505 04/07/2005

ELECTRIC HOSE WINDER מגולל צינורות חשמלי

XU XIAOHUA 13/04/2005 200520101572.5 CN PCT/CN/2005/000974 WO/2006/108327

B65D 180506 02/01/2007

A FOLDING, STORAGE AND אחסון ונשיאה, מתקן קיפולCARRYING DEVICE

SHAY DAGAN שי דגן


517

H01B 180507 02/01/2007

כבל גמיש ועמיד בפני מים ומכרסמים המתאים במיוחד לשימוש ככבל תקשורת

אופטי

HIGHLY FLEXIBLE WATER-PROOF, RODENT-PROOF CABLES PARTICULARLY USEFUL AS OPTICAL COMMUNICATION CABLES

.TELDOR WIRES AND CABLES LTD מ"כים וכבלים בעטלדור מולי

C07D 180508 29/06/2005

פירימידינים מותמרים לשימוש כמודולטורים של קולטנים של

גלוקוקורטיקואיד

MODIFIED PYRIMIDINE GLUCOCORTICOID RECEPTOR MODULATORS

CORCEPT THERAPEUTICS, INC. 02/07/2004 60/585018 US PCT/US/2005/023675 WO/2006/014394

A61N 180509 05/07/2005

DELIVERY SYSTEM FOR מערכת הולכה לחיסון דרך העורTRANSDERMAL IMMUNIZATION

.TRANSPHARMA MEDICAL LTD מ"טראנספארמה מדיקל בע 06/07/2004 60/585081 US PCT/IL/2005/000710 WO/2006/003659

G06F 180510 04/07/2005

CRUSH MODELLING מודל התנגשות

ENGENUITY LIMITED 02/07/2004 0414992.8 GB 31/08/2004 0419292.8 GB PCT/GB/2005/002627


WO/2006/003438

H01M 180511 08/07/2005

דלק –זרזים לאלקטרודות של תא הכנה , מבוסס פלטינה וסגסוגות שלה

דלק המכילים –ותאי, ושימוש שלהם אותם

CATALYSTS FOR FUEL CELL ELECTRODES BASED ON PLATINUM AND ITS ALLOYS, THE PREPARATION AND USE THEREOF, AS WELL AS FUEL CELLS CONTAINING THEM

ACTA S.P.A. 09/07/2004 FI2004A000154 IT PCT/EP/2005/053270 WO/2006/005724

C07C 180512 07/07/2004

– 4(תהליך לסינתזה וניקוי של – 4) (מתוקסיבוטיל

מתאמנון) טריפלואורומתילפניל

PROCESS FOR THE SYNTHESIS AND PURIFICATION OF (4-METHOXYBUTYL)(4-TRIFLUOROMETHYLPHENYL)METHANONE

LUNDBECK PHARMACEUTICALS ITALY S.P.A.

PCT/EP/2004/051390 WO/2006/002691

C07C 180513 07/07/2004

– דיאמינו–' 4 – 4תהליך לסינתזה של סולפון–דיפניל

PROCESS FOR SYNTHESIS OF 4-4'-DIAMINO-DIPHENYL-SULFONE

LUNDBECK PHARMACEUTICALS ITALY S.P.A.

PCT/EP/2004/051389 WO/2006/002690

C12N 180514 07/07/2005

ביטוי ארעי ביולוגי של חלבון שלא ניזוק בצמחים

BIOLOGICALLY SAFE TRANSIENT PROTEIN EXPRESSION IN PLANTS

ICON GENETICS GMBH 07/07/2004 04016011.1 EP


519

15/01/2005 60/593454 US PCT/EP/2005/007361 WO/2006/003018

G01G 180515 02/01/2007

NETWORKED WEIGHT SCALE מאזנים מרושתות

MICHAL LAOR מיכל לאור

C07K 180518 07/07/2005

שעבר EPOתרכובת חדשה של קרבמילציה ושיטה ליצורה

NOVEL CARBAMYLATED EPO AND METHOD FOR ITS PRODUCTION

H. LUNDBECK A/S

07/07/2004 PA 2004 01075

DK

07/07/2004 60/586370 US 23/06/2005 60/693870 US PCT/DK/2005/000477 WO/2006/002646

A61B 180519 02/01/2007

מערכת ושיטה לטיפול ברקמה ביולוגית באמצעות שחרור גז פלזמה

SYSTEM AND METHOD FOR TREATING BIOLOGICAL TISSUE WITH A PLASMA GAS DISCHARGE

ALMA LASERS LTD מ"אלמה לייזרס בע 18/06/2006 11/333308 US

G06Q 180520 10/08/2005

–בזמן, שיטה ומערכת להוספה דינמיתשל פרסומות לתכנים סטטיים , אמת

מורדים

METHOD AND SYSTEM FOR DYNAMIC, REAL-TIME ADDITION OF ADVERTISEMENTS TO DOWNLOADED STATIC CONTENT

.HIRO-MEDIA LTD מ"מדיה בע-הירו 10/08/2004 60/599876 US


PCT/IL/2005/000866 WO/2006/016365

D06F 180521 03/01/2007

AN APPARATUS FOR DRYING מייבש כביסה חיצוניCLOTHES

SHALOM REHAVI שלום רחבי

A61B 180522 03/01/2007

RESPIRATION MONITOR מוניטור נשימה

RONEN PADOWICZ רונן פדוביץ

A61P 180523 24/05/2000

-COMPOSITIONS FOR IAPP ושימושםIAPPתרכובות מעכבות INHIBITION AND USES THEREON

QUEEN'S UNIVERSITY AT KINGSTON 24/05/1999 60/135545 US 09/07/1999 60/143123 US 23/05/2000 09/576677 US PCT/CA/2000/000607 WO/2000/071101

C07D 180524 05/07/2005


521

–5{–4–הידרוקסי–Nתהליך משופר להכנת –תיאזול–3,1–מתיל–2–איסופרופיל–5(–4[ בנזאמידין–}פנטוקסי–]פנוקסי–)איל–4

AN IMPROVED PROCESS FOR PREPARING N-HYDROXY-4-{5-[4-(5-ISOPROPYL-2-METHYL-1,3-THIAZOL-4-YL)-PHENOXY]-PENTOXY}-BENZAMIDINE

DONG WHA PHARMACEUTICAL IND. CO. LTD.

05/07/2004 10-2004-0052070

KR

PCT/KR/2005/002137 WO/2006/004368

B65H 180527 07/07/2005

Zחומר עטיפה עם מערכת נעילה מסוג בוושיטות לייצורו ושימוש

A WRAPPING MATERIAL WITH A Z-LOCK SYSTEM AND METHODS OF MAKING AND USING THE SAME

TAMA PLASTIC INDUSTRY תמה תעשיות פלסטיק 07/07/2004 10/884966 US PCT/IB/2005/003691 WO/2006/048779

C12P 180528 23/02/2000

תכשירי רוקחות לטיפול במחלות יטוכונדריאליותמ

PHARMACEUTICAL FORMULATIONS FOR TREATING MITOCHONDRIAL DISORDERS

Wellstat Therapeutics Corporation 23/02/1999 60/121588 US PCT/US/2000/004663 WO/2000/050043

E06B 180529 03/01/2007


SLAT BLIND TILTING LEVER מנוף לכוונון רפרפות תריסים

YEHUDA KOSTA יהודה קוסטה

C12Q 180531 07/07/2005

רצף חדש לשיפור ביטוי חומצת גרעין

NOVEL SEQUENCE FOR IMPROVING EXPRESSION OF NUCLEIC ACID

CHROMAGENICS B.V. 08/07/2004 60/587007 US 08/07/2004 PCT/EP2004/51405 EP PCT/EP/2005/053251 WO/2006/005718

G03F 180532 01/02/2005

–תכשירי ניקוי מיקרואלקטרוניים אל מימיים המכילים פרוקטוז

NON-AQUEOUS MICROELECTRONIC CLEANING COMPOSITIONS CONTAINING FRUCTOSE

MALLINCKRODT BAKER, INC. 15/07/2004 60/588248 US PCT/US/2005/003422 WO/2006/019402

G01N 180533 11/07/2005

DROPLET DEPOSITION APPARATUS התקן לפליטת טיפונת

XAAR TECHNOLOGY LIMITED 10/07/2004 0415529.7 GB PCT/GB/2005/002746 WO/2006/005952

E03D 180534 15/06/2005

W.C. DISPENSER WITH PERFUMING דיספנסר לאסלה עם מיכל מבושםCHAMBER

RE.LE.VI-S.P.A.


523

14/07/2004 RE2004A000084 IT PCT/EP/2005/006514 WO/2006/005410

F24J 180535 06/07/2005

SOLAR ENERGY CONTROL בקרת אנרגיה סולארית

SHEC LABS-SOLAR HYDROGEN ENERGY CORPORATION

06/07/2004 2473042 CA PCT/CA/2005/001048 WO/2006/002545

A43B 180536 03/01/2007

PROTECTIVE GAITER מגן לנעל ולגרב YUVAL SHOR עינב מקובר

B65D 180538 04/01/2007

TRAY מגש

.SARI KLEIN LTD מ"שרי קליין בע

A61B 180539 23/06/2005

שיטה לייצור קצה בחון סיב אופטי ן רפואילשימוש בהתק

METHOD OF MAKING A FIBER OPTIC PROBE TIP FOR USE IN A MEDICAL DEVICE

ONDINE INTERNATIONAL LTD. 22/07/2004 60/590420 US 30/03/2005 11/094084 US PCT/US/2005/022336 WO/2006/019510

A61N 180540 03/06/2005


יישומים ריפוי בסונופוטודינמיקה עבור דנטליים

SONOPHOTODYNAMIC THERAPY FOR DENTAL APPLICATIONS

ONDINE INTERNATIONAL LTD. 22/07/2004 60/590421 US 27/10/2004 60/622463 US PCT/US/2005/019707 WO/2006/022970

A61N 180541 08/07/2005

מערכת לסילוק חומר מינירלי ומניעת ור התקנים רפואיים מוליכיםקרישה עב

ANTI-COAGULATION AND DEMINERALIZATION SYSTEM FOR CONDUCTIVE MEDICAL DEVICES

ATS MEDICAL, INC. 12/07/2004 10/889328 US PCT/US/2005/024502 WO/2006/017213

C07D 180543 09/07/2005

פירולידין מותמר כקוטלי –2תולדות קולטי חרקיםפטריות ו

SUBSTITUTED 2-PYRROLIDONE DERIVATIVES AS FUNGICIDES AND INSECTICIDES

BAYER CROPSCIENCE AG 12/07/2004 04016320.6 EP PCT/EP/2005/007442 WO/2006/005551

C07D 180544 27/07/2005

הכנתן , נגזרות של דיארילמתיל פיפרזין ושימושן

DIARYLMETHYL PIPERAZINE DERIVATIVES, PREPARATIONS THEREOF AND USES THEREOF

ASTRAZENECA AB 02/08/2004 0401968-3 SE 18/08/2004 60/602363 US PCT/SE/2005/001186 WO/2006/014133

C07D 180545 26/07/2005


525

הינו Q של היבריד בהן A Qמולקולות , הינו משקע אנטיביוטי A–אמינוקוינולין ו

והסינתזה והשמושים שלהן כחומרים נגד חיידקים

HYBRID MOLECULES QA WHERE Q IS A AMINOQUINOLINE AND A IS AN ANTIBIOTIC RESIDUE, AND THE SYNTHESIS AND USES THEREOF AS ANTIBACTERIAL AGENTS

PALUMED S.A. 30/07/2004 0408441 FR 23/12/2004 11/019450 US PCT/FR/2005/001937 WO/2006/024741

C07D 180546 27/07/2005

נגזרת חדשה של פיפרידין לטיפול בדיכאון

NOVEL PIPERIDINE DERIVATIVE FOR THE TREATMENT OF DEPRESSION

ASTRAZENECA AB 02/08/2004 0401969-1 SE PCT/SE/2005/001187 WO/2006/014134

C07D 180547 27/07/2005

נגזרות חדשות של פיפרידין כליגנדים של קולטן

לטיפול בדיכאון3Hהיסטמין

NOVEL PIPERIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR LIGANDS FOR TREATMENT OF DEPRESSION



C07D 180548 27/07/2005

נגזרות של פיפרידין כלינגדים של קולטן 3Hהיסטמין

PIPERIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR LIGANDS


G01N 180549 12/07/2005

FCזיהוי והנדסת נוגדנים בעלי איזור משתנה ושיטות לשימושם

IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT FC REGIONS AND METHODS OF USING SAME

MACROGENICS, INC. 12/07/2004 60/587251 US 28/07/2004 10/902588 US PCT/US/2005/024645 WO/2006/088494

H05C 180550 06/07/2005

שיטה ומערכת לאספקת זרם חשמלי לתוך אובייקט או מדיום

METHOD AND APPARATUS FOR PROVIDING ELECTRIC CURRENT INTO AN OBJECT OR MEDIUM

THE COMMONWEALTH OF AUSTRALIA, C/O MINISTER FOR DEFENCE

07/07/2004 2004903724 AU PCT/AU/2005/000984 WO/2006/002485


527

G01N 180552 08/09/2005

METHOD OF EXPLOSIVE DETECTION שיטה לגילוי וזיהוי חומרי נפץAND IDENTIFICATION

ZAKRYTOE AKTSIONERNOE OBSCHESTVO "INTELLEKTUALNYE SKANIRUYUSCHIE SISTEMY"

09/09/2004 2004126993 RU PCT/RU/2005/000456 WO/2006/031155

C07D 180553 06/07/2005

קווינאזולין המאפננים גורם גידול לטיפול MET –Cפעילות / הפאטוציטי

בסרטן

QUINAZOLINE MODULATORS OF HEPATOCYTE GROWTH FACTOR C-MET ACTIVITY FOR THE TREATMENT OF CANCER

ANGION BIOMEDICA CORPORATION 06/07/2004 60/585734 US PCT/US/2005/023801 WO/2006/014420

C07K 180554 03/08/2005

RAGE FUSION PROTEINS AND ושיטות שימושRAGEחלבונים אחויים METHODS OF USE

TRANSTECH PHARMA, INC. 03/08/2004 60/598555 US PCT/US/2005/027705 WO/2006/017647

C12N 180555 03/08/2005


RAGE FUSION PROTEINS AND ושיטות שימושRAGEחלבונים אחויים METHODS OF USE

TRANSTECH PHARMA, INC. 03/08/2004 60/598362 US PCT/US/2005/027694 WO/2006/017643

H01S 180556 20/12/2005

זיגוג שכבת מגן עבור רכיב לייזר ושיטת אנקפסולציה

ARTICULATED GLAZE CLADDING FOR LASER COMPONENTS AND METHOD OF ENCAPSULATION

RAYTHEON COMPANY 23/12/2004 11/021413 US PCT/US/2005/047624 WO/2006/130180

A61K 180558 08/07/2005

רב ערכיים המכילים VLA–4אנטגוניסטים חלקים פולימריים

MULTIVALENT VLA-4 ANTAGONISTS COMPRISING POLYMER MOIETIES

ELAN PHARMACEUTICALS, INC. 08/07/2004 60/586975 US PCT/US/2005/024369 WO/2006/010054

H04N 180559 08/07/2005

שיטה ומערכת לניהול זכויות עבור יקה דיגיטליתמוז

METHOD AND SYSTEM FOR MANAGING RIGHTS FOR DIGITAL MUSIC

CATCH MEDIA, INC. 16/07/2004 10/893473 US PCT/US/2005/024212 WO/2006/019608


529

H04L 180560 07/07/2005

מערכת לריבוד תוכן להעברה מתוזמנת ברשת תקשורת

SYSTEM FOR LAYERING CONTENT FOR SCHEDULED DELIVERY IN A DATA NETWORK


F24H 180561 04/01/2007

אוגן לדוד שמש או חימום הכולל ברז לריקון המים מהדוד

A FLANGE OF A TANK OF HEATING WATER THAT INCLUDES A TAP FOR EMPTYING THE WATER

UDI RAHMANI עודי רחמני

G09B 180562 04/01/2007

מקלדת אנגלית ללימוד עצמי לילדים עם דיסלקציה

A SELF TEACHING ENGLISH KEYBOARD FOR CHILDREN WITH DYSLEXIA

MARINA VIGODSKY מרינה ויגודסקי

F04D 180563 04/01/2007

AUTOMATIC VACUUM PUMP משאבת ואקום אוטומטית

DAN BRON )אצל ברקוביץ(דן ברון

H01R 180564 04/01/2007

תקע מכשיר חשמלי עם שקע למכשיר חשמלי נוסף

AN ELECTRICAL CONNECTION-REPRODUCING ELECTRICAL PLUG

YAIR MESHULAM יאיר משולם


A61` 180565 04/01/2007

ברז מפסיק משופר למתן תרופות לתוך הגוף של מטופל

AN IMPROVED STOPCOCK FOR ADMINISTERING MEDICAMENTS INTO THE PATIENT'S BODY

.PLASTMED LTD מ"פלאסטמד בע

G06K 180567 04/07/2005

SYSTEM AND METHOD FOR מערכת ושיטה להדמיהIMAGING

.REAL IMAGING LTD מ"ינג בע'ל אימגרי 07/07/2004 60/586162 US PCT/IL/2005/000707 WO/2006/003658

G01N 180568 06/07/2005

שיטות ומכשירים לאיתור דמות שקע בתמונת רכיב נושא שקעים

METHOD AND DEVICE FOR IDENTIFYING AN IMAGE OF A WELL IN AN IMAGE OF A WELL-BEARING COMPONENT

SENG ENTERPRISES LTD. 07/07/2004 60/585571 US 13/09/2004 10/938951 US 15/10/2004 60/618585 US 05/11/2004 60/625096 US PCT/IL/2005/000719 WO/2006/003664


531

H04Q 180569 04/07/2005

מערכת שירות מולטימדיה אינטראקטיבית ושיטה

AN INTERACTIVE MULTIMEDIA SERVICE SYSTEM AND METHOD THEREOF

SK TELECOM CO., LTD.

05/07/2004 10-2004-0052129

KR

PCT/KR/2005/002119 WO/2006/004363

C07D 180570 02/07/2005

נגזרות דיפנילאמין מותמר סליצילתיאזול ותרכובות קרובות –B1כמעכבות פוספוטירוזין פוספטאז

PTP1B לשימוש בהפחתת המרכיבים הפעילים של סוכר בדם במסגרת טיפול

בסכרת

DIPHENYLAMINE-SUBSTITUTED SALICYLTHIAZOLE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOTYROSINE PHOSPHATASE 1B (PTP1B) INHIBITORS FOR USING AS BLOOD-SUGAR DECREASING ACTIVE INGREDIENTS FOR TREATING DIABETES

SANOFI-AVENTIS DEUTSCHLAND GMBH

17/07/2004 102004034697.6 DE PCT/EP/2005/007151 WO/2006/007959

C07C 180571 28/06/2005

שיטה לייצור צורה אננטיומרית של דיאמינו–3,2נגזרות חומצה פרופיונית

METHOD FOR PRODUCING ENANTIOMERIC FROM OF 2,3-DIAMINOPROPIONIC ACID DERIVATIVES

SANOFI-AVENTIS DEUTSCHLAND GMBH

10/07/2004 102004033406.4 DE PCT/EP/2005/006920 WO/2006/005436


C12Q 180572 07/07/2005

חומרים פעילים להגברת ההגנה ת למציאתםושיטו, הפתוגנית בצמחים

ACTIVE INGREDIENTS FOR ENHANCING PATHOGEN DEFENSE IN PLANTS, AND METHODS OF FINDING THEM

BAYER CROPSCIENCE GMBH 20/07/2004 102004035137.6 DE PCT/EP/2005/007344 WO/2006/007981

A01N 180573 07/07/2005

SAFENING METHOD שיטה להגנה


A61K 180577 08/08/2005

תכשיר המכיל וזודילטור לעידוד הרפית שריר חלק וסקולרי

A COMPOSITION CONTAINING A VASODILATOR FOR PROMOTING VASCULAR SMOOTH MUSCLE RELAXATION

FUTURA MEDICAL DEVELOPMENTS LIMITED

09/08/2004 0417675.6 GB PCT/GB/2005/003110 WO/2006/016139

G06C 180578 07/01/2007

CREDIT PHONE SYSTEM פון–מערכת קרדיט

SHLOMI AZRIEL שלמה מאיר עזריאל

A61P 180579 07/01/2007


533

קבלתם תהליך ל, נגזרות פיפירידין והרכבים ריקחיים הכוללים אותן

PIPERIDINE DERIVATIVES, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

SANOFI AVENTIS 10/02/1999 99/01593 FR 07/04/1999 99/04429 FR PCT/FR/2000/000284 WO/2000/047572

E04C 180580 07/07/2005

BALLISTIC ABATEMENT BARRIER שיטה ומערכת להפחתת מחסום בליסטיMETHOD AND SYSTEM

BLASHIELD, INC. 08/07/2004 10/886975 US PCT/US/2005/024073 WO/2006/085980

C12Q 180581 14/07/2005

מערכות ושיטות אנליזה לחומצות ומרכיבים קשוריםגרעיניות פולימריות

SYSTEMS AND METHODS OF ANALYZING NUCLEIC ACID POLYMERS AND RELATED COMPONENTS

ZS GENETICS, INC. 14/07/2004 60/587997 US PCT/US/2005/024979 WO/2006/019903

G02B 180582 06/07/2005

INTELLIGENT INTERACTIVE LOCK מנעול הידודי חכם ומערכת נעילהAND LOCKING SYSTEM

SEGEV, EREZ שגב ארז 06/07/2004 60/585089 US PCT/IL/2005/000715 WO/2006/003661


G07F 180583 05/07/2004

שיטה לקבלת מזומנים במכונות קופה ללא י שימוש בהוראת תשלום "כרטיס ע

)אס אמ אס(באמצעות הודעות טקסט

METHOD FOR OBTAINING CASH AT CARDLESS TELLER MACHINES, USING A PAYMENT ORDER VIA SMS

CAJA DE AHORROS DE GALICIA PCT/ES/2004/000321 WO/2006/013218

A61K 180584 12/07/2005

MSF–A תלוי HIFחומרים להורדת ושימושם לטיפול בסרטן

AGENTS CAPABLE OF DOWNREGULATING AN MSF-A-DEPENDENT HIF-1ALPHA AND USE THEREOF IN CANCER TREATMENT



12/07/2004 60/586697 US PCT/IL/2005/000736 WO/2006/038208

G06F 180585 18/05/2005

ארכיטקטורה בעלת עוצמה נמוכה הניתנת לעיצוב מחדש ליישום סימולטני

של סטנדרטים לתקשורת ברורים

LOW-POWER RECONFIGURABLE ARCHITECTURE FOR SIMULTANEOUS IMPLEMENTATION OF DISTINCT COMMUNICATION STANDARDS

ASOCS LTD 08/07/2004 60/586353 US 08/07/2004 60/586389 US


535

08/07/2004 60/586390 US 08/07/2004 60/586391 US PCT/IB/2005/002485 WO/2006/006076

G06F 180586 08/07/2005

שיטה ומערכת ליישום שינויים אורטוגונלים מהירים בגדלים משתנים

A METHOD OF AND APPARATUS FOR IMPLEMENTING FAST ORTHOGONAL TRANSFORMS OF VARIABLE SIZE

ASOCS LTD 08/07/2004 60/586390 US 08/07/2004 60/586391 US 08/07/2004 60/586389 US 08/07/2004 60/586353 US 25/08/2004 60/604258 US 03/03/2005 11/071340 US PCT/US/2005/024063 WO/2006/014528

C07D 180587 02/08/2005

HETEROCYCLIC COMPOUNDS תרכובות הטרוציקליות

PALAU PHARMA S.A. 03/08/2004 200401971 ES PCT/EP/2005/008371 WO/2006/013095

C07K 180588 04/08/2005

CMET HUMANIZED ANTI-CMETאנטגוניסטים ממקור אנושי נוגדי ANTAGONISTS



A61K 180589 29/07/2005

לטיפול בסרטן –29IL– וIL–28–שימוש ב ואי סדרים של חיסון עצמי

USE OF IL-28 AND IL-29 TO TREAT CANCER AND AUTOIMMUNE DISORDERS

ZymoGenetics INC. 29/07/2004 60/592069 US 19/11/2004 60/629702 US 29/04/2005 60/676047 US PCT/US/2005/026951 WO/2006/012644

G06K 180592 11/07/2005

DISAMBIGUATING AMBIGUOUS הבהרה דו משמעית של תווים מעורפליםCHARACTERS

AOL LLC 09/07/2004 60/586502 US PCT/US/2005/024519 WO/2006/010114

E01F 180593 11/07/2005

ANTI-VEHICLE SECURITY SYSTEM מערכת ביטחון נגד כלי רכב

VAN BIBBER, MICHAEL 09/07/2004 10/888337 US PCT/US/2005/024537 WO/2006/010122

A23B 180594 08/01/2007

METHOD OF PROCESSING GARLIC שיטה לעיבוד שום

ZIVA MORENO זיוה מורנו 09/01/2006 60/757007 US

G09G 180595 16/08/2005


537

מאפיין של מעגל מנהל התקן תצוגה המאפשר הפעלה במצב חיי

CURRENT MODE DISPLAY DRIVER CIRCUIT REALIZATION FEATURE

IDC, LLC. 27/08/2004 60/604893 US 15/07/2005 11/182389 US PCT/US/2005/029161 WO/2006/026162

G09F 180596 22/07/2005

FIELD LABELED BUTTON מתג תיוג שדה LUTRON ELECTRONICS CO. INC. 23/07/2004 60/590627 US PCT/US/2005/026119 WO/2006/012545

A61K 180597 25/07/2005

טבלית פרמצבטית רב שכבות עבורשחרור מבוקר של מרכיבים פעילים בעלי

גבוההPH–מסיסות על תלות

PHARMACEUTICAL MULTILAYER TABLET FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS WITH HIGHLY PH-DEPENDENT SOLUBILITY

SANOFI-AVENTIS 29/07/2004 04291943.1 EP PCT/EP/2005/008719 WO/2006/010640

G01N 180601 08/07/2005

שיטות ותרכובות לגילוי סרטן שחלותMETHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN CANCER

TRIPATH IMAGING, INC. 09/07/2004 60/586856 US PCT/US/2005/024359 WO/2006/010047


C07D 180603 27/03/2000

של רצפטור מודולטורים גלוקוקורטיקואיד

GLUCOCORTICOID RECEPTOR MODULATORS


B65D 180605 09/01/2007

-CONTAINER WITH MULTI מיכל עם מכסה הושטה משולבFUNCTION DISPENSING COVER

.ZEUS AVIV LTD מ"מית מן הטבע בעחמ

G06F 180606 05/07/2000

סינון וסינטזה של חומר טכני, ניהול, הצגהREPRESENTATION, MANAGEMENT, FILTERING AND SYNTHESIS OF TECHNICAL CONTENT

COHESIA CORPORATION 08/07/1999 09/349753 US PCT/US/2000/018422 WO/2001/004812

C12Q 180607 03/08/2005

בחנים ושיטות המשתמשים בסימנים ביולוגיים

ASSAYS AND METHODS USING BIOMARKERS



539

C07K 180608 15/07/2005

HER2 HER2 ANTIBODY COMPOSITIONתכשיר של נוגדן


G06F 180609 12/07/2005

שיטה והתקן לעיצוב מעגלים אלקטרונים באמצעות אופטימיזציה

METHOD AND APPARATUS FOR DESIGNING ELECTRONIC CIRCUITS USING OPTIMIZATION

KIMOTION TECHNOLOGIES 13/07/2004 10/890349 US PCT/US/2005/024595 WO/2006/017247

A61B 180610 09/01/2007

GRIPPING TOOL מכשיר לאחיזה SHERWOOD SERVICES AG 16/01/2006 2006-7828 JP

H04B 180611 29/06/2005

רת איזוריות סריקת שכן במערכות תקשו חוטיות–אל

NEIGHBOR SCANNING IN WIRELESS LOCAL AREA NETWORKS


12/07/2004 60/587159 US PCT/US/2005/023145 WO/2006/017024


C08B 180612 11/07/2005

חומרים ושיטות להמרצת המערכת החיסונית

MATERIALS AND METHODS FOR IMMUNE SYSTEM STIMULATION

VARIETY CHILDREN'S HOSPITAL d/b/a MIAMI CHILDREN'S HOSPITAL

09/07/2004 60/586548 US PCT/US/2005/024410 WO/2006/010069

G05F 180613 05/07/2005

מערכות ושיטות להקטנה ככל האפשר של דליפה בעלת ערך קבוע ממעגל

שולבמ

SYSTEMS AND METHODS FOR MINIMIZING STATIC LEAKAGE OF AN INTEGRATED CIRCUIT

VIRTUAL SILICON TECHNOLOGY, INC.

09/07/2004 60/586565 US 24/11/2004 10/996739 US PCT/US/2005/023839 WO/2006/017082

B01D 180614 12/04/2005

של גזי בעירה הכולל הסרת ניקוי ביתרCo2

ULTRA CLEANING OF COMBUSTION GAS INCLUDING THE REMOVAL OF CO2

EIG, INC. 06/08/2004 60/599228 US 13/10/2004 60/617779 US PCT/US/2005/012794 WO/2006/022885


541

G01N 180615 20/07/2005

אומטי קטטר הניתן להכוונה עם מפעל פנ או הידראולי

STEERABLE CATHETER WITH HYDRAULIC OR PNEUMATIC ACTUATOR

ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC.

20/07/2004 10/895510 US PCT/US/2005/025888 WO/2006/012421

H04L 180617 28/07/2005

ר שיטה להספקת וקליטת שירות רב שידוושידור לקהל בזמן עבירה במערכת גישה

אלחוטית פס רחב

METHOD OF PROVIDING AND RECEIVING MULTICAST AND BROADCASTING SERVICE DURING HANDOVER IN BROADBAND WIRELESS ACCESS SYSTEM

LG ELECTRONICS INC.

29/07/2004 10-2004-0059932

KR

PCT/KR/2005/002458 WO/2006/011763

H04Q 180618 29/07/2004

יירוט חוקי של שרות תעבורת נתונים מבוסס מיקום במערכת גישה אלחוטית פס

רחב

LAWFUL INTERCEPTION OF LOCATION BASED SERVICE TRAFFIC

TELEFONAKTIEBOLAGET LM ERICSSON (PUBL)

PCT/IT/2004/000417 WO/2006/011165


H04Q 180619 29/07/2004

IRI PROVISION OF LOCATIONהספקה של מידע מיקום לתוך INFORMATION INTO IRI

TELEFONAKTIEBOLAGET LM ERICSSON (PUBL)

PCT/IT/2004/000418 WO/2006/011166

F02K 180620 09/01/2007

סילון טרוף /מערכת הצתה קרה מגח סילון טור גז רב תכליתיגנר

MULTIPURPOSE GAS GENERATOR RAMJET/ SCRAMJET COLD START SYSTEM

UNITED TECHNOLOGIES CORPORATION

31/01/2006 11/344764 US

B60N 180621 11/11/2004

, מבנה מושב הניתן לכיוון נועל ממסרה צירית–שיבולת שתי דו, צילוב סינכרוני

BILATERAL, WARP-TOLERANT, CROSS-SYNCHRONIZED, GEAR-LOCK ADJUSTABLE SEAT STRUCTURE

MJD INNOVATIONS, L.L.C. 18/08/2004 10/921051 US PCT/US/2004/038006 WO/2006/022789

A61B 180623 07/07/2005

SURGICAL IMAGING DEVICE התקן לדימות ניתוח

POWER MEDICAL INTERVENTIONS, INC.

09/07/2004 10/888285 US PCT/US/2005/024141 WO/2006/017128


543

H04Q 180624 11/07/2005

מרובת פרוטוקולים או RFIDמערכת מרובת הוראות

MULTI-PROTOCOL OR MULTI-COMMAND RFID SYSTEM

TC LICENSE LTD. 09/07/2004 10/887320 US PCT/US/2005/024432 WO/2006/010076

A61B 180625 10/07/2005

מערכת ושיטה למדידת , מכשיר לביש פרמטרים חיוניים

WEARABLE DEVICE, SYSTEM AND METHOD FOR MEASURING VITAL PARAMETERS

.TADIRAN SPECTRALINK LTD מ"תדיראן ספקטרלינק בע 09/07/2004 60/586241 US PCT/IL/2005/000732 WO/2006/006158

A61B 180626 10/07/2005

מערכת ושיטה לניטור , מכשיר לביש פרמטרים פיזיולוגיים

או סביבתיים/ ו

A WEARABLE DEVICE, SYSTEM AND METHOD FOR MONITORING PHYSIOLOGICAL AND/OR ENVIRONMENTAL PARAMETERS

.TADIRAN SPECTRALINK LTD מ"תדיראן ספקטרלינק בע 09/07/2004 60/586243 US 09/07/2004 60/586242 US 21/07/2004 60/589599 US PCT/IL/2005/000733 WO/2006/006159

B41J 180627 12/07/2005

שיטה להפחתת שוני צפיפות הדפסה במיוחד במדפסות הזרקת דיו, במדפסות

METHOD FOR REDUCING PRINT-DENSITY VARIATIONS IN PRINTERS, PARTICULARY IN INKJET PRINTERS

.JEMTEX INK JET PRINTING LTD מ"ט פרינטינג בע'מטקס אינק ג'ג 12/07/2004 60/586712 US PCT/IL/2005/000737 WO/2006/006162


C07F 180628 10/07/2005

תהליכים להכנת פוספוליפידים מחומצניםIMPROVED PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS

.VASCULAR BIOGENICS LTD מ"ניק בע'וסקולר ביוג 09/07/2004 60/586219 US PCT/IL/2005/000735 WO/2006/006161

G06K 180629 24/05/2000

IDENTITY CODED SURFACE משטח שזהותו מקודדת

SILVERBROOK RESEARCH PTY. LTD.

25/05/1999 PQ0559 AU 30/06/1999 PQ1313 AU 15/10/1999 PQ3457 AU 01/12/1999 PQ4392 AU PCT/AU/2000/000570 WO/2000/072250

C07D 180630 30/07/2005

PYRROLE DERIVATIVES AS תולדות פירול כגורמי רוקחותPHARMACEUTICAL AGENTS

EXELIXIS, INC. 30/07/2004 60/592469 US 30/07/2004 60/592439 US PCT/US/2005/026916 WO/2006/012642

B41J 180633 10/01/2007

EFFICIENT KEYBOARD מקלדת יעילה

ZIV FISHER זיו פישר

A61K 180635 13/07/2005


545

אקטיבי זריקתי לשם –שימוש צבע רדיו הלימפה השומרותזיהוי בלוטות

USE OF AN INJECTABLE RADIOACTIVE DYE FOR SENTINEL LYMPH NODE IDENTIFICATION

BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE

13/07/2004 10/890420 US PCT/US/2005/024786 WO/2006/010144

H01T 180636 08/07/2005

מפסק מתח גבוה והשימוש בו במחוללי מיקרוגל

HIGH-VOLTAGE SWITCH AND USE THEREOF IN A MICROWAVE GENERATOR

DIEHL BGT DEFENCE GMBH & CO. KG 19/07/2004 102004034895.2 DE PCT/EP/2005/007426 WO/2006/008000

C07D 180637 08/07/2005

תולדות טריציקליות של פיראזול כמווסתי קולטניקאנאבינואיד

TRICYCLIC PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS

CADILA HEALTHCARE LTD. 12/07/2004 745/MUM/2004 IN PCT/IN/2005/000237 WO/2006/025069

A61K 180638 11/07/2005

רכבים לטיפול בדלקת וכאב באמצעות ה COX–2שילוב של מעכב סלקטיבי של

LTB4ואנטגוניסט של קולטן

COMPOSITIONS FOR TREATMENT OF INFLAMMATION AND PAIN USING A COMBINATION OF A COX-2 SELECTIVE INHIBITOR AND A LTB4 RECEPTOR ANTAGONIST

PHARMACIA CORPORATION


22/07/2004 60/590076 US PCT/IB/2005/002203 WO/2006/011048

B25B 180639 10/01/2007

מערכת הידוק לתיקון והעמדת חלקי עבודה

CLAMPING APPARATUS FOR POSITIONING AND FIXING WORK PIECES

F-TOOL INTERNATIONAL AG 13/03/2006 00393/06 CH

G06K 180640 08/07/2005

SYSTEM AND METHOD FOR מערכת ושיטה לאבטחת חשבון אשראיSECURING A CREDIT ACCOUNT

DAVID, N. HARRIS 12/07/2004 10/889227 US PCT/US/2005/024242 WO/2006/017165

G01R 180641 14/07/2005

שיטה ומערכת לקביעת סדקים ורכיבים שבורים בשריון

METHOD AND SYSTEM FOR DETERMINING CRACKS AND BROKEN COMPONENTS IN ARMOR

SIMULA, INC. 16/07/2004 10/892357 US PCT/US/2005/024859 WO/2006/019820

G09B 180642 11/01/2007

שיטה להוראת שפה זרה תוך יישום כלים של מודעות אינטליגנציה רגשית

A METHOD OF TEACHING A FOREIGN LANGUAGE BY APPLYING AWARENESS AND EMOTIONAL INTELLIGENCE TOOLS

GILA FRISCHER גילה פרישר


547

C07D 180643 24/06/2005

שיטות לקבלת פאקליטאקסל מצמחי טאקסוס

METHODS FOR OBTAINING PACLITAXEL FROM TAXUS PLANTS

INDENA S.P.A. 13/07/2004 04016493.1 EP PCT/EP/2005/006846 WO/2006/005429

G01N 180644 12/07/2005

התקן ושיטה לאנליזה אוטומטית של דגימות דם

DEVICE AND METHOD FOR AUTOMATICALLY ANALYSING BLOOD SAMPLES

VDG-VON DER GOLTZ GMBH 12/07/2004 102004033654.7 DE PCT/DE/2005/001228 WO/2006/005326

H04Q 180646 30/06/2005

העברה מהירה ויעילה במערכת תקשורת אלחוטית מקומית

ROBUST AND FAST HANDOVER IN A WIRELESS LOCAL AREA NETWORK


12/07/2004 60/587273 US PCT/US/2005/023756 WO/2006/017064

C12Q 180647 03/08/2005

בחנים ושיטות המשתמשים בסימנים ביולוגיים

ASSAYS AND METHODS USING BIOMARKERS



C09K 180648 03/05/2005

OXYGEN-ABSORBING PACKAGING חומר אריזה הסופג חמצןMATERIAL

MULTISORB TECHNOLOGIES, INC. 13/07/2004 10/889731 US PCT/US/2005/015236 WO/2006/016916

A61K 180650 08/07/2005

INFUSION AND INJECTION תמיסת לבודופה לאינפוזיה ולהזרקהSOLUTION OF LEVODOPA

DIZLIN MEDICAL DESIGN AB 12/07/2004 0401842-0 SE PCT/SE/2005/001135 WO/2006/006929

G08B 180652 17/10/2005

ארגון משורשר של מצמדי השראה לתקשורת נתונים

ARRANGEMENT OF DAISY CHAINED INDUCTIVE COUPLERS FOR DATA COMMUNICATION

AMBIENT CORPORATION 14/12/2004 11/011574 US PCT/US/2005/037463 WO/2006/065340

F25B 180653 13/07/2005

התקן מחזור יחידי לעיבוי מים מאוויר אופף

SINGLE CYCLE APPARATUS FOR CONDENSING WATER FROM AMBIENT AIR

GRAEME ALLAN COLLINS 13/07/2004 2004903841 AU PCT/AU/2005/001027 WO/2006/005133


549

C07D 180654 13/07/2005

נגזרות אוקסינדול מותמרות ותרופות המכילות אותן

SUBSTITUTED OXINDOL DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME

ABBOTT GMBH & CO. KG 13/07/2004 102004033834.5 DE 13/07/2004 60/587407 US PCT/EP/2005/007631 WO/2006/005609

A61F 180655 11/01/2007

מיפוי של אלקטרוגרם אטריאלי בעל חלוקות מורכבות

MAPPING OF COMPLEX FRACTIONATED ATRIAL ELECTROGRAM

BIOSENSE WEBSTER, INC. 12/01/2006 60/758317 US 05/01/2007 11/620370 US

B21D 180656 12/07/2005

עייפות –ים לגליון חסיןשיטה להכנסת חתכ והגליון הנוצר

FATIGUE-RESISTANCE SHEET SLITTING METHOD AND RESULTING SHEET

INDUSTRIAL ORIGAMI, LLC 12/07/2004 60/587470 US PCT/US/2005/024693 WO/2006/017290

B08B 180658 11/01/2007

EAR PROTECTION מגן אוזניים

EDRI OFER אדרי עופר


H04L 180659 13/07/2005

שיטה להשגת גישה למידע על אובייקט , ONSהרשאת , שרת מקומי, בעל תווית

התקן בעל , שיטת יצירת תווית, תוכניתותוכנית לשליטה על , תווית, כתיבת תווית

ההתקן בעל כתיבת התווית

METHOD FOR ACCESSING INFORMATION ON OBJECT HAVING TAG, LOCAL SERVER, ONS PROXY, PROGRAM, TAG CREATION METHOD, DEVICE HAVING TAG WRITER, TAG, AND PROGRAM FOR CONTROLLING DEVICE HAVING TAG WRITER

IBM CORPORATION

15/07/2004 2004-208935

JP

PCT/JP/2005/012938 WO/2006/009040

B23B 180660 11/01/2007

CUTTING TOOL AND CUTTING ימת שיבוב וכלי שיבובשINSERT

.ISCAR LTD מ"ישקר בע

A61M 180661 14/07/2005

MATERIAL DELIVERY SYSTEM מערכת לשחרור חומר BY-PASS, INC. 14/07/2004 60/587335 US 10/08/2004 60/599884 US 23/08/2004 60/603262 US 28/04/2005 60/675477 US PCT/IL/2005/000749 WO/2006/006169

B64D 180662 11/01/2007

SIZE ADJUSTABLE SAFETY AND ניצרת גודל מתכווננת וריפוד נוח לקסדהCOMFORT LINER FOR A HELMET

GENTEX CORPORATION 19/01/2006 11/337040 US


551

F03D 180664 14/07/2005

ערכת אוגרת אנרגיית רוח בקנה מידה מ תעשייתי שניתן להתקינה בים

INDUSTRIAL-SCALE WIND-ENERGY-COLLECTION SYSTEM WHICH CAN BE INSTALLED IN THE SEA

VICTORINO GONZALEZ DIAZ 14/07/2004 P200401716 ES PCT/ES/2005/000403 WO/2006/018467

C07D 180665 15/07/2005

VIRAL POLYMERASE INHIBITORS מעכבי פולימראז וירלי

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

16/07/2004 60/588670 US PCT/CA/2005/001103 WO/2006/007693

C12Q 180666 27/06/2005

שיטות ובחנים לזיהוי פעילות גוונילאט ציקלאז

METHODS AND ASSAYS FOR DETECTING GUANYLATE CYCLASE ACTIVITY

AXXAM S.R.L. 16/07/2004 04016774.4 EP PCT/EP/2005/006887 WO/2006/007937

A01N 180667 13/07/2005

שימוש באלקנולים פוספטים כחומרים חומרים המשמשים ליצירת , מפזרים

חומרי , חומרים הידרוטרופים, תחליביםוחומרים מתאימים בתכשירים הרטבה חקלאיים

USE OF PHOSPHATED ALCANOLS AS DISPERSANTS, EMULSIFIERS, HYDROTROPES, WETTING AGENTS AND COMPATABILITY AGENTS IN AGRICULTURAL COMPOSITIONS


AKZO NOBEL N.V. 15/07/2004 04077043.0 EP 08/09/2004 60/608167 US PCT/US/2005/024777 WO/2006/019772

A23L 180670 27/06/2005

תוצרי מזון מאווררים המכילים הידרופובין

AERATED FOOD PRODUCTS CONTAINING HYDROPHOBIN

UNILEVER PLC 27/07/2004 04254483.3 EP 03/03/2005 05251282.9 EP PCT/EP/2005/006996 WO/2006/010425

A23L 180671 27/06/2005

תוצרי מזון מאווררים המכילים הידרופובין

AERATED FOOD PRODUCTS CONTAINING HYDROPHOBIN

UNILEVER PLC 27/07/2004 04254483.3 EP 03/03/2005 05251282.9 EP PCT/EP/2005/006997 WO/2006/010426

E04H 180672 11/01/2007

STRUCTURE AND ACCESSORIES זרים עבורומבנה ואביTHEREFOR

AVRAHAM SORYAS אברהם סוריאס

A61B 180674 11/01/2007

IMPROVED SURGICAL CASSETTE קלטת כירורגית משופרת

ALCON, INC. 24/01/2006 11/338491 US


553

A61K 180675 18/07/2005

שיטות לטיפול במחלות או הפרעות ווכות המת CCR2ידי –על

METHODS OF TREATING CCR2 MEDIATED DISEASES OR DISORSERS


C07D 180676 27/07/2005

מאפנני קינז הטרוציקליים עם טבעת מאוחדת

FUSED RING HETEROCYCLE KINASE MODULATORS

SGX PHARMACEUTICALS, INC. 27/07/2004 60/591778 US 27/07/2004 60/591886 US 11/05/2005 60/680091 US PCT/US/2005/026794 WO/2006/015124

C07C 180679 18/10/2001

תהליך להכנת מודולטורים של רצפטור קואידסטרואידלי של גלוקוקורטי–לא

PROCESS FOR THE PREPARATION OF NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS

PFIZER PRODUCTS, INC. 27/10/2000 60/243873 US

C07D 180680 26/07/2005

נגזרות של פיפרזין המשמשות לטיפול בהפרעות של קיבה ומעיים

PIPERAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

GLAXO GROUP LIMITED 28/07/2004 0416844.9 GB 08/07/2005 0514029.8 GB


PCT/EP/2005/008263 WO/2006/010629

C07D 180681 20/07/2005

PYRIDINE DERIVATIVES, THEIR הכנתן והשימוש בהן, תולדות פירידיןPREPARATION AND USE

APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

21/07/2004 04103483.6 EP 21/07/2004 60/589621 US PCT/EP/2005/053501 WO/2006/008303

C07D 180682 25/07/2005

הכנתן , הידרוקסיאמיד–Nתולדות והשימוש בהן

N-HYDROXAMIDE DERIVATIVES, THEIR PREPARATION AND USE

APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

26/07/2004 04103574.2 EP 26/07/2004 60/591111 US 31/01/2005 05100641.9 EP 01/02/2005 60/648924 US PCT/EP/2005/053616 WO/2006/010751

B25J 180683 18/07/2005

פעיל הנע של רצועה עם גלגילות הנע מ בעלות מהירות היקפית שונה

DRIVE BELT ACTUATOR WITH DRIVE PULLEYS OF DIFFERENT CIRCUMFERENTIAL SPEED

TIMOTHY JOHN JONES 20/07/2004 0416186.5 GB PCT/GB/2005/002834


555

WO/2006/008515

E02F 180684 22/07/2005

קן לניווט חפירה לעבר מטרה שיטה והת קבורה

METHOD AND DEVICE FOR NAVIGATING EXCAVATION TOWARDS A BURIED TARGET

KEIBERG INTERNATIONAL INC. 22/07/2004 10/896333 US PCT/CA/2005/001160 WO/2006/007732

C23C 180685 26/01/2006

CUTTING INSERT WITH EXCELLENT תותבת חיתוך בעלת קשיחות גבוההTOUGHNESS


31/01/2005 0500234-0 SE PCT/SE/2006/000117 WO/2006/080888

C23C 180686 26/01/2006

תותבות מצופות מקארביד מודבק עבור מכשיר חתוך

COATED CEMENTED CARBIDE CUTTING TOOL INSERTS


31/01/2005 0500235-7 SE PCT/SE/2006/000118 WO/2006/080889

G06F 180688 14/07/2005

A METHOD AND APPARATUS FOR שיטה ומערכת למסירת מפתחותDELIVERING KEYS

QUALCOMM INCORPORATED 14/07/2004 60/588203 US PCT/US/2005/025151


WO/2006/020015

G08B 180689 14/07/2005

-VEHICLE ACTIVATED MILLIMETER שידור בגל מילימטרי מופעל מכשירWAVE INTERROGATING

SAFEVIEW, INC. 16/07/2004 10/893017 US PCT/US/2005/025115 WO/2006/019994

A61L 180690 14/07/2005

התקן ושיטת הזנה ליצירת , עי מילויאמצ מבנה תומך בחלל בעצם

FILLER MEANS, FEEDING DEVICE AND METHOD FOR THE FORMING OF A SUPPORT STRUCTURE IN A BONE CAVITY

SIDLER, BRUNO 14/07/2004 04405451.8 EP PCT/EP/2005/007936 WO/2005/094735

A61K 180691 11/10/2005

ORGANO-GEL FORMULATIONS FOR ל ליישומים רפואיים'ג–תכשירי אורגנוTHERAPEUTIC APPLICATIONS

MEDIQUEST THERAPEUTICS, INC. 08/10/2004 10/960516 US 28/02/2005 11/066485 US 13/06/2005 11/150254 US PCT/US/2005/036064 WO/2006/042059

A01N 180692 30/06/2005

HERBICIDAL AGENTS תכשיר קוטל עשבים



557

C12N 180694 13/01/2005

חומר מסלק רעלים בעל פעילות המשנה אפלטוקסין ואת קידודו הגנטי

A DETOXIFIZYME HAVING ACTIVITY OF TRANSFORMING AFLATOXIN AND THE GENE ENCODES THEREOF

GUANGZHOU CO-WIN BIOENGINEERING CO. LTD.

17/08/2004 200410051120.0 CN PCT/CN/2005/000050 WO/2006/017960

G06K 180695 15/07/2005

מיכשור התייחסות לבדיקת התקני תשלום ללא מגע

REFERENCE EQUIPMENT FOR TESTING CONTACTLESS PAYMENT DEVICES

MASTERCARD INTERNATIONAL INCORPORATED

15/07/2004 60/588270 US PCT/US/2005/025107 WO/2006/019989

G06K 180696 15/07/2005

שיטה ומערכת לביצוע עסקאות באמצעות כרטיסי תשלום ללא מגע

METHOD AND SYSTEM FOR CONDUCTING CONTACTLESS PAYMENT CARD TRANSACTIONS


15/07/2004 60/588270 US PCT/US/2005/025119 WO/2006/019997

G06K 180697 15/07/2005

מערכת לגילוי התנגשות ולהימנעות ם ללא ממנה עבור מערכות כרטיסי תשלו

מגע

COLLISION DETECTION AND AVOIDANCE SCHEME FOR CONTACTLESS CARD PAYMENT SYSTEMS



15/07/2004 60/588270 US PCT/US/2005/025317 WO/2006/020144

G06K 180698 15/07/2005

שיטה ומערכת המשתמשים בביטמפ רת משתנים המתייחסים לעסקאות למסי

באמצעות כרטיסי תשלום ללא מגע במבני נתונים תקניים

METHOD AND SYSTEM USING A BITMAP FOR PASSING CONTACTLESS PAYMENT CARD TRANSACTION VARIABLES IN STANDARDIZED DATA FORMATS


15/07/2004 60/588624 US PCT/US/2005/025221 WO/2006/020073

G06K 180699 15/07/2005

שיטות ומעגלי אפיון עבור אותות כרטיסי תשלום

PAYMENT CARD SIGNAL CHARACTERIZATION METHODS AND CIRCUITS


15/07/2004 60/588270 US PCT/US/2005/025220 WO/2006/020072

G06K 180700 15/07/2005

קורא כרטיסי תשלום ללא מגע עם נפח מקוטעת–עבודה בצורה קונית

CONTACTLESS PAYMENT CARD READER WITH A FRUSTO-CONICAL OPERATING VOLUME



559

15/07/2004 60/588270 US PCT/US/2005/025110 WO/2006/019990

C07D 180702 13/07/2005

DIMERIC PIPERIDINE DERIVATIVES תולדות של פיפרדין דימריים

JANSSEN PHARMACEUTICA N.V. 16/07/2004 60/588711 US 16/07/2004 04103412.5 EP PCT/EP/2005/053351 WO/2006/008260

C07D 180703 13/07/2005

, פיפראזין, תרכובות דימריות של פיפרדיןמורפולין או אנלוגיים שלהם המכילים

אטומים המתאימות 7טבעות בעלות לטיפול באי סדרים הקשורים לניוון עצבי

DIMERIC COMPOUNDS OF PIPERIDINE, PIPERAZINE OR MORPHOLINE OR THEIR 7-MEMBERED ANALOGS SUITABLE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

JANSSEN PHARMACEUTICA N.V. 16/07/2004 60/588446 US 16/07/2004 04103413.3 EP PCT/EP/2005/053345 WO/2006/008259

G05B 180704 14/07/2005

PROGRAMMABLE WALLBOX עמעם למתג תאורה הניתן לתכנותDIMMER

LUTRON ELECTRONICS CO., INC. 15/07/2004 10/892510 US


PCT/US/2005/025002 WO/2006/019918

F01K 180705 18/07/2005

נוזלי עבודה עבור המרת אנרגיה חומנית של חום נפלט מתאי דלק וזאת באמצעות

מערכות ראנקין מעגליות

WORKING FLUIDS FOR THERMAL ENERGY CONVERSION OF WASTE HEAT FROM FUEL CELLS USING RANKINE CYCLE SYSTEMS

HONEYWELL INTERNATIONAL INC. 16/07/2004 10/892913 US PCT/US/2005/025522 WO/2006/014609

A61K 180706 26/07/2005

PHARMACEUTICAL DOSAGE FORMS ילין'צורות מינון רוקחיות הכוללות ראסגINCLUDING RASAGILINE


26/07/2004 60/591359 US 01/09/2004 60/606241 US PCT/US/2005/026517 WO/2006/014973

C07C 180707 21/07/2005

POLYMORPHS OF ATOMOXETINE פולימורפים של אטמוקסטין הידרוכלורידHYDROCHLORIDE


22/07/2004 60/590851 US PCT/US/2005/026008 WO/2006/020348

C07D 180708 22/07/2005

צורות קריסטליניות חדשות של קלציום ותהליכים –אטורבסטטין המי

להכנתן

NOVEL CRYSTAL FORMS OF ATORVASTATIN HEMI-CALCIUM AND PROCESSES FOR THEIR PREPARATION


561


22/07/2004 60/590945 US PCT/US/2005/026015 WO/2006/012499

A61K 180710 24/01/2001

שחרור שתל פרמצבטי ניתן להזרקה בעל מבוקר

CONTROLLED-RELEASE, INJECTABLE PHARMACEUTICAL IMPLANT

ARDANA BIOSCIENCE LIMITED 27/01/2000 09/491978 US PCT/EP/2001/000733 WO/2001/054662

B23B 180711 15/07/2005

כלי , מערכת לחיבור כלי חיתוך למתאם חיתוך ואביזר

SYSTEM FOR CLAMPING A CUTTING HEAD TO AN ADAPTER, A CUTTING HEAD AND A FIXTURE

TEENESS ASA 22/07/2004 20043161 NO PCT/NO/2005/000264 WO/2006/019305

H04S 180712 13/07/2005

צירוף אותות אודיו באמצעות ניתוח קטעי אודיו

COMBINING AUDIO SIGNALS USING AUDITORY SCENE ANALYSIS

DOLBY LABORATORIES LICENSING CORPORATION

03/08/2004 10/911404 US PCT/US/2005/024630 WO/2006/019719

C12P 180713 15/07/2005

IMMUNE MODULATING COMPOUNDS חיסון רכיבים מתכווננים מפטריותFROM FUNGI

MEDIMUSH A/S


16/07/2004 10/892393 US 15/06/2005 PA200500881 DK 15/06/2005 60/690477 US 15/06/2005 PA200500882 DK 15/06/2005 60/690482 US 15/06/2005 PA200500880 DK 15/06/2005 60/690496 US PCT/DK/2005/000498 WO/2006/007848

A61K 180714 20/07/2005

של תערובות מתחלבות יישומים גלניים מעצמן של אקסיפיינטים ליפידיים

GALENIC APPLICATIONS OF SELF-EMULSIFYING MIXTURES OF LIPIDIC EXCIPIENTS

AVENTIS PHARMA S.A. 27/07/2004 0408269 FR PCT/FR/2005/001853 WO/2006/018501

H01L 180715 15/01/2007

אוטומטי של שיטה ותהליך לייצור אלקטרים–מפסקים פיאזו

A METHOD FOR THE FULLY AUTOMATED PRODUCTION OF A PIEZOELECTRIC SWITCH AND A PROCESS THEREFOR

BARAN ADVANCED TECHNOLOGIES מ"בע) 86(ברן טכנולוגיות מתקדמות (86) LTD.

B01J 180716 02/07/2005

גתי של שיטה ומתקן לייצור הדר ידי שימוש בהמסת עיבוי–פולימרים על

METHOD AND DEVICE FOR THE GRADUAL PRODUCTION OF POLYMERS USING MELT CONDENSATION


563

ZIMMER AKTIENGESELLSCHAFT 17/07/2004 102004034708.5 DE PCT/EP/2005/007171 WO/2006/007966

A61K 180717 04/08/2005

IL IL-17 ANTAGONISTIC ANTOBODIES – 17ים אנטגוניסטים נוגדנ

NOVARTIS AG 05/08/2004 0417487.6 GB PCT/EP/2005/008470 WO/2006/013107

C07D 180718 01/11/2000

מודולטורים חיוביים של אגוניסטים של רצפטור ניקוטיני

POSITIVE MODULATORS OF NICOTINIC RECEPTOR AGONISTS


G02B 180719 06/07/2005

עדשות עם מרחק פוקלי משתנה ומערך מראות הנשלטות –עדשות המכילות מיקרו

באופן יחידני

VARIABLE FOCAL LENGTH LENS AND LENS ARRAY COMPRISING DISCRETELY CONTROLLED MICROMIRRORS

STEREO DISPLAY, INC. 16/07/2004 10/893039 US PCT/US/2005/023920 WO/2006/019571

B23K 180720 14/07/2005

SOLDER PASTE DISPENSER FOR A מנפק משחת לחם עבור מדפסת תדמיותSTENCIL PRINTER

SPEEDLINE TECHNOLOGIES, INC.


15/07/2004 10/891625 US PCT/US/2005/025071 WO/2006/019966

C07D 180721 15/07/2005

אגוניסטים של קולטני ניקוטין לטיפול במחלות דלקתיות

NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES

UNIVERSITE LAVAL 15/07/2004 10/890987 US PCT/CA/2005/001120 WO/2006/005195

C07D 180722 15/07/2005

תולדות תיאינופירימידין ותכשירי רוקחות המכילים אותן

THIENOPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

SUNESIS PHARMACEUTICALS, INC. 16/07/2004 60/588718 US 01/12/2004 60/632568 US PCT/US/2005/025340 WO/2006/036266

G01C 180723 04/01/2007

LEVELING DEVICE פלס .KAPRO INDUSTRIES LTD מ"קפרו תעשיות בע

C07K 180725 19/07/2005

, 4–אנגיופיוטין–מעכבים של חלבון דמוי םתצריפיהם ושימוש בה

INHIBITORS OF ANGIOPOIETIN-LIKE 4 PROTEIN, COMBINATIONS, AND THEIR USE

GENENTECH, INC.


565

20/07/2004 60/589782 US PCT/US/2005/025734 WO/2006/014729

B23K 180726 27/07/2005

שיטה ומכשיר להרכבה אוטומטית והלחמת לייזר של מכשור רפואי

METHOD AND APPARATUS FOR AUTOMATED ASSEMBLY AND LASER WELDING OF MEDICAL DEVICES

MEDTRONIC, INC. 28/07/2004 10/900858 US PCT/US/2005/026691 WO/2006/015068

C07K 180727 18/08/2005

פפטידים אנטי מיקרוביאליים המכילים או ליזין/מוטיב של ארגינין ו

ANTIMICROBIAL PEPTIDES COMPRISING AN ARGININE AND/OR LYSINE -CONTAINING MOTIF

NOVABIOTICS LIMITED 18/08/2004 0418414.9 GB 14/03/2005 11/079795 US PCT/GB/2005/003245 WO/2006/018652

G02C 180728 22/02/2005

משקפיים מסוג חסר מסגרת הכוללים נטולות ציר מניתנות , תייל צידיותזרועות לכיפוף

FRAMELESS-TYPE SPECTACLES COMPRISING HINGE-FREE, BENDABLE WIRE SIDEARMS


MINIMA 19/08/2004 0408983 FR PCT/FR/2005/000406 WO/2006/027428

C07F 180729 15/07/2005

COMPOUNDS AND METHODS FOR תרכובות ושיטות לטיפול בסרטןTREATMENT OF CANCER

THE TEXAS A&M UNIVERSITY SYSTEM

16/07/2004 60/588596 US PCT/US/2005/025192 WO/2006/020048

C07K 180733 15/07/2005

APOLIPOPROTEIN A1 MIMETICS ושימושיהם1Aמחקי אפוליפופרוטאין AND USES THEREOF

TRUSTEES OF TUFTS COLLEGE 16/07/2004 60/588722 US PCT/US/2005/025182 WO/2006/020040

C12N 180734 15/07/2005

טרנסגן של רטינל דיסטרופין ושיטות לשימוש בו

RETINAL DYSTROPHIN TRANSGENE AND METHODS OF USE THEREOF

THE CHILDREN'S MERCY HOSPITAL 16/07/2004 60/588700 US 09/09/2004 60/608252 US 24/09/2004 60/613026 US 04/02/2005 11/050911 US PCT/US/2005/025375 WO/2006/020184

A61L 180735 19/07/2005

קישור חומרים פעילים לפני שטח מוליכים של גופים שונים

MODIFIED CONDUCTIVE SURFACES HAVING ACTIVE SUBSTANCES ATTACHED THERETO

.ELUTEX LTD מ"אלוטקס בע


567

19/07/2004 60/588749 US PCT/IL/2005/000769 WO/2006/008739

C07D 180736 13/07/2005

נגזרות של הידנטואין לטיפול במחלות דלקתיות

HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS

SCHERING CORPORATION 16/07/2004 60/588502 US PCT/US/2005/024771 WO/2006/019768

C07C 180737 26/08/2005

נגזרות ארילסולפונילסטילבין לטיפול באינסומניה ומצבים קשורים

ARYLSULPHONYLSTILBENE DERIVATIVES FOR TREATMENT OF INSOMNIA AND RELATED CONDITIONS

MERCK SHARP & DOHME LTD 27/08/2004 0419192.0 GB PCT/GB/2005/003353 WO/2006/021806

C07D 180738 15/07/2005

C INHIBITORS OF HCV REPLICATIONמעכבי שכפול של וירוס הפטיטיס

BRISTOL-MYERS SQUIBB COMPANY 09/08/2004 60/608932 US 11/03/2005 60/660555 US 14/07/2005 11/181639 US PCT/US/2005/025234 WO/2006/020082

A61K 180739 04/08/2005

פורמולציות פנופיבראט חדישות ושיטות טיפול קשורות

NOVEL FENOFIBRATE FORMULATIONS AND RELATED METHODS OF TREATMENT


TRANSFORM PHARMACEUTICALS, INC.

06/08/2004 60/599320 US 27/08/2004 60/604861 US 24/02/2005 60/655762 US 06/06/2005 60/687704 US PCT/US/2005/027806 WO/2006/017692

A61K 180740 25/07/2005

שיטות והרכבים תזונתיים לטיפול או מניעה של אוסטיאופרוזיס

NUTRITIONAL COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS

ABBOTT LABORATORIES 28/07/2004 60/591656 US PCT/US/2005/026342 WO/2006/014878

B41J 180742 25/07/2005

METHOD OF MANUFACTURE שיטת ייצור XAAR TECHNOLOGY LIMITED 23/07/2004 0416523.9 GB PCT/GB/2005/002923 WO/2006/008555

H04Q 180743 18/07/2005

HANDOFFקצב שידור משתנה עם SOFT

VARIABLE RATE BROADCAST WITH SOFT HANDOFF


H04L 180744 18/07/2005


569

אומדן חוזר של ערוץ והפרעה עם צלילי PILOT מוקצים ל OFDMA

ITERATIVE CHANNEL AND INTERFERENCE ESTIMATION WITH DEDICATED PILOT TONES FOR OFDMA


H04L 180745 15/07/2005

לאומדן PILOTהחרדה הדרגתית של ערוץ והפרעה

INCREMENTAL PILOT INSERTION FOR CHANNEL AND INTERFERENCE ESTIMATION


B22D 180746 16/01/2007

פריט מעוצב בהזרקת מתכת עם פיזור אטום לקרינה ושיטות לעשייה זהה

METAL INJECTION MOLDED ARTICLE WITH A RADIOPAQUE DISPERSION AND METHODS OF MAKING SAME

ACCELLENT, INC. 27/01/2006 11/342182 US

C09D 180747 30/06/2005

AN INK-JET PRINTING PROCESS AND דיו ותהליך הזרקת דיוINK

SUN CHEMICAL B.V. 23/07/2004 0416571.8 GB PCT/GB/2005/002589 WO/2006/008441


H04S 180749 15/08/2005

ל שיטה להרחבת ערבוב קול למילוי כ הערוצים היוצאים הפנויים

METHOD FOR EXPANDING AN AUDIO MIX TO FILL ALL AVAILABLE OUTPUT CHANNELS

DOLBY LABORATORIES LICENSING CORPORATION

23/08/2004 10/924757 US PCT/US/2005/029164 WO/2006/023509

B65D 180750 14/07/2005

CONTAINER מיכל

MICHAEL JAMES WARWICK 19/07/2004 2004/5728 ZA PCT/IB/2005/052342 WO/2006/011093

C07K 180752 19/07/2005

תרכובות ושיטות לשימוש בחלבון דמוי 4אנגיופויטין

COMPOSITIONS AND METHODS OF USING ANGIOPOIETIN-LIKE 4 PROTEIN


F41G 180753 17/01/2007

נקודה אדומה "מתקן תצפית משופר מסוג "נעה

IMPROVED "MOVING RED DOT" SIGHTING DEVICE

"FN HERSTAL" S.A. 08/02/2006 2006/0078 BE


571

A61B 180754 17/01/2007

חללי לחיבור –תוך, אליפטי, מהדק כירורגי רקמות

ELLIPTICAL INTRALUMINAL SURGICAL STAPLER FOR ANASTOMOSIS

ETHICON ENDO-SURGERY, INC. 01/02/2006 11/344542 US

C12N 180755 04/08/2005

ושיטות לשימוש AHASSרצפי מונוקוט בהם

MONOCOT AHASS SEQUENCES AND METHODS OF USE

BASF PLANT SCIENCE GMBH 04/08/2004 60/598671 US PCT/US/2005/027729 WO/2006/015376

C07D 180757 26/07/2005

שימושיהם , פירימידינים ] D–5 , 4[אמידזו ושיטות להכנתם

IMIDAZO[4,5-D] PYRIMIDINES, THEIR USES AND METHODS OF PREPARATION


C07D 180759 01/08/2005

אינדזולים היעילים לטיפול במחלות כלי דם ולב

INDAZOLES USEFUL IN TREATING CARDIOVASCULAR DISEASES

WYETH 03/08/2004 60/598573 US 08/04/2005 60/669737 US PCT/US/2005/026970 WO/2006/017284


C07D 180760 29/09/2005

פירימידינים מותמרים בהטרוציקליים או ב HIV קרבו כמעכבי –5

HIV INHIBITING 5-CARBO- OR HETEROCYCLIC SUBSTITUTED PYRIMIDINES

TIBOTEC PHARMACEUTICALS LTD. 30/09/2004 04104814.1 EP PCT/EP/2005/054931 WO/2006/035068

C07K 180762 19/07/2005

פורמולציות של קוניוגטים של אוליגומרי אינסולין ושימוש בהן

INSULIN-OLIGOMER CONJUGATES, FORMULATIONS AND USES THEREOF

NOBEX CORPORATION 19/07/2004 60/589058 US 15/10/2004 60/619153 US 02/12/2004 60/632578 US 24/02/2005 60/655803 US 24/02/2005 60/655838 US PCT/US/2005/025644 WO/2006/014673

C07D 180763 27/12/2005

קרבוקסאמידי פאניל דיאזאפן ואנאלייטד קרבוקסאמידי פאניל

דיאזאפן המכילים חמצן ובשימוש כאנטגוניסטים

D 3של

PHENYL DIAZEPANE CARBOXAMIDES AND ANNELATED PHENYL PIPERAZINE CARBOXAMIDES CONTAINING OXYGEN AND USED AS DOPAMINE D3 ANTAGONISTS

SCHWARZ PHARMA AG 30/12/2004 102004063797.0 DE PCT/EP/2005/014047 WO/2006/072430


573

C23C 180764 29/07/2005

לשיקוע של ) II(לקסים של נחושת קומפפילמים של נחושת על ידי שיקוע של

שכבות אוטומיות

COPPER (II) COMPLEXES FOR DEPOSITION OF COPPER FILMS BY ATOMIC LAYER DEPOSITION

E.I. DU PONT DE NEMOURS AND COMPANY

30/07/2004 60/592785 US 30/07/2004 60/592816 US PCT/US/2005/027019 WO/2006/015225

B29C 180765 02/08/2005

תהליך עיצוב בטמפרטורה נמוכה לעשיית פריטים מוצקים הניתנים לפירוק ביולוגי

LOW TEMPERATURE MOLDING PROCESS FOR MAKING SOLID BIODEGRADABLE ARTICLES

R&D GREEN MATERIALS, LLC 05/08/2004 60/599215 US PCT/US/2005/027380 WO/2006/017481

C07D 180766 20/07/2005

הכנתם ושימושם , תולדות אמינופיפרידין כאגוניסטים של קולטני מלנוקורטין

AMINOPIPERIDINE DERIVATIVES , PREPARATION THEREOF AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONISTS



H04N 180767 20/07/2005

FRAMEשיטה ומערכת להמרה מבוססת RATE UP עבור דחיסת וידאו )FRUC–EA(

METHOD AND APPARATUS FOR ENCODER ASSISTED-FRAME RATE UP CONVERSION (EA-FRUC) FOR VIDEO COMPRESSION

QUALCOMM INCORPORATED 20/07/2004 60/589901 US PCT/US/2005/025813 WO/2006/012384

C23C 180768 29/07/2005

לשיקוע של ) II(קומפלקסים של נחושת פילמים של נחושת על ידי שיקוע של

שכבות אוטומיות

COPPER (II) COMPLEXES FOR DEPOSITION OF COPPER FILMS BY ATOMIC LAYER DEPOSITION

E.I. DU PONT DE NEMOURS AND COMPANY

30/07/2004 60/592785 US 30/07/2004 60/592816 US PCT/US/2005/026953 WO/2006/015200

G06F 180769 28/06/2005

SYSTEM FOR PROVIDING ACCESS מערכת לאספקת גישה למידע תפעוליTO OPERATION INFORMATION

NDS LIMITED 16/08/2004 60/601890 US 16/08/2004 0418279.6 GB PCT/IL/2005/000685 WO/2006/018827


575

C07D 180770 20/07/2005

הכנתן והשימוש , תולדות אוקסופיפרידין הרפואי בהן

OXOPIPERIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF


A61K 180771 19/07/2005

תכשיר רפואי המכיל נורוטוקסין של בוטולינום

THERAPEUTIC COMPOSITION WITH A BOUTULINUM NEUROTOXIN

MERZ PHARMA GMBH & CO. KGAA 26/07/2004 60/591196 US PCT/US/2005/025408 WO/2006/020208

A61K 180772 03/08/2005

CARRIER FOR ENTERAL מעי–נשא למתן תוךADMINISTRATION

VITAL HEALTH SCIENCES PTY LTD. 03/08/2004 2004904366 AU 07/04/2005 2005901723 AU PCT/AU/2005/001159 WO/2006/012692

F26B 180773 19/07/2005

תהליך ומערכת לייבוש וטיפול בחום בחומרים

PROCESS AND SYSTEM FOR DRYING AND HEAT TREATING MATERIALS

EARTHRENEW IP HOLDINGS LLC 19/07/2004 10/895030 US PCT/US/2005/025640 WO/2006/014670


F26B 180774 18/07/2005

PROCESS AND APPARATUS OF תהליך ומכשיר לייבוש חומר גלם לדישוןFEEDSTOCK DRYING FERTILIZER

EARTHRENEW IP HOLDINGS LLC 19/07/2004 60/894645 US PCT/US/2005/025466 WO/2006/020253

C07D 180775 19/07/2005

7לין ניקוטיני מאפננים של קולטן אצטילכו ושימושיהם?

MODULATORS OF ALPH7 NICOTINIC ACETYLCHOLINE RECEPTORS AND THERAPEUTIC USES THEREOF

SIENA BIOTECH S.P.A. 20/07/2004 60/589003 US PCT/EP/2005/007846 WO/2006/008133

A63B 180776 15/08/2005

FREE STANDING BALLET BAR צמאימתקן קורה לתרגול בלט העומד עEXERCISE DEVICE

FLUIDITY ENTERPRISES, INC. 16/08/2004 10/710975 US PCT/US/2005/028988 WO/2006/023446

C07D 180777 28/09/2005

און חדשות והשימוש –2–תולדות כרומןבהן כמעכבי ספיגה חוזרת של נוירוטרנסמיטרים מונואמיניים

NOVEL CHROMEN-2- ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS

NEUROSEARCH A/S 30/09/2004 60/614052 US 30/09/2004 PA200401491 DK PCT/EP/2005/054861 WO/2006/035034


577

A61B 180778 18/01/2007

LANCING DEVICE WITH DAMPENED פיץ מרסןהתקן ניקוב עם קSPRING

LIFESCAN, INC. 20/01/2006 60/760497 US 31/03/2006 11/395908 US

A61B 180779 18/01/2007

LANCING DEVICE WITH DAMPENER התקן ניקוב עם מרין


A61B 180780 18/01/2007

METHOD FOR DAMPENED LANCING שיטה לריסון ניקוב


C07F 180781 26/07/2005

אנלוגים פוספונאטים של תרכובות HIVמעכבות

PHOSPHONATE ANALOGS OF HIV INHIBITOR COMPOUNDS



C12N 180782 22/07/2005

סמנים לתאי אב נוירוניים דופאמינרגיים CORIN /4 Lrp

Lrp4/CORIN DOPAMINERGIC NEURON PROGENITOR CELL MARKERS

EISAI CO. LTD.

22/07/2004 2004-213743

JP

29/10/2004 2004-315060 JP PCT/JP/2005/013453 WO/2006/009241

F01D 180783 18/01/2007

CERAMIC MATRIX LAMINATES שכבות מטריצה קרמיות

UNITED TECHNOLOGIES CORPORATION

20/01/2006 60/760990 US 17/01/2007 11/654302 US

C12Q 180784 25/07/2005

שיטה ומתקן בדיקת אימונו לגילוי דלקת התוספתן

A METHOD AND AN IMMUNOASSAY TEST DEVICE FOR DETECTING APPENDICITIS

ASPENBIO PHARMA, INC. 23/07/2004 60/590631 US PCT/US/2005/026218 WO/2006/012588

C12N 180786 03/08/2005

ידי שינוי –שיטת אפנון לביטוי גנים על CPGתוכן של

METHOD FOR MODULATING GENE EXPRESSION BY ALTERING THE CPG CONTENT

GENEART AG 03/08/2004 102004037611.5 DE 03/08/2004 102004037652.2 DE PCT/EP/2005/008423 WO/2006/015789


579

C07D 180787 25/07/2005

טריאזנים מותמרים כליגנדים של חלבוני פריון והשימוש בהם לזיהוי או הסרה של

פריונים

SUBSTITUTED TRIAZINES AS PRION PROTEIN LIGANDS AND THEIR USE TO DETECT OR REMOVE PRIONS

PROMETIC BIOSCIENCES LIMITED 27/07/2004 0416699.7 GB PCT/GB/2005/002910 WO/2006/010915

C07D 180788 28/07/2005

וקולטן VEGFמעכבי איתות של קולטן HGF

INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING

METHYLGENE, INC. 30/07/2004 60/592913 US 20/05/2005 60/683038 US PCT/CA/2005/001177 WO/2006/010264

C07K 180789 02/08/2005

IL– 4נוגדנים אנושיים מונוקלונליים נגד אנושי

HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN IL-4

NOVARTIS AG 03/08/2004 0417301.9 GB 03/08/2004 0417302.7 GB 03/08/2004 0417303.5 GB 03/08/2004 0417304.3 GB 03/08/2004 0417305.0 GB 03/08/2004 0417306.8 GB PCT/EP/2005/008361 WO/2006/013087


C07D 180790 27/07/2005

PYRROLO-PYRIDINE KINASE פירידין–מאפנני קינז פירולוMODULATORS

SGX PHARMACEUTICALS, INC. 27/07/2004 60/591888 US 27/07/2004 60/591887 US 19/05/2005 60/683510 US PCT/US/2005/026792 WO/2006/015123

C07D 180791 27/07/2005

MAOB BENZYLOXY DERIVATIVES ASנגזרות בנזילאוקסי כמעכבי MAOB INHIBITORS

F. HOFFMANN-LA ROCHE AG 02/08/2004 04103710.2 EP PCT/EP/2005/008143 WO/2006/013049

A47B 180792 18/01/2007

תפילין , ספרי תורה(ם "שולחן לכתיבת סת, רישום גראפי, כתיבה חופשית, )ומזוזות

גראפיקה ידנית וכל אופן כתיבה בעל אפיון דומה

TABLE FOR "STAM" WRITING (TORA BOOKS, PHYLACTERIES, MEZUZAH), FREE WIRITING, GENERAL WRITING, GRAPHIC ARTS, DRAWING, WHICH HAVE SIMILAR CHARACTERISTICS.

ELIRAN ELDAR אלירן אלדר

B61L 180793 18/01/2007

שיטה לזיהוי מכשולים על פסי רכבת ומניעת תאונות רכבת

A METHOD OF DETECTING OBSTACLES ON RAILWAYS AND PREVENTING TRAIN ACCIDENTS

TAL ISRAELI אליטל ישר 13/02/2006 US60/760781 US


581

A61B 180794 11/05/2005

מכשירים רפואיים המיוצרים מסגסוגות עם זיכרון צורתן המופיעות מעמד

ושיטה , מרטינסיטי ממושך במאמץ לשימושם

MEDICAL DEVICES FORMED FROM SHAPE MEMORY ALLOYS DISPLAYING A STRESS-RETAINED MARTENSITIC STATE AND METHOD FOR USE THEREOF

.NITI MEDICAL TECHNOLOGIES LTD מ"ניטי טכנולוגיות רפואיות בע 30/07/2004 10/903823 US PCT/IL/2005/000492 WO/2006/011127

C07D 180797 20/07/2005

הכנתם ושימושים , טרופאן–תולדות אמינו רפואיים בהם

AMINO-TROPANE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF


G02B 180798 31/08/2005

תהליך להתאמת קיזוז מאפייני מתח חשמלי של מאפנן אינטרפרומטרי

PROCESS FOR MODIFYING OFFSET VOLTAGE CHARACTERISTICS OF AN INTERFEROMETRIC MODULATOR

IDC, LLC 27/09/2004 60/613499 US 19/08/2005 11/208052 US PCT/US/2005/030962 WO/2006/036439

H04L 180799 20/07/2005

מעבר ערוצי שידור בתשורת סלולרית בין ולרית ומערכת תקשורת סלSIPרשת

HANDOFF BETWEEN A SIP NETWORK AND A CELLULAR COMMUNICATION SYSTEM



C12N 180802 20/07/2005

בררניים SIRNAS A 5– EIF–שימוש בס לאפופטוזה ופולינוקלאוטידים אנטיסנ

דיכוי תגובה דלקתית/לעיכוב

USE OF APOPTOSIS-SPECIFIC EIF-5A SIRNAS AND ANTISENSE POLYNUCLEOTIDES TO INHIBIT/SUPPRESS AN INFLAMMATORY RESPONSE

SENESCO TECHNOLOGIES, INC. 20/07/2004 60/589073 US PCT/US/2005/025766 WO/2006/014752

F41H 180803 08/06/2005

התקן עם גלאי מגנטי להגנה על כלי רכב צבאי או אזרחי נגד מוקשים

DEVICE FOR PROTECTING A MILITARY OR CIVILIAN VEHICLE AGAINST MINES WITH MAGNETIC DETECTION

GIAT INDUSTRIES 23/07/2004 0408212 FR PCT/FR/2005/001407 WO/2006/021630

C07C 180804 02/02/2005

ZONE REACTOR כור תגובה למקטעים

GRT, INC. 19/07/2004 10/894165 US PCT/US/2005/002829 WO/2006/019399

G09B 180805 01/06/2005

SYSTEM AND METHOD FOR מערכת ושיטה למעקב על נהיגהMONITORING DRIVING

,DRIVE DIAGNOSTIC LTD מ"דרייב דיאגנוסטיקה בע 20/07/2004 10/894345 US PCT/IL/2005/000566


583

WO/2006/008731

C07D 180806 20/07/2005

IMIDAZOPYRAZINE AS TYROSINE אימידאזופיראזינים כמעכבי טירוזין קינאזKINASE INHIBITORS

OSI PHARMACEUTICALS, INC. 20/07/2004 60/589514 US PCT/US/2005/025891 WO/2006/012422

A61B 180807 20/07/2005

OBSTETRIC VACUUM EXTRACTOR שולפן וואקום לסיוע בלידה

MONTY MEDICAL LIMITED 20/07/2004 0416172.5 GB PCT/GB/2005/002863 WO/2006/008532

H01K 180808 18/01/2007

A LAMP AND A METHOD FOR מנורה ושיטה להארהILLUMINATING

HERSHNZON GALI הירשנזון גלי

B60J 180809 27/05/2005

מבנה למינציה שקוף שיש לו שכבות עם פילם הניתן לקילוף לשימוש במגן רוח של

כלי טיס

TRANSPARENT LAMINATED STRUCTURE HAVING PEEL-AWAY FILM LAYERS FOR USE ON AIRCRAFT WINDSCREENS

UNITED PROTECTIVE TECHNOLOGIES, LLC

30/07/2004 10/909129 US PCT/US/2005/018771 WO/2006/028532


C07D 180810 16/08/2005

אננטיומרים של פירימידונים מאוחים נבחרים ושימושים בטיפול ובמניעה של

סרטן

ENANTIOMERS OF SELECTED FUSED PYRIMIDONES AND USES IN THE TREATMENT AND PREVENTION OF CANCER

ASTRAZENECA AB 18/08/2004 60/602366 US PCT/GB/2005/003207 WO/2006/018628

C07D 180811 16/08/2005

הטרוציקלים מאוחים נבחרים ושימושים בהם

SELECTED FUSED HETEROCYCLICS AND USES THEREOF

ASTRAZENECA AB 18/08/2004 60/602399 US PCT/GB/2005/003202 WO/2006/018627

A61B 180813 20/07/2005

מערכת ושיטה למדידת , מכשיר לביש או סביבתיים/פרמטרים פיסיולוגיים ו

WEARABLE DEVICE, SYSTEM AND METHOD FOR MEASURING PHYSIOLOGICAL AND/OR ENVIRONMENTAL PARAMETERS

.TADIRAN SPECTRALINK LTD מ"תדיראן ספקטרלינק בע 21/07/2004 60/589581 US 21/07/2004 60/589572 US PCT/IL/2005/000772 WO/2006/008740


585

B65D 180815 20/07/2005

מנגנון מודולרי ושיטה לפיסול שטח של מפרק

MODULAR APPARATUS AND METHOD FOR SCULPTING THE SURFACE OF A JOINT

ALEXANDRIA RESEARCH TECHNOLOGIES LLC

20/07/2004 60/589320 US 20/07/2005 11/186485 US PCT/US/2005/025794 WO/2006/012370

A61K 180817 20/07/2005

עיכוב ספציפי של אוטואימוניות ומחלות קשורות לאוטואנטיגנים

SPECIFIC INHIBITION OF AUTOIMMUNITY AND DISEASES ASSOCIATED WITH AUTOANTIGENS

ISOGENIS, INC. 20/07/2004 60/589707 US 29/09/2004 60/614529 US PCT/US/2005/025878 WO/2006/012416

F21L 180818 24/10/2005

RUGGEDIZED DIGITAL LOW -LIGHT מכשיר דיגיטלי קשיח לראיה באור נמוךVIEWING DEVICE

XENONICS, INC. 22/10/2004 60/621415 US 18/02/2005 11/060903 US PCT/US/2005/038652 WO/2006/047630

B60T 180819 21/01/2007

INTENCITY BREAKING INDCATOR חיווי עוצמת בלימה

ארז עזר


B23D 180820 21/01/2007

ROTATABLE HOUSING DEVICE התקן מעטה הניתן לסיבוב YEFIM KERETH יפים קרת

H04L 180821 23/06/2005

END USER RISK MANAGEMENT ניהול סיכון משתמש סופי

REFLECTENT SOFTWARE, INC. 20/07/2004 10/894714 US PCT/US/2005/022352 WO/2006/019513

F01D 180822 28/01/2005

FAN BLADES AND MODIFICATIONS להבי מניפה ותאומים

DELTA T CORPORATION 21/07/2004 60/589945 US PCT/US/2005/002703 WO/2006/022812

A62C 180823 13/06/2005

DISCHARGE OF FIRE פריקה של חומר לכיבוי אשEXTINGUISHING AGENT

KIDDE IP HOLDINGS LIMITED 21/07/2004 10/895729 US PCT/GB/2005/002398 WO/2006/008436


587

H04L 180824 14/07/2005

שיטה לאספקת אינדיקציית פער במהלך משימה דביקה

A METHOD OF PROVIDING A GAP INDICATION DURING A STICKY ASSIGNMENT


H04L 180825 20/07/2005

מתזמן מודע לפקטות במערכות תקשורת אלחוטית

PACKET AWARE SCHEDULER IN WIRELESS COMMUNICATION SYSTEMS


H04L 180826 11/07/2005

סינון תחום תדר לשיפור אומדן ערוץ במערכת מרובות אותות תקשורת

FREQUENCY DOMAIN FILTERING TO IMPROVE CHANNEL ESTIMATION IN MULTICARRIER SYSTEMS


H04N 180827 21/07/2005

METHOD AND APPARATUS FOR שיטה ומערכת להעברת וקטור תנועהMOTION VECTOR ASSIGNMENT



H04L 180828 19/07/2005

CONTROLLING AND MANAGING בקרה וניהול גישה ורשתות מרובותACCESS TO MULTIPLE NETWORKS


H04B 180829 19/07/2005

בקרת כוח של חיבור חוזר במערכת אורטוגונלית

REVERSE LINK POWER CONTROL IN AN ORTHOGONAL SYSTEM


H04Q 180830 11/07/2005

EFFICIENT SIGNALING OVER איתות יעיל מעבר ערוץ גישהACCESS CHANNEL


A47K 180831 21/01/2007

METHOD AND APPARATUS FOR נוזל–שיטה ומתקן למיצוי נוזלLIQUID-LIQUID EXTRACTION

LAVIE, RAM לביא רם


589

C07H 180832 21/07/2005

–די–פלואורו–2–דאוקסי–2תכשיר של אלקיל פירידינים –ריבופוראנוסיל מותמר ופורינים ונגזרותיהם

PREPARATION OF ALKYL-SUBSTITUTED 2-DEOXY-2 FLURO-D-RIBOFURANOSYL PYRIMIDINES AND PURINES AND THEIR DERIVATIVES

PHARMASSET, INC. 21/07/2004 60/589866 US 09/09/2004 60/608320 US PCT/US/2005/025916 WO/2006/012440

A23L 180834 22/07/2005

ANTI-HYPERTENSIVE FUNCTIONAL תוצרי מזון פעילים נגד יתר לחץ דםFOOD PRODUCTS

GLOBUS EGG SCIENCES B.V. 22/07/2004 60/589902 US 27/01/2005 05100544.5 EP PCT/NL/2005/000535 WO/2006/009448

G01N 180835 21/07/2005

שיטה ומכשיר לבדיקת דוגמת משטח ושימוש בחמרים פלורסטיים

METHOD AND APPARATUS FOR INSPECTING A SPECIMEN SURFACE AND USE OF FLUORESCENT MATERIALS

NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO

23/07/2004 04077130.5 EP PCT/NL/2005/000529 WO/2006/009444


A62C 180836 19/07/2005

THERMOSENSITIVE SPRINKLER ממטיר רגיש חום KIL, JONG-JIN

28/07/2004 10-2004-0059444

KR

04/07/2005 10-2005-0059693 KR

PCT/KR/2005/002319 WO/2006/011725

C12Q 180837 28/07/2005

הייחודיות , שיטות לקביעת החוזק סינטאז 2Dוהרעילות של פרודטגלנדין

מטופויטיה

METHODS FOR DETERMINING THE POTENCY, SPECIFICITY, AND TOXICITY OF HEMATOPOIETIC PROSTAGLANDIN D2 SYNTHASE

AVENTIS PHARMACEUTICALS INC. 30/07/2004 60/592501 US PCT/US/2005/026945 WO/2006/015195

B60C 180838 21/01/2007

חרוזי טבעתי תהליך להכנת גוף חיתוך עבור חיתוך –להקצעה לתיל

חומרים קשים יחסית

PROCESS FOR MAKING AN ANNULAR ABRASION BEAD ELEMENT FOR A CUTTING WIRE FOR CUTTING RELATIVELY HARD MATERIALS

AROS S.R.L. 23/01/2006 VR2006A000016 IT

H01L 180840 20/07/2005

EXPOSURE METHOD AND DEVICE יטה לייצר מתקןשיטת חשיפה ושMANUFACTURING METHOD

NIKON CORPORATION

21/07/2004 2004-212756

JP

29/06/2005 2005-190728 JP PCT/JP/2005/013311 WO/2006/009169


591

F02B 180841 20/07/2004

מזרק מונעת באופן הידראולי עם –משאבה עבור מנועי בעירה פנימייםמנגנון בקרה

HYDRAULICALLY DRIVEN PUMP-INJECTOR WITH CONTROLLING MECHANISM FOR INTERNAL COMBUSTION ENGINES

.MAZREK LTD מ"מזרק בע PCT/IL/2004/000656 WO/2006/008726

F02M 180842 20/07/2004

קפיץ עבור –התקן נעילה עם מנגנון מחטמזרק המיועדת למנועי בעירה –משאבה פנימיים

NEEDLE-SPRING LOCKING DEVICE FOR PUMP-INJECTOR (INJECTOR) FOR INTERNAL COMBUSTION ENGINES


F02M 180843 20/07/2004

מזרק מונעת באופן הידראולי עם –משאבההגברת לחץ רב שלבית עבור מנועי

בעירה פנימיים

HYDRAULICALLY DRIVEN PUMP-INJECTOR WITH MULTISTAGE PRESSURE AMPLIFICATION FOR INTERNAL COMBUSTION ENGINES


A61K 180844 22/07/2005

COMPOSITIONS AND METHODS FOR יטות לטיפול בדימום יתרתכשירים ושTREATING EXCESSIVE BLEEDING

ALLAN D., PRONOVOST 22/07/2004 60/590214 US 23/07/2004 60/590845 US PCT/US/2005/026105 WO/2006/012541


G01N 180845 26/07/2005

VIBRATION SENSOR חיישן תנודות

SPIDER TECHNOLOGIES SECURITY LTD.

26/07/2004 60/590896 US PCT/IL/2005/000797 WO/2006/011145

C07D 180846 25/07/2005

ארילאטאנים או ) הטרו(טטרא – 2, 2, 1, 1 טרי –2,1,1

הטרוציקלילאטאנים –2–אריל) הטרו( כמעכבי תעלות אשלגן

1,1,2,2-TETRA (HETERO) ARYLETHANES OR 1,1,2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS POTASSIUM CHANNEL INHIBITORS

MERCK & CO., INC. 29/07/2004 60/592181 US PCT/US/2005/026334 WO/2006/028590

G07D 180847 19/07/2005

DEVICE AND METHOD FOR VERIFYING מכשיר ושיטה לאימות מסמכי ערךVALUE DOCUMENTS

GIESECKE & DEVRIENT GMBH 22/07/2004 102004035494.4 DE PCT/EP/2005/007872 WO/2006/010537


593

-ז " לחוק הפטנטים תשכ26הודעה לפי סעיף 1976

NOTICE UNDER SECTION 26 OF THE PATENTS LAW, 5727-1967

סמים להלן קובלו הבקשות שפרטיהן מתפרכל המעונין . לחוק הפטנטים17לפי סעיף

להתנגד למתן פטנט על פי בקשה מהבקשות תוך שלושה חדשים , המתפרסמות רשאי

להגיש לרשם הפטנטים , מתאריך יומן זה לחוק הפטנטים 30הודעת התנגדות לפי סעיף

ואילך לתקנות 57בדרך הקבועה בתקנה .1968 –ח "תשכ, הפטנטים

The applications, particulars of which are set out below, have been accepted pursuant to Section 17 of the Patents Law. Any person wishing to oppose the grant of a patent on any of the applications published here, may, within three months from the date of this journal, give to the Commissioner of Patents notice under Section 30 of the Patents Law, in the manner prescribed in regulations 57 et seq of the Patents Regulations, 5728-1968

פרטי הבקשות במידה ויישימים מובאים לפי

:סדר זהParticulars of the applications, where applicable, are given in the following order:

Number of application [21] [11] מספר הבקשה Title of invention [54] שם האמצאה

Application date [22] תאריך הבקשה מדינת –יך של בקשות החוץ מספר ותאר

האגוד[31] [32] [33] Number and date of foreign application – convention country.

.Int.Cl [51]* מהדורה שביעית–סיווג בינלאומי * Application for patent of addition [61] בקשה לפטנט מוסף

Divisional application [62] בקשת חלוקה Applicant [71] קשהמב

Inventor [72] הממציא International Publication Number [87] פרסום של בקשה הבינלאומית' מס

Address for service [74] מען למסירת מסמכים Abridgement of invention (in the [57] )בשפה בה ערוך הפירוט(תקציר האמצאה

language in which the specification is drawn up)

' החל מיומן הפטנטים והמדגמים מס: הערה*

ניתן ציון לבקשות פטנטים הסיווג לפי 1/06המהדורה השמינית של הסיווג הבינלאומי

)2006משנה (של פטנטים

*Note: As from Patents and Designs Journal No.1/06, patent applications are classified according to the Eighth Edition of the International Patent Classification (2006)


116223 ]21][11[

מימד ושיטה-מצלמה טלצנטרית תלת

TELECENTRIC 3D CAMERA AND METHOD

]54[

01.12.1995 ]22[ Int. Cl.8 G01S 017/00 ]51[

]3DV SYSTEMS LIMITED ]71 יקנעם, מ"מערכות בע. וי. די3 ]GAVRIEL IDDAN, GIORA YAHAV ]72 גיורה יהב, גבריאל עידן ,מ"קניין רוחני בע',פנסטר ושות

, 10256. ד.ת, קרית אריה , 1 כניסה 12 בזל פתח תקוה

FENSTER & COMPANY, INTELLECTUAL PROPERTY LTD, 12 BASEL STREET ENTRANCE 1 P.O.BOX 10256 PETACH TIKVA

]74[

[57] Apparatus for creating an image indicating distances to objects (A, B) in a scene (11), comprising a modulated source of radiation (1), which directs radiation toward a scene, such that a portion of the radiation from the source is reflected from the scene and reaches the apparatus; a detector (12), which detects an image formed from the radiation that reaches the apparatus; a processor (22), which forms an image having an intensity value distribution indicative of the distance of objects from the apparatus, responsive to the intensity distribution of the detected image; and comprising a first telecentric optics comprising at least one lens (42) and an iris (40) located substantially at the

focal point of said at least one lens which receives and collimates the radiation reflected form the scene that reaches the apparatus; and a modulator (18), which modulates the collimated radiation, such that a part of the portion of the radiation which reaches the apparatus is passed by the modulator to a second telecentric optics comprising at least one image lens (44) that sends the light to pass through an iris (46) located substantially at the focal point of the image lens wherein light that passes through the iris forms the image detected by the detector, the part being dependent on the distance of respective portions of the scene from the apparatus.

__________


595

124728 ]21][11[

AURORA–2 – ו AURORA–1חלבוני

AURORA-1 AND AURORA-2 PROTEINS

]54[

25.11.1996 ]22[ US ]33[ 18.12.1995 ]32[ 60/008809 ]31[ US 14.08.1996 60/023943

Int. Cl.8 C07K 014/435, 014/47, C12N 009/12, 015/54 ]51[ SUGEN, INC., U.S.A. ]71[ WO/1997/022702 ]87[

,ריינהולד כהן ושותפיו תל אביב, 4060. ד.ת , 21 רחוב אחד העם

REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040

]74[

[57] Isolated enriched or purified polypeptide, wherein said polypeptide comprises at least 100 contiguous amino

acids of the amino acid sequence depicted in SEQ IN NO:3 and SEQ.ID NO:4.

__________

124939 ]21][11[

חלבונים הטרולוגיים המיוצרים בתאי שמר ושיטות להכנתם

HETEROLOGOUS PROTEIN PRODUCTS FROM YEAST AND PROCESSES FOR PRODUCTION THEREOF

]54[

18.12.1996 ]22[ DK ]33[ 20.12.1995 ]32[ 1449/95 ]31[

Int. Cl.8 C07K 014/435, 014/62, C12N 001/19, 015/12, 015/62, 015/67, 015/81 ]51[ NOVO NORDISK A/S, DENMARK ]71[ WO/1997/022706 ]87[



]74[

[57] DNA construct encoding a polypeptide and having the following

structure signal peptide-leader peptide-EEAEPK-heterologous protein.

__________


125855 ]21][11[

שיטה לייצור חומרים קרמיים מוקצפים

METHOD OF PRODUCING CERAMIC FOAMS

]54[

19.08.1998 ]22[ IL ]33[ 06.04.1998 ]32[ 123969 ]31[

Int. Cl.8 C04B 035/624 ]51[ ]CELLARIS LTD. ]71 נשר, מ"סלריס בע ]72[ גדעון גרדר

,ריינהולד כהן ושותפיו תל אביב, 4060. ד.ת, 21 רחוב אחד העם


]74[

[57] A method of producing a ceramic foam based on foaming at least one precursor comprising a A1C13(Pri

2O) complex or a mixture of precursors comprising aluminium sec butoxide (ASB) and SiC14, the method comprising the steps of: placing said precursor or mixture

of precursors in a pressure vessel; heating and pressurizing said precursor or mixture of precursors to accelerate the transformation of the complex to a solution of isopropyl chloride and partially condensed Al-O-Al species.

__________

126552 ]21][11[

שימוש אלחוטי של כרטיסים חכמים במערכת גישה בטוחות

REMOTE ADMINISTRATION OF SMART CARDS FOR SECURE ACCESS SYSTEMS

]54[

13.10.1998 ]22[ Int. Cl.8 G06F 002/100000 012/14, G07F 007/10, H04L 009/32, 012/22 ]51[

NDS LIMITED, UNITED KINGDOM ]71[ ]SHLOMO KIPNIS, RANNEN MEIR ]72 רענן מאיר, יסשלמה קיפנ ',קולב ושות. סנפורד ט

רחובות, 2273. ד.ת, מרמורק , 4 שער הגיא SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT

]74[

[57] A system for remote administration of at least one smart card via a communication network, the system comprising: a remote administrator having administrator identification information; at least one user unit; at least one smart card associated with said remote administrator by storing in the least one smart card said administrator identification information of

the remote administrator; and a local administrator other than the remote administrator, the local administrator being positioned in the communication network in a proximity to said at least one user unit and determined as a proxy administrator for administrating said at least one smart card by transmitting at least authorization information from the remote


597

administrator to the local administrator, wherein said at least one smart card inserted in said at least one user unit is operative to employ the administrator identification information to identify the remote administrator associated with said

at least one smart card, and to establish communication via the communication network between the at least one smart card and the remote administrator in accordance with the administrator identification information.

__________

126918 ]21][11[

להמרצת גידול עצבי וכליניRETליגאנד

RET LIGAND (RETL) FOR STIMULATING NEURAL AND RENAL GROWTH

]54[

07.05.1997 ]22[ US ]33[ 08.05.1996 ]32[ 60/017427 ]31[ US 07.06.1996 60/019300 US 16.07.1996 60/021859 US 11.04.1997 60/043533

Int. Cl.8 A61K 039/395, C07K 014/47, 016/18, 019/00, C12N 005/10, 015/12, 015/63 ]51[ BIOGEN IDEC MA INC., U.S.A. ]71[ WO/1997/044356 ]87[

,ן וגולרברגמ, וולף, 1352. ד.ת' , ב19 רחוב קרן היסוד

ירושלים

WOLFF, BREGMAN AND GOLLER, 19B KEREN HAYESOD ST. P.O.B. 1352, JERUSALEM 91013

]74[

[57] Isolated nucleic acid encoding a polypeptide with at least 80% sequence identity to an amino acid sequence selected from the group consisting of SEQ ID NO:17 and SEQ ID NO:21, wherein said

polypeptide interacts with a receptor protein Ret to trigger dimerization of the receptor protein Ret or autophosphorylation of a tyrosine kinase domain of the receptor protein Ret.

__________


128058 ]21][11[

אנלוגים של אילודין ותכשירי רוקחות המכילים אותם

ILLUDIN ANALOGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

]54[

14.07.1997 ]22[ US ]33[ 18.07.1996 ]32[ 08/683687 ]31[

Int. Cl.8 A61K 031/12, A61P 035/00, C07C 035/37, 039/225, 049/753, 049/757, 059/80, 062/38, 069/007, 205/45, 225/14, 225/20, 323/17, 323/22, 323/25, 323/52, C07D 233/60, 317/70, 317/72, C07F 007/08, C07H 015/18

]51[

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, U.S.A.

]71[

WO/1998/003458 ]87[ ,ברגמן וגולר, וולף

, 1352. ד.ת' , ב19יסוד רחוב קרן ה ירושלים


]74[

[57] A compound of the formula

wherein R1 is (CH2)n-X-Y, where n is 0 to 4; X is O or S or NH, and Y is –CH2OC(O)(C1-C4) alkyl, (C1-C8) alkyl optionally substituted with 1 OH or 1-2 halo; a monosaccharide, -CH2C(O)-O-C(CH2)2-O-C(O)CH2SH, -(CH2)2-O-(CH2)2W where W is halo; -(C1-C8) alkyl-O-(C1-C8) alkyl, (C6-C10) aryl, (C6-C10) aryl (C1-C4) alkyl, -C(O)O(C6-C10) aryl wherein the aryl group is optionally substituted with 1-2 OH, halo, (C1-C4) alkyl, or O(C1-C4) alkyl; -

CH2CO2(C1-C4) alkyl, - CH2CO2H, Si((C1-C4) alkyl)3 or an amino acid residue; R3 is H or (C1-C4) alkyl; R4 is SCH2(C1-C4), -S-(C6-C10) aryl optionally substituted with halo, OH or (C1-C4) alkyl, or H; R5 is H, OH or absent; R6 is (C1-C4) alkyl; R7 is OH or –O(Si((C1-C4) alkyl)3; or R6 and R7 together are ethylenedioxy; R8 is (C1-C4) alkyl optionally comprising OH or halo; the bond represented by ------ is present or absent; or a pharmaceutically acceptable salt thereof.

__________


599

128792 ]21][11[

קטונים הטרוציקלים ותערובות רוקחות המכילים אותן

HETEROCYCLIC KETONES AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME

]54[

09.09.1997 ]22[ US ]33[ 25.09.1996 ]32[ 08/721765 ]31[ US 01.08.1997 08/904461

Int. Cl.8 A61K 031/40, 031/445, A61P 025/28, C07D 207/12, 207/16, 211/30, 211/60, 401/06, 409/06

]51[

GPI NIL HOLDINGS, INC., U.S.A. ]71[ WO/1998/013343 ]87[ ,פ"עו, ר יצחק הס ושותפיו"ד

תל אביב, 6451. ד.ת , 279 רחוב הירקון DR. YITZHAK HESS & PARTNERS, 279 HAYARKON STREET P.O.B. 6451 TEL AVIV 61063

]74[

[57] Compounds of the formula

or pharmaceutically acceptable salt thereof, wherein: n is 1 or 2; X is O; Z is selected from the group consisting of CH2, CHR1 and C(R2)2; R1 is C1-C5 straight or branched chain alkyl which is substituted with Ar1;

R2 is selected from the group consisting of: -C1-C9 straight or branched chain alkyl, -C2-C9 straight or branched chain alkenyl,

-C3-C8 cycloalkyl, -C5-C7 cycloalkenyl, and, -Ar1, Ar1 is phenyl, pyridyl, fluorenyl benzo[b] thiophen, or naphthyl, wherein said Ar1 is unsubstituted or substituted in one or more positions with halo, hydroxy, nitro, C1-C6 straight or branched chain alkyl, C2-C6 straight or branched chain alkenyl C1-C4 alkoxy, C2-C4 alkenyloxy, phenoxy, benzyloxy, amino, or a combination thereof.

בקשות חלוקה מבקשה זו

.שטרם פורסמו167896, The applications for division

from this application have not yet been published


__________

129912 ]21][11[

חומר כיסוי לצמחים ושיטה שימוש בו

PLANT COVER MATERIAL AND METHOD OF USING IT

]54[

19.11.1997 ]22[ NZ ]33[ 19.11.1996 ]32[ 299783 ]31[ NZ 18.09.1997 328780

Int. Cl.8 A01G 013/02 ]51[ JONATHAN DALLAS TOYE, NEW

ZEALAND ]71[

WO/1998/021935 ]87[ ,לצר וכהן צדק, פרל, איתן

הרצליה, 12688. ד.ת , 7 רחוב שנקר EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733

]74[

[57] A reflective plant treatment material which reflects at least 55% of solar radiation in the UV (about 280-400 nm) range, which reflects more solar radiation than it transmits and absorbs in the UV,

visible (about 400-700 nm) and near infrared (about 700-800 nm) ranges, and which transmits at least 5% of solar radiation in the range about 800-20000 nm.

__________

131478 ]21][11[

בהכנת Oשימושים בסטרפטוליזין תכשירים רפואים לטיפול ברקמת צלקת

USES OF STREPTOLYSIN O IN THE PREPARATION OF MEDICAMENTS ADAPTED TO TREAT SCAR TISSUE

]54[

02.03.1998 ]22[ US ]33[ 04.03.1997 ]32[ 08/131478 ]31[

Int. Cl.8 A61K 038/00, 038/16, 038/43, 039/09, A61P 017/02, C07K 014/00, 014/315 ]51[ MILKHAUS LABORATORY, INC.,

U.S.A. ]71[

WO/1998/039020 ]87[ ',קולב ושות. סנפורד ט

, 2273. ד.ת, מרמורק , 4 שער הגיא רחובות

SANFORD T.COLB & CO., P.O.B. 2273, REHOVOT

]74[

[57] Use of streptolysin O for the preparation of a medicament for

eliminating or reducing the appearance of scar tissue.

__________


601

133032 ]21][11[

וקטורים אדנו וירליים להעברת גנים או /בעלי זיקה רקמתית לתאי שריר ו

תאי אנדותל

ADENOVIRAL GENE DELIVERY VECTORS PROVIDED WITH A TISSUE TROPISM FOR SMOOTH MUSCLE CELLS AND /OR ENDOTHELIAL CELLS

]54[

18.11.1999 ]22[ EP ]33[ 20.11.1998 ]32[ 98203921.6 ]31[

Int. Cl.8 A61K 048/00, A61P 009/00, C07K 014/075, C12N 005/10, 015/34, 015/62, 015/861

]51[

INTROGENE B.V., THE NETHERLANDS

]71[

,לצר וכהן צדק, פרל, איתן הרצליה, 12688. ד.ת , 7 רחוב שנקר

EITAN, PEARL, LATZER AND COHEN ZEDEK, P.O.B. 12688, HERZLIYA 46733

]74[

[57] A recombinant adenoviral vector of a serotype from subgroup C, having been provided with at least a tissue tropism for smooth muscle cells and/or endothelial cells and having been deprived of at least a tissue tropism for liver cells, wherein said adenoviral vector comprises a capsid

comprising a tropism determining fragment of a fiber protein of an adenovirus of a serotype from subgroup B, and wherein said adenovirus serotype from subgroup B is selected from the group consisting of: adenovirus 11, adenovirus 16, adenovirus 35 and adenovirus 51.

__________

133693 ]21][11[

תכשירי רוקחות ושיטות להגדלת חדירות של ממברנות ביולוגיות

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INCREASING PERMEABILITY OF BIOMEMBRANES

]54[

07.07.1998 ]22[ IL ]33[ 09.07.1997 ]32[ 121269 ]31[

Int. Cl.8 A61K 031/20, 031/21, A61P 025/00, 043/00, C07C 053/128, 057/03, 057/12, 069/003, 233/02

]51[

]D-PHARM LIMITED ]71 רחובות, מ"פארם בע-די WO/1999/002120 ]87[


,מ"פארם בע-די, 2313. ד.ת, פארק המדע קרית ויצמן

רחובות

D-PHARM LIMITED, KIRYAT WEIZMANN SCIENCE PARK P.O.B. 2313 REHOVOT 76123

]74[

[57] Use of a compound of the formula

A |

R-CH-R' (III)

wherein R denotes a saturated or unsaturated chain of between 1 to 10 carbon atoms and R' denotes a saturated or unsaturated chain of between 5 and 30 carbon atoms, and A is selected from the group consisting of COOH, COOR", CONH2, CONH-R", and COO-Y+, wherein R" is a lower alkyl group comprising 1-5 carbon atoms, and Y denotes any pharmaceutically acceptable counter-ion for the preparation of a pharmaceutical

composition for reversibly permeabilizing a biological membrane. A pharmaceutical composition for the permeabilization of biological membranes comprising a pharmaceutically effective amount of a compound of formula (III) wherein R denotes a saturated or unsaturated chain of between 4 to 10 carbon atoms, A, R', R" and Y as defined above and at least one pharmaceutically acceptable carrier is also claimed as novel.

__________

135288 ]21][11[

טראי –Dמתן גלילה כרוני של מתילפנידט

CHRONIC BOLUS ADMINISTRATION OF D-THREO METHYLPHENIDATE

]54[

17.06.1998 ]22[ US ]33[ 29.09.1997 ]32[ 08/937684 ]31[

Int. Cl.8 A61K 031/445, A61P 025/00, C07D 211/34 ]51[ CELGENE CORPORATION, U.S.A. ]71[ WO/1999/016439 ]87[

',קולב ושות. סנפורד ט, 2273. ד.ת, מרמורק , 4 שער הגיא

רחובות


]74[

[57] Use of D-threo methylphenidate or a pharmaceutically acceptable salt thereof, substantially free of both L-threo methylphenidate and erythro methylphenidates, in the preparation of a medicament for treating at least one of

attention deficit disorder, attention deficit hyperactivity disorder, or AIDS-related dementia, wherein said medicament is suitable for chronic administration in single, bolus dosage of said D-threo


603

methylphenidate in each twenty-four hour period. __________

135332 ]21][11[

מתקן ושיטה להתקשרות אל מערכת הפעלה שפועלת לבקרת משאבי מחשב

מימדים3–בעזרת ממשק הדמייה ב

APPARATUS AND METHOD FOR INTERACTING WITH A SIMULATED 3D INTERFACE TO AN OPERATING SYSTEM OPERATIVE TO CONTROL COMPUTER RESOURCES

]54[

01.10.1998 ]22[ US ]33[ 02.10.1997 ]32[ 08/946106 ]31[

Int. Cl.8 G06F 009/45, 009/455 ]51[ ]CLOCKWISE TECHNOLOGIES LTD. ]71 אביב-תל, מ"קלוקוייז טכנולוגיות בע



]74[

[57] A computer system comprising: computer resources (40); an operating system operative to control said computer resources; and a 3D interface (20) enabling a user generating camera motion to interact with the operating system and providing at least one screen display image (30) of a 3D

virtual scene including a simulated three-dimensional representation of at least a portion of the computer resources, said interface configured to be operative to monitor said camera motion and to determine which of said computer resources are visible in said display image.


__________

135345 ]21][11[

הומנייםTOLLהומולוגיי

HUMAN TOLL HOMOLOGUES

]54[

07.10.1998 ]22[ US ]33[ 17.10.1997 ]32[ 60/062250 ]31[ US 13.11.1997 60/065311 US 28.04.1998 60/083322 US 26.06.1998 60/090863 US 26.06.1998 09/105413

Int. Cl.8 A61K 039/395, C07K 014/705, C12N 015/12 ]51[ GENENTECH, INC., U.S.A. ]71[ WO/1999/020756 ]87[



]74[

[57] An isolated nucleic acid molecule comprising a polynucleotide sequence having at least a 95% sequence identity to (a) a DNA molecule encoding a PRO285 polypeptide having amino acid residues 27 to 839 of Figure 1 (SEQ ID NO:1) as shown in the specification wherein the polypeptide has the ability to induce the

activation of NF-kB, or the complement of the DNA molecule; or (b) a DNA molecule encoding the same mature polypeptide encoded by the human Toll protein cDNA in ATCC Deposit No. 209389 (DNA40021-1154) wherein the polypeptide has the ability to induce the activation of NF-кB, or the complement of the DNA molecule.


605

בקשות חלוקה מבקשה זו .שטרם פורסמו

180967, The applications for division from this application have not yet been published

__________

136310 ]21][11[

שיטה לבדיקת יכולת ההפרשה של פפטיד

METHOD FOR EXAMINING THE SECRETORY ABILITY OF A PEPTIDE

]54[

26.11.1998 ]22[ JP ]33[ 26.11.1997 ]32[ 9-324912 ]31[

Int. Cl.8 C12N 005/10, 015/12, 015/62, C12Q 001/68 ]51[

CHUGAI SEIYAKU KABUSHIKI KAISHA, JAPAN TOSHIO KITAMURA, JAPAN

]71[

WO/1999/026978 ]87[ ,ריינהולד כהן ושותפיו

תל אביב, 4060. ד.ת , 21 רחוב אחד העם REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040

]74[

[57] A method for examining whether a peptide encoded by a test cDNA contains the secretory ability, the method comprising: (a) providing a vector wherein the test cDNA which encodes the peptide to be examined whether it contains the secretory ability is ligated to the 5'-upstream of the DNA which encodes a peptide capable of

inducing cell proliferation through dimerization on the cell surface and lacking the secretory ability; (b) introducing the vector prepared in (a) into a cell; and (c) culturing the transformant prepared in (b), and detecting the cell proliferation ability.


__________

136455 ]21][11[

בקטריה חודרנית שעברה החלשה

ATTENUATED INVASIVE BACTERIA

]54[

18.12.1998 ]22[ US ]33[ 29.12.1997 ]32[ 08/999391 ]31[

Int. Cl.8 A61K 048/00, C12N 001/21, 015/74, 015/85, 015/87 ]51[ SCHERING

AKTIENGESELLSCHAFT, GERMANY

]71[


, 1352. ד.ת' , ב19 רחוב קרן היסוד ירושלים


]74[

[57] An attenuated invasive intracellular Listeria bacterium capable of infecting a mammalian host or host cell thereof, but having a decreased ability in intra-and intercellular movement in said host as compared to a wild type bacterium, transformed with (a) a promoter activated when said bacterium is present in the cytosol of a

host cell, operably linked to a structural gene or a biologically active fragment thereof encoding a Listeria bacteriphage lysine which is lethal to the bacterium; (b) a host cell-compatible promoter, operably linked to a structural gene or fragment thereof, encoding a polypeptide.

__________


607

136647 ]21][11[

שיטת הכנה ושימוש , תולדות אכינוקנדין כתכשירים נגד פטריות

ECHINOCANDIN DERIVATIVES, PREPARATION METHOD AND APPLICATION AS ANTI-FUNGAL AGENTS

]54[

09.12.1998 ]22[ FR ]33[ 10.12.1997 ]32[ 97/15628 ]31[ FR 26.10.1998 98/13361

Int. Cl.8 A61K 038/12, A61P 031/10, C07K 007/56 ]51[ NOVEXEL, FRANCE ]71[ OLIVIER COURTIN, PATRICK

FAUVEAU, ASTRID MARKUS, DOMINIQUE MELON MANGUER, JEAN-MARC MICHEL, LAURENT SCHIO

]72[

WO/1999/029716 ]87[ עורכי , ל כהן צדק לצר עורכי דיןפר

,פטנטים ונוטריונים, 12704. ד.ת , 5שנקר ' רח, 1ים - מרכז גב הרצליה

PEARL COHEN ZEDEK LATZER, 5 SHENKAR STREET, P.O.B. 12704 HERZLIYA 46733

]74[

[57] A compound selected from the group consisting of all possible stereoisomeric forms of a compound of the formula


wherein R1 and R2 are individually selected from the group consisting of hydrogen, -OH, alkyl and cycloalkyl of up to 8 carbon

atoms optionally interrupted with oxygen and optionally substituted by a member selected from the group consisting of halogen, - OH and

a and b are individually hydrogen or alkyl of 1 to 8 carbon atoms or taken together with the nitrogen form a heterocycle optionally containing at least one

heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, or R1 forms a double bond with the endocyclic carbon atom carrying the

wherein R2 is –XRa, X is selected from the group consisting of oxygen, -NH- and – N-alkyl radical, containing up to 8 carbon atoms, Ra is selected from the group consisting of hydrogen and alkyl and

cycloalkyl of up to 8 carbon atoms unsubstituted or substituted with at least one member of the group consisting of halogen, -OH-, -COOH, -COOAlk,

Alk is alkyl of 1 to 8 carbon atoms, a' and b' are individually selected from the group consisting of hydrogen and alkyl of

1 to 8 carbon atoms or taken with the nitrogen form a heterocycle optionally containing at least one heteroatom selected


609

from the group consisting of oxygen, sulfur and nitrogen and/or substituted by a

heterocycle containing at least one heteroatom or R2 is

d and e are hydrogen or alkyl of 1 to 8 carbon atoms, f and g are selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms and acyl of an organic carboxylic acid of 1 to 8 carbon atoms or e and f together with –N=C-N- form a heterocycle optionally containing at least one other heteroatom selected from the group consisting of oxygen, sulfur and nitrogen, R3 is selected from the group consisting of hydrogen, methyl and –OH, R4 is hydrogen or –OH, R representing either a linear or branched or cyclic chain containing up to 30 carbon atoms, optionally containing one or several heteroatoms, one or several heterocycles or a linear, branched or cyclic

acyl radical containing up to 30 carbon atoms optionally containing one or several heteroatoms selected from the group consisting of oxygen, sulfur and nitrogen and/or one or several heterocycles, T is selected from the group consisting of hydrogen, methyl, -CH2 –CONH2, -CH2-CN, -(CH2)2-NH2 and –(CH2)2Nalk3

+X-, alk is alkyl of 1 to 8 carbon atoms, X is halogen, Y is selected from the group consisting of hydrogen, -OH, halogen and –SO3H and salts thereof, W is hydrogen, or –OH, Z is hydrogen or methyl or a non-toxic, pharmaceutically acceptable acid addition salt thereof.



__________

136833 ]21][11[


, שיטה ליצירת תאי פרקורסור עצביים תאים לא תומוריגני המכיל אותם הרכב

ושימושם להכנת תכשירי רוקחות

METHOD FOR GENERATING NEURAL PRECURSOR CELLS, NON-TUMORIGENIC CELL COMPOSITION CONTAINING THEM AND USES THEREOF IN PREPARATION OF PHARMACEUTICAL COMPOSITIONS

]54[

18.12.1998 ]22[ DE ]33[ 19.12.1997 ]32[ 19756864.5 ]31[

Int. Cl.8 A61K 048/00, C12N 005/08, 005/10 ]51[ OLIVER BRUESTLE, GERMANY ]71[ WO/1999/032606 ]87[

,לוצאטו את לוצאטו באר שבע, 5352. ד.ת, עומר , גן תעשייה

LUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER P.O.B. 5352 BEER-SHEVA 84152

]74[

[57] Non-tumorigenic cell composition obtained from mammalian embryonic stem cells, containing: (a) at least 85% isolated neural precursor cells with the ability to differentiate into neuronal or glial cells, and (b) no more than 15% primitive embryonic and non-neural cells, obtainable by the steps of: (a) proliferation of ES cells; (b) cultivation of the ES cells from step (a) into neural precursor cells; (c) proliferation of the neural precursor cells in growth factor-containing serum-free medium; (d) proliferation of the neural precursor cells from step (c) in another growth

factor-containing serum-free medium and isolation of the purified neural precursor cells; and (e) proliferation of the neural precursor cells from step (d) in another growth factor-containing serum-free medium and isolation of the purified precursor cells with the ability to differentiate into neuronal or glial cells, wherein the growth factor-containing, serum-free medium in step (d) comprises bFGF and EGF, and wherein the growth factor-containing, serum-free medium in step (e) comprises bFGF and PDGF, with the proviso that the method does not include the destruction of human embryos.

__________

137257 ]21][11[


611

חומר לטיפול בחרדה ותוקפנות המתקבל וטה ביונק מהפרשה בעור סביב בל ותמידה המכילה אותו

COMPOSITION FOR THE TREATMENT OF STRESS AND AGGRESSIVE BEHAVIOR OBTAINABLE FROM A SECRETION DERIVED FROM THE SKIN AROUND MAMMALIAN GLAND AND A SOLUTION COMPRISING SAME

]54[

21.01.1999 ]22[ EP ]33[ 21.01.1998 ]32[ 98400117.2 ]31[

Int. Cl.8 A61K 035/00, 035/55 ]51[ FIDELINE, FRANCE ]71[ WO/1999/037297 ]87[



]74[

[57] A composition for the treatment of stress, anxiety and/or aggressive behavior in a mammal, obtainable from a secretion derived from the skin around mammalian

gland, said secretion containing, as a main active ingredient, a mixture of at least the three fatty acids palmitic acid, linoleic acid and oleic acid or derivatives thereof.

__________

137292 ]21][11[

מודלים ביולוגים המציגים תופעות משניות של מחלות

BIOLOGICAL MODELS EXHIBITING SECONDARY DISEASE MANIFESTATIONS

]54[

13.07.2000 ]22[ US ]33[ 16.07.1999 ]32[ 09/356293 ]31[

Int. Cl.8 A01K 067/027, C12N 005/06 ]51[ ENZO THERAPEUTICS, INC., U.S.A. ]71[


,ברגמן וגולר, וולף, 1352. ד.ת' , ב19 רחוב קרן היסוד

ירושלים


]74[

[57] A Tupaia animal model for a chronic disease caused by a human viral pathogen, wherein said Tupaia animal model infected by said pathogen exhibits analogous secondary disease manifestations that are

secondary to a viral infection caused by said pathogen and said secondary disease manifestations are similar to those seen in humans with said chronic disease.

__________

137299 ]21][11[

פולימרים בעלי זיכרון צורה הניתנים לפירוק ביולוגי

BIODEGRADABLE SHAPE MEMORY POLYMERS

]54[

23.02.1999 ]22[ US ]33[ 23.02.1998 ]32[ 60/075523 ]31[

Int. Cl.8 A61L 027/00, C08L 101/12 ]51[ MASSACHUSETTS INSTITUTE OF

TECHNOLOGY, U.S.A. ]71[




]74[

[57] A degradable shape memory polymer composition having at least one shape in memory, the polymer comprising (1) hard and soft segments or (2) at least one soft segment, which is crosslinked covalently or ionically, or

(3) polymer blends, wherein the original shape of the polymer is recovered by a change in temperature or by application of another stimulus.

__________

137455 ]21][11[

מכשיר לטפול ברקמות הגוף בחשמל או תרופות

APPARATUS FOR TREATING BODY TISSUES WITH ELECTRICITY OR MEDICAMENTS

]54[

23.07.2000 ]22[ US ]33[ 26.07.1999 ]32[ 09/360893 ]31[

Int. Cl.8 A61N 007/00 ]51[ ]ZULI HOLDINGS LTD. ]71 רמת השרון, מ"זולי החזקות בע


613

,קוגלר, פאפו, מהולל, איתן הרצליה, 11 המנופים

EITAN, MEHULAL, PAPPO, KUGLER, 11 HAMENOFIM ST. HERZLIYA 46120

]74[

[57] A device (3) to be inserted into the body for treating body tissue, comprising: (a) a device (8) capable of generating electrical current at a therapeutic voltage and amperage, for treating body issue, in response to ultrasonic vibrations; (b) sensor means (11), the sensor means adapted to receive preselected stimuli generated by the body tissue, and

(c) means (10) for selectively generating and transmitting ultrasonic vibrations to the device for a location outside the device, (d) wherein the sensor means is adapted to communicate with and selectively energize the means for selectively generating and transmitting ultrasonic vibrations to the device in response to the preselected stimuli generated by the body tissue.

__________

137617 ]21][11[

– 5, 1 [– טריאזולו –] 4, 2, 1 [– פניל – 6a [ 7פירימידינים מותמרים בקבוצה –

הכנתן , אריל או ציקלואליפטיתחמה נגד ותכשירים המכילים אותם למל

פטריות פטוגניות בצמחים

6 - PHENYL - [1, 2, 4] - TRIAZOLO - [1, 5 - A]-PYRIMIDINES SUBSTITUTED BY A 7 - ARYL OR (CYCLO) ALIPHATIC GROUP, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM FOR COMBATING PHYTOPATHOGENIC FUNGI

]54[

09.02.1999 ]22[


US ]33[ 11.02.1998 ]32[ 022288 ]31[ US 03.02.1999 243851

Int. Cl.8 C07D 487/04 ]51[ WYETH HOLDINGS

CORPORATION, U.S.A. ]71[



]74[


wherein R1 represents an optionally substituted alkyl, alkenyl, alkynyl, alkadienyl, or aryl group, or an optionally substituted cycloalkyl or cycloalkenyl group wherein one CH2 group of said cycloalkyl or cycloalkenyl group may also be replaced by O, S or NR2, in which R2 represents a hydrogen atom or an alkyl group; X

represents a hydrogen or halogen atom, or a hydroxy, alkoxy, aryloxy, aralkyloxy, haloalkoxy, alkylthio, cyano, amino, alkylamino, azido or dialkylamino group; L1, L2, L3, L4 and L5 each independently represent an hydrogen or halogen atom or an optionally substituted alkyl or alkoxy group or a nitro or cyano group.

__________

137893 ]21][11[

– באמצעות זירוז על ידי יצור נוטקאטון לקאז

PRODUCTION OF NOOTKATONE BY LACCASE CATALYSIS

]54[

16.08.2000 ]22[ US ]33[ 08.09.1999 ]32[ 09/391785 ]31[

Int. Cl.8 A23L 001/222, C07C 049/653, 409/14, C12P 007/26 ]51[ GIVAUDAN SA, SWITZERLAND ]71[

,פיוריינהולד כהן ושות תל אביב, 4060. ד.ת , 21 רחוב אחד העם


]74[


615

[57] A process for producing nootkatone comprising: (a) reacting valencene and a composition having laccase activity, wherein valencene is at a concentration of greater than 0.1%,

in the presence of an oxygen source to form valencene hydroperoxide, (b) degrading the hydroperoxide to form nootkatone, and (c) recovering nootkatone.

__________

137954 ]21][11[

זינים מותמרים אריפיפר–פירידינוהיעילים בטיפול ביתר התרבות תאים לא

סרטנית בפרוסטטה

SUBSTITUTED PYRIDINO ARYLPIPERAZINES USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

]54[

19.02.1999 ]22[ US ]33[ 20.02.1998 ]32[ 60/075321 ]31[

Int. Cl.8 A61K 031/44, A61P 043/00, C07D 401/12 ]51[ ORTHO-MCNEIL

PHARMACEUTICAL, INC., U.S.A. ]71[



]74[


R1 is hydrogen, halogen, C1-5 alkoxy, hydroxyl, or C1-5 alkyl; R2 is C1-6 alkyl, substituted C1-6 alkyl where the alkyl substituents are independently selected from one or more halogens, phenyl, substituted phenyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, C1-5 alkoxy,

and trihalo C1-5 alkyl, phenyl C1-5 alkyl, or substituted phenyl C1-5 alkyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, halogen, C1-

5 alkoxy, and trihalo C1-5 alkyl; R3 is hydrogen, hydroxy or C1-5 alkoxy if the dashed line is absent or is oxygen if the dashed line is present; R4 is hydrogen, C1-5


alkyl, phenyl C1-5 alkyl or substituted phenyl C1-5 alkyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-5 alkyl, C1-5 alkoxy, and trihalo C1-5 alkyl; R5 is C1-6 alkyl, substituted C1-6 alkyl where the alkyl substituents are independently selected from one or more halogens, phenyl, substituted phenyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-8 alkyl, hydrogen, halogen, hydroxy, C1-8 alkyl, substituted C1-8 alkyl where the alkyl substituents are independently selected from one or more halogens, C1-5 alkoxy, amino, C1-5 alkylamino, di C1-5 alkylamino, C1-5 alkylcarbonyl, C1-5 alkoxycarbonyl, arylcarbonyl, nitrile, aminosulfonyl, C1-5 alkylsulfonyl, phenylsulfonyl, and

substituted phenylsulfonyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-8 alkyl, hydrogen, halogen, hydroxy and nitro; phenyl C1-5 alkyl, substituted phenyl C1-5 alkyl where the phenyl substituents are independently selected from one or more members of the group consisting of C1-8 alkyl, hydrogen, halogen, hydroxy, C1-8 alkyl, substituted C1-8 alkyl where the alkyl substituents are independently selected from one or more halogens, C1-5 alkoxy, amino, C1-5 alkylamino, di C1-5 alkylamino, C1-5 alkylcarbonyl, C1-5 alkoxycarbonyl, and nitro; X is oxygen, sulfur or NH; pharmaceutically acceptable salts thereof; and stereoisomers, racemic mixtures, as well as enantiomers thereof.

__________

138090 ]21][11[

זמן רכישה מחדש סתגלני בסביבת זימון מרובת מקומות

ADAPTIVE REACQUISITION TIME IN A SLOTTED PAGING ENVIRONMENT

]54[

16.03.1999 ]22[ US ]33[ 16.03.1998 ]32[ 09/039985 ]31[

Int. Cl.8 H04B 007/216, H04Q 007/32 ]51[ QUALCOMM INCORPORATED,

U.S.A. ]71[




]74[

[57] A method for adaptively determining a pilot signal reacquisition time, the

method comprising the steps of: measuring a magnitude of a shift in phase of said pilot


617

signal; comparing said measured magnitude to a shift threshold; and decreasing said reacquisition time if said

measured magnitude is not greater than said shift threshold.

__________

138199 ]21][11[

מסנן מעבר איטי עבור יחידה דיפלקסר

LOW-PASS FILTER FOR A DIPLEXER

]54[

02.03.1999 ]22[ DE ]33[ 03.03.1998 ]32[ 19809021.8 ]31[

Int. Cl.8 H03H 007/01 ]51[ VACUUMSCHELZE GMBH,

GERMANY ]71[

JORG PETZOLD, JOHANNES BEICHLER, DIRK HEUMANN

]72[

WO/1999/045643 ]87[ ,שמעון לביא

ירושלים, 21הרצוג ' רחSIMON LAVIE, 21 HERZOG ST. JERUSALEM

]74[

[57] Low-pass filter (8) for a diplexer for separating low-frequency signals of

analogue communication systems from high-frequency signal of digital


communication systems, comprising a plurality of series inductors (9) formed with the aid of magnetic cores, characterised in that the magnetic cores are produced from an amorphous or manocrystalline alloy in such a manner

that the series inductors display saturation induction of Bs > 0.6 T, a saturation to remanence ratio of Br/Bs < 0.2 and substantially constant permeability to more than 10kHz.

__________

138336 ]21][11[

תכשירים פרמצבטיים המכילים תימרוסל לטיפול בזיהומי וירוס הרפס

PHARMACEUTICAL COMPOSITIONS COMPRISING THIMEROSAL FOR TREATMENT OF HERPES VIRUS INFECTIONS

]54[

06.02.1998 ]22[ Int. Cl.8 A61K 031/305, 031/555, 038/00, 039/20, A61P 009/10, 025/16, 025/28, 031/22, C07F 003/10, 003/12, C07K 014/00

]51[

DIVISION FROM 123206 ]62[ MILKHAUS LABORATORY, INC.,

U.S.A. ]71[

',קולב ושות. סנפורד ט רחובות, 2273. ד.ת, מרמורק , 4 שער הגיא


]74[

[57] Use of effective amount of thimerosal free of association with influenza virus and

optionally in addition a rubella virus vaccine to make a pharmaceutical


619

composition for treating subjects suffering from herpes virus infections, wherein said

composition is adapted to be administered systemically.

__________

138767 ]21][11[

תרכיזים של טקסיין המתחלבים –טרום ויציבים באיחסון

STORAGE-STABLE SELF- EMULSIFYING PRECONCENTRATES OF A TAXANE

]54[

30.03.1999 ]22[ US ]33[ 01.04.1998 ]32[ 60/080272 ]31[ US 01.04.1998 60/080273

Int. Cl.8 A61K 009/107, 045/00, 047/26, 047/44, A61P 035/00, C07D 305/14 ]51[ RTP PHARMA INC., U.S.A. ]71[ ISKANDAR MOUSSA, INDU

PARIKH, ALAIN CARRIER ]72[

WO/1999/049848 ]87[ ,מ"בע' דוד ושות-בן. ירמיהו מ

, 45087. ד.ת, הר חוצבים , רחוב המרפא ירושלים

JEREMY M. BEN-DAVID & CO. LTD., HAR HOTZVIM HI-TECH PARK, P.O. B. 45087, JERUSALEM 91450

]74[

[57] A storage-stable, self-emulsifying preconcentrate of a taxane in a microemulsion, composed of: (i) 10 to 80% w/w of at least one hydrophobic component selected from triglyceride, diglyceride, monoglyceride, free fatty acid, fatty acid ester, fish oil, vegetable oil, or mixtures thereof; (ii) 20 to 80% w/w of a surfactant phase comprising at least one non-ionic surfactant;

(iii) 0 to 35% w/w of diethylene glycol monoethylether; and (iv) 0 to 40% w/w of at least one hydrophilic component selected from hydroxyalkane, dihydroxyalkane, a polyethylene glycol having an average molecular weight of less than or equal to 1000, and mixtures thereof; said preconcentrate producing an average particle size of less than or equal to 10 µm when mixed with an aqueous medium.

__________

139297 ]21][11[


נגזרות של אמידו פירידין המעכבים הפרשת חומצה גסטרית

IMIDAZO PYRIDINE DERIVATIVES WHICH INHIBIT GASTRIC ACID SECRETION

]54[

23.04.1999 ]22[ SE ]33[ 29.04.1998 ]32[ 9801526-6 ]31[

Int. Cl.8 A61K 031/437, 045/00, A61P 001/04, C07D 471/04 ]51[ ASTRAZENECA AB, SWEDEN ]71[ KOSRAT AMIN, PETER

NORDBERG, INGEMAR STARKE, MICHAEL DAHLSTROM

]72[

WO/1999/055706 ]87[ ,לוצאטו את לוצאטו

אר שבעב, 5352. ד.ת, עומר , גן תעשייהLUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER P.O.B. 5352 BEER-SHEVA 84152

]74[


or a pharmaceutically acceptable salt thereof, wherein R1 is H, CH3, or CH2 OH; R2 is CH3 or CH2 CH3; R3 is H, C1-C6 alkyl,

hydroxylated C1-C6 alkyl or halogen; R4 is H, C1-C6 alkyl, hydroxylated C1-C6 alkyl, or halogen; R5 is H, or halogen, R6 and R7 are the same or different and selected from H, C1-C6 alkyl, hydroxylated C1-C6 alkoxy-substituted C1-C6 alkyl; and X is NH, or O.

__________

139813 ]21][11[

שיטות ומוצרים לגרימת חסינות ריריתית

OLIGONUCLEOTIDE COMPRISING COMPOSITION FOR INDUCING MUCOSAL IMMUNITY

]54[

21.05.1999 ]22[


621

US ]33[ 22.05.1998 ]32[ 60/086393 ]31[ Int. Cl.8 A61K 039/39 ]51[

COLEY PHARMACEUTICALS, INC., U.S.A. THE OTTAWA HEALTH RESEARCH INSTITUTE, CANADA

]71[




]74[

[57] A composition for inducing a mucosal immune response in a subject, also exposed to an antigen that is not encoded in a nucleic acid vector, on administration to a mucosal surface of the

subject, wherein the composition comprises an oligonucleotide having a sequence including at least the following formula:

5'X1X2CGX3X43';

wherein C is unmethylated, and X1, X2, X3 and X4 are nucleotides; and a pharmaceutically acceptable carrier.

__________

140028 ]21][11[

מדידת מינון ספציפי לחולה

PATIENT SPECIFIC DOSIMETRY

]54[

04.06.1999 ]22[ US ]33[ 04.06.1998 ]32[ 60/088327 ]31[

Int. Cl.8 A61K 051/00, 051/12 ]51[

THE REGENTS OF THE UNIVERSITY OF MICHIGAN, U.S.A. SMITHKLINE BEECHAM CORPORATION, U.S.A.

]71[

WO/1999/062565 ]87[ ,קוגלר, פאפו, מהולל, איתן

הרצליה, 11 המנופיםEITAN, MEHULAL, PAPPO, KUGLER, 11 HAMENOFIM ST. HERZLIYA 46120

]74[


[57] A method of establishing a patient-specific optimally effective dose for administration of a radiopharmaceutical to a patient, the method comprising: determining a maximum tolerated dose for the radiopharmaceutical for the patient population; determining a desired total body dose of the radiopharmaceutical for the patient; determining the clearance profile for the radiopharmaceutical or radiopharmaceutical analog; determining the patient's mass and maximum effective mass; selecting the lower of the patient's mass and maximum effective mass; determining the activity hours for the

radiopharmaceutical or radiopharmaceutical analog based on the lower of the patient's mass or maximum effective mass and the desired total body dose; administering a tracer dose of the radiopharmaceutical or the radiopharmaceutical analog to the patient; determining the residence time for the radiopharmaceutical or the radiopharmaceutical analog; and establishing the optimally effective dose of the radiopharmaceutical for the patient by solving for therapeutic dose in the following equation:

Activity Hours desired total body dose

therapeutic dose= –––––––––––––––– X –––––––––––––––––––– Residence time maximum tolerated dose.

__________

140367 ]21][11[

מערכת ושיטה עבור תקשורת , התקן ת ובקרת גישהמאובטח

DEVICE, SYSTEM AND METHOD FOR SECURE COMMUNICATION AND ACCESS CONTROL

]54[

23.06.1999 ]22[ US ]33[ 24.06.1998 ]32[ 09/104014 ]31[ US 11.05.1999 09/309873

Int. Cl.8 G06F 007/58, H04L 009/12, 017/22 ]51[

תל אביב, בינימין רוןWARCOP INVESTMENT LTD., BRITISH VIRGIN ISLANDS BENYAMIN RON

]71[

]ADAM SHEFI ]72 אדם שפי WO/2000/067548 ]87[


623

,מ"בע) 1995(ארליך .אי.י'גרחוב מנחם בגין ,15קומה , מגדל אילון

רמת גן, 11

G.E. EHRLICH (1995) LTD., �� ÿ�Ĥ� � ��⌠�� ´♀� Ŧ�� 11 MENACHEM BEGIN STREET 52521 RAMAT GAN

]74[

[57] A method for generating a practically unlimited quantity of true random numbers, the true random numbers being identical in a plurality of locations, the method being operable by a data processor and the method comprising the steps of: (a) providing an identical table of true random numbers, an identical pointer, an identical seed and an identical pseudorandom number generator at each of the plurality of locations; (b) obtaining an obtained true random number from said identical table of true

random numbers according to said pointer, said obtained true random number being identical at the plurality of locations; (c) generating a generated pseudorandom number by said pseudorandom number generator, said generated pseudorandom number being identical at the plurality of locations; and (d) combining said obtained true random number and said generated pseudorandom number to form at least one of the quantity of true random numbers, said at least one of the quantity of true random numbers being identical at the plurality of locations.

__________


140429 ]21][11[

תכשירי פוליאוריתן השימושיים כסופגי אנרגיה ושיטה להכנתן

POLYURETHANE COMPOSITIONS USEFUL AS SHOCK ABSORBERS AND A METHOD FOR THEIR PREPARATION

]54[

20.12.2000 ]22[ Int. Cl.8 C08G 018/48, 071/00, C08J 009/00, C08L 075/08 ]51[

]ORYCLE APPLICATIONS LTD. ]71 קרית גת, מ"אוריקל יישומים בע ,פ"אייל ברסלר עו' דר

גן-רמת , 11 תובל DR. EYAL BRESSLER, 11 TOVAL ST. RAMAT GAN 52522

]74[

[57] A polyurethane foam composition comprising: at least one polyether polyol having an average molecular weight from

100-20,000; an aromatic polyisocyanate; a tackifying resin; a surfactant; a blowing agent, and a catalyst.

__________

140553 ]21][11[

רים גנים לפורמאלדיהיד דהידרוגנז משמ מתילטרופיים

FORMALDEHYDE DEHYDROGENASE GENES FROM METHYLOTROPHIC YEASTS

]54[

02.07.1999 ]22[ US ]33[ 03.07.1998 ]32[ 60/091699 ]31[

Int. Cl.8 C12N 015/53 ]51[ RESEARCH CORPORATION

TECHNOLOGIES, INC., U.S.A. ]71[

WO/2000/001829 ]87[ ,רגמן וגולרב, וולף



]74[

[57] An isolated nucleic acid comprising a promoter that is inducible by methanol, methylamine, and a mixture of both methanol and methylamine in a

methylotrophic yeast, wherein said isolated nucleic acid is derivable from Pichia pastoris.

__________

140669 ]21][11[


625

תכשיר אבקתי למתן דרך הרירית המכיל תרופה פולימרית

POWDERY PREPARATION FOR MUCOSAL ADMINISTRATION CONTAINING POLYMERICMEDICINE

]54[

01.07.1999 ]22[ JP ]33[ 08.07.1998 ]32[ 10-192722 ]31[ JP 25.03.1999 11-81549

Int. Cl.8 A61K 009/00, 009/14, 038/00 ]51[ KIRIN-AMGEN INC., U.S.A. ]71[ WO/2000/002574 ]87[



]74[

[57] A preparation in powder form for administration through mucosa, comprising a medicine of high molecular weight selected from the group consisting

of bioactive peptides and proteins, antibodies, vaccines, and antigens, and aminoalkylmethacrylate copolymer or polyvinyl acetal diethylaminoacetate.

__________

141410 ]21][11[

, תהליך להכנתם, ארילפיפראזיניםתכשירי רוקחות המכילים אותם

הם להכנת תרופות לטיפול והשימוש בבמצבי מחלה המתווכים על ידי

)MMP(מטאלופרוטאינזות

ARYLPIPERAZINES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING DISEASE CONDITIONS MEDIATED BY METALLOPROTEINASES (MMP)

]54[

25.08.1999 ]22[ EP ]33[ 31.08.1998 ]32[ 98402144.4 ]31[ EP 04.06.1999 99401351.4

Int. Cl.8 A61K 031/495, A61P 043/00, C07D 401/00, 403/12, 405/12, 409/12, 413/12, 417/12

]51[

ASTRAZENECA AB, SWEDEN ]71[ WO/2000/012478 ]87[ ',הורוביץ ושות. ש

תל , 41-45 בית ציון שדרות רוטשילד אביב

S. HOROWITZ & CO., ZION HOUSE, 41-45 ROTHSCHILD BLVD., TEL AVIV 65784

]74[



wherein ring B is a monocyclic or bicyclic alkyl, aryl, aralkyl, heteroaryl or heteroaralkyl ring comprising up to 12 ring atoms and containing one or more heteroatoms independently chosen from N, O, and S; alternatively ring B may be biphenyl; ring B may optionally be linked to ring A by a C1-4 alkyl or a C1-4 alkoxy chain linking the 2-position of ring B with a carbon atoms alpha to X2; each R3 is independently selected from hydrogen, halogen, NO2, COOR wherein R is

hydrogen or C1-6 alkyl, CN, CF3, C1-6 alkyl, -S-C1-6 alkyl, -SO-C1-6 alkyl, -SO2-C1-6 alkyl, C1-6 alkoxy and up to C10 aryloxy, n is 1, 2 or 3; P is –(CH2)n- wherein n=0, 1, 2: or P is an alkene or alkyne chain of up to six carbon atoms; or P may be selected from –CO-N(R6)-, -N(R6)-CO-, -SO2-N(R6)- and- N(R6)-SO2-, and R6 is hydrogen, C1-6 alkyl, up to C10 aralkyl or up to C9 heteroalkyl; Ring A is piperazine and may optionally be mono- or di-substituted by optionally

substituted C1-6 alkyl or C1-6 alkoxy, each substituent being independently selected from halogen, C1-6 alkyl or an oxo group. X1 and X2 are each N; Y is selected from –SO2- and –CO-;

Z is –N(OH)HO and Q is selected from –CH(R6)-, -CH(R6)-CH2-, and- N(R6)-CH2-; R1 is H, C1-6 alkyl, C5-7 cycloalkyl, up to C10 aryl, up to C10 heteroaryl, up to C12 aralkyl, or up to C12 heteroarylalkyl, all optionally substituted by up to three groups independently selected from NO2, CF3, halogen, C1-4 alkyl, carboxyl (C1-4) alkyl, up to C6 cycloalkyl, -OR4, -SR4, C1-4 alkyl substituted with –OR4, SR4 (and its oxidized analogues), or C1-4 alkyl-Y-NR4, or R1 is 2,3,4,5,6-pentafluorophenyl; R4 is hydrogen, C1-6 alkyl, up to C10 aryl or up to C10 heteroaryl or up to C9 aralkyl, each independently optionally substituted by halogen, NO2, CN, CF3, C1-6 alkyl, -S-C1-6 alkyl, -SO-C1-6 alkyl, -SO2-C1-6 alkyl or C1-6 alkoxy; R2 is H, C1-6 alkyl, or together with R1 forms a carbocyclic or heterocyclic spiro 5, 6 or 7 membered ring, the latter containing at least one heteroatom selected from N, O, and S; also the group Q can be linked to either R1 or R2 to form a 5, 6 or 7 membered alkyl or heteroalkyl ring comprising one or more of O, S and N; and wherein any alkyl groups outlined above may be straight chain or branched, or a pharmaceutically-acceptable salt or in vivo hydrolysable precursor thereof.

__________

141458 ]21][11[


627

וגיתהבהרה מורפול

MORPHOLOGICAL DISAMBIGUATION

]54[

15.02.2001 ]22[ US ]33[ 29.06.2000 ]32[ 09/606326 ]31[

Int. Cl.8 G06F 017/27 ]51[ IBM CORPORATION, U.S.A. ]71[


רחובות


]74[

[57] A method for morphological disambiguation, comprising: building a statistical base by morphologically analyzing a corpus of text comprising multiple words having lemmas so as to find respective linguistic patterns of the words independently of the lemmas to which the linguistic patterns are applied, each pattern comprising a specification of at least one characteristic selected from a set of characteristics including a part of speech, prefix, number, gender and person,

and finding relative frequencies of occurrence of the linguistic patterns in the corpus; receiving an input string;

morphologically analyzing the string to generate a list of candidate analyses of the string, each candidate analysis comprising a respective word, having a linguistic pattern and a lemma; and evaluating the pattern in each of the analyses using the statistical base so as to determine a relative frequency of occurrence of the pattern in each of the analyses, independent of the

lemma to which the pattern is applied; and selecting from the list one or more of the analyses that comprise respective patterns whose frequency of occurrence is above a predetermined threshold.

__________

141710 ]21][11[

שיטה ומערכת לגילוי אובייקט

OBJECT DETECTION METHOD AND SYSTEM

]54[

28.02.2001 ]22[ Int. Cl.8 G01S 017/02 ]51[


, מ"רשות לפיתוח אמצעי לחימה בע-רפאל חיפה

RAFAEL-ARMAMENT DEVELOPMENT AUTHORITY LTD.

]71[



]74[

[57] A method for monitoring a region of interest, the method comprising: (i) transmitting incident radiation towards the region of interest with a certain transmitting angle to define a plane of propagation of the incident radiation, and with a predetermined angular intensity distribution, I(θ), of the incident radiation, the region of interest being located within said plane; (ii) collecting reflections of the incident radiation with a solid angle of collection intersecting with said plane, a region of intersection being a detecting window of a

predetermined geometry containing at least a portion of said region of interest; detecting the collected radiation coming from within said detecting window utilizing a detector having a sensing surface configured with a predetermined geometry and with a spatially variable sensitivity within this surface selected in accordance with the geometry of the detecting window and the angular intensity distribution of the incident radiation; and generating output signals indicative of the detected radiation.

__________

141743 ]21][11[

ציוד ושיטה עבור בקרת דימולטיפלקסר ומולטיפלקסר בשימוש להתאמת קצב

במערכת תקשורת ניידת

APPARATUS AND METHOD FOR CONTROLLING A DEMULTIPLEXER AND A MULTIPLEXER USED FOR RATE MATCHING IN A MOBILE COMMUNICATION SYSTEM

]54[

08.07.2000 ]22[ KR ]33[ 08.07.1999 ]32[ 1999/27407 ]31[ KR 23.07.1999 1999/30095 KR 30.08.1999 1999/37496

Int. Cl.8 H03M 013/03, H04B 007/02, 007/216 ]51[ SAMSUNG ELECTRONICS CO.,

LTD., REPUBLIC OF KOREA ]71[




]74[

[57] An uplink transmitting device in a mobile communication system,

comprising: an encoder for receiving a first information bit stream and for outputting


629

three streams, a second information bit stream, a first parity stream, and a second parity stream, by encoding the first information bit stream; an interleaver for interleaving the encoded streams by a predetermined interleaving rule; a radio frame segmenter for receiving the interleaved stream from the interleaver and mapping the received interleaved stream onto at least one consecutive radio frame; a demultiplexer for separating each of the at

least one radio frames received from the radio frame segmenter into a third information bit stream, and first and second parity streams from the demultiplexer; and a rate matcher for bypassing the third information bit stream and for puncturing a part of the first and second parity streams from the demultiplexer according to a given rate matching rule.



__________

141761 ]21][11[

כרטיס לגישה ללא מגע ושיטה לייצורו

CONTACTLESS ACCESS TICKET AND METHOD FOR MAKING SAME

]54[

07.07.2000 ]22[ FR ]33[ 07.07.1999 ]32[ 99/08802 ]31[

Int. Cl.8 G06K 019/06 ]51[ ASK, FRANCE ]71[ WO/2001/004834 ]87[



]74[

[57] A ticket (10) providing access to a zone with controlled access when said ticket is presented without contact in front of a ticket reader authorizing access to the zone, said ticket having an Edmonson

format and comprising a paper ticket body (12) covered on both surfaces with a protective coating (18, 20), said paper ticket body being provided with a through-hole wherein is located an electronic


module (14) comprising an integrated circuit (22) and an antenna (24), said antenna being formed by at least one turn obtained by screen printing with silvery powder in a polymerisable composition before being heat-cured, wherein said electronic module also includes an overlay

having a thickness slightly greater than that of said electronic circuit and provided with an opening whose dimensions are slightly greater than that of said electronic circuit such that said electronic circuit fits into said opening, so that said module has a substantially constant thickness.

__________

142265 ]21][11[

מערכת עיבוד נתונים בעלת גישה לא המקדימה בקשת ) NUMA(אחידה לזכרון

קריאה לענף עיבוד מרוחק על בסיס משוער

NON-UNIFORM MEMORY ACCESS (NUMA) DATA PROCESSING SYSTEM THAT SPECULATIVELY FORWARDS A READ REQUEST TO A REMOTE PROCESSING NODE

]54[

10.12.1999 ]22[ US ]33[ 15.12.1998 ]32[ 09/211351 ]31[

Int. Cl.8 G06F 012/08, 013/00 ]51[ INTERNATIONAL BUSINESS

MACHINES CORPORATION, U.S.A. ]71[




]74[

[57] A computer system, comprising: a node interconnect; and at least a local node

and a remote node that are each coupled to said node interconnect, said local node


631

including a local interconnect and said local and remote nodes each including one or more snoopers, wherein said one or more snoopers of said local node include a node controller insterposed between said local interconnect and said node interconnect, wherein said node controller speculatively transmits a request transaction received from said local interconnect to said remote node via said node interconnect prior to determination of

a local response, wherein snoopers at the local node and the remote node independently process the request transaction to obtain the local node response at the local node and a remote node response at the remote node, and wherein said node controller of the local node handles the remote node response to said request transaction in accordance with the local node response.

__________

142572 ]21][11[

שיטה לקביעת ההבדלים בין שני מודלים או יותר

METHOD FOR DETERMINING DIFFERENCES BETWEEN TWO OR MORE MODELS

]54[

15.10.1999 ]22[ US ]33[ 16.10.1998 ]32[ 60/104682 ]31[

Int. Cl.8 G06F 017/30 ]51[ COMPUTER ASSOCIATES THINK,

INC., U.S.A. ]71[


באר שבע, 5352. ד.ת, עומר , גן תעשייהLUZZATTO & LUZZATTO, INDUSTRIAL PARK, OMER P.O.B. 5352 BEER-SHEVA 84152

]74[


[57] A method for comparing a first model and a second model, comprising: identifying metadata in the first model and in the second model; calculating a first set of signatures for objects of the metadata of the first model and a second set of signatures for objects of the metadata of the second model, wherein the objects to the first model and the objects of the second model corresponding with each

other have the same signatures; determining which signatures of the first set of signatures match signatures of the second set of signatures; and determining for the matched signatures whether the objects associated with the signatures of the first set of signatures equal the objects associated with the signatures of the second set of signatures.

__________

142650 ]21][11[

שימוש של קוניוגטים של חומצת מרה או של מלח מרה וחומצה שומנית או חומצות

ומניות להכנת תכשירי רוקחות להורדת שלטיפול בכבד שומני ולטיפול , כולסטרול

בהיפרגליקמיה וסכרת

USE OF BILE ACID OR BILE SALT FATTY ACIDS CONJUGATES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR REDUCING CHOLESTEROL, TREATING FATTY LIVER AND TREATING HYPERGLYCEMIA AND DIABETES

]54[

17.04.2001 ]22[ Int. Cl.8 A61K 031/575, C07J 009/00, 041/00 ]51[


633

GALMED INTERNATIONAL LIMITED, MALTA

]71[

,מ"בע) 1995(ארליך .אי.י'ג, 11רחוב מנחם בגין ,15קומה , מגדל אילון

רמת גן

G.E. EHRLICH (1995) LTD., AYALON TOWER 15TH FLOOR 11 MENACHEM BEGIN STREET 52521 RAMAT GAN

]74[

[57] Use of a bile acid or bile salt fatty acid conjugate of the formula W-X-G in which G is a bile acid or bile salt radical, which, if desired, is conjugated in position 24 with a suitable amino acid, W stands for one or two fatty acid radicals

having 14-22 carbon atoms, and X stands for a suitable bonding member or for a direct C=C bond between said bile acid or bile salt radical and the fatty acid(s) or of a pharmaceutical composition comprising same for the manufacture of a medicament for the reduction of the cholesterol in blood and body, wherein said suitable bonding member provides a solid bond that is not substantially deconjugated during the absorption process of the conjugate, with the proviso that said bond is not an ester bond.

__________

142787 ]21][11[

חלקיקים מצופים של איבופרופאן גבישי מגורען

COATED PARTICLES OF GRANULATED CRYSTALLINE IBUPROFEN

]54[

03.11.1999 ]22[ FR ]33[ 06.11.1998 ]32[ 98/14033 ]31[

Int. Cl.8 A61K 009/28, 009/50, 031/19 ]51[ ETHYPHARM, FRANCE ]71[ WO/2000/027368 ]87[



]74[

[57] Coated particles based on granulated microcrystals of ibuprofen, its isomers and its pharmaceutically acceptable salts, characterized in that they have a coating consisting of a mixture comprising (a) from 5 to 50% by weight, preferably from 10 to 30% by weight, of ethyl cellulose, based on the ibuprofen,

(b) from 10 to 60% by weight, preferably from 15 to 50% by weight, of hydroxypropyl methyl cellulose, based on the ethyl cellulose, and (c) from 0.1 to 40% by weight, preferably from 3 to 25% by weight, of silica with antistatic and permeabilizing properties, based on the ethyl cellulose,


said coating – of which at least one of the constituents can be used for the granulation of the ibuprofen microcrystals to produce said particles – masking the unpleasant taste of the ibuprofen,

significantly reducing its irritant effect on the throat after swallowing, and releasing the ibuprofen substantially immediately when the particles are placed in an aqueous medium.

__________

142876 ]21][11[

חומצה –5אמולסיה של –נאנו אמינולוולינית

NANO-EMULSION OF 5-AMINOLEVULINIC ACID

]54[

12.11.1999 ]22[ DE ]33[ 12.11.1998 ]32[ 19852245.2 ]31[

Int. Cl.8 A61K 009/107 ]51[ BIOFRONTERA BIOSCIENCE

GMBH, GERMANY ]71[

WO/2000/028971 ]87[ ,טולוצאטו את לוצא


]74[

[57] Composition characterized in that it contains a nanoemulsion which comprises an active substance selected from 5-aminolevulinic acid, or a salt, a complex or an addition compound thereof, and/or precursors and/or metabolites thereof

which can be converted into protoporphyrin IX, and a carrier in an aqueous phase, with the carrier being formed from one or more lipids and from one or more emulsifiers including soybean lecithin.

__________

143013 ]21][11[

המתיישר מעצמו בעל MOSFETשבב שער כפול עם שערים נפרדים

SELF-ALIGNED DOUBLE GATE MOSFET WITH SEPARATE GATES

]54[

07.05.2001 ]22[ US ]33[ 15.05.2000 ]32[ 60/204131 ]31[ US 07.07.2000 09/612260

Int. Cl.8 H01L 029/76 ]51[ IBM CORPORATION, U.S.A. ]71[


רחובות


]74[


635

[57] A transistor comprising: a channel region (5); a first gate (16) on top of said channel region; a second gate (22) below said channel region; and source and drain regions (8) laterally adjacent said channel region, wherein said channel region

includes an extension into said source and drain regions, and wherein said first gate comprises the same material as said second gate, and has a different doping concentration than said second gate.

__________

143014 ]21][11[

עוריים–מתן תרופה והוצאת אנליט תת

TRANSDERMAL DRUG DELIVERY AND ANALYTE EXTRACTION

]54[

01.11.1999 ]22[


US ]33[ 09.11.1998 ]32[ 09/189170 ]31[ Int. Cl.8 A61N 001/30 ]51[

]TRANSPHARMA MEDICAL LTD. ]71 יהוד, מ"טראנספארמה מדיקל בע WO/2000/027473 ]87[


רחובות


]74[

[57] A device (20) for ablating stratum corneum epidermidis of skin on the body of a subject, comprising; a plurality of electrodes (60), which are adapted to be applied to the skin of the subject at respective points; and a power source,

(52) which is adapted to apply electrical energy between two or more of the plurality of electrodes, to cause ablation of an area of the stratum corneum during a first time period, so as to facilitate passage of a substance through the ablated area during a second time period, subsequent to the first time period.

__________

143202 ]21][11[

הדמיה ממוחשבת מסתגלת

COMPUTERIZED ADAPTIVE IMAGING

]54[

30.11.1999 ]22[ IL ]33[ 01.12.1998 ]32[ 127359 ]31[ US 27.01.1999 09/238225

Int. Cl.8 G01N 021/17, 021/64, G02B 021/00, G06T 001/00 ]51[ רחובות, מ"ידע חברה למחקר ופיתוח בע

YEDA RESEARCH AND DEVELOPMENT CO. LTD. THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, U.S.A.

]71[

WO/2000/033250 ]87[


637

,אפרים סקמסקי ירושלים, 4500. ד.ת ,

EPHRAIM SECEMSKI, P.O.BOX 4500 JERUSALEM 91045

]74[

[57] Apparatus for three-dimensional image processing, comprising: an imaging system reading a three dimensional map of variations in the refractive characteristics in a volume; a ray tracer, utilizing said three dimensional map to analytically trace a multiplicity of rays from a multiplicity of locations in said volume through said

volume, thereby providing a location dependent point spread function; and a three dimensional deconvolver, utilizing the location dependent point spread function, to provide an output image corrected for distortions due to three dimensional variations in the refractive characteristics in said volume.

__________

143229 ]21][11[

שיטה לייצור נגזרות פעילות מבחינה –4–אמינו–1אופטית של

אין–2– ציקלופנט–)הידרוקסימתיל(

METHOD FOR PRODUCING OPTICALLY ACTIVE 1-AMINO-4-(HYDROXYMETHYL)-CYCLOPENT-2-ENE DERIVATIVES

]54[

23.12.1999 ]22[ EP ]33[ 23.12.1998 ]32[ 98124570.7 ]31[

Int. Cl.8 C07C 235/30, 235/40, C12P 041/00 ]51[ LONZA AG, SWITZERLAND ]71[ WO/2000/039324 ]87[



]74[


[57] Process for preparing enantiomerically enriched 1-amino-4-

(hydroxymethyl) cyclopent-2-ene derivatives of the formulae

in which R1 is hydrogen or an optoionally substituted C1-8-alkyl radical, aryl radical

or cycloalkyl radical and R2 is an optionally substituted acyl, in that a racemic 1-amino-4-(hydroxymethyl) cyclopent-2-ene derivative of the formula

in which R1 is as defined above is reacted using a hydrolase in the presence of an acylating agent.

__________

143253 ]21][11[

זרנוק להשקייה בטיפטוף בעל נקודות טיפטוף מים בקצב שונה

DRIP IRRIGATION HOSE WITH EMITTERS HAVING DIFFERENT DISCHARGE RATES

]54[

19.11.1999 ]22[ US ]33[ 20.11.1998 ]32[ 60/109667 ]31[

Int. Cl.8 A01G 025/02 ]51[ T-SYSTEMS INTERNATIONAL,

INC., U.S.A. ]71[




]74[

[57] A drip irrigation hose (10) having a water supply passage (26) and a plurality of flow regulating channels (24) manufactured into the hose that are smaller than the water supply passage, the flow

regulating channels each comprising: a predesignated geometry to provide a desired discharge rate at a given pressure, an inlet section (32) comprising one or more openings connecting the water


639

supply passage to that flow regulating channel, and an outlet section (28) comprising one or more openings (36) connecting that flow regulating channel to the exterior of the hose, wherein the

plurality of flow regulating channels have at least two different geometries to provide at least two different discharge rates at the given pressure.

__________

143270 ]21][11[

שיטה עבור הגברת פעילות של חיות מחמד

METHOD FOR INCREASING PET ACTIVITY

]54[

21.09.2000 ]22[ US ]33[ 22.09.1999 ]32[ 60/155451 ]31[

Int. Cl.8 A23K 001/14, 001/18 ]51[ SOCIETE DES PRODUITS NESTLE

S.A., SWITZERLAND ]71[

WO/2001/021008 ]87[ ,פ"עו, ר יצחק הס ושותפיו"ד

תל אביב, 6451. ד.ת , 279ון רחוב הירקDR. YITZHAK HESS & PARTNERS, 279 HAYARKON STREET P.O.B. 6451 TEL AVIV 61063

]74[

[57] A method for improving activity in a pet, the method comprising administering

to the pet a nutritional agent which promotes the growth of bifido-and lactic-


bacteria in the gastro-intestinal tract of the pet.

__________

143693 ]21][11[

שיטה ומערכת לגישה דינמית לקבצים שרת–במערכת לקוח

CLIENT-SERVER DYNAMIC FILE ACCESS SYSTEM AND METHOD

]54[

29.12.1999 ]22[ US ]33[ 31.12.1998 ]32[ 09/224622 ]31[

Int. Cl.8 G06F 015/173, 019/00 ]51[ COMPUTER ASSOCIATES THINK,

INC., U.S.A. ]71[



]74[

[57] A system for dynamically viewing updates to a data file, comprising: a file access client operable to request dynamic access to a data file; and a file access server coupled to the file access client, the file access server operable to transmit an

initial content of the data file to the file access client and data file modifications dynamically occurring over time, wherein the file access client is enabled to dynamically view the updates to the data file as they occur.


641

__________

143709 ]21][11[

מעכבים לקולטני אנדרוגן

ANDROGEN RECEPTOR SUPPRESSORS

]54[

12.11.1999 ]22[ US ]33[ 18.12.1998 ]32[ 09/215351 ]31[

Int. Cl.8 A61K 031/145, 031/165, 031/275, 031/40, C07C 237/04, 237/22, 255/56, 255/58, 275/30, 317/46, 323/51, 335/06, 335/16, C07D 207/40, 233/66

]51[

BIOPHYSICA, INC., U.S.A. ]71[ WO/2000/037430 ]87[ ,מ"בע) 1995(ארליך .אי.י'ג

רחוב מנחם בגין ,15קומה , מגדל אילון רמת גן, 11


]74[

[57] A compound of the formula:


wherein: X is nitro, cyano or halogen; V is CF3, halogen or H; W is OH when T is H and is methyl when T and T1 are taken together to form a C=Z bridge; U is N when T and T1 are taken together to form a C=Z bridge or is taken together with T1 to form a bond or O or N; Q is a chalcogen; n is 1 or 2 and d is 0 or 1; when d is 0, T and T1 are hydrogen; when d is 1, then: when n is 1, Y is a bond or linking group of from 1 to 10 carbon atoms and from 0 to 6 heteroatoms in the chain, where the

heteroatoms are N, O, or S; Z, when other than taken together with Y, is an aliphatic group of from 1 to 6 carbon atoms, a polyfluoroacylamido group of from 2 to 8 carbon atoms and having at least 2 fluorines and not more than 2m-1 fluorines, wherein m is the number of carbon atoms, or haloanilino, where halo is of atomic number 9 to 80; and when n is 2, Y and Z are taken together to form a bond or a linking group of from 1 to 10 carbon atoms and from 0 to 6 heteroatoms, with from 0 to 4 heteroatoms in the chain, where the heteroatoms are N,O, and S.

__________

143780 ]21][11[

תהליך לייצור אלקטרודה

PROCESS FOR MANUFACTURING ELECTRODE

]54[

14.06.2001 ]22[ Int. Cl.8 H01G 009/052 ]51[

יקנעם , מ"בע) טכנולוגיות קרמיקה(קראל יליתע

CEREL (CERAMIC TECHNOLOGIES) LTD.

]71[

טלי , רניאק'לודמילה צ, ישראל שוסטר ניסים כהן, פלד

ISRAEL SCHUSTER, LUDMILA CHERNIAK, TALI PELED, NISSIM COHEN

]72[



]74[

[57] An electrophoretic process for


643

producing a tantalum electrode having a substantially uniform layer of deposited tantalum particles thereon, comprising the steps: (a) providing a suspension of tantalum particles in a polar organic solvent; (b) immersing a temporary tantalum foil deposition electrode and a counter electrode in said suspension; (c) providing an electric field to charge said particles using said temporary

deposition electrode and said counter electrode; (d) replacing said temporary deposition electrode with a new deposition electrode; and, applying a suitable direct current to said new deposition electrode and said counter electrode, such as to cause electrophoretic homogeneous deposition of tantalum particles onto the surface of said deposition electrode.

__________

143886 ]21][11[

תרמיל הכולל מערכת גלילה וגרירה אינטגרלית

RUCKSACK WITH INTEGRATED ROLLING AND TRACTION SYSTEM

]54[

01.10.1999 ]22[ BE ]33[ 02.10.1998 ]32[ 9800714 ]31[

Int. Cl.8 A45F 003/04 ]51[ ROGER DE LATHOUWER,

BELGIUM ]71[

WO/2000/019862 ]87[ ,מ"בע' דוד ושות-בן. מירמיהו



]74[


[57] Rucksack with supple material walls comprising a retractable handle (7) and an incurvated base plate, such plate made to be integrated with the base of at least one telescopic housing of the rod(s) of the retractable handle, said base plate comprising openings at the incurvation, openings receiving projecting wheels, characterized in that the upper extremity of the telescopic housing(s) is connected to a

supporting plate of the supple material extending perpendicular to the telescopic system and in that the base plate is an interior base plate and the telescopic housing provided internally in the baggage along one face, and in that the face in contact with the back and provided with straps (31) is opposite the face adjacent to the telescopic housing.

__________

143940 ]21][11[

מערכת ושיטה לקורלציה דינמית של אירועים

SYSTEM AND METHOD FOR DYNAMIC CORRELATION OF EVENTS

]54[

29.12.1999 ]22[ US ]33[ 31.12.1998 ]32[ 09/224487 ]31[


INC., U.S.A. ]71[



]74[

[57] An event management system comprising: ane event manager, the event

manager receiving on or more subscription requests for one or more event data from


645

one or more subscribers, the event manager receiving one or more events and if the one or more events matches an existing condition, applying the one or more events as an update to the existing condition, the event manager further routing the one or more event data to the one or more subscribers; an alarm rule store, the alarm rule store storing alarm rules; an event correlator coupled to the event manager and to the alarm rule store,

the event correlator correlating the one or more event data provided by the event manager based on the alarm rules, the event correlator further dynamically determining whether a rule has changed, added or deleted to dynamically execute the added or modified rule; and a response engine coupled to the event manager, the response engine executing a response policy based on the correlation of events by the event correlator.

__________

143952 ]21][11[

, דשן אורגני בעל תכונות רקבוביות שיטה לייצורו ושימושו

ORGANIC FERTILIZER HAVING HUMIC PROPERTIES, ITS METHOD OF PRODUCTION AND ITS USE

]54[

17.12.1999 ]22[ DE ]33[ 22.12.1998 ]32[ 19859068.7 ]31[

Int. Cl.8 C05F 011/02, C05G 003/00 ]51[ TECHNISCHE UNIVERSITAT

DRESDEN, GERMANY ]71[

KLAUS FISCHER, RAINER SCHIENE, JOACHIM KATZUR

]72[

WO/2000/037394 ]87[


,מ"ר מרק פרידמן בע"ד תל אביב, 7האומנים ' רח, בית שמואלוב

DR. MARK FRIEDMAN LTD., BEIT SAMUELOFF, 7 HAOMANIM STREET, TEL AVIV

]74[

[57] A method for the production of organic fertilizer having humic properties, comprising suspending lignite in an aqueous-ammoniacal medium of pH greater than about 9 and up to about 12, dissolving partially and oxidizing the lignite at a temperature of about 20 to

about 100oC, under atmospheric pressure thereby to obtain the organic fertilizer as a dispersion in aqueous medium and thickening or drying the dispersion, the organic fertilizer having a C/N ratio of about 9 to about 15.

__________

144067 ]21][11[

מערכת ושיטה להצגת נתונים מתועלים

SYSTEM AND METHOD OF PRESENTING CHANNELIZED DATA

]54[

20.01.2000 ]22[ US ]33[ 20.01.1999 ]32[ 09/233870 ]31[


INC., U.S.A. ]71[



]74[

[57] A method of channelising data within a system having a user interface and a server, characterized by: identifying, at the user interface, data to be published as published content; sending a request to the server identifying the data to the server;

generating, at the server, an object key to the the data to be published; storing the object key into a content directory as a function of values stored in a virtual directory; associating the object key with a channel; and displaying the channel on the user interface.


647

__________

144290 ]21][11[

הקצבה אנטיטכיכרדיאלית

ANTITACHYCARDIAL PACING

]54[

14.01.2000 ]22[ US ]33[ 14.01.1999 ]32[ 231570 ]31[

Int. Cl.8 A61N 001/37 ]51[ THE MOWER FAMILY CHF

TREATMENT IRREVOCABLE TRUST, U.S.A.

]71[

MORTON M. MOWER ]72[ WO/2000/041766 ]87[

,מ"בע' דוד ושות-בן. ירמיהו מ, 45087. ד.ת, הר חוצבים , רחוב המרפא

ירושלים


]74[

[57] A method for setting up an implantable cardiac stimulator preparatory to the stimulator's use on the human body to perform cardioverting, the cardiac stimulator having output means for delivering electrical stimulation of a predetermined polarity, amplitude, shape and duration, the method comprising: selecting a first intensity level for

application of pulses of biphasic

pacing stimulation, upon sensing the onset of tachycardia, each pulse of biphasic pacing stimulation comprising a first stimulation phase with a first phase polarity, a first phase amplitude, a first phase shape and a first phase duration; and a second stimulation phase with a second phase polarity, a second phase amplitude, a second phase shape and a second phase duration wherein said first phase amplitude is less than said second phase amplitude, said selecting comprising selection from


the group consisting of at the diastolic depolarization threshold, below the

diastolic depolarization threshold or above the diastolic depolarization threshold.

__________

144411 ]21][11[

תאי אב מכבד אנושי

HUMAN LIVER PROGENITORS

]54[

19.01.2000 ]22[ US ]33[ 19.01.1999 ]32[ 60/116331 ]31[

Int. Cl.8 A61K 035/407, C12N 005/08 ]51[ UNIVERSITY OF NORTH

CAROLINA AT CHAPEL HILL, U.S.A.

]71[


תל אביב, 4060. ד.ת , 21רחוב אחד העם REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040

]74[

[57] A method of preparing a composition comprising a mixture of cells derived from human liver tissue, which mixture comprises an enriched population of human liver progenitors, the method comprising: (a) providing a cell suspension of human liver tissue comprising a mixture of cells of varying sizes, including immature cells and mature cells; (b) debulking the suspension based upon cell size, buoyant density, or a

combination thereof to remove mature cells under conditions that permit the removal of mature cells and those of relatively larger size, while retaining immature cells and those cells of less than about 15 micrometer in diameter; and (c) selecting those cells that express alpha-fetoprotein and one or more markers selected from the group consisting of CD14, CD34, CD38,ICAM, CD117, and albumin.

__________

144756 ]21][11[

שיטה לשליטה על גודל הליפוזום

METHOD FOR CONTROLLING LIPOSOME SIZE

]54[

03.02.2000 ]22[ US ]33[ 08.02.1999 ]32[ 60/119229 ]31[

Int. Cl.8 A61K 009/00, 009/127, 009/133 ]51[ ALZA CORPORATION, U.S.A. ]71[ WO/2000/045791 ]87[


649



]74[

[57] A method for preparing a liposome composition comprising liposomes having a desired size, the method comprising (i) determining an amount of lipid solvent required to achieve the desired liposome size from a profile of liposome size as a function of amount of lipid solvent in a hydration mixture of the lipid solvent and a

second solvent with which the lipid solvent is miscible, and (ii) hydrating a vesicle-forming lipid dissolved in said determined amount of lipid solvent with the second solvent to form the hydration mixture, said determined amount of lipid solvent being between 10-50 weight percent.

__________

144966 ]21][11[

שיטה להפעלת פעולות מחשב על פי הזמן לחוציםבו מקשי מקלדת המחשב

METHOD FOR EXECUTING COMPUTER OPERATIONS ACCORDING TO COMPUTER KEYBOARD'S KEYS DOWN TIME

]54[

19.08.2001 ]22[ Int. Cl.8 G06F 003/02 ]51[

]ISRAEL ELIEZEROV ]71 תל אביב, ישראל אליעזרוב ,ישראל אליעזרוב

תל אביב, 16בלוך ' רחISRAEL ELIEZEROV, 16 BLOCH ST. TEL AVIV

]74[

[57] A method for enabling users of computer keyboards to generate different characters using the same keyboard keys said method comprising timing the keydown time of said key whereby a predetermined short duration results with

the character that a regular keystroke would generate being outputted, and a predetermined longer duration results with the character that would have been generated if the shift key was pressed while the key was pressed.

__________

145069 ]21][11[

תכשיר רוקחות לנתינה דרך משטח חצוני של מעבר או חלל של הגוף

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY TO AN EXTERNAL WALL OF A BODY PASSAGEWAY OR CAVITY

]54[

23.02.2000 ]22[ US ]33[ 23.02.1999 ]32[ 60/121424 ]31[


Int. Cl.8 A61K 009/00, 009/70 ]51[

UNIVERSITY OF BRITISH COLUMBIA, CANADA ANGIOTECH INTERNATIONAL AG., SWITZERLAND

]71[




]74[

[57] Use of a factor that induces fibrosis for the manufacture of a medicament for improving or increasing body passageway or cavity integrity, when said factor is

delivered to a non-luminal surface of said body passageway or cavity substantially as described in the specification.

__________

145090 ]21][11[

שיטה לעיבוד נתונים המתקבלים בערוץ תקשורת בצורת אפליקציה אריתמטית

APPROACH FOR PROCESSING DATA RECEIVED FROM A COMMUNICATION CHANNEL IN FINITE PRECISION ARITHMETIC APPLICATIONS

]54[

02.01.2001 ]22[ US ]33[ 30.12.1999 ]32[ 60/173785 ]31[ US 30.12.1999 60/173778

Int. Cl.8 H04B 003/06, H04J 011/00, H04L 027/01, 027/26 ]51[ BANDSPEED, INC., U.S.A. ]71[ WO/2001/050697 ]87[



]74[

[57] An apparatus for processing data received from a communications channel comprising: an equalizer configured to equalize received data from the communications channel and generate equalized data, wherein the received data is based upon both modulated data and distortion introduced by the communications channel, and the modulated data is the result of original data

modulated onto one or more carriers, and wherein the equalizer is configured to use an algorithm with a set of one or more coefficients selected to account for a frequency domain response of the equalizer and to reduce the distortion introduced by the communications channel; and a demodulator configured to generation an estimate of the original data by demodulating the equalized data.


651

__________

145125 ]21][11[

מערכת ושיטה לצימצום ההעברה TCP/IPהחוזרת של הודעות בסביבת

SYSTEM AND METHOD OF REDUCING RETRANSMISSION OF MESSAGES ON A TCP/IP ENVIRONMENT

]54[

27.08.2001 ]22[ US ]33[ 13.09.2000 ]32[ 661402 ]31[

Int. Cl.8 H04L 012/56, 029/06 ]51[ HARRIS CORPORATION, U.S.A. ]71[



]74[

[57] In a radio network using TCP as the transport protocol for acknowledging message packets successfully received at a destination station and retransmitting message packets from the source station which are not acknowledged within a predetermined period of time, a method of reducing the unnecessary retransmission of message packets characterized by the steps of: (a) receiving a TCP retransmission packet at a source radio from a source station for retransmission to a destination station and

maintaining the packet in a message queue until retransmission; (b) receiving a TCP acknowledgment packet at the source radio from a destination station; (c) comparing the received acknowledgment packet from the destination station with the retransmission packet in the message queue; and (d) discarding the retransmission packet from the message queue if the retransmission packet corresponds to the acknowledgment packet.


__________

145150 ]21][11[


653

– a10 , 8–נגזרות הקסאהידרו מתאנופירידו

ותכשירי , אזפיןd–3,2[[פיראנו ' 2',6,5:3[[ רוקחות המכילים אותן

HEXAHYDRO-8, 10A-METHANO PYRIDO [2',3':5,6] PYRANO [2,3-D] AZEPINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

]54[

01.03.2000 ]22[ FR ]33[ 05.03.1999 ]32[ 99/02784 ]31[

Int. Cl.8 A61K 031/439, A61P 001/00, 025/30, 029/00, C07D 491/22 ]51[ SANOFI AVENTIS, FRANCE ]71[ WO/2000/053608 ]87[


רחובות


]74[

[57] A compound in the form of pure geometrical or optical isomers or a mixture of such isomers, of the formula

in which R1 is a hydrogen atom, a (C1-C4) alkyl group, a phenyl (C1-C4) alkyl group, a phenylhydroxy (C1-C4) alkyl group, a furanyl (C1-C4) alkyl group, or a furanylhydroxy (C1-C4) alkyl group, R2 is either a hydrogen or halogen atom or a trifluoromethyl, cyano, hydroxyl, nitro, acetyl, (C1-C6) alkyl or (C1-C6) alkoxy group or a group of general formula NR4R5 in which R4 is a hydrogen atom or a (C1-C4) alkyl or (C1-C4) alkanoyl group and R5 is a hydrogen atom or a (C1-C4) alkyl

group, or else R4 and R5 form, with the nitrogen atom which carries them, a C4-C7 ring, or a phenyl or naphthyl group optionally subsituted by a halogen atom or a trifluoromethyl, trifluoromethoxy, cyano, hydroxyl, nitro, acetyl, (C1-C6) alkyl, (C1-C6) alkoxy or methylenedioxy group linked in the 2 and 3 positions of the phenyl ring, and R3 is a hydrogen or halogen atom or a (C1-C4) alkyl group, in the state of a base or an addition salt to an acid.

__________

145325 ]21][11[


מערכת ושיטה לחילוץ מפתח אינדקס של שדות נתונים

SYSTEM AND METHOD FOR EXTRACTING INDEX KEY DATA FIELDS

]54[

24.03.2000 ]22[ US ]33[ 26.03.1999 ]32[ 09/276994 ]31[


INC., U.S.A. ]71[



]74[

[57] A system (100) for extracting index key data fields, comprising: a definition interrogator (102) operable to extract index definitions and column definitions from a database; a code generator (104) coupled to the definition interrogator, the code generator operable to build computer code for extracting index key data fields based upon the index definitions and the column

definitions, the computer code including instructions to skip reading a selected number of characters in a data table (108) to read index key data fields; and a table analyzer (106) coupled to the code generator, the table analyzer operable to use the computer code to extract index data from a data table.

__________

145362 ]21][11[


655

גיפור מחצבי סולפיד עבור מיצוי חושת ומתכות הידרומטלורגי של נ

אחרות

SULPHIDISATION OF SULPHIDE ORES FOR HYDROMETALLURGICAL EXTRACTION OF COPPER AND OTHER METALS

]54[

14.12.2000 ]22[ DE ]33[ 14.12.1999 ]32[ 19960132.1 ]31[

Int. Cl.8 C22B 001/00, 015/00 ]51[ ALEXANDER BECKMANN,

GERMANY ]71[


תל , 4060. ד.ת , 21 רחוב אחד העם אביב


]74[

[57] A process for extracting metals from chalcopyrite-containing ores comprising leaching steps of microbiological or chemical nature for leaching out the metals, characterized in that (a) the ores are converted in an inert atmosphere to a reaction product

compriusing covelline, pyrite, and accompanying sulfides by adding sulfur and additives in a conversion step interposed prior to the leaching steps, and (b) copper and other metals, precious metals, and rare earths contained in the reaction product are extracted.

__________

145470 ]21][11[

תולדות ריסורצינול עם קבוצות אלקיל

ALKYLATED RESORCINOL DERIVATIVES

]54[

22.03.2000 ]22[ US ]33[ 22.03.1999 ]32[ 60/125674 ]31[ US 30.08.1999 60/151595

Int. Cl.8 C07C 039/10, 039/19, 043/20, 043/23 ]51[ IMMUGEN PHARMACEUTICALS,

INC., U.S.A. ]71[




]74[

[57] An alkylated resorcinol derivative


of the formula:

wherein, R1 is: OH, OCH3 R2 is: H R3 is: 1, 1,5-trimethylhexyl, 1,1,5,5-tetramethylhexyl, or 1,1,5-trimethyl-hept-

4-enyl, R4 is: H R5 is: OH, or OCH3; and R6 is: H, OH, methyl, or ethyl.

__________

145483 ]21][11[

תרכובות הטרוארומטיות ביציקליות שימוש בטיפול מותמרות ארבע פעמים ל

תכשירי רוקחות הכוללים אותן , תרופתי וכמה תרכובות חדשות

TETRASUBSTITUTED BICYCLIC HETEROAROMATIC COMPOUNDS FOR USE IN THERAPY, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SOME NOVEL COMPOUNDS

]54[

03.04.2000 ]22[ EP ]33[ 08.04.1999 ]32[ 99201152.8 ]31[

Int. Cl.8 A61K 031/395, A61P 005/06, C07D 471/04, 487/04, 491/04, 495/00 ]51[ N.V. ORGANON, THE

NETHERLANDS ]71[



]74[

[57] A bicyclic heteroaromatic derivative compound of the formula

or a pharmaceutically acceptable salt


657

thereof wherein R1 is NR5R6, OR5, SR5 or R7; R5 and R6 are independently selected from H, (1-8C) alkyl, (2-8C) alkenyl, (2-8C) alkynyl, (3-8C) cycloalkyl, (2-7C) heterocycloalkyl, alkyl (1-8C) carbonyl, (6-14C) arylcarbonyl, (6-14C) aryl or (4-13C) heteroaryl, or R5 and R6 together are joined in a (2-7C) heterocycloalkyl ring and wherein the alkyl group, alkenyl group or alkynyl group, if present in R5 and/or R6 optionally are substituted with one or more substituents selected from hydroxyl, (6-14C) aryl, (1-8C) alkoxy, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (1-8C) alkoxycarbonyl, (6-14C) aryloxycarbonyl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, amino, (1-8C) alkylaminocarbonyl, (6-14C) arylaminocarbonyl, (1-8C) alkylcarbonylamino, (6-14C) arylcarbonylamino, (6-14C)(di) arylamino and/or (1-8C) (di) alkylamino; R7 is (3-8C) cycloalkyl, (2-7C) heterocycloalkyl or (6-14C) aryl or (4-13C) heteroaryl, both optionally substituted at the ortho and/or meta position with one or more substituents selected from R8, (6-14C) aryl, (4-13C) heteroaryl, (2-7C) heterocycloalkyl, (3-8C) cycloalkyl, NHR8, OR8 and/or SR8 in which R8 is (6-14C) aryl, (4-13C) heteroaryl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, (1-8C) alkyl, (2-8C) alkenyl, (2-8C) alkynyl, the alkyl group of which may be optionally substituted with one or more substituents selected from hydroxyl, (1-8C) alkoxy, (2-7C) heterocycloalkyl (1-8C) alkoxy, (3-8C) cycloalkyl (1-8C) alkoxy, (6-14C) aryl (1-8C) alkoxy, (4-13C) heteroaryl (1-8C) alkoxy, (2-7C) heterocycloalkyl, (3-8C) cycloalkyl, (6-14C) aryl, (4-13C) heteroaryl, (1-8C) alkoxycarbonyl, (6-14C) arylyloxycarbonyl, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (1-8C) alkylcarbonyl, (6-

14C) arylcarbonyl, amino, 1-8C) alkylamino-carbonyl, (6-14C) arylaminocarbonyl, (1-8C) alkylarbonylamino, (6-14C) aryl-carbonylamino, (6-14C) (di) arylamino and/or (1-8C) (di) alkylamino; R2 is (1-8C) alkyl, (2-8C) alkenyl or (2-8) alkynyl, all optionally substituted with one or more substituents selected from (6-14C) aryl, (4-13C) hetdroaryl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (6-14C) aryloxcarbonyl and/or (1-8C) alkoxycarbonyl or R2 is (6-14C) aryl or (4-13C) heteroaryl, both optionally substituted with one or more substituents selected from (1-8C) alkyl, (1-8C) alkylthio, (1-8C) (di) alkylamino, (1-8C) alkoxy, (2-8C) alkenyl, or (2-8C) alkynyl; R3 is (1-8C) alkyl, (2-8C) alkenyl or (2-8C) alkynyl, all optionally substituted with one or more substituents selected from hydroxyl, (1-8C) alkoxy, (6-14C) aryloxy, (3-8C) cycloalkyl (1-8C) alkoxy, (2-7C) heterocycloalkyl (1-8C) alkoxy, (6-14C) aryl (1-8C) alkoxy, (4-13C) heteroaryl (1-8C) alkoxy, (2-7C) heterocycloalkyl, (6-14C) aryl, (4-13C) heteroaryl, (1-8C) alkoxycarbonyl, (6-14C) aryloxycarbonyl, (1-8C) alkylcarbonyloxy, (6-14C) arylcarbonyloxy, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl, amino, (1-8C) alkylaminocarbonyl, (6-14C) arylaminocarbonyl, (1-8C) alkylcarbonylamino, (6-14C) arylcarbonylamino, (6-14C)(di) arylamino or (1-8C)(di) alkylamino, or R3 is (3-8C cycloalkyl, (2-7C) heterocycloalkyl, or (6-14C) aryl or (4-13C) heteroaryl, both optionally substituted with one or more substituents selected from (1-8C) alkyl, (1-8C) (di) alkylamino or (1-8C) alkoxy; X is S, O or N(R4); R4 is H, (1-8C) alkyl, (1-8C) alkylcarbonyl, (6-14C) arylcarbonyl or (6-14C) aryl (1-8C) alkyl;


Y is CH or N; Z is NH2 or OH; A is S, N(H), N(R9), O or a bond;

R9 can be selected from the same groups as described for R2; B is N(H), O, or a bond; for use in therapy.

__________

145553 ]21][11[

פדיבורג עצמות לשימוש בניתוח אורטו

BONE SCREW FOR USE IN ORTHOPAEDIC SURGERY

]54[

03.04.2000 ]22[ EP ]33[ 08.04.1999 ]32[ 99830204.6 ]31[

Int. Cl.8 A61B 017/86 ]51[ ORTHOFIX INTERNATIONAL B.V.,

THE NETHERLANDS ]71[

DANIELE VENTURINI ]72[ WO/2000/061022 ]87[ ,מ"ן בער מרק פרידמ"ד

תל אביב, 7האומנים ' רח, בית שמואלובDR. MARK FRIEDMAN LTD., BEIT SAMUELOFF, 7 HAOMANIM STREET, TEL AVIV

]74[

[57] A bone screw for use in orthopaedic surgery, in particular with external fracture fixation devices, comprising a head (3), a shank (4), and a threaded portion (5) tapering towards a tip (2) at the opposite end from the head, wherein said threaded portion has at least one constant pitch

section comprising threads (9) with an acute angle or cusp-like triangular profile in cross-section, characterised in that said threads are separated from each other by a shaped bottom land having a concave profile (10) defined by two countersloping planes.

__________


659

145572 ]21][11[

ממשק משתמש להזנת נתונים של זמן

USER INTERFACE FOR INPUTTING TIME-RELATED DATA

]54[

23.09.2001 ]22[ Int. Cl.8 G04B 027/08, G04C 009/00 ]51[

באר שבע, ראובן ברמן באר שבע, אנה ברמן

REUBEN BERMAN ANNA BERMAN

]71[

,ראובן ברמן באר שבע, 16 זלמן ארן

REUBEN BERMAN, 16 ZALMAN ARAN ST. BEER-SHEBA

]74[

[57] A non-virtual apparatus for inputting time-related data, comprising: an analog clock whose notches and/or the surrounding thereof is sensitive to a touch of a rigid object, inputting said time via said apparatus being carried out by: (a) inputting the hour of said time by touching the corresponding notch or its surrounding with a rigid object;

(b) inputting the minute of said time by touching the corresponding notch or its surrounding with a rigid object; (c) optionally, setting the second of said time by touching the corresponding notch or its surrounding with a rigid object.

__________


145668 ]21][11[

מזרק חסר מחט

NEEDLELESS SYRINGE

]54[

14.04.2000 ]22[ US ]33[ 16.04.1999 ]32[ 293320 ]31[

Int. Cl.8 A61M 005/30 ]51[ POWDERJECT RESEARCH

LIMITED, UNITED KINGDOM ]71[



]74[

[57] A needleless syringe device for accelerating particles into a target tissue of a vertebrate subject, said syringe comprising: an elongate, tubular duct (1) having a lumen (2) for delivering the particles towards the target tissue, the duct having an upstream end and a downstream end; a receptacle (10) holding the particles to be accelerated; and a gas discharge chamber (4), upstream of the receptacle for the controlled discharge therefrom of

pressurized gas to accelerate the particles from the receptacle down the duct lumen towards the target tissue; wherein the pressurized gas discharged from the gas discharge chamber has a maximum total pressure which is less than 10 bar, and which is sufficient to accelerate the particles down the duct such that the particles are configured to exit the duct with sufficient energy to penetrate into the target tissue.

__________


661

146058 ]21][11[

מתג של נתיך

FUSE SWITCH

]54[

20.04.2000 ]22[ AT ]33[ 20.04.1999 ]32[ A702/99 ]31[

Int. Cl.8 H01H 085/54 ]51[ MOELLER

GEBAUDEAUTOMATION KG, AUSTRIA

]71[



]74[

[57] A fuse switch with an insulating housing (1) in which two live housing contacts (14) are arranged in a stationary fashion and with a switching slide (22) which is guided in a displaceable or swivelable manner between an on position and an off or exchange position in the insulating housing for receiving a cartridge fuse link (20), which switching slide is also formed from an insulating material and whose final contact caps (21) rest in the on position directly on the stationary housing contacts and in the off or exchange position are spaced from the

stationary housing contacts, characterized by a carriage (24) with a pin (27), which carriage is held displaceably in the switching slide and holds the cartridge fuse-link and engages in a connecting link (28) arranged on the insulating housing, with the connecting link being shaped in such a way that the carriage is displaced during the displacement or swiveling of the switching slide to such an extent from the the same that the cartridge fuse-link projects in sections beyond the switching slide.


__________

146098 ]21][11[

צורת מינון למתן דרך הפה של 12,7,6,3,2, 12a –2– הקסאהידרו –

– 4, 3 (– 6–) דימתיל– 3, 2 –ו(מתיל] 1,6: 1,'2'[פיראזינו ) יאוקסיפנילמתילנד דיאון– 4, 1 –אינדול ] b – 4,3[פירידו

UNIT DOSAGE FORM OF 2,3,6,7,12, 12A - HEXAHYDRO - 2 - METHYL - (AND 2,3 - DIMETHYL) -6 - (3,4 - METHYLENEDIOXYPHENYL) PYRAZINO [2',1',: 1,6] PYRIDO [3,4-B] INDOLE - 1,4 - DIONE FOR ORAL ADMINISTRATION

]54[

26.04.2000 ]22[ US ]33[ 30.04.1999 ]32[ 60/132036 ]31[

Int. Cl.8 A61K 031/4985, A61P 015/10, C07D 471/14 ]51[ LILLY ICOS LLC, U.S.A. ]71[ WO/2000/066099 ]87[

,ריינהולד כהן ושותפיותל , 4060. ד.ת , 21 רחוב אחד העם

אביב


]74[

[57] A pharmaceutical unit dosage composition comprising about 1 to about 20 mg of a compound of the formula


663

said unit dosage form being suitable for oral administration.

__________

146211 ]21][11[

פולימרים אניוניים כקושרי רעלן וחומרים אנטיבקטריאליים

ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS

]54[

11.05.2000 ]22[ US ]33[ 13.05.1999 ]32[ 60/133975 ]31[ US 03.04.2000 09/541268

Int. Cl.8 A61K 031/74, 047/00, A61P 001/12 ]51[ GENZYME CORPORATION, U.S.A. ]71[ WO/2000/069428 ]87[



]74[

[57] Use of a therapeutically effective amount of a polymer comprising pendant acid functional groups or a salt thereof with a pharmaceutically acceptable cation

in the preparation of a medicament for inhibiting a pathogenic toxin in a patient, said polymer being substantially free of acid anhydride groups.

__________


146232 ]21][11[

D3שימוש בליגנדות לקולטן דופאמין לייצור תרופות לטיפול במחלות כליה

USE OF DOPAMINE D3 RECEPTOR LIGANDS FOR PRODUCING MEDICAMENTS FOR TREATING KIDNEY DISORDERS

]54[

28.04.2000 ]22[ DE ]33[ 07.05.1999 ]32[ 19922443.9 ]31[

Int. Cl.8 A61K 045/00, C07D 403/14 ]51[ ABBOTT GMBH & CO. KG,

GERMANY ]71[



]74[

[57] Use of dopamine D3 receptor antagonists for the production of drugs for the treatment of renal function disorders.

__________

146276 ]21][11[

, הכנתם, תולדות של ספירואמידזולידין שימושם והכנות רפואיות המכילות אותם

SPIROIMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

]54[

06.05.2000 ]22[ DE ]33[ 17.05.1999 ]32[ 19922462.5 ]31[

Int. Cl.8 A61K 031/4184, A61P 009/00, 043/00, C07D 235/00, 235/02 ]51[ SANOFI-AVENTIS DEUTSCHLAND

GMBH, GERMANY ]71[

WO/2000/069831 ]87[ עורכי , פרל כהן צדק לצר עורכי דין



]74[


665


in which R1 is hydrogen or methyl; R2 is unsubsituted phenyl, phenyl which is substituted by a methylenedioxy residue or an ethylenedioxy residue, phenyl which is substituted by one or two (C1-C4) – alkoxy groups, or (C1-C4) – alkyl; X is –CH2-CH2- or –CH2-CH2-CH2-, where one of the CH2 groups in these two residues can be replaced by a carbonyl group C=O; W is isopropyl or cyclopropyl; V is hydrogen or methoxy; E is –CO-R3, -CO-H, -CH2-O-R4, -CH2-O-CO-R4, -CH2-O-CO-O-R5 or 5-tetrazolyl; R3 is hydroxy, (C1-C10)-alkoxy, phenyl-(C1-C8) – alkoxy-, phenyloxy –,(C1-C8)- alkylcarbonyloxy-(C1-C6)-alkoxy-, phenylcarbonyloxy – (C1-C6)-alkoxy-, phenyl-(C1-C6)- alkylcarbonyloxy-(C1-C6)-alkoxy-, (C1-C8)-alkoxycarbonyloxy-(C1-C6)-alkoxy-phenyloxycarbonyloxy- (C1-

C6)-alkoxy-, phenyl-(C1-C6)-alkoxycarbonyloxy-(C1-C6)-alkoxy-, amino, mono-((C1-C10)-alkyl)-amino-, di-((C1-C10)-alkyl-amino-or R4R4N-CO-(C1-C6)-alkoxy-in which the residues R4 are independent of one another and can be identical or different; R4 is hydrogen, (C1-C10) – alkyl, phenyl or phenyl-(C1-C8)-alkyl-; R5 has one of the meanings of R4 with the exception of hydrogen; phenyl present in the groups R3, R4 and R5 is an unsubstituted phenyl residue or a phenyl residue which is substituted by one or more identical or different substituents from the group consisting of (C1-C4)-alkyl, (C1-C4)-alkoxy, methylenedioxy, ethylenedioxy, halogen, trifluoromethyl and trifluoromethoxy; in all its stereosiomeric forms and mixtures thereof in all ratios, and its physiologically tolerable salts.

__________


146420 ]21][11[

1,7,7 –] PHENYL] – 2 – [(ETHOXY – ( DIMETHYLAMINO – N, N) – '2)] – 2 –

(–) –(4R, 2S, 1R) HEPTANE HIGH PURITY [2.2.1]BICYCLO – [METHYL]

– TRI – באיכות גבוהה ומלחי תוספהתהליך , חומציות למטרות רפואיות שלהם

להכנת התרכיבים ותרופות המכילות אותם

HIGH PURITY (1R,2S,4R) - (-) - 2 - [(2' - (N, N - DIMETHYLAMINO) - ETHOXY)] - 2- [PHENYL] - 1,7,7 -TRI - [METHYL]-BICYCLO [2.2.1] HEPTANE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, PROCESS FOR THE PREPARATION OF THESE COMPOUNDS AND MEDICAMENTS CONTAINING THEM

]54[

10.05.2000 ]22[ HU ]33[ 11.05.1999 ]32[ P9901559 ]31[

Int. Cl.8 C07C 217/00 ]51[ EGIS GYOGYSZERGYAR RT.,

HUNGARY ]71[

GYULA LUKACS, GYULA SIMIG, TIBOR MEZEI, ZOLTAN BUDAI, MARTA PORCS-MAKKAY, GYORGY KRASZNAI, KALMAN NAGY, GYORGYI DONATH VERECZKEY, TIBOR SZABO, NORBERT NEMETH, JANOS SZYLAGYI

]72[

WO/2000/068183 ]87[ ,מ"ר מרק פרידמן בע"ד


]74[

[57] (1R, 2S, 4R)-(-)-2-[(2'-(N, N-dimethylamino)-ethoxy)]-2-[phenyl]-

1,7,7,-tri-[methyl]-bicyclo [2.2.1] heptane of formula


667

and pharmaceutically acceptable acid addition salts thereof, charactgerised by that they contain not more than 0.2% of

(1R, 3S, 4R)-3-[(2'-(N, N-dimethylamino)-ethyl)]-1,7,7-tri-[methyl]-bicyclo (2.2.1) heptane-2-one of formula

or of a pharmaceutically acceptable acid addition salt thereof.

__________

146432 ]21][11[

טטראפפטיד ותכשירי רוקחות המכילים אותן

TETRAPEPTIDE AND PHARMACEUTICALCOMPOSITION CONTAINING THE SAME

]54[

20.01.2000 ]22[ RU ]33[ 11.05.1999 ]32[ 99108841 ]31[

Int. Cl.8 A61K 038/07, A61P 011/06, 039/06, 043/00, C07K 005/10, 005/103 ]51[ OBSCHESTVO S OGRANICHENNOI

OTVETSTVENNOSTIJU "KLINIKA INSTITUTA BIOREGUL YATSII I GERONTOLOGII", RUSSIA

]71[




]74[

[57] A tetrapeptide L-alanyl-L-glutamyl-L-aspartyl-glycine of the general formula L-Ala-L-Glu-L-Asp-Gly.

__________


146471 ]21][11[

איל – 3 – אוקסולאן – Nאגוניסטים 2,'3,'5 ,')O–אדנוזינים לקולטנים ) מותמר

רוקחיים , לים בפה הפעיA1לאדנוזין המכילים אותם

ORALLY ACTIVE A1 ADENOSINE RECEPTOR AGONIST N- OXOLAN - 3 - YL - 2`,3`,5` - TRIS (O- SUBSTITUTED) ADENOSINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

]54[

19.05.2000 ]22[ US ]33[ 24.05.1999 ]32[ 09/317523 ]31[

Int. Cl.8 C07H 019/00 ]51[ CV THERAPEUTICS, INC., U.S.A. ]71[ WO/2000/071558 ]87[


רחובות


]74[


wherein R2, R2' and R2" are independently selected from the group of C1-5 alkyl, C3-6 cycloalkyl, and 2-, 3-, 4-pyridinyl, which alkyl, cycloalkyl, and pyridinyl are optionally substituted with 1 to 3 substituents independently selected from

the group consisting of OR20 and N(R20)2; and R20 is selected from the group consisting of hydrogen and C1-5 alkyl, which alkyl group is optionally substituted with 1 to 3 phenyl groups.

__________


669

146619 ]21][11[

שיטה ומערכת למשלוח פקס

METHOD AND SYSTEM FOR DELIVERY OF FACSIMILE

]54[

24.05.2000 ]22[ AU ]33[ 25.05.1999 ]32[ PQ0559 ]31[ AU 30.06.1999 PQ1313

Int. Cl.8 G06F 013/00, 015/00, H04N 001/00 ]51[ SILVERBROOK RESEARCH PTY.

LTD., AUSTRALIA ]71[



]74[

[57] A method of enabling composition of a facsimile by a user and delivery thereof, the method including the steps of: providing a form to the user, the form printed onto at least one paper surface, the form including visible information relating to the user and at least one area for the user to enter a message, the at least one paper surface having invisible coded data indicative of an identity of the form and of the at least one area, wherein the visible information and the invisible coded data are printed substantially simultaneously and wherein at the time of printing a computer system associates the type and spatial extent of the coded data with the spatial extent of at least some of the visible

information; receiving, in a computer system, interaction data from a sensing device used to compose the message, the interaction data being indicative of an identity of the form and a position of the sensing device relative to the area on the paper surface, the sensing device, when placed operatively relative to the area in order to compose the message, generating the interaction data based at least partially on sensing at least some of the coded data in the vicinity of the position; capturing electronically, in the computer system and from the interaction data, at least the message, and transmitting the message to a designated recipient address for facsimile delivery.

__________


146688 ]21][11[

שיטה והתקן לחיפוש והשוואת דמויות

METHOD AND APPARATUS FOR SEARCHING FOR AND COMPARING IMAGES

]54[

23.05.2000 ]22[ US ]33[ 04.06.1999 ]32[ 09/326362 ]31[

Int. Cl.8 G06K 009/68, G06T 007/00 ]51[ LOOK DYNAMICS, INC., U.S.A. ]71[ WO/2000/075867 ]87[


ירושלים


]74[

[57] A search method for locating particular content or similar content that has been converted to a digital format for storage in a digital file at a location somewhere in at least one of a plurality of database and/or server devices, which are connected to and accessible via a computer network, comprising: producing a reference image in an optical pattern that is characteristic of the particular content; accessing and downloading a plurality of digital candidate files from their respective storage locations in one or more of the plurality of database and/or server devices along with location information that is

indicative of said respective storage locations; producing a plurality of candidate images in optical patterns that are characteristic of content in the respective downloaded digital candidate files; comparing the candidate image to the reference image by optical correlation to detect degree of correlation between the reference image and the candidate images, and reporting results based on the degree of correlation for the digital candidate files from the storage locations that are determined by the degree of correlation to have content that is closest to or matches the particular content.

__________


671

146707 ]21][11[

– ציאנואינדול – 5 (– 4 [– 1שימוש של YL– 3( 4 –] בוטיל –) קרבמואיל – 2 –

פיפרזין והמלחים –) YL – 5 –בנזופורן ם פיזיולוגית שלו להכנת המקובלי תרופות

USE OF 1 - [4 - (5 - CYANOINDOL - 3 - YL) BUTYL] - 4 - (2 - CARBAMOYL - BENZOFURAN - 5 - YL) - PIPERAZINE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS FOR THE MANUFACTURE OF MEDICAMENTS

]54[

16.05.2000 ]22[ EP ]33[ 27.05.1999 ]32[ 99109295.8 ]31[

Int. Cl.8 A61K 031/00, A61P 005/00, 009/10, 009/12, 025/00, 025/06, C07D 405/00 ]51[ MERCK PATENT GMBH,

GERMANY ]71[



]74[

[57] Use of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbamoyl-benzofuran-5-yl)- piperazine or a physiologically acceptable salt thereof, for the manufacture of a medicament for the treatment of sub-type anxiety disorders chosen from the the sub-

types: panic disorder with or without agoraphobia, agoraphobia, obsessive-compulsive spectrum disorders, social phobia, posttraumatic stress disorder, acute stress indication and/or generalized-anxiety disorder.

__________

146758 ]21][11[

תהליך לייצור אסטר של חומצת אמית

PROCESS FOR PRODUCTION OF AMIC ACID ESTER

]54[

02.04.2001 ]22[ JP ]33[ 03.04.2000 ]32[ 2000-100786 ]31[

Int. Cl.8 C07D 277/64 ]51[ IHARA CHEMICAL INDUSTRY CO.,

LTD., JAPAN ]71[

WO/2001/074795 ]87[ ',זליגסון גבריאלי ושות

תל אביב, 1426. ד.ת , 31יבנה ' רחSELIGSOHN GABRIELI & CO., 31 YAVNE ST. P.O.B. 1426 TEL AVIV 61013

]74[


[57] A process for producing an amic acid ester of the formula:

(wherein A is a substituted or unsubstituted lower alkylene group, a substituted or unsubstituted cycloalkylene group, a substituted or unsubstituted arylene group, a substituted or unsubsituted cycloalkylalkylene group, or a substituted or unsubstituted aralkylene group; R1 is a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a

substituted or unsubstituted aryl group, a substituted or unsubstituted cycloalkylalkyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted heterocyclic alkyl group; and R3 is a hydrogen atom or a lower alkyl group), which process comprises reacting, in the presence of water, an amino acid of the formula:

(wherein A has the same definition as given above) with a halogenated carbonic acid ester of the formula

(wherein R1 has the same definition as given above and X is a halogen atom) to

form a carbamate compound of the the formula

(wherein A and R1 have the same definitions as given above), then reacting the carbamate compound with a

halogenated carbonic acid ester of the formula


673

(wherein R2 is a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted cycloalkylalkyl group, a substituted or

unsubstituted aralkyl group, a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted heterocyclic alkyl group; and X is a halogen atom) to form, in the system, a mixed acid anhydride of the formula

(wherein A, R1 and R2 and R2 have the same definitions as given above), and

reacting the mixed acid anhydride with an amine compound of the formula

(wherein R3 has the same definition as given above and Het is a substituted or unsubstituted heterocyclic group).

__________

146810 ]21][11[

– 10,11תהליך להכנת נגזרות של מתנובנזוסבראן

PROCESS FOR PREPARING 10,11-METHANOBENZOSUBERANE DERIVATIVES

]54[

26.05.2000 ]22[ US ]33[ 03.06.1999 ]32[ 60/137283 ]31[

Int. Cl.8 C07D 241/12, 295/088, 401/12 ]51[ ELI LILLY AND COMPANY, U.S.A. ]71[ WO/2000/075121 ]87[



]74[


[57] A process for preparing a compound of the formula

wherein A is –CH2-CH2-, -CH2-CHRa-CH2-, -CH2-CHRa-CH2-CH2-, and Ra is OH; R1 is H, F, Cl, or Br; R2 is H, F,Cl, or Br; and

R3 is heteroaryl or phenyl, each optionally substituted with F, Cl, Br, CF3, CN, NO2, or OCHF2; or the pharmaceutically acceptable salts thereof, comprising the steps of: (a) reacting a compound of the formula

with a nucleophile source to form a compound of the formula


675

wherein X is a leaving group; (b) reacting a compound of formula (5)

with pyrazine to provide a compound of the formula

(c) reducing the compound of formula (6) to provide a compound of the formula

(d) reacting a compound of formula (8) with either:

(i) an epoxy compound of the formula


wherein R3 is as defined above, and n is an integer 1 or 2; or

(ii) a halo compound of the formula

X1-(CH2)m-O-R3

wherein R3 is as defined above, X1 is halo, and m is 2, 3 or 4; and (e) optionally forming a pharmaceutically acceptable salt from the compound produced in step (d).

Claimed as novel are intermediate compounds of formula (6) wherein R1 and R2 are as above defined and X is selected from the group consisting of I, Br, Cl, OMs, and OTs.

__________

146923 ]21][11[

פולימרים של חומצות –אוליגומרים ו קרבוקסיליות אימנו ציקליות

OLIGOMERS AND POLYMERS OF CYCLIC IMINO CARBOXYLIC ACIDS

]54[

13.06.2000 ]22[ US ]33[ 14.06.1999 ]32[ 60/138972 ]31[

Int. Cl.8 A61K 031/40, 031/445, 031/495, A61P 043/00, C07D 207/16, 211/00, 211/60, 241/04, 401/06, 403/06, G01N 033/53

]51[

WISCONSIN ALUMNI RESEARCH FOUNDATION, U.S.A.

]71[

SAMUEL H. GELLMAN, BAYARD R. HUCK, MICHELE R. RICHARDS

]72[



]74[

[57] Compound of the formula:

X-{A}n-Y

wherein n is an integer greater than 1; and each A, independent of every other A, is selected from the group consisting of:


677

wherein R1, R2, and R5 are independently selected from the group consisting of hydrogen, linear or branched C1-C6-alkyl, alkenyl, or alkynyl; mono-or di-C1-C6 alkylamino, mono- or bicyclic aryl, mono- or bicyclic heteroaryl having up to 5 heteroatoms selected from N, O, and S; mono- or bicyclic aryl-C1-C6-alkyl, mono-or bicycle heteroaryl- C1-C6-alkyl, -(CH2)1-

6-OR3, -(CH2)1-6-SR3, -(CH2)1-6-S(=O)-CH2-R3, -(CH2)1-6-S(=O)2-CH2-R3, -(CH2)1-6-NR3R3, -(CH2)1-6-NHC(=O)R3, -(CH2)1-6-NHS(=O)2-CH2-R3, -(CH2)1-6-O-(CH2)2-6-R4, -(CH2)1-6-S-(CH2)2-6-R4, -(CH2)1-6-S(=O) -(CH2)2-6-R4, -(CH2)1-6-S(=O)2-(CH2)2-6-R4, -(CH2)1-6-NH-(CH2)2-6-R4, -(CH2)1-6-N- {(CH2)2-6-R4}2, -(CH2)1-6-NHC(=O) -(CH2)2-6-R4, and -(CH2)1-6 –NHS=(=O)2-(CH2)2-6-R4; wherein R3 is independently selected from the group consisting of hydrogen, C1-C6-alkyl, alkenyl, or alkynyl; mono- or bicyclic aryl, mono-or bicyclic heteraryl having up to 5 heteroatoms selected from N, O, and S; mono- or bicyclic aryl- C1-C6-alkyl, mono- or bicyclic heteroaryl- C1-C6 – alkyl; and R4 is selected from the group consisting of hydroxy, C1-C6-alkyloxy, aryloxy, heteroaryloxy, thio, C1-C6- alkylthio, C1-C6 - alkylsulfinyl, C1-C6 – alkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl, heteroarylthio, heteroarylsulfinyl, heteroarylsulfonyl, amino, mono-or di- C1-C6 – alkylamino, mono – or diarylamino, mono-or diheteroarylamino, N-alkyl-N-arylamino, N-alkyl-N-heteroarylamino, N-

aryl-N-heteroarylamino, aryl- C1-C6

– alkylamino, carboxylic acid, carboxamide, mono- or di- C1-C6 – alkylcarboxamide, mono- or diarylcarboxamide, mono- or diheterarylcarboxamide, N-alkyl-N-arylcarboxamide, N-alkyl-N-heteroarylcarboxamide, N-aryl-N-heteroarylcarboxamide, sulfonic acid, sulfonamide, mono- or di- C1-C6 alkylsulfonamide, mono- or diarylsulfonamide, mono- or diheteroarylsulfonamide, N-alkyl-N-arylsulfonamide, N-alkyl-N-heteroarylsulfonamide, N-aryl-N-heteroarylsulfonamide, urea; mono- di- or tri-substituted urea, wherein the subsitutent(s) is selected from the group consisting of C1-C6 - alkyl, aryl, heteroaryl; O-alkylurethane, O-arylurethane, and O-heteroarylurethane; R6 is selected from the group consisting of hydrogen, linear or branched C1-C6 – alkyl, alkenyl, or alkynyl; mono-or di- C1-C6 alkylamino, mono- or bicyclic aryl, mono- or bicyclic heteroaryl having up to 5 heteroatoms selected from N, O, and S; mono- or bicyclic heteroaryl- C1-C6 – alkyl, -S(=O)2-(CH2)1-6-(CH2)1-6-R3, -C(=O)R3, -S(=O)2-(CH2)2-6R4, and –C(=O)-(CH2)1-6-R4; wherein R3 and R4 are as defined above; R7 and R8 are selected from the group listed above for R1, R2, and R5, and are further selected from the group consisting of hydroxy, C1-C6 – alkyloxy, aryloxy, heteroaryloxy, thio, C1-C6 – alkylthio, C1-C6 – alkylsulfinyl, C1-C6 –alkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl, heteroarylthio, heteroarylsulfinyl, heteroarylsulfonyl, amino, mono – or di-


C1-C6 – alkylamino, mono- or diarylamino, mono-or diheteroarylamino, N-alkyl-N-arylamino, N-alkyl-N-heteroarylamino, N-aryl-N-heteroarylamino, aryl- C1-C6 - alkylamino, carboxylic acid, carboxamide, mono-or di- C1-C6 - alkylcarboxamide, mono – or diarylcarboxamide, mono- or diheteroarylcarboxamide, N-alkyl-N-arylcarboxamide, N-alkyl-N-heteroarylcarboxamide, N-aryl-N-heteroarylcarboxamide, sulfonic acid, sulfonamide, mono- or di- C1-C6 – alkylsulfonamide, mono- or diarylsulfonamide, mono- or

diheteroarylsulfonamide, N-alkyl-N-arylsulfonamide, N-alkyl-N-heteroarylsulfonamide, N-aryl-N-heteroarylsulfonamide, urea; mono-di- or trisubstituted urea, wherein the subsitutent(s) is selected from the group consisting of C1-C6 – alkyl, aryl, heteroaryl; O-alkylurethane, O-arylurethane, and O-heteroarylurethane; one of X or Y is hydrogen or an amino-terminal capping group; the other of X or Y is hydroxy or a carboxy-terminal capping group; and salts thereof.

לתקנות 35פירוט זה נבחן בהתאם לתקנה

1968 –ח "תשכ, הפטנטיםThis specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968

__________

146993 ]21][11[

כבל נתונים בעל ביצועים גבוהים וכבל ה נתונים ביצועים גבוהים בעל מעט

שאינו מכיל פלאורUL 910קיבול

HIGH PERFORMANCE DATA CABLE AND A UL 910 PLENUM NON-FLUORINATED JACKET HIGH PERFORMANCE DATA CABLE

]54[

14.06.2000 ]22[ US ]33[ 22.07.1999 ]32[ 60/144998 ]31[

Int. Cl.8 H01B 007/18 ]51[ BELDEN WIRE & CABLE

COMPANY, U.S.A. ]71[




]74[

[57] An individual bound lateral shielded twisted pair data cable comprising: an insulated twisted pair cable (10); a shielding tape selected from the group consisting of a metal tape (16), a first composite tape having a non-metal base and a layer of metal on one side of said base, and a second composite tape having a non-metal base and a layer of metal on

both sides of said base; said shielding tape being laterally wrapped with at least a 10% overlap around said individual twisted pair cable; a fabric or metal binder (18) being wrapped around said shielding tape to provide a bound lateral shielded twisted pair cable; said shielding tape having a metal thickness of 0.33 to 2.00 mils; said shielding tape and binder being wrapped


679

around said twisted pair at a tension to eliminate a substantial amount of the air and to leave a cross-sectional void area of less than 25% of the cross-sectional area of the shielded twisted pair cable to provide said bound lateral shielded twisted pair

data cable, and to provide said bound lateral shielded twisted pair data cable with an adjusted to 20o C standard impedance deviation of 4.5 or less when said standard deviation is calculated around a mean or average impedance of 50 to 200 ohms.

__________

147012 ]21][11[

תכשירי רוקחות , תולדות של אינדולהמכילים אותן ושימושן בהכנת תרופה

במחלות הקשורות לפעילות יתר לטיפול של אוסטאוקלאסטס

INDOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE THEREOF FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH OVER ACTIVITY OF OSTEOCLASTS

]54[

16.06.2000 ]22[ GB ]33[ 18.06.1999 ]32[ 9914371.1 ]31[

Int. Cl.8 A61K 031/404, 031/435, A61P 019/10, C07D 401/12, 403/12 ]51[ NIKEM RESEARCH S.R.L., ITALY ]71[ WO/2001/002388 ]87[



]74[

[57] Compounds selected from the list consisting of: 4-(5,6-dichloro-1H-indol-2-yl) 3-ethoxy-N(2,2,6,6- tetramethylpiperidin-4-yl)-benzamide; 4-(5,6-dichloro-1H-indol-2-yl)-3-benzyloxy-N-(2,2,6,6- tetramethylpiperidin-4-yl)-benzamide;

4-(5,6-dichloro-1H-indol-2yl)-3-propoxy-N-(2,2, 6,6- tetramethylpiperidin-4-yl) benzamide; 4-(5,6-dichloro-1H-indol-2-yl)-N-[3-[4-(3-methoxyphenyl) piperazin- 1-yl]propyl]-3-methoxybenzamide; 4-(5,6-dichloro-1H-indol-2-yl)-N-[3-[4-(2-pyrimidiyl) piperazin-


1yl]propy]-3-methoxybenzamide; 4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)- 3-methoxybenzamide; 4-(5,6-dichloro-1H-indol-2-yl)-N-(1,2,2,6,6-pentamethylpiperidin-4- yl)-3-ethoxybenzamide; 4-(5, 6-dichloro-1H-indol-2-yl)-N(3-pyridyl)-3-ethoxybenzamide, 4-(5,6,-dichloro-1H-indo-2-yl)-N-(3-(6-methoxypyridyl)-3- ethoxybenzamide; 4-(5,6-dichloro-1H-indol-2yl)-N-(1-benzylpiperidin-4-yl)-3- ethoxybenzamide; 4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)- 2,5-dimethoxybenzamide; 4-(5, 6-dichloro-1H-indol-2-yl)-N-(1,2,2,6,6-pentamethylpiperidin-4- yl)2,5-dimethoxybenzamide; 4-(5-methoxy-6-chloro-1H-indol-2-yl)-N-(2,2,6,6- tetramethylpiperidin-4-yl)-3-ethoxybenzamide;

4-(5,6-dichloro-1H-indol-2-yl)-3-methoxy-N- ((1-ethoxycarbonylpentyl) piperidin-4-yl) benzamide; 4-(5,6-dichloro-1H-indol-2-yl)-3-methoxy-N- ((carboxybutyl) piperidin-4-yl)benzamide; 4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)- 3-(hydroxycarbonylmethoxy) benzamide; 4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethypiperidin-4-yl)- 3-(2-hydroxyethoxy) benzamide; 4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)- 3-(3-aminopropoxy) benzamide; 4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)- 3-(2-dimethylamino-ethoxy) benzamide, and; 4-(5,6-dichloro-1H-indol-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)- 3-(2, 3-dihydroxypropoxy) benzamide; or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof.

__________

147091 ]21][11[

מערכת בקרת משוב לקילוף משטח אויר עם מערכת משולבת של ניהול מים

ומיחזור חומצה

FEEDBACK CONTROLLED AIRFOIL STRIPPING SYSTEM WITH INTEGRATED WATER MANAGEMENT AND ACID RECYCLING SYSTEM

]54[

13.12.2001 ]22[ US ]33[ 15.12.2000 ]32[ 09/738449 ]31[

Int. Cl.8 B22D 029/00 ]51[ UNITED TECHNOLOGIES



ירושלים


]74[

[57] A coating removal system comprising: a stripping tank (12) containing an electrolyte bath stripping

solution for removing a coating from at least one workpiece immersed in said electrolyte bath while a controlled absolute


681

electrical potential is maintained on said at least one workpiece with respect to a reference electrode immersed in said electrolyte bath; a rinse tank (14) containing a rinse solution for rinsing said at least one workpiece after completion of removal of said coating from said at least

one workpiece; and a distillation unit (16) for receiving electrolyte from said stripping tank containing dissolved metals, for purifying said electrolyte received from said stripping tank, and for returning said electrolyte in a purified form to said stripping tank.

__________

147118 ]21][11[

חיבור דינמי למספר שרתי מקור בשרת פרוקסי מקודד מעבר

DYNAMIC CONNECTION TO MULTIPLE ORIGIN SERVERS IN A TRANSCODING PROXY

]54[

28.06.2000 ]22[ US ]33[ 30.06.1999 ]32[ 09/343454 ]31[

Int. Cl.8 H04L 009/08, 012/22, 012/66, 029/00, 029/06 ]51[ INTERNATIONAL BUSINESS

MACHINES CORPORATION, U.S.A. ]71[




]74[

[57] A method of enabling a proxy (15) to participate in secure communication between a client (10') and a first origin server (12a'), comprising the step of:

(a) establishing (20, 22) a first secure session between the client and the proxy; (b) upon verifying the first secure session, establishing (24, 26) a second secure


session between the client and the proxy, the second secure session requesting the proxy to act as a conduit to the first origin server; (c) having the client and the first origin server negotiate (30) a session master secret; (d) having the client deliver (32) the session master secret to the proxy using the first secure session to enable the proxy to participate in the secure communication;

(e) responsive to a client request to the first origin server, establishing a third secure session between the client and the proxy, the third secure session requesting the proxy to act as conduit to the second origin server; (f) having the client and the second origin server negotiate a new session master secret; and (g) having the client deliver the new session master secret to the proxy using the first secure session generated in step (a).

__________


683

147169 ]21][11[

שיטה אוטומטית ליצירת בר קוד לשם איחזור והעברת נתונים

AUTOMATIC BARCODE CREATION FOR DATA TRANSFER AND RETRIEVAL

]54[

11.06.2000 ]22[ US ]33[ 18.06.1999 ]32[ 335838 ]31[

Int. Cl.8 G06K 007/10 ]51[ ]I.C. CODE LTD. ]71 מתן, מ"קוד בע. סי.איי



]74[

[57] A system for automatically printing an at least two-dimensional barcode onto a printable substrate (24); the barcode featuring a pattern of a plurality of marks, the system comprising: (a) an output device (16) for receiving a plurality of printing commands and for printing a printable substrate according to said plurality of printing commands; (b) a computational device (12) for receiving data to be printed; and (c) a printer driver module (14) for being operated by said computational device and for automatically translating into the at

least two dimensional barcode, at least a portion of said data to be printed including at least one selected from a group including: substantially all text and substantially all graphical images, and for automatically determining at least one command for printing the barcode onto said printable substrate to form a printed barcode, said printer driver module passing said at least one command to said output device, so that said output device is enabled to print the barcode in addition to said data to be printed.


__________

147199 ]21][11[

שיטה לאריזת יסודות המשוקעים אלקטרוכימית

METHOD FOR PACKING ELECTROCHEMICALLY-DEPOSITED ELEMENTS

]54[

20.12.2001 ]22[ Int. Cl.8 A61N 005/10, G21G 004/06 ]51[

הרשות למחקר , גוריון בנגב-אוניברסיטת בן באר שבע, ופיתוח

BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY

]71[

משה , גד שני, ברנדה לסטר, יובל גולן רוברטו טולמן, י'פרג

YUVAL GOLAN, BRENDA H. LASTER, GAD SHANI, MOSHE FARAGGI

]72[

,פ"יירניק רוטמן עופבאר , 10012. ד.ת , 91הרצל ' בית עציון רח

שבע

PYERNIK RUTMAN, BEIT ETSION HERZL ST. 91 P.O.B. 10012 BEER SHEVA

]74[

[57] A method for densely packaging an element inside a casing, such that the element-containing casing is suitable for use in the preparation of a radiation source, comprising providing a solution containing ions of said element, positioning a working electrode and at least one counter electrode in contact with said solution, connecting said working electrode and said at least one counter electrode to the negative and

positive poles of a power source, respectively, passing an electrical current between said electrodes to electrochemically deposit said element on said working electrode in a geometrical form corresponding to the form of the interior of the casing and concurrently or sequentially loading said casing with said element.

__________


685

147265 ]21][11[

, התקן המספק תכשיר למתן דרך הפההמכיל שרף אורגנוסילוקסאן

ומשתמש בפסתומך ניתן להסרה

DELIVERY SYSTEM FOR ORAL CARE COMPOSITIONS COMPRISING ORGANOSILOXANE RESINS USING A REMOVABLE BACKING STRIP

]54[

30.06.2000 ]22[ WO ]33[ 02.07.1999 ]32[ PCT/US99/15131 ]31[ WO 02.07.1999 PCT/US99/15130 WO 09.06.2000 PCT/US00/15890 WO 09.06.2000 PCT/US00/15891

Int. Cl.7 A61K 000/889000 009/00 ]51[ THE PROCTER & GAMBLE

COMPANY, U.S.A. ]71[




]74[

[57] A delivery system for delivering an oral care substance to the oral cavity, the delivery system comprising: (a) a removable backing strip having sufficient flexibility so as to be readily conformable to an oral surface when the delivery system is placed thereagainst; and (b) an oral care composition applied to the backing strip such that when the delivery system is placed on the oral surface the

oral care composition contacts the oral surface, the oral care composition comprising: (i) an organosiloxane resin; (ii) a rheology modifier; and (iii) at least one oral care substance; wherein the oral care composition remains on the oral surface after the backing strip is removed.

__________


147319 ]21][11[

הרס של פגמים – אלשיטה והתקן לגילוי חבויים

METHOD AND APPARATUS FOR NON-DESTRUCTIVE DETECTION OF HIDDEN FLAWS

]54[

10.05.2000 ]22[ US ]33[ 14.05.1999 ]32[ 09/311442 ]31[

Int. Cl.8 G01B 015/06 ]51[ SCANNEX TECHNOLOGIES, LLC,

U.S.A. ]71[

WO/2000/070306 ]87[ ',קולב ושות. רד טסנפו



]74[

[57] A method for non-destructive examination a test sample comprising the steps of: (a) directing radiation into said test sample; (b) directing radiation into an unflawed standard sample; (c) detecting radiation emanating from said test sample to obtain a set of responses R;

(d) detecting radiation emanating from said standard sample to obtain a set of responses S; (e) utilizing said set of responses R and said set of responses S to obtain a single figure-of-merit; and (f) determining the deviation of said single figure-of-merit from a reference value.


687

__________

147327 ]21][11[

, בנזאימידיאזולים ואימידאזופירידיניםתכשירי , םתהליך וחומר ביניים להכנת

רוקחות המכילים אותם והשימוש בהם להכנת תרופות לטיפול או מניעת זיהום

ויראלי נשמתי סינסיציאלי

BENZIMIDAZOLES AND IMIDAZOPYRIDINES, A PROCESS AND AN INTERMEDIATE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE FOR TREATING OR PREVENTING RESPIRATORY SYNCYTIAL VIRUS

]54[

20.06.2000 ]22[ EP ]33[ 28.06.1999 ]32[ 99202088.3 ]31[

Int. Cl.8 A61K 031/395, A61P 031/00, C07D 401/00, 471/02, 491/02, 495/02 ]51[ JANSSEN PHARMACEUTICA N.V.,

BELGIUM ]71[



]74[



a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein -a1=a2-a3=a4-represents a bivalent radical of formula -CH=CH-CH=CH- (a-1); -N=CH-CH=CH- (a-2); -CH=N-CH=CH- (a-3); -CH=CH-N=CH- (a-4); or

-CH=CH-CH=N- (a-5); wherein each hydrogen atom in the radicals (a-1), (a-2), (a-3), (a-4) and (a-5) may optionally be replaced by halo, C1-6 alkyl, nitro, amino, hydroxy, C1-6 alkyl-oxy, polyhalo C1-6 alkyl, carboxyl, amino C1-6 alkyl, mono- or di(C1-4 alkyl)- amino C1-6 alkyl, C1-6 alkyloxycarbonyl, hydroxy C1-6 alkyl, or a radical or formula

wherein =Z is =O, =CH-C(=O)-NR5aR5b, =CH2, =CH-C1-6 alkyl, =N-OH or =N-O-C1-6 alkyl;

Q is a radical of formula

wherein Alk is C1-6 alkanediyl; Y1 is a bivalent radical of formula –NR2- or –CH(NR2R4)-; X1 is NR4, S, S(=O), S(=O)2, O, CH2, C(=O), C(=CH2), CH(OH), CH(CH3), CH(OCH3), CH(SCH3), CH(NR5aR5b), CH2-NR4 or NR4-CH2;

X2 is a direct bond, CH2, C(=O), NR4, C1-4 alkyl-NR4, NR4 –C1-4 alkyl; t is 2, 3 4 or 5; u is 1, 2, 3, 4 or 5; v is 2 or 3; and whereby each hydrogen atom in Alk and the carbocycles and the


689

heterocycles defined in radicals (b-3), (b-4), (b-5), (b-6), (b-7) and (b-8) may optionally be replaced by R3; with the proviso that when R3 is hydroxy or C1-6 alkyloxy, then R3 can not replace a hydrogen atom in the α position relative to a nitrogen atom; G is C1-10 alkanediyl substituted with one or more hydroxy, C1-6 alkyloxy, aryl C1-6 alkyloxy, C1-6 alkylthio, aryl C1-6 alkylthio, HO(-CH2-CH2-O)n-, C1-6 alkyloxy-(-CH2-CH2-O)n- or aryl C1-6 alkyloxy (-CH2-CH2-O)n-; R1 is a monocyclic heterocycle or aryl; said heterocycle being selected from piperidinyl, piperazinyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, tetrahydrofuranyl, thienyl, pyrrolyl, thiazolyl, oxazolyl, imidazolyl, isothiazolyl, pyrazoly l, isoxazolyl, oxadiazolyl; and each heterocycle may optionally be substituted with1 or where possible more, such as 2, 3 or 4, substituents selected from halo, hydroxy, amino, cyano, carboxy, C1-6 alkyl, C1-6 alkyloxy, C1-6 alkylthio, C1-6 alkyloxy C1-6 alkyl, aryl, aryl C1-6 alkyl, aryl C1-6 alkyloxy, hydroxy C1-6 alkyl, mono-or di(C1-6 alkyl) amino, mono-or di(C1-6 alkyl) amino C1-6 alkyl, polyhalo C1-6 alkyl, C1-6 alkylcarbonylamino, C1-6 alkyl-SO2-NR5c-, aryl-SO2-NR5c-, -C1-6 alkyloxycarbonyl, -C(=O)-NR5cR5d, HO(-CH2-CH2-O)n-, halo (-CH2-CH2-O)n-, C1-6 alkyloxy (-CH2-CH2-O)n-,

aryl C1-6 alkyloxy (-CH2-CH2-O)n- and mono-or di(C1-6 alkyl) amino (-CH2-CH2O)n-; each n independently is 1, 2, 3 or 4; R2 is hydrogen, formyl, C1-6 alkylcarbonyl, Hetcarbonyl, pyrrolidinyl, piperidinyl, homopiperidinyl, C3-7 cycloalkyl substituted with N(R6)2, or C1-10 alkyl substituted with N(R6)2 and optionally with a second, third or fourth substituent selected from amino, hydroxy, C3-7 cycloalkyl, C2-5 alkanediyl, piperidinyl, mono-or di(C1-6 alkyl) amino, C1-6 alkyloxycarbonylamino, aryl and aryloxy; R3 is hydrogen, hydroxy, C1-6 alkyl, C1-6 alkyloxy, aryl C1-6 alkyl or aryl C1-6 alkyloxy; R4 is hydrogen, C1-6 alkyl or aryl C1-6 alkyl; R5a, R5b, R5c and R5d each independently are hydrogen or C1-6 alkyl; or R5a and R5b, or R5c and R5d taken together form a bivalent radical of formula –(CH2)s- wherein s is 4 or 5; R6 is hydrogen, C1-4 alkyl, formyl, hydroxy C1-6 alkyl, C1-6 alkylcarbonyl or C1-6 alkyloxycarbonyl; aryl is phenyl or phenyl substituted with 1 or more, such as 2, 3 or 4, substituents selected from halo, hydroxy, C1-6 alkyl, hydroxy C1-6 alkyl, polyhalo C1-6 alkyl, and C1-6 alkyloxy; Het is pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl.

__________

147328 ]21][11[


ות בנזימידזול ואימידזופירידין תרכובוהשימוש בהן להכנת תרופה לטיפול או

מניעת זיהומים וירליים

BENZIMIDAZOLE AND IMIDAZOPYRIDINE COMPOUNDS AND THEIR USE FOR PREPARING A MEDICINE FOR TREATMENT OR PREVENTION OF VIRAL INFECTIONS

]54[

20.06.2000 ]22[ EP ]33[ 28.06.1999 ]32[ 99202089.1 ]31[

Int. Cl.8 A61K 031/395, A61P 031/00, C07D 401/00, 471/02, 491/02, 495/02 ]51[ JANSSEN PHARMACEUTICA N.V.,

BELGIUM ]71[



]74[


a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein -a1=a2-a3=a4-represents a bivalent radical of formula -CH=CH-CH=CH- (a-1); -N=CH-CH=CH- (a-2); -CH=N-CH=CH- (a-3);

-CH=CH-N=CH- (a-4); or -CH=CH-CH=N- (a-5); wherein each hydrogen atom in the radicals (a-1), (a-2), (a-3), (a-4) and (a-5) may optionally be replaced by halo, C1-6 alkyl, nitro, amino, hydroxy, C1-6 alkyl-oxy, polyhalo C1-6 alkyl, carboxyl, amino C1-6 alkyl, mono- or di(C1-4 alkyl)- amino C1-6 alkyl, C1-6 alkyloxycarbonyl, hydroxy C1-6 alkyl, or a radical of formula

wherein =Z is =O, =CH-C(=O)-NR5aR5b, =CH2, =CH-C1-6 alkyl, =N-OH or =N-O-C1-6 alkyl;

Q is a radical of formula


691

wherein Alk is C1-6 alkanediyl; Y1 is a bivalent radical of formula –NR2- or –CH(NR2R4)-; X1 is NR4, S, S(=O), S(=O)2, O, CH2, C(=O), C(=CH2), CH(OH), CH(CH3), CH(OCH3), CH(SCH3), CH(NR5aR5b), CH2-NR4 or NR4-CH2; X2 is a direct bond, CH2, C(=O), NR4, C1-4 alkyl-NR4, NR4 –C1-4 alkyl; t is 2, 3 4 or 5; u is 1, 2, 3, 4 or 5; v is 2 or 3; and whereby each hydrogen atom in Alk and the carbocycles and the heterocycles defined in radicals (b-3), (b-4), (b-5), (b- 6), (b-7) and (b-8) may optionally be replaced by R3; with the proviso that when R3 is hydroxy or C1-6 alkyloxy, then R3 can

not replace a hydrogen atom in the α position relative to a nitrogen atom; G is C1-10 alkanediyl substituted with one or more hydroxy, C1-6 alkyloxy, aryl C1-6 alkyloxy, C1-6 alkylthio, aryl C1-6 alkylthio, HO(-CH2-CH2-O)n-, C1-6 alkyloxy-(-CH2-CH2-O)n- or aryl C1-6 alkyloxy (-CH2-CH2-O)n-; aryl C1-6 alyloxy (-CH2-CH2-O)n-, amino, mono-or-di(C1-6 alkyl) amino, C1-6 alkyloxycarbonylamino and aryl; R1 is a bicyclic heterocycle selected from quinolinyl, quinoxalinyl, benzofuranyl, benzothienyl, benzimidazolyl, benzoxazolyl, benzthiazolyl, pyridopyridyl, naphthiridinyl, 1H-imidazo [4, 5-b] pyridinyl, 3H-imidazo [4,5] pyridinyl, imidazo [1,2-a] pyridinyl, 2, 3-dihydro-1,4-dioxino [2,3-b] pyridyl or a radical of the formula


and said bicyclic heterocylces may optionally be substituted in either of the two cycles with 1 or where possible more, such as 2, 3 or 4, substituents selected from halo, hydroxy, amino, cyano, carboxyl, C1-6 alkyl, C1-6 alkyloxy, C1-6 alkylthio, C1-6 alkyloxy-C1-6 alkyl, aryl, aryl C1-6 alkyl, aryl C1-6 alkyloxy, hydroxy C1-6 alkyl, mono-or di(C1-6 alkyl)-amino, mono-or di(C1-6 alkyl) amino C1-6 alkyl, polyhalo C1-6 alkyl, C1-6 alkycarbonylamino, C1-6 alkyl –SO2-NR5c-, aryl-SO2-NR5c-, C1-6 alkyloxycarbonyl, -C(=O)-NR5CR5d, HO(-CH2-CH2-O)n-, halo (-CH2-CH2-O)n-, C1-6 alkyloxy (-CH2-CH2-O)n-, aryl C1-6 alkoxy (-CH2-CH2-O)n- and mono-or di(C1-6 alkyl) amino(-CH2-CH2-O)n-; each n independently is 1, 2, 3 or 4; each m independently is 1 or 2; each p independently is 1 or 2; each R2 indepdnently is hydrogen, formyl, C1-6 alkylcarbonyl, Hetcharbonyl, pyrrolidinyl, piperidinyl, homopiperidinyl, C3-7 cycloalkyl substituted with N(R6)2, or C1-10 alkyl substituted with N(R6)2 and

optionally with a second, third or fourth substituent selected from amino, hydroxy, C3-7 cycloalkyl, C2-5 alkanediyl, piperidinyl, mono-or di (C1-6 alkyl) amino, C1-6 alkyloxycarbonylamino, aryl and aryloxy; R3 is hydrogen, hydroxy, C1-6 alkyl, C1-6 alkyloxy, aryl C1-6 alkyl or aryl C1-6 alkyloxy; R4 is hydrogen, C1-6 alkyl or aryl C1-6 alkyl; R5a, R5b, R5c and R5d each independently are hydrogen or C1-6 alkyl; or R5a and R5b, or R5c and R5d taken together form a bivalent radical of formula –(CH2)s-wherein s is 4 or 5; R6 is hydrogen, C1-4 alkyl, formyl, hydroxy C1-6 alkyl, C1-6 alkylcarbonyl or C1-6 alkyloxycarbonyl; aryl is phenyl or phenyl substituted with 1 or more, such as 2, 3 or 4, substituents selected from halo, hydroxy, C1-6 alkyl, hydroxy C1-6 alkyl, polyhalo C1-6 alkyl, and C1-6 alkyloxy; Het is pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl. Intermediates of formula

with P being a protective group, and Q1


693

being defined as, Q above defined but being devoided of the R2 or R6 substituent,

and of the formula

with (O=)Q3 being a carbonyl derivative of Q provided that it is devoided of the NR2R4 or NR2 substituent.

and of the formula

with (O=)G2 being a carbonyl derivative of G are claimed as novel.

__________

147418 ]21][11[

מערכת ושיטה לזיהוי קצה כיסוי במכשיר תקשורת אלחוטי

SYSTEM AND METHOD FOR EDGE OF COVERAGE DETECTION IN A WIRELESS COMMUNICATION DEVICE

]54[

06.07.2000 ]22[ US ]33[ 07.07.1999 ]32[ 09/348442 ]31[

Int. Cl.8 H04Q 007/38 ]51[ QUALCOMM INCORPORATED,

U.S.A. ]71[




]74[

[57] In a wireless telephone communication system having more than one service provider system a method to enhance performance of a mobile phone,

comprising: when the mobile phone that is communicating with a first service provider system is in an idle mode, monitoring a first performance level and a second performance level;


if the first performance level falls below a first threshold and the second performance level falls below a second threshold. starting a timer; if, while the timer is running, either the first or second performance levels exceed their respective thresholds, resetting the timer and continue

monitoring the first and second performance levels; and if the timer exceeds a predetermined duration, switching the mobile telephone from the first service provider system to a second service provider system.

__________

147441 ]21][11[


695

–פיפראזין)פניל מותמר]N–]4–)1–תולדות –אוקסו–7–מותמר–5–]אלקיל]איל–1

קרבוקסאמיד –3–פיראן]B–2,3[תיאנו ותכשירי רוקחות המכילים אותן

[N-[4-(1-SUBSTITUTED PHENYL)PIPERAZIN-1-YL]ALKYL]-5-SUBSTITUTED-7-OXO-THIENO[3,2-B]PYRAN-3-CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

]54[

28.07.2000 ]22[ IT ]33[ 30.07.1999 ]32[ MI99A001704 ]31[

Int. Cl.8 A61K 031/396, A61P 013/00, 025/00, 027/02, C07D 495/00, 495/04 ]51[ RECORDATI IRELAND LIMITED,

IRELAND ]71[




]74[


wherein R represents an aryl, cycloalkyl or polyhaloalkyl group, R1 represents an alkyl, alkoxy, polyfuoroalkoxy, hydroxy or trifluoromethanesulphonyloxy group, each

of R2 and R3 independently represents a hydrogen or halogen atom or an alkoxy or polyfluoroalkoxy group, and n is 0, 1 or 2, or an N-oxide or a pharmaceutically acceptable salt of such a compound.

__________

147510 ]21][11[


תכשיר רוקחות נוזלי בעל טעם מוסווה

TASTE MASKED PHARMACEUTICAL LIQUID FORMULATIONS

]54[

21.06.2000 ]22[ US ]33[ 09.07.1999 ]32[ 60/143019 ]31[

Int. Cl.8 A61K 009/00, 009/14, 009/16 ]51[ ORTHO-MCNEIL

PHARMACEUTICAL, INC., U.S.A. ]71[



]74[

[57] An orally consumable liquid composition comprising a pharmaceutically active agent wherein the active agent is levofloxacin in particle form contained in a liquid suspension having a pH greater than about 6.0, each particle comprising a core of the pharmaceutically active agent, optionally associated with inactive pharmaceutical adjuvants; the core being coated with a

taste masking effective amount of a polymer blend of (a) dimethylaminoethyl methacrylate and neutral methacrylic acid ester (MM/MAE) and (b) a cellulose ester, in an aqueous vehicle, wherein the cellulose ester and the MM/MAE are present in a polymer weight ratio of the cellulose ester to the MM/MAE of about 40:60 to about 90:10.

__________

147628 ]21][11[

יידת של ערוץ בקרה קדמי פיקוח תחנה נ יעודי במצב שידור מקוטע

MOBILE STATION SUPERVISION OF THE FORWARD DEDICATED CONTROL CHANNEL WHEN IN THE DISCONTINUOUS TRANSMISSION MODE

]54[

20.07.2000 ]22[ US ]33[ 21.07.1999 ]32[ 09/358634 ]31[

Int. Cl.8 H04B 007/185, H04J 003/12, H04Q 007/20, 007/38 ]51[ QUALCOMM INCORPORATED,

U.S.A. ]71[




]74[

[57] An apparatus used to supervise a dedicated control channel transmitted operating in a discontinuous transmission

(DTX) mode, comprising: transceiver means for transmitting and receiving transmissions; count means


697

communicatively coupled to said transceiver means for counting a number of bad, good, and empty frames received in a transmission, wherein said count means is reset when a new transmission is received, and wherein said count means counts the number of bad frames received (COUNT1), the number of good frames received (COUNT2), and the number of empty frames received (COUNT3), and where said COUNTs may be incremented when: COUNT1 is incremented if a bad frame is received; COUNT2 is incremented if a good frame is received, and reset to zero if a bad frame is received; and COUNT3 is incremented if an empty frame is received, and reset to zero if a

good frame is received; a fade timer, wherein said fade timer is set for a designated period if COUNT2 exceeds a third threshold (TH3); disabling/enabling means for disabling said transceiver, wherein said transceiver is enabled if COUNT2 exceeds a second threshold (TH2), and wherein said transceiver is disabled if said fade timer expires before COUNT1 is reset to zero, and wherein said transceiver is disabled if COUNT3 exceeds a fourth threshold (TH4); and terminating means for terminating a transmission, wherein said transmission is terminated if said fade timer expires before COUNT1 is reset to zero, or if COUNT3 exceeds a fifth threshold (TH5).



__________

147672 ]21][11[


מערכת הקלטה ושיטת , מצלמת וידאו הקלטה בעלות טווח דינמי משופר

DYNAMIC RANGE VIDEO CAMERA, RECORDING SYSTEM AND RECORDING METHOD

]54[

16.08.2000 ]22[ US ]33[ 17.08.1999 ]32[ 60/149237 ]31[

Int. Cl.8 G03B 007/00, H04N 003/14, 005/225, 005/235, 005/238 ]51[ APPLIED VISION SYSTEMS, INC.,

U.S.A. ]71[

WO/2001/013171 ]87[ ',הורוביץ ושות. ש

תל , 41-45 בית ציון שדרות רוטשילד אביב

S. HOROWITZ & CO., ZION HOUSE, 41-45 ROTHSCHILD BLVD., TEL AVIV 65784

]74[

[57] A method of producing a video recording with improved dynamic range comprising: providing a video camera comprising a video detector capable of converting an optical image into a sequence of video fields or frames, and an electronic shutter for adjusting the amount of light received by said detector from an optical image viewed by said camera; operating said camera to capture an optical image; commanding said electronic shutter to vary the amount of light received by said video detector from said captured optical image whereby to produce from said detector an output video signal constituting a sequence of video fields or frames representing the captured optical image, with said sequence comprising at least first and second fields or frames representing different exposure values of

the captured image occurring repetitively in said sequence according to a predetermined repetition frequency; recording said output video signal in a recording medium; subsequently playing said output video signal out of said recording medium; processing said output video signal played out of said recording medium so as to produce a modified video signal consisting of a continuous sequence of said first fields or frames or a continuous sequence of said second fields or frames; and selectively applying said modified video signal as an input signal to a video display apparatus whereby to cause said apparatus to display said captured optical image according to the first or second fields or frames contained in said modified video signal.


699

__________

147761 ]21][11[

שיטה ומערכת לבקרת אנרגיית שידור במערכת תקשורת בעלת שער שמבקר

על מהירות משתנה

METHOD AND SYSTEM FOR CONTROLLING TRANSMISSION ENERGY IN A VARIABLE RATE GATED COMMUNICATION SYSTEM

]54[

27.07.2000 ]22[ US ]33[ 29.07.1999 ]32[ 09/363545 ]31[

Int. Cl.8 H04B 007/005, 007/216, 007/26 ]51[ QUALCOMM INCORPORATED,

U.S.A. ]71[


, 2273. ד.ת, מרמורק , 4 שער הגיא תרחובו


]74[

[57] In a wireless communication device, a method for controlling transmission energy of a remote station in response to received closed loop power control commands, comprising the steps of: (a) identifying ones of said received closed loop power control commands generated based upon gated out portions of a reverse link signal wherein said step of identifying is performed by receiving a predetermined number of power control bit estimates

requesting said remote station to increase its transmission energy in a set of said received closed loop power control commands consisting of alternating power control commands; and (b) adjusting transmission energy in response to said step of identifying ones of said received closed loop power control commands generated based upon gated out portions of a reverse link signal.


__________

147767 ]21][11[

ארילויניל – 2תהליכים להכנת תרכובות – 2 – דיאריל – 1, 4 –אלקיל אתר ו

בוטן– 2 –פלורורו

PROCESSES FOR THE PREPARATION OF 2 - ARYLVINYL ALKYL ETHER AND 1,4 - DIARYL - 2 - FLUORO - 2 - BUTENE COMPOUNDS

]54[

07.08.2000 ]22[ US ]33[ 12.08.1999 ]32[ 373262 ]31[

Int. Cl.8 C07C 017/263, 022/08, 025/24, 041/01, 041/28, 041/30, 043/00, 043/176, 043/215, 043/225, 043/29, 069/773, C07D 213/24, 213/62

]51[

BASF AKTIENGESELLSCHAFT, GERMANY

]71[



]74[

[57] A process for the preparation of a 2-arylvinyl alkyl ether compound of the formula


701

wherein R is hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl or C3-C6 halocycloalkyl; R1 is C1-C6 alkyl; and Ar is phenyl optionally substituted with any combination of from one to three halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy groups, 1-or 2-naphthyl optionally substituted with any combination of from one to three halogen,

C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy groups, or a 5- or 6-membered heteroaromatic ring optionally substituted with any combination of from one to three halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy groups, in the absence of phosphonium halide compounds, which process comprises reacting a first acid with either (a) an aldehyde compound of the formula

wherein R and Ar are as described above and an alkanol compound of the formula

R1OH wherein R1 is as described above, or (b) an acetal compound of the formula

in the presence of an aprotic solvent at an elevated temperature.

__________


147791 ]21][11[

שיטה והתקן לייצור בתים רבים של רצפים דמויי רעש בכל דופק שעון על ידי

חישוב הבתים במקביל

METHOD AND APPARATUS FOR GENERATING MULTIPLE BITS OF A PSEUDONOISE SEQUENCE WITH EACH CLOCK PULSE BY COMPUTING THE BITS IN PARALLEL

]54[

30.08.2000 ]22[ US ]33[ 31.08.1999 ]32[ 09/386600 ]31[

Int. Cl.8 G06F 007/58, H04B 007/216 ]51[ QUALCOMM INCORPORATED,

U.S.A. ]71[




]74[

[57] An apparatus for generating multiple bits of a pseudonoise sequence by computing the bit in parallel, comprising: (a) a state memory; (b) a next state generator communicatively connected with said state memory, said

next state generator being configured to provide next state pre-determined number of states apart from a current state by a single operation; and (c) an output generator communicatively connected with said state memory.

__________


703

147795 ]21][11[

שיטה והתקן להפחתת זמני חיפוש ראשוניים באמצעות מידע איכון תחנות

ניידות

METHOD AND APPARATUS FOR REDUCING PILOT SEARCH TIMES UTILIZING MOBILE STATION LOCATION INFORMATION

]54[

30.08.2000 ]22[ US ]33[ 31.08.1999 ]32[ 09/387102 ]31[

Int. Cl.8 H04B 001/707, H04J 013/00, H04Q 007/22, 007/32, 007/34, 007/38 ]51[ QUALCOMM INCORPORATED,

U.S.A. ]71[




]74[

[57] A method for conducting pilot signal search in a wireless communications system, comprising: determining a location of a mobile station within said wireless

communications system; determining a plurality of search window sizes corresponding to a plurality of pilot signals.




__________

147916 ]21][11[

יטה והתקן לתקשורת אלחוטית בעלת ש קצבי מידע משתנים

METHOD AND APPARATUS FOR WIRELESS COMMUNICATIONS HAVING VARYING DATA RATES

]54[

28.07.2000 ]22[ US ]33[ 04.08.1999 ]32[ 09/368637 ]31[

Int. Cl.8 H04B 007/005, H04J 003/16, H04L 001/00, 012/28, H04Q 007/00 ]51[ ATHEROS COMMUNICATIONS,

INC., U.S.A. ]71[




]74[

[57] A method of dynamically allocating a data rate for wireless communication between a first transceiver and a second transceiver, the method comprising: transmitting initial first data at a first predetermined power level and at an initial first data rate from a first transceiver to a second transceiver; receiving the initial first data at the second transceiver; sensing the received power level of the received initial first data; determining a modified

first data rate greater than said initial first data rate at which to transmit further first data, said modified first data rate having a maximum data rate that is determined based upon the received power level of the received initial first data; transmitting the further first data at the modified first data rate and at the first predetermined power level from the first transceiver to the second transceiver; and receiving the further first data at the second transceiver.


705

__________

148003 ]21][11[

תכשיר רוקחות מורחף המכיל פעולה ופאזה לא פעילה

FLOATING PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE PHASE AND A NON-ACTIVE PHASE

]54[

02.08.2000 ]22[ FR ]33[ 06.08.1999 ]32[ 99/10285 ]31[

Int. Cl.8 A61K 009/00, 009/20, 009/50 ]51[ GALENIX DEVELOPPEMENT,

FRANCE ]71[



]74[

[57] Floating pharmaceutical composition characterized in that is it constituted by at least: (a) a first phase, termed active phase,

comprising at least one active

ingredient and at least one disintegrating agent selected from hydroxypropylmethylcellulose, highly substituted hydroxy propylcellulose and ethylcellulose, the at least one


disintegrating agent being in quantities less than 15% by weight of the active phase and in a form making it possible to obtain a disintegrating effect while preventing the formation of a continuous network; (b) a second phase, termed inactive phase, comprising at least one gas-generating

system and at least one hydrophilic polymer or a porous mineral compound, the active phase comprising a quantity of active ingredient(s) constituting at least 80% by weight of the active phase.

לתקנות 35פירוט זה נבחן בהתאם לתקנה 1968 –ח "תשכ, הפטנטים

This specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968

__________

148042 ]21][11[

דיאונים–5,8–שיטה להכנת קינולין

METHOD FOR PREPARING QUINOLINE-5,8-DIONES

]54[

10.08.2000 ]22[ FR ]33[ 13.08.1999 ]32[ 99/10491 ]31[

Int. Cl.8 C07D 215/20 ]51[ LABORATOIRE L. LAFON, FRANCE ]71[ WO/2001/012597 ]87[



]74[

[57] A process for preparing quinoline-5, 8-diones of the formula:

in which: R1, R2 and R3 are chosen from hydrogen, a halogen atom, a C1-C6 alkyl group, -CHO,

-OH, -OR, -COOH, -CN, -CO2R, -CONHR, -CONRR'-, -NH2, -NHCOR,


707

morpholino and SO3H, R and R' being chosen from C1-C6 alkyl groups and Ar being a C6-C14 aryl group,

in which an 8-hydroxyquinoline of the formula:

in which R1, R2 and R3 have the meaning given above, is oxidized with oxygen under the action of actinic radiation in solution in an organic solvent and in the

presence of a catalytic amount of a sensitizer, and the hydroperoxide formed, of the formula:

is then decomposed to a compound of formula I.

__________


148068 ]21][11[

ליפואית או –שימוש בחומצה אלפאבנגזרותיה כמרכיב פעיל בתרופות

לטיפול או מניעת מיגרנה

USE OF ALPHA- LIPOIC ACID OR DERIVATIVES THEREOF AS AN ACTIVE INGREDENT IN THE MANUFACTURE OF MEDICAMENTS FOR TREATING OR PREVENTING MIGRAINE

]54[

26.08.2000 ]22[ DE ]33[ 30.08.1999 ]32[ 19941217.0 ]31[

Int. Cl.8 A61K 031/385, 031/405, A61P 025/06, C07D 209/04, 339/00, 339/04 ]51[ MEDA PHARMA GMBH & CO. KG,

GERMANY ]71[

JEAN SCHOENEN, JURGEN ENGEL, KLAUS WESSEL, MANFRED PEUKERT, MICHAEL LOBISCH, HARALD BORBE

]72[

WO/2001/015693 ]87[ ,מ"בע) 1995(ארליך .אי.י'ג

רחוב מנחם בגין ,15קומה , מגדל אילון רמת גן, 11


]74[

[57] Use of racemic α-lipoic acid or its enantiomers or pharmaceutically acceptable salts, amides, esters or thioesters thereof, in reduced or oxidized

form, as an active ingredient for the manufacture of a medicament for prevention or treatment of migraine.

__________

148137 ]21][11[

סינתזה מעגל מסונכרנת באמצעות פירוט אסינכרוני

SYNCHRONOUS CIRCUIT SYNTHESIS USING AN ASYNCHRONOUS SPECIFICATION

]54[

18.08.2000 ]22[ US ]33[ 19.08.1999 ]32[ 377372 ]31[ US 09.11.1999 60/164201

Int. Cl.8 G06F 017/50, H04L 012/66 ]51[ MASSACHUSETTS INSTITUTE OF

TECHNOLOGY, U.S.A. ]71[

WO/2001/013285 ]87[


709



]74[

[57] A method for designing a synchronous digital system according to an asynchronous system specification for a first system comprising: accepting the asynchronous system specification, including accepting specifications of a plurality of data elements whose values define a state of the first system and accepting specifications of a plurality of state transition rules, wherein application of any of the state transition rules atomically updates values of the data element according to the specification of said state transition rule; and processing

the asynchronous system specification to form a specification of the synchronous digital system; wherein: processing the asynchronous system specification includes identifying a sequence of two or more of the state transition rules of the asynchronous system specification for application in a single state transition of the synchronous digital system; and at least some state transition of said synchronous digital system corresponds to sequential application of two or more of the state transition rules of the identified sequence.

__________


148162 ]21][11[

שיטה להלחם בחרקי אדמה באמצעות פירזולים–פניל

METHOD FOR FIGHTING SOIL INSECTS WITH PHENYL-PYRAZOLES

]54[

07.09.2000 ]22[ FR ]33[ 07.09.1999 ]32[ 99/11312 ]31[

Int. Cl.8 A01N 043/56, C07D 231/14, 401/02 ]51[ BAYER CROPSCIENCE S.A.,

FRANCE ]71[



]74[

[57] Insecticidal compositions comprising: (a) between 0.001 and 5%, preferably between 0.05 and 1% and still more

advantageously between 0.05 and 0.5% of a compound of the formula

in which: R1 is a halogen atom or a CN group or a methyl group or a CH3CO group; R2 is S(O)nR3; R3 is alkyl or haloalkyl; R4 represents a hydrogen or halogen atom, or an NR5R6, S(O)mR7, C(O)R7 or C(O)-R7, alkyl, haloalkyl or OR8 radical or an –N=C(R9)(R10) radical; R5 and R6 independently represent a hydrogen atom

or an alkyl, haloalkyl, C(O) alkyl or S(O) rCF3 radical, or R5 and R6 can together form a divalent alkylene radical which may be interrupted by one or two divalent heteroatoms such as oxygen or sulphur; R7 represents an alkyl or haloalkyl radical; R8 represents an alkyl or haloalkyl radical or a hydrogen atom; R9 represents an alkyl radical or a hydrogen atom; R10 represents a phenyl or heteroaryl group optionally


711

substituted with one or more halogen atoms or groups such as OH, -O-alkyl, -S-alkyl, cyano or alkyl; X represents a trivalent nitrogen atom or a C-R12 radical; R11 and R12 represent, independently of each other, a hydrogen or halogen atom; R13 represents a halogen atom or a haloalkyl, haloalkoxy, S(O)qCF3 or SF5 group; m, n, q, r represent, independently of each other, an integer equal to 0, 1 or 2; with the proviso that when R1 is methyl,

then R3 is haloalkyl, R4 is NH2, R11 is Cl, R13 is CF3 and X is N; (b) between 0.05 and 10%, preferably between 0.1 and 5% of one (or more) moisture-retaining agents, preferably a moisture-retaining agent of an organic nature; and (c) between 40 and 99%, preferably between 50 and 98% (and more preferably between 70 and 97%) of vegetable meal.

__________

148325 ]21][11[

אנטגוניסטים של רצפטור של ויטרונקטין

VITRONECTIN RECEPTOR ANTAGONISTS

]54[

07.09.2000 ]22[ US ]33[ 07.09.1999 ]32[ 60/152780 ]31[

Int. Cl.8 A61K 031/4375, 031/4439, A61P 003/14, 009/00, 019/10, 035/00, C07D 213/74, 401/06, 413/12, 417/12, 471/04

]51[

SMITHKLINE BEECHAM CORPORATION, U.S.A.

]71[



]74[


wherein: R1 is Het-or Ar; R2 is

or a pharmaceutically acceptable salt thereof.


__________

148375 ]21][11[

וסת אויר לתעלת אויר

AIR DUCT DAMPER

]54[

25.02.2002 ]22[ Int. Cl.8 F24F 007/06 ]51[

]TWITOPLAST LTD. ]71 תקוה-פתח, מ"ופלסט בעטויט ,לצר וכהן צדק, פרל, איתן


]74[

[57] An air damper particularly useful in air conditioning ducts, comprising a plurality of radial blades, each blade being pivotally supported between an outer housing ring and a central hub member, said blades being rotatable about a radial pivot axis between a fully closed position blocking air flow in a duct containing said

damper to a fully open position allowing substantially free air flow in said duct, and including any desired intermediate position, said radial blades being interlinked so that the rotation of one blade causes the same degree of rotation in all remaining blades.

__________


713

148406 ]21][11[

מלחי טרמדול לשימוש רוקחי

PHARMACEUTICAL TRAMADOL SALTS

]54[

03.08.2000 ]22[ DE ]33[ 31.08.1999 ]32[ 19940740.1 ]31[

Int. Cl.8 C07D 215/00 ]51[ GRUNENTHAL GMBH, GERMANY ]71[ WO/2001/015682 ]87[

, כהן ושותפיוריינהולד תל אביב, 4060. ד.ת , 21 רחוב אחד העם


]74[

[57] A pharmaceutically acceptable salt of tramadol and a sugar substitute, wherein

the solubility of the salt in water or aqueous body fluids is <100 mg/ml.

__________

148521 ]21][11[

שיטה ומערכת לשידור סידרת הודעות עבור בסיס נתונים

METHOD AND SYSTEM FOR TRANSMITTING A CHAIN OF MESSAGES FOR DATABASE

]54[

14.09.2000 ]22[ CH ]33[ 17.09.1999 ]32[ 1713/99 ]31[

Int. Cl.8 G06F 009/445, H04L 012/18, 029/06, H04N 007/24 ]51[ NAGRACARD S.A., SWITZERLAND ]71[ WO/2001/022684 ]87[


ירושלים


]74[

[57] Method of transmission of chain of database managing messages between a management centre and a plurality of subscriber databases, each management message comprising a chain header (HD), a chain identifier (FM) allowing the simultaneous transmission of several

chains and a chain index (FI) allowing to identify the message in the chain, characterized in that it consists in adding to each message a conditional block (CD) which determines if this message is to be processed without references to all or part of elements of the chain or to be processed


according to the conditions linked to the previous processing of all or part of

elements of the chain.

__________

148568 ]21][11[

במיוחד לשימוש במערכת , סרטי דבק דרמלית או טרנסדרמלית

PLASTIC FILMS, ESPECIALLY FOR USE IN A DERMAL OR TRANSDERMAL THERAPEUTIC SYSTEM

]54[

26.08.2000 ]22[ DE ]33[ 10.09.1999 ]32[ 1994317.8 ]31[

Int. Cl.8 A61K 035/00 ]51[ LTS LOHMANN THERAPIE-

SYSTEME AG, GERMANY ]71[

WO/2001/019351 ]87[ ,ת לוצאטולוצאטו א באר שבע, 5352. ד.ת, עומר , גן תעשייה


]74[

[57] Dermal or transdermal therapeutic system comprising a sheet-like substrate or reservoir containing readily volatile auxiliary agents or active agents, which substrate or reservoir is covered on one of its sides with a backing layer impermeable to the ingredients and on the opposite side

with a detachable, likewise impermeable protective layer to prevent loss of ingredients during prolonged storage, characterized in that both the backing layer and the protective layer are made of plastic film which is impermeably coated on both sides with vapour-deposited metal.

__________


715

148619 ]21][11[

–זכרון לאמערכת ושיטה לאפשר לוולטיליל בצע קוד תוך כדי תפקוד

כמתקן אגירה ועיבוד מידע

SYSTEM AND METHOD FOR ENABLING NON-VOLATILE MEMORY TO EXECUTE CODE WHILE OPERATING AS A DATA STORAGE/PROCESSING DEVICE

]54[

18.06.2001 ]22[ US ]33[ 31.07.2000 ]32[ 09/629966 ]31[

Int. Cl.8 G06F 012/00, 015/78 ]51[ M-SYSTEMS FLASH DISK מ"סיסטמס פלאש דיסק פיונירס בע-אם

PIONEERS LTD. ]71[

,AMIR BAN, MOSHE GEFEN שוקה זרנוויצקי, משה גפן, אמיר בןSHUKA ZERNOVIZKY

]72[



]74[

[57] A method for executing code while processing data on a non-volatile memory device, comprising the following steps: (i) adding at least one logic circuit to the non-volatile memory device; (ii) sensing a read request while the device is in program/erase mode/operation, by said at least one logic circuit; (iii) in response to said sensing, entering of program and/or erase operations into suspended mode, by said at least one logic circuit; (iv) signaling to CPU/Bus to delay executing said read request, by said at least one logic circuit;

(v) turning off signal to allow CPU/Bus to execute said read request, by said at least one logic circuit; and (vi) exiting of said device from said suspended mode to continue program/erase operation, by said at least one logic circuit. A single flash memory device comprising: a suspend logic circuit for enabling hardware initiated suspending of data processing operations in response to at least one read request received by the memory device from a host; and a resume logic circuit for enabling hardware initiated resuming of data processing operations.


__________

148683 ]21][11[

מחיצה , מקטע מסילה לקיבוע בד נמתחאו קיר מדומה מדומה כגון תקרה מדומה

המורכב ממנו

RAIL SECTION FOR FIXING A STRETCHED WEB, FALSE PARTITION SUCH AS A FALSE CEILING OR FALSE WALL COMPRISING SAME

]54[

11.07.2001 ]22[ FR ]33[ 13.07.2000 ]32[ 00/09186 ]31[

Int. Cl.8 E04B 009/30 ]51[ NEWMAT, S.A., FRANCE ]71[ WO/2002/006604 ]87[



]74[

[57] A rail section (3) for stretched fabric false partitions affixed to a mounting surface (4), said rail section comprising: a groove (3) defined by an internal wing (7), an external wing (5) and a base (6); an interval adjacent to the external wing and separating the external wing from a mounting surface; a joint (12) including a lip (13), and a flap (14) outside the groove, said flap extending outward from said

external wing toward said mounting surface; said lip being shaped and configured to pinch the fabric of the false partition between said lip and said internal wing; wherein the lip is approximately flat, an internal face (16) of the lip being approximately parallel to an external face of the lip; wherein the lip has a free edge that is disposed inside the groove.


717

__________

148953 ]21][11[

תכשיר הורמונלי ושימוש בו

HORMONAL COMPOSITION AND USE THEREOF

]54[

24.10.2000 ]22[ WO ]33[ 25.10.1999 ]32[ PCT/FR99/02588 ]31[

Int. Cl.8 A61K 045/00, C07J 005/00 ]51[ LABORATOIRE THERAMEX,

MONACO ]71[


תל, 4060. ד.ת , 21 רחוב אחד העם אביב


]74[

[57] Use of a combined estroprogestative association to be administered by the oral route for the preparation of a medicament intended to correct estrogen deficiencies in women, more particularly in menopausal women, wherein the association contains an estrogen at a dose ranging from 0.3 to 3

mg, and a progestative selected from nomegestrol and esters thereof at a dose ranging from 0.3 to 1.25 mg, in combination or admixture with one or more non-toxic, inert, pharmaceutically acceptable excipient(s).

__________


149209 ]21][11[

N–הכנתם, גואנידינו אלקילאמידים ,השמוש בהם ותכשירי רוקחות המכילים

אותם

N-GUANIDINOALKYLAMIDES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

]54[

21.10.2000 ]22[ EP ]33[ 30.10.1999 ]32[ 99121623.5 ]31[

Int. Cl.8 A61K 031/16, 031/395, A61P 007/02, 009/00, C07C 279/14, C07D 213/30, 213/40, 215/48, 239/28

]51[

SANOFI-AVENTIS DEUTSCHLAND GMBH, GERMANY

]71[



]74[

[57] Compounds of the formula

in which one or two of the groups Y are carbon atoms carrying a group of the formula

Ro-(CH2)n-O- and zero, one, two or three of the groups Y are nitrogen atoms, and the remaining groups Y are carbon atoms carrying a group R1, where the groups Y are independent of each other and can be identical or different; L is chosen from hydrogen, (C1-C6)-alkylcarbonyl, (C6-C14)-aryl-(C1-C4) – alkylcarbonyl, (C6-C14)-arylcarbonyl, (C1-C6)-alkyloxycarbonyl,

(C6-C14)-aryl-(C1-C4)- alkyloxycarbonyl and (C6-C14)-aryloxycarbonyl, where the aryl groups present in L are unsubstituted or substituted by one or more identical or different substituents R13, and where all groups L are independent of each other and can be identical or different; A is chosen from R3O- and R4R6N-; k is 1, 2, 3 or 4;


719

n is 0, 1, 2, 3 or 4; Ro is chosen from phenyl and monocyclic 6-membered heteroaryl containing one or two nitrogen atoms as ring heteroatoms, where the group Ro is unsubstituted or substituted by one or more identical or different groups R2; R1 is chosen from hydrogen, halogen, nitro, hydroxy, (C1-C6)-alkyloxy-, (C6-C14)-aryl, (C1-C8)-alkyl, hydroxycarbonyl-(C1-C8)-alkylureido-, (C1-C8)-alkyloxycarbonyl-(C1-C8)-alkylureido-, (C1-C8)-alkylsulfonyl-and R11R12N-, where the groups R1 are independent of each other and can be identical or different, and where alkyl and aryl groups present in R1 are unsubstituted or substituted by one or more identical of different substituents R13, or two groups R1 bonded to adjacent ring carbon atoms together with the carbon atoms to which they are bonded form an aromatic ring condensed to the ring depicted in formula l, where the ring formed by the two groups R1 is unsubstituted or substituted by one or more identical or different substituents R13; R2 is chosen from halogen, nitro, (C1-C8)-alkyl, cyano, hydroxy, amino and (C1-C8)- alkyloxy-, where alkyl groups present in R2 are unsubstituted or substituted by one or more identical or different halogen atoms; R3, R4 and R5 are chosen from hydrogen, (C1-C12)-alkyl, (C6-C14)-aryl-(C1-C4)-alkyl-, (C6-C14)-aryl-, Het-and Het-(C1-C4)-alkyl, where R4 and R5 are independent of each other and can be identical or different, and where the groups alkyl, aryl and Het present in R3, R4 and R5 are unsubstituted or substituted by one or more identical or different substituents R13, or R4

and R5 together with the nitrogen atom to which they are bonded form a saturated 3-membered to 8-membered monocyclic ring which in addition to the nitrogen atom carrying R4 and R5 can contain one or two identical or different ring heteroatoms chosen from oxygen, sulfur and nitrogen; R11 and R12 which are independent of each other and can be identical or different, are chosen from hydrogen, (C1-C8)-alkyl, (C6-C14)- (C1-C4)-alkyl, -Het-(C1-C4)-alkyl-, hydroxycarbonyl-(C1-C8)-alkyl-, (C1-C8)-alkyloycarbonyl-(C1-C8)-alkyl-, hydroxycarbonyl-(C1-C8)-alkyloxcarbonyl-(C1-C8)- alkylcarbonyl- and (C1-C8)-alkylcarbonyl-, where alkyl and aryl groups present in R11 and R12 are unsubstituted or substituted by one or more identical or different substituents R13, or R11 and R12 together with the nitrogen atom to which they are bonded form a saturated or unsaturated 5-membered to 8-membered monocyclic heterocyclic ring which in addition to the nitrogen atom carrying R11 and R12 can contain one or two identical or different ring heteroatoms chosen from oxygen, sulfur and nitrogen, and in which one or two of the ring carbon atoms can be substituted by oxo to form C=O group(s); R13 is chosen from halogen, nitro, cyano, hydroxy, (C1-C8)-alkyl, (C1-C8)-alkyloxy, trifluoromethyl and amino; Het is a residue of a saturated, partially unsaturated or aromatic monocyclic or bicyclic, 3-membered to 10-membered heterocyclic ring system containing one, two, three or four identical or different heteroatoms chosen from nitrogen, oxygen and sulfur; in all their stereoisomeric forms and mixtures thereof in any ratio, and their physiologically tolerable salts.

__________


149324 ]21][11[

שיטה לאיתור סימן של דיספרסיה אופטית בקווי תקשורת אופטיים

TECHNIQUE FOR DETERMINING SIGN OF OPTICAL DISPERSION IN OPTICAL COMMUNICATION LINES

]54[

24.04.2002 ]22[ Int. Cl.8 G02B 006/34 ]51[

]ECI TELECOM LTD. ]71 פתח תקוה, מ"טלקום בע. איי.סי.אי ,מ"טלקום בע. איי. סי. אי

פתח תקוה, 30 רחוב הסיביםECI TELECOM LTD, 30 HASIVIM ST. PETACH TIKVA 49517

]74[

[57] A method for determining the sign of chromatic dispersion in an optical communication line suitable for transmitting an optical signal at a predetermined optical wavelength, the method comprising steps of: introducing controlled changes of wavelength around said predetermined wavelength, monitoring the optical signal that has passed said line, and obtaining a first

signal reflecting changes of the carrier wavelength of said optical signal, a second signal reflecting changes of delay of the optical signal transmitted via said line, comparing the first signal with the second signal, and determining the chromatic dispersion sign based on the phase difference between the compared first and second signals.

__________

149356 ]21[]11[

רשת מערכת תקשורת המאפשרת למספר רב של ספקי רשת להשתמש

במבנה רשת משותף

DISTRIBUTED NETWORK COMMUNICATION SYSTEM WHICH ENABLES MULTIPLE NETWORK PROVIDERS TO USE A COMMON DISTRIBUTED NETWORK INFRASTRUCTURE

]54[

03.11.2000 ]22[ US ]33[ 03.11.1999 ]32[ 433818 ]31[ US 18.04.2000 551291

Int. Cl.8 H04L 012/14, 012/28, 029/06, 029/12 ]51[ WAYPORT, INC., U.S.A. ]71[ WO/2001/037517 ]87[



]74[

[57] A method for providing access to a


721

network system, wherein the network system includes a plurality of access points coupled to a network, the method comprising: a first access point receiving identification information from a portable computing device, wherein the identification information indicates a network provider of a plurality of possible

network providers; determining the network provider for the portable computing device after receiving the identification information; the first access to the portable computing device through the network provider determined in said determining.

__________

149439 ]21][11[

מערכת ושיטה לבקרת אחת או יותר יחידות בקרה מרובות כניסות כיחידה

מרובת כניסות אחת

SYSTEM AND METHOD FOR CONTROLLING ONE OR MORE MULTIPOINT CONTROL UNITS AS ONE MULTIPOINT CONTROL UNIT

]54[

08.11.2000 ]22[ US ]33[ 08.11.1999 ]32[ 60/164298 ]31[

Int. Cl.8 H04L 012/18, 029/06, H04N 007/00, 007/15 ]51[ ]POLYCOM ISRAEL LTD. ]71 פתח תקווה, מ"פוליקום ישראל בע



]74[

[57] A method for multimedia communication, comprising the steps of: communicatively interconnecting a

plurality of multimedia terminals to a plurality of corresponding multipoint control units, wherein each multimedia


terminal is connectable to two or more of said plurality of multipoint control units; communicatively interconnecting the plurality of corresponding multipoint control units to a central control unit; identifying capability factors for each of the plurality of multimedia terminals and each of the plurality of corresponding multipoint control units; responsive to a command to initiate a multimedia communication between at least two of the plurality of multimedia terminals, evaluating the capability factors for each of the at least two multimedia terminals; comparing the capability factors for each of the at least two multimedia terminals to the capability factors of the multipoint

control units communicatively interconnected to the central control unit to determine an optimum assignment of resources for a multimedia interconnection between the at least two participating multimedia terminals and responsive to the comparing of capability factors, the central control unit assigning the multimedia control unit to be used for the multimedia interconnection of the participating multimedia terminals to one of said plurality of multimedia control units and directing a communicative interconnection between the at least two multimedia terminals via at least one of the plurality of multipoint control units.

__________


723

149538 ]21][11[

תצורת אפיק לחיבור אופטי הדדי של חישובמספר יחידות

BUS CONFIGURATION FOR OPTICALLY INTERCONNECTING A PLURALITY OF CALCULATION UNITS

]54[

29.09.2000 ]22[ US ]33[ 11.11.1999 ]32[ 09/438345 ]31[

Int. Cl.8 G02B 006/28 ]51[ INTEL CORPORATION, U.S.A. ]71[ WO/2001/035137 ]87[


ירושלים


]74[

[57] A method for optically interconnecting a plurality of devices, comprising: splitting a first optical signal beam received from a first device; optically coupling a second device and a third device to receive the first optical signal beam; splitting a second optical signal beam received from the second device; optically coupling the first device and the third device to receive the second

optical signal beam; splitting a third optical signal beam received from the third device; optically coupling the first device and the second device to receive the third optical signal beam, and deflecting a portion of at least one of the first, second, and third optical signal beams directed from a first beam splitter back to the first beam splitter.

__________

149659 ]21][11[

מערכת למעקב אחרי כלי

SYSTEM FOR TRACKING A CRAFT

]54[

17.10.2001 ]22[ FR ]33[ 20.10.2000 ]32[ 00/13484 ]31[

Int. Cl.8 G01S 001/04, 005/14 ]51[ THALES, FRANCE ]71[ WO/2002/033437 ]87[


רחובות


]74[

[57] A system for tracking a craft from a monitoring station by means of signals transmitted by satellites of a positioning

system and frequency-transposed and relayed by a transponder placed onboard the craft, said signals transmitted by the


satellites of the positioning system each resulting from the modulation of a carrier by a spreading code, this craft tracking system comprising: onboard the craft, a transponder retransmitting the signals from the satellites of the positioning system after an infradyne frequency transposition by means of a transposition carrier of higher frequency KFQ than F0 of the satellite signals, by associating a transposition driver FQ representative of the phase and frequency of the carrier used for the transposition KFQ, and at the monitoring station; a receiver responsive to the signals retransmitted by the transponder, with: a signal processing part incorporating a demodulation stage with a spreading code recovery loop nested within a carrier recovery loop each slaved to its own error signal, the error signal of the code recovery loop being representative of the delay affecting, on reception, the spreading code of the signal undergoing demodulation and the error signal of the carrier recovery loop being representative of the frequency gap affecting, on reception, the carrier of the signal undergoing demodulation; a part for determining the frequency gap K∆F2, with respect to its preset value, of the transposition carrier used by the

transponder, operating on the basis of the transposition driver received from the transponder; means for correcting the error signal of the carrier recovery loop, of the bias caused by the frequency gap ∆F2 determined by the part for determining frequency gap, and a part for signal utilization, extracting information regarding the position and the speed of the craft from the error signals of the code recovery loop and of the carrier recovery loop of the processing part, the error signal of the carrier recovery loop being corrected beforehand of the frequency gap K∆F2 delivered by the frequency gap determining part, said craft tracking system being characterized in that it comprises: at the level of the monitoring station, means for interpreting the error signal of the carrier recovery loop, after correction of the bias caused by the frequency gap K∆F2 determined by the frequency gap determining part (40, 41) as a measurement representative of the Doppler effect caused, on the initial frequency F0 of the signal relayed by the transponder, by an approach speed corresponding to the sum of the craft/satellite Vos and craft/receiver VOR relative retreat speeds.

__________


725

149730 ]21][11[

VMEbusעיצוב רקע מסך וירטואלי מסוג עמיד לפגמים

FAULT TOLERANT VIRTUAL VMEBUS BACKPLANE DESIGN

]54[

15.11.2000 ]22[ US ]33[ 18.11.1999 ]32[ 442702 ]31[

Int. Cl.8 G06F 011/20, 013/40 ]51[ HONEYWELL INC., U.S.A. ]71[ WO/2001/037102 ]87[



]74[

[57] A fault tolerant virtual VMEbus backplane for computer systems, the apparatus comprising: at least two VMEbus backplanes, each VMEbus backplane comprising a power supply and

a fault detection apparatus; and at least two bridge modules, each bridge module comprising a switch for connecting and disconnecting each of said VMEbus backplanes.

__________


149738 ]21][11[

שינוי צורה של להבים על רוטור באמצעות אולטרה סאונד רוחבי

TRANSVERSE ULTRASOUND PEENING OF BLADES ON A ROTOR

]54[

20.09.2001 ]22[ FR ]33[ 21.09.2000 ]32[ 00/12017 ]31[

Int. Cl.8 B24B 039/00 ]51[ SNECMA MOTEURS, FRANCE ]71[ BENOIT JEAN HENRI BERTHELET,

GERARD MICHEL ROLAND GUELDRY, CLAUDE MARCEL MONS, MARIE-CHRISTINE NTSAMA-ETOUNDI

]72[


,נטים ונוטריוניםפט, 12704. ד.ת , 5שנקר ' רח, 1ים - מרכז גב הרצליה


]74[

[57] A method for ultrasonic peening of parts lying radially at a periphery of a wheel, comprising: setting the wheel in rotation about its geometric axis; creating a mist of microbeads in a fixed active chamber arranged to a side of said wheel, by a first vibrating surface arranged in a lower part of said active chamber, said active chamber comprising an opening

shaped to allow the parts to be put in and removed as the wheel rotates and being sized to accommodate at least three adjacent parts; wherein the wheel is rotated about said geometric axis which is substantially vertical, and the first vibrating surface is arranged under a path of the parts in the active chamber.

__________


727

149748 ]21][11[

– 3 ,1 –ניטרוגואנידינים –2שיטה להכין דימותמרים

METHOD FOR PRODUCTION OF 1,3 - DISUBSTITUTED 2-NITROGUANIDINES

]54[

08.12.2000 ]22[ DE ]33[ 21.12.1999 ]32[ 19961604.3 ]31[

Int. Cl.8 C07D 213/36, 213/61, 277/28, 277/32, 307/14 ]51[ BAYER AKTIENGESELLSCHAFT,

GERMANY ]71[



]74[

[57] A process for the preparation of a compound of the formula

wherein R1 is hydrogen or alkyl, R2 is hydrogen, alkyl, cycloalkyl or –CH2R3, R3 is alkenyl, alkinyl, or aryl or heteroaryl each of which is optionally substituted,

Het is an unsubstituted or substituted aromatic or non-aromatic, monocyclic or bicyclic heterocyclic radical, comprising the step of: reacting a compound of the formula

wherein R1, R2 and Het are as defined above, and R4 is alkyl, cycloalkyl, aryl, arylalkyl or heterocyclylalkyl, each of which may be unsubstituted or substituted,

with anhydrous hydrogen chloride or with one or more compounds which can generate hydrogen chloride in the presence or absence of a diluent.

__________


149812 ]21][11[

מערכות תרופתיות טרנסדרמליות בעלות יציבות משופרת וייצורן

TRANSDERMAL THERAPEUTIC SYSTEMS HAVING IMPROVED STABILITY AND THEIR PRODUCTION

]54[

24.11.2000 ]22[ DE ]33[ 29.11.1999 ]32[ 19957401.4 ]31[ DE 04.11.2000 10054713.3

Int. Cl.8 A61K 009/00, 009/70 ]51[ LTS LOHMANN THERAPIE-

SYSTEME AG, GERMANY ]71[

WALTER MULLER ]72[ WO/2001/039753 ]87[



]74[

[57] A transdermal therapeutic system (TTS) in which the formation of oxidative degradation products of at least one active substance present in this system and oxidizable by hydroperoxides is reduced during storage of the TTS, wherein the

sum of the peroxide numbers (PON) of the formulation constituents in contact with the active substance or substances in the proportionate weighting dictated by the formula for the TTS is not more than 20.

__________

149816 ]21][11[

מערכת ושיטה לתיאום תצוגת מוזיקה נים בתזמורתבין נג

SYSTEM AND METHOD FOR COORDINATING MUSIC DISPLAY AMONG PLAYERS IN AN ORCHESTRA

]54[

22.11.2000 ]22[ US ]33[ 23.11.1999 ]32[ 447916 ]31[

Int. Cl.8 G09B 015/00, 015/02 ]51[ HARRY CONNICK, JR., U.S.A. ]71[ WO/2001/039158 ]87[

',גבריאלי ושותזליגסון תל אביב, 1426. ד.ת , 31יבנה ' רח

SELIGSOHN GABRIELI & CO., 31 YAVNE ST. P.O.B. 1426 TEL AVIV 61013

]74[

[57] In a network of computerized devices


729

each containing programming for displaying music on a display device, the computerized devices being used by each of a plurality of players in an orchestra under direction of a conductor, a method for facilitating leading of the orchestra, the method comprising: registering an identity of an instrument in use by each player and the corresponding computerized device being used by the player; receiving at a computerized device in use by the conductor a change to a musical arrangement represented in a handwritten format, the conductor's format to electronic music type format; allowing the conductor to select whether the change is to be sent to all players in the orchestra or only to one

or more players using an instrument impacted by the change; if the conductor selects to send the change only to the player or players using an instrument impacted by the change, determining which instrument or instruments are impacted by the change and identifying the corresponding computerized device or devices registered for that instrument; allowing the conductor to select whether the change should be converted to electronic music type format before transmission to the one or more players; and transmitting the change to one or more players in accordance with the conductor's selections.

__________


149822 ]21][11[

הורדת קובץ ממספר שרתים

MULTI-SERVER FILE DOWNLOAD

]54[

23.11.2000 ]22[ US ]33[ 24.11.1999 ]32[ 09/448179 ]31[

Int. Cl.8 G06F 011/00, 013/00 ]51[ ]SPEEDBIT LTD. ]71 מ"ספידביט בע

WO/2001/039002 ]87[ ,פ"מ עו"אלפאפטנט עמיתים בע

בית שמש, 55ראובן ' רחALPHAPATENT LTD., 55 REUVEN ST., BET-SHEMESH 99544

]74[

[57] A method for downloading a file to a client, the method comprising the steps of: (a) determining the presence of said file on each of a plurality of secondary servers; (b) retrieving a plurality of portions of said file from any of said servers, wherein at

least a first of said portions is retrieved from a first on any of said servers and at least a second of said portions is retrieved from a second on any of said servers; and (c) assembling said file at said client from said plurality of portions.

__________


731

149823 ]21][11[

שיטה והתקן להורדת קובץ משרת

METHODS AND APPARATUS FOR DOWNLOADING A FILE FROM A SERVER

]54[

18.01.2001 ]22[ US ]33[ 19.01.2000 ]32[ 09/487338 ]31[

Int. Cl.8 G06F 011/00, 013/00 ]51[ ]SPEEDBIT LTD. ]71 מ"ספידביט בע

WO/2001/053953 ]87[ ,פ"מ עו"אלפאפטנט עמיתים בע

בית שמש, 55ראובן ' רחALPHAPATENT LTD., 55 REUVEN ST., BET-SHEMESH 99544

]74[

[57] A method for downloading files, the method comprising the steps of: at a client: (a) requesting a proxy server to initiate a first download of a file from a first server, said first server determined by said client to lack download resume capability and said proxy server possessing download resume capability; at said proxy server:

(b) initiating said first download of said file from said first server; and at said client: (c) initiating at least a second download of at least a portion of said file from said proxy server, said portion not being downloaded to said client directly from said first server.

__________


149880 ]21][11[

מערכת מד חניה אלקטרונית

ELECTRONIC PARKING METER SYSTEM

]54[

28.05.2002 ]22[ US ]33[ 30.05.2001 ]32[ 09/866919 ]31[

Int. Cl.8 G07C 001/30, G08G 001/14 ]51[ INNOVAPARK, LLC, U.S.A. ]71[

,ולרברגמן וג, וולף, 1352. ד.ת' , ב19 רחוב קרן היסוד

ירושלים


]74[

[57] An electronic parking meter system comprising: an electronic parking meter (4, 6) for determining the time a parking space associated with the parking meter is occupied by a vehicle and receiving coins denoting desired parking time and indicating said time; an inductive loop vehicle detection sensor (8, 10) located to detect both the physical presence or absence of a vehicle in said parking space and emitting a respective signal indicative thereof, a microprocessor controller (14) coupled to the sensor and the electronic parking meter for selectively controlling the electronic parking meter and the controller responsive to the sensor signal; the electronic parking meter indicating time provided upon payment with a vehicle occupying said space to obtain a fixed amount of time in accordance with the amount of payment, said electronic parking meter decrementing the indicated time; said controller initializing said electronic parking meter to zero when the sensor signals the controller that a vehicle no longer occupies the parking space; said detection sensor includes a variable oscillator circuit oscillating at a base frequency and responsive to the inductance of the inductive loop for providing said signals to the microprocessor indicating the presence or absence of a vehicle in the

parking space; said microprocessor controller including a crystal oscillator producing pulses and operating at approximately 50 times the base frequency of the variable oscillator circuit and initiating a 12.5 ms long charge to said variable oscillator circuit every 2.5 seconds for the purpose of measuring the operating frequency of said circuit while conserving power as needed for the practical application of the technology in parking control; the presence or absence of a vehicle in the parking space causing a respective decrease or increase in the inductance of the inductive loop and a respective commensurate increase or decrease in the operating frequency and a respective decrease or increase in the period of the variable oscillator circuit, thereby decreasing or increasing the number of crystal oscillator pulses in each period of the variable oscillator circuit; said oscillator providing an output signal including said crystal oscillator pulses to said microprocessor controller, and said microprocessor controller superimposes the signals received from the variable oscillator circuit during each 12.5 ms time frame in which the variable oscillator circuit is charged with the crystal oscillator pulses to determine the presence or absence of a vehicle in the parking space.


733

__________

149898 ]21][11[

שקית בעלת אלמנט סגירה בולט

BUTT-ENDED BAG WITH A BUCKLE-OVER CLOSING ELEMENT

]54[

20.10.2000 ]22[ DE ]33[ 30.11.1999 ]32[ 19957563.0 ]31[

Int. Cl.8 B65D 075/00, 075/58 ]51[ SPS VERPACKUNGS-SYSTEM

GMBH, GERMANY ]71[


תל אביב,4060. ד.ת , 21 רחוב אחד העם REINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040

]74[

[57] Stand-up pouch (1) made of heat-sealable or weldable plastic foil for receiving liquid and/or paste-like substances, having two side walls (2, 3), which are joined to one another at their longitudinal edges, wherein disposed at the bottom stand-up pouch end between the bottom transverse edges (8, 9) is a foldable bottom part, which lies between the side wall and serves as a standing base (10),

and situated at the top stand-up pouch end between the side walls is a foldable top part, and having a discharge opening (12) between the upper transverse edge (13, 20) of a first side wall and the associated top-part edge (21, 22), wherein a closure element (20) is inserted into the discharge opening, the stand-up pouch in the first side wall in a region below the closure element comprising a means (33) of


stabilizing and supporting the closure element in a forward-tilted position,

wherein the means of stabilizing and supporting the closure element is formed by at least one embossing (33, 34).

__________

149984 ]21][11[

אבקה לשאיפה המכילה טיאוטרופיום

TIOTROPIUM-CONTAINING INHALATION POWDER

]54[

28.09.2001 ]22[ DE ]33[ 12.10.2000 ]32[ 10050635.6 ]31[

Int. Cl.8 A61K 009/00, 009/72, C07D 451/02 ]51[ BOEHRINGER INGELHEIM

PHARMA GMBH & CO. KG, GERMANY

]71[



]74[

[57] Inhalable powder containing 0.04 to 0.8% by weight of tiotropium in admixture with a physiologically acceptable excipient, characterized in that the excipient consists of a mixture of coarser excipient with an average particle size of

15 to 80 µm and finer excipient with an average particle size of 1 to 9 µm, the proportion of finer excipient constituting 3 to 15% by weight of the total amount of excipient.

__________


735

150159 ]21][11[

הנצלת רקמה ללא פגע בפולשנות מזערית

MINIMALLY INVASIVE INTACT RECOVERY OF TISSUE

]54[

01.09.2000 ]22[ US ]33[ 27.12.1999 ]32[ 09/472673 ]31[

Int. Cl.8 A61B 010/00 ]51[ NEOTHERMIA CORPORATION,

U.S.A. ]71[

WO/2001/047409 ]87[ ,מ"בע) 1995(ארליך .אי.י'ג

רחוב מנחם בגין ,15קומה , מגדל אילון רמת גן,11


]74[

[57] Apparatus (10) for retrieving a tissue volume of predetermined peripheral extent, comprising a delivery cannula (12) having an outer surface surmounting an interior channel and extending from a proximal end portion along a longitudinal axis to a forward region, having a distal end positionable in confronting adjacency with said tissue volume; a capture component positioned within said delivery cannula interior channel, having an expansible forward portion extending to a forwardly disposed electrically conducting electrosurgical cutting leading edge portion and being extendible and expandable toward an outer peripheral dimension selected for the circumscriptive

engagement of said tissue volume peripheral extent when moved along said longitudinal axis to egress from said delivery cannula; and a deployment assembly (18) extending within said interior channel, drivably coupled with said capture component and actuable to effect said movement of said capture component along said longitudinal axis, and for effecting a subsequent contraction of said leading edge portion to provide closure of said capture component leading edge portion, and including a terminal assembly for simultaneously effecting the conduction of electrical energy to said leading edge portion.

__________


150173 ]21][11[

פוספונומתילגליצין–Nשיטה להכנת

METHOD FOR PRODUCTION OF N-PHOSPHONOMETHYLGLYCINE

]54[

22.12.2000 ]22[ DE ]33[ 23.12.1999 ]32[ 19962601.4 ]31[

Int. Cl.8 C07F 009/00, 009/28, 009/38, 009/40, 009/50 ]51[ BASF AKTIENGESELLSCHAFT,

GERMANY ]71[




]74[

[57] A process for the preparation of N-phosphonomethylglycine, wherein

(a) a hexahydrotriazine derivative of the formula

in which X is CN, COOZ, CONR1R2 or CH2OY, Y is H or a radical which is readily exchangeable for H, Z is H, an alkali metal, alkaline earth metal, C1-C18-alkyl or aryl, which is

unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl, R1 and R2 can be identical or different and are H or C1-C4-alkyl, is reacted with a triacyl phosphate of the formula

P(OCOR3)3

in which the radicals R3, which can be identical or different, are C1-C18-alkyl or aryl, which is unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl, and

(b) the product obtained is hydrolyzed, and, if X is CH2OY, oxidized. Claimed as novel is the phosphono compound of the formula


737

in which the radicals R3, which can be identical or different, are C1-C18-alkyl or aryl which is unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl, and X is CN, COOZ, CONR1R2 or CH2OY, Y is H or a radical which is readily exchangeable for H:

Z is H, and alkali metal, alkaline earth metal, C1-C18-alkyl or aryl, which is unsubstituted or substituted by C1-C4-alkyl, NO2 or OC1-C4-alkyl; R1 and R2, which can be identical or different, are H or C1-C4-alkyl, or a salt thereof.

__________

150177 ]21][11[

אמצעים משחררי הידרוקסיד המגבירים את חדירות העור

HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS

]54[

15.12.2000 ]22[ US ]33[ 16.12.1999 ]32[ 465098 ]31[ US 11.05.2000 569889 US 30.06.2000 607892 US 14.12.2000 738410 US 14.12.2000 738395

Int. Cl.8 A61K 009/70, 047/02 ]51[ DERMATRENDS, INC. ]71[ WO/2001/043775 ]87[

,ריינהולד כהן ושותפיו יבתל אב, 4060. ד.ת , 21 רחוב אחד העם


]74[

[57] Use of (a) a drug selected from the group consisting of amino acids, analgesic agents, anesthetic agents, anti-acne agents, antiarthritic agents, antiarrhythmic agents, antiasthmatic agents, antibiotic agents, anticancer agents, anticholinergic agents, anticonvulsant agents, antidepressant agents, antidiabetic agents, antidiarrheal agents, antifugal agents, antiglaucoma agents, antihelminthic agents, antihistamines, antihyperlipidemic agents, antihypertensive agents, antimigraine preparations, antinauseants, antineoplastic agents, antiparkinsonism drugs, antipruritic agents, antipsoriatic agents,antipsychotic agents, antipyretic agents, antispasmodic

agents, antitubercular agents, antiulcer agents, antiviral agents, anxiolytic agents, appetite suppressants, attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) drugs, beta-blockers, calcium channel blockers, central nervous system stimulants, decongestants, diuretics, fatty acids, genetic materials, herbal remedies, hormonolytics, hypnotic agents, hypoglycemic agents, immunosuppressive agents, leukotriene inhibitors, mitotic inhibitors, muscle relaxants, narcotic antagonists, nicotine, parasympatholytic agents, peptide drugs, psychostimulants, sedatives, steroids, sympathomimetics,


tranquilizers, vasodilators, vitamins, and combinations thereof, wherein the drug is (i) a basic drug in the form of a free base, (ii) an acidic drug in the form of a free acid, (iii) an acidic drug in the form of a basic addition salt, or (iv) a nonionizable compound; and (b) an amount of an inorganic hydroxide effective to enhance the flux of the drug through the body surface without causing damage thereto, wherein the inorganic hydroxide is selected from the group consisting of monovalent metal hydroxides, divalent metal hydroxides, and ammonium hydroxide wherein the amount of inorganic hydroxide in the formulation

applied to the body surface is the total of (a) the amount required to neutralize any acidic species in the formulation plus (b) an amount equal to 0.5 wt.% to 4.0% of the formulation; for the preparation of a pharmaceutical formulation suitable for topical or transdermal drug administration for administering the drug to a localized region of a human patient's body surface for enhancing the flux of a drug through a body surface, and wherein following application to the body surface, the formulation provides a pH at the interface between the body surface and the formulation in the range of 8.5 to 13.

__________

150251 ]21][11[

מערכת בדיקת פריטים בתהליך שינוע

SCREENING SYSTEM FOR OBJECTS IN TRANSIT

]54[

16.06.2002 ]22[ Int. Cl.8 B61J 001/02 ]51[

]SECURELOGIC LTD. ]71 נתניה, מ"יק בע'ספייסלוג ,לצר וכהן צדק, פרל, איתן


]74[

[57] An automated security inspection and conveying system for in-transit objects, comprising means for identifying the sender of each object and to profile the security status data of said sender into said system, and a plurality of various cargo security screening machines in combination with conveying and storing components, to route and track said objects from a reception point through said screening machines to reach a storing junction, via a user-adjustable screening process, said conveying and storing components being interfaced with said

security status data for assigning a risk assessment factor to object of said sender, whereby each object is routed via an appropriate number of screening devices, the output of said screening devices being processed and said risk assessment factor being adjusted accordingly, the new risk assessment factor being sent to a control system of said conveying and storing components, whereby object is accordingly diverted to a track leading to a "reject" bay, or to a track for further screening of doubtful object, or to a loading track for objects cleared for transportation.


739

__________

150301 ]21][11[

מערכת ושיטה לבקרה של מחלות לבלב

METHOD AND SYSTEM FOR MONITORING PANCREATIC PATHOLOGIES

]54[

07.01.2001 ]22[ US ]33[ 06.01.2000 ]32[ 60/174663 ]31[

Int. Cl.8 A61B 005/04 ]51[ YEDA RESEARCH AND רחובות, מ"ידע חברה למחקר ופיתוח בע

DEVELOPMENT CO. LTD. ]71[

ליאור , רענן מרגלית, ירון כהן, הדסה דגני ברוקר

HADASSA DEGANI, IRUN COHEN, RAANAN MARGALIT, LIOR BRUKER

]72[

WO/2001/049161 ]87[ ',ר וב ושות"ד

רחובות, 2189. ד.ת , 2פקריס ' רחWEBB & ASSOCIATES, 2 PEKERIS STREET P.O.B. 2189 REHOVOT 76121

]74[

[57] A method for monitoring a pancreatic pathology in a patient comprising the steps of: obtaining a first magnetic resonance image of an internal body organ using defined sequence parameters; injecting a contrast agent to the patient; obtaining a plurality of subsequent contrast enhancement images of the internal body organ using the defined sequence parameters; creating an intensity curve, by plotting intensity over time, from the

plurality of subsequent contrast enhancement images, converting the intensity curve to an enhancement curve, said enhancement curve having a linear portion and a plateau portion; extracting an enhancement value at plateau from the enhancement curve; and comparing the enhancement value at plateau to a standard, thereby monitoring the pancreatic pathology in the patient.

__________


150306 ]21][11[

תרכובות פרוסטגלנדין ושיטות לטיפול תפקוד זיקפה גברית–באי

PROSTAGLANDIN COMPOSITIONS AND METHODS OF TREATMENT FOR MALE ERECTILE DYSFUNCTION

]54[

10.01.2001 ]22[ US ]33[ 10.01.2000 ]32[ 09/480738 ]31[

Int. Cl.8 A61K 031/5575, A61P 015/10, C07C 405/00 ]51[ NEXMED HOLDINGS, INC., U.S.A. ]71[ WO/2001/051053 ]87[


רחובות


]74[

[57] Use of prostaglandin E1; a skin penetration enhancer which is a member of the group consisting of an alkyl-2-(N, N-disubstituted amino)-alkanoate, an (N, N-disubstituted amino)-alkanol alkanoate, pharmaceutically acceptable salts thereof and a mixture thereof; a polysaccharide gum or a polyacrylic acid polymer; a lipophilic compound which is a member of the group consisting of an aliphatic C1 to

C8 alcohol, an aliphatic C8 to C30 ester, and a mixture thereof; and an acidic buffer system for the preparation of a pharmaceutical composition for treating erectile dysfunction in a patient needing such treatment, whereby the pharmaceutical composition is to be supplied in the fossa navicularis of the patient.

__________


741

150403 ]21][11[

–4–2(–תהליך להכנת אלפא בוטילניטרון –טרט–N–)דיסולפופניל

ומלחי רוקחות מקובלים שלהם

PROCESS FOR THE PREPARATION OF ALPHA-(2-4-DISULFOPHENYL)-N-TERT- BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

]54[

04.01.2001 ]22[ SE ]33[ 10.01.2000 ]32[ 0000055-4 ]31[

Int. Cl.8 C07C 303/02, 303/32, 309/46 ]51[

ASTRAZENECA AB, SWEDEN CENTAUR PHARMACEUTICALS, INC., U.S.A.

]71[

JORGEN BLIXT, HENRY KRUK, JOHN MCGINLEY, SERGEI POUHOV, JOHN VAJDA

]72[

WO/2001/051460 ]87[ ,ו את לוצאטולוצאט


]74[

[57] A process for the preparation of a compound of the formula

wherein each R independently represents SO3H or a salt thereof, which process

involves reaction of an aldehyde of the formula

wherein R is as defined above, with N-tert-butylhydroxylammonium acetate in a liquid reaction solvent.

__________


150549 ]21][11[

תכשיר רוקחות להושטה בהזרקה המכיל ביפוספונאט

PHARMACEUTICAL PARENTERAL COMPOSITION CONTAINING A BIPHOSPHONATE

]54[

16.01.2001 ]22[ EP ]33[ 20.01.2000 ]32[ 00101044.6 ]31[

Int. Cl.8 A61K 031/66, 031/675, A61P 019/00, C07F 009/00, 009/38, 009/572, 009/58, 009/6558

]51[

F. HOFFMANN-LA ROCHE AG, SWITZERLAND

]71[



]74[

[57] A parenteral composition having pH from about 6 to about 8 comprising (1) a bisphosphonate, selected from the group consisting of (a) N-methyl-4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid, (b) 4-(N,N-dimethylamino)-1-hydroxybutylidene-1,1-bis-phosphonic acid, (c) 3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid (pamidronate), (d) 3-(N-methyl-N-pentyl) amino-1-hydroxypropane-1,1-bisphosphonic acid (ibandronic acid), (e) 3-(N-methyl-N-pentyl) amino-1-hydroxypropane-1,1-bisphosphonic acid, monosodium salt, monohydrate (ibandronate), (f) 1-hydroxy-3-(N-methyl-N-pentylamino) propylidene-1,1-bisphosphonic acid, (g) 1-hydroxy-2-[3-pyridinyl] ethylidene-1,1-bisphosphonic acid (risedronate), (h) 4-(hydroxymethylene-1,1-bisphosphonic acid) piperidine, (i) cycloheptylaminomethylene-1,1-

bisphosphonic acid (cimadronate), (j) 1,1-dichloromethylene-1,1-diphosphonic acid and the disodium salt (clodronate), (k) 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonic acid (EB-1053), (l) 1-hydroxyethane-1,1-diphosphonic acid (etidronic acid), (m) 6-amino-1-hydroxyhexylidene-1,1-bisphosphonic acid (neridronate), (n) 3-(dimethylamino)-1-hydroxypropylidene-1,1-bisphosphonic acid (olpadronate), (o) [2-(2-pyridinyl) ethylidene]-1,1-bisphosphonic acid (piridronate), (p) (4-chlorophenyl) thiomethane-1,1-diphosponic acid (tiludronate), (q) 1-hydroxy-2-(1H-imidazol-1-yl) ethylidene-1,1-bisphosphonic acid (zolendronate), (r) [(cycloheptylamino)-methylene]-bisphosphonic acid (icadronate), and (s) [1-hydroxy-2-imidazo-(1,2-a) pyridine-3-ylethylidene]-bisphosphonic acid and pharmaceutically acceptable salts thereof; (2) a pharmaceutically acceptable

chelating agent selected from EDTA and


743

DTPA and pharmaceutically acceptable salt thereof; and

(3) a pharmaceutically acceptable excipient.

__________

150560 ]21][11[

ובות מצעים נושאים פולימרים של תרכצמודות סנדוויץ קואורדינציה קשורות

ותהליכים לשימוש בהן

SUBSTRATES CARRYING POLYMERS OF LINKED SANDWICH COORDINATION COMPOUNDS AND METHODS OF USE THEREOF

]54[

05.01.2001 ]22[ US ]33[ 14.01.2000 ]32[ 09/483500 ]31[ US 28.06.2000 09/605587

Int. Cl.8 C08F 026/06, G11C 013/00 ]51[ NORTH CAROLINA STATE

UNIVERSITY, U.S.A. ]71[



]74[

[57] An apparatus for storing data, said apparatus comprising: a fixed electrode (103, 101) electrically coupled to a storage medium (102) having a plurality of different and distinguishable oxidation states wherein data is stored in said oxidation states by the addition or withdrawal of one or more electrons from said storage medium via the electrically

coupled electrode; said storage medium comprising a polymer; said polymer comprising a plurality of covalently joined monomeric units, each of said monomeric units comprising an independently selected sandwich coordination compound; and wherein said storage medium comprises a plurality of double-decker or triple-decker sandwich coordination compounds.

__________


150669 ]21][11[

רוכימי המכיל תאי פס בדיקה אלקט תגובה רבים ושיטות לשימושו

ELECTROCHEMICAL TEST STRIP HAVING A PLURALITY OF REACTION CHAMBERS AND METHODS FOR USING THE SAME

]54[

09.07.2002 ]22[ Int. Cl.8 G01N 027/327 ]51[

LIFESCAN, INC., U.S.A. ]71[ ',קולב ושות. סנפורד ט רחובות, 2273. ד.ת, מרמורק , 4יא שער הג


]74[

[57] An electrochemical test strip (20) comprising: (a) a plurality of reaction zones (22) defined by opposing working and reference electrodes separated by a spacer layer, wherein each of said reaction zones is defined by a bore through said spacer layer and further wherein each of said

reaction zones has its own fluid ingress channel to provide for fluid communication between said reaction zones and the external environment of said test strip; and (b) a reagent composition present in each of said reaction zones.

__________


745

150811 ]21][11[

מערכת ושיטה לשיוור מבני נצנוץ גבישיים עבור הדמיה ממוחשבת

טומוגרפית

SYSTEM AND METHOD OF ALIGNING SCINTILLATOR CRYSTALLINE STRUCTURES FOR COMPUTED TOMOGRAPHY IMAGING

]54[

18.12.2001 ]22[ US ]33[ 19.12.2000 ]32[ 09/681067 ]31[

Int. Cl.8 G01T 001/00 ]51[ GE MEDICAL SYSTEMS GLOBAL

TECHNOLOGY COMPANY, LLC, U.S.A.

]71[

WO/2002/050569 ]87[ ',זליגסון גבריאלי ושות

תל אביב, 1426. ד.ת , 31יבנה ' רחSELIGSOHN GABRIELI & CO., 31 YAVNE ST. P.O.B. 1426 TEL AVIV 61013

]74[

[57] A method of CT imaging comprising the steps of: providing a plurality of scintillators forming a scintillator array wherein each scintillator comprises a plurality of crystallites; aligning the crystallites of each scintillator in a uniform direction to receive high frequency electromagnetic energy from a projection

source; directing high frequency electromagnetic energy toward the scintillator array; converting the high frequency electromagnetic energy to light energy; transmitting signals indicative of light energy intensity to a data acquisition system; and generating a CT image from the transmitted signals.

__________

150855 ]21][11[

טובולרי–ה תוךמתקן אנסטומוז

INTRATUBULAR ANASTOMOSIS APPARATUS

]54[

22.07.2002 ]22[ Int. Cl.8 A61B 017/11 ]51[

NITI MEDICAL TECHNOLOGIES נתניה, מ"ניטי טכנולוגיות רפואיות בעLTD.

]71[

מיכאל , בנימין ספנסר, לאוניד מונסביץ רונן נאמן, ערד

LEONID MONASSEVITCH, BENJAMIN SPENSER, MICHAEL ARAD, RONEN NE'EMAN

]72[

,מ"בע' דוד ושות-בן. ירמיהו מ, 45087. ד.ת, הר חוצבים , רחוב המרפא

ירושלים


]74[


[57] An intratubular anastomosis apparatus for joning organ portions of a hollow organ after intussusception thereof, said apparatus including: (a) an anastomosis ring (50), and (b) a crimping support element (52) for use therewith, wherein said anastomosis ring includes a length of a wire having a predetermined cross-sectional configuration and formed of a shape memory alloy defining a closed generally circular shape, having a central opening, and having overlapping end portions, said anastomosis ring for crimping adjacent organ portions against said crimping support element so as to cause anastomosis therebetween, wherein said anastomosis ring and said shape memory alloy assume (i) a plastic state, when at a first, lower temperature and (ii) an elastic state, when reaching at least a second, higher temperature, thereby enabling said anastomosis ring to retain a

preselected configuration at the first, lower temperature, and an elastic crimping configuration upon reverting to the second, higher temperature; and wherein said crimping support element for intratubular insertion so as to provide a support for crimping said organ portions against said support element, said crimping support element having (i) a generally cylindrical side-wall (54); (ii) proximal and distal end walls formed generally transversely to said side-wall, thereby to define therewith said crimping support element; (iii) a generally axial aperture (60) for providing flow communication therethrough; and (iv) attachment means for operationally engaging said crimping support element to a crimping applicator member so as to position said crimping support element adjacent to said anastomosis ring for facilitating crimping of preselected wall portions of a hollow organ therebetween.

__________


747

150880 ]21][11[

לשינוי שידור ממכשיר מערכת ושיטה לחישה תוך גופית

SYSTEM AND METHOD FOR CHANGING TRANSMISSION FROM AN IN VIVO SENSING DEVICE

]54[

23.07.2002 ]22[ US ]33[ 23.07.2001 ]32[ 60/306872 ]31[

Int. Cl.8 A61B 005/05 ]51[ ]GIVEN IMAGING LTD. ]71 יקנעם, מ"ינג בע'גיוון אימג

ARKADY GLUKHOVSKY, BARUCH ברוך ארליך, גלוקחובסקי ארקדיERLICH

]72[

עורכי , פרל כהן צדק לצר עורכי דין ,פטנטים ונוטריונים

, 12704. ד.ת , 5שנקר ' רח, 1ים - מרכז גב הרצליה


]74[

[57] A system for obtaining in vivo data, the system comprising: a swallowable capsule; and a receiving unit; said swallowable capsule comprising at least one in vivo sensor, or at least one signal transmitter and at least one power level

receiver to receive a command to adjust the power level of said at least one signal transmitter; and said receiving unit comprising at least one receiver and at least one power level transmitter.

__________

150888 ]21][11[

שיטה לסילוק חרקים מזיקים על ידי אידוי כימי

DEBUGGING METHOD OF EXPELLING HARMFUL INSECTS BY CHEMICAL VOLATILIZATION

]54[

30.01.2001 ]22[ JP ]33[ 13.04.2000 ]32[ 2000-111596 ]31[

Int. Cl.8 A01N 025/18, 053/00, 061/00 ]51[ FUMAKILLA LIMITED, JAPAN ]71[ WO/2001/078508 ]87[

,תפיוריינהולד כהן ושו תל אביב, 4060. ד.ת , 21 רחוב אחד העם


]74[


[57] A method for repelling or expelling a harmful or noxious insect comprising: (a) providing a pyrethroid chemical, said pyrethroid chemical having the following characteristics: (i) a higher vapour pressure than d,d-T80-prallethrin, determined when the pyrethroid chemical is heated at 60 to 250˚ C, the retention time of the pyrethroid

chemical in minutes being 24.5 to 26.4; and (ii) a higher debugging potency than transfuluthrin, determined when the pyrethroid chemical is spontaneously volatilized for 70 days in a room having a volume of 33m3, the pyrethroid chemical having an average KT50 in minutes of 7.92 to 10.86; and (b) contacting the pyrethroid chemical with the harmful or noxious insect or a locus thereof.

__________

151000 ]21][11[

התקן למיצוי שקיקי מיץ מרימונים

DEVICE FOR EXTRACTING JUICE SACS FROM POMEGRANATES

]54[

31.07.2002 ]22[ Int. Cl.8 A47J 019/02 ]51[

]ITZHAK GVILI ]71 נתניה, יצחק גוילי ,ריינהולד כהן ושותפיו


]74[

[57] A device for extracting juice sacs from at least a portion of a pomegranate, comprising: (a) a mallet having a mallet arm and a mallet head;

(b) a driving mechanism operatively connected to the mallet configured to position the mallet at one or more positions and to swing the mallet when the mallet is positioned at each of the one or more positions.


749

__________

151011 ]21][11[

התקן לשליפת גוף זר

FOREIGN BODY RETRIEVAL DEVICE

]54[

02.02.2001 ]22[ US ]33[ 02.02.2000 ]32[ 09/496482 ]31[

Int. Cl.8 A61B 017/50 ]51[ BOARD OF REGENTS, THE

UNIVERSITY OF TEXAS SYSTEM, U.S.A.

]71[




]74[

[57] A retrieval device comprising: a first catheter having a distal end, a proximal end, a lumen system configured to accept at least one wire such that the at least one wire may extend beyond either end of the first catheter, and an opening system through which a loop may be formed, the opening system positioned between the distal end and the proximal end, the lumen system having an opening separate from

the opening system, the opening of the lumen system configured to accept the at least one wire such that the at least one wire may extend beyond the distal end of the first catheter; and a wire having a distal end attached to the first catheter, and a proximal end; wherein the proximal end of the wire may be manipulated to cause a


portion of the wire to form a loop external of the first catheter, the loop being capable

of grasping foreign bodies within a patient.

__________

151182 ]21][11[

–בחום ותנורים גבוהי–חומר עמיד טמפרטורה המשתמשים בו

HEAT-RESISTANT MATERIAL BASED ON SILICIDES AND HIGH-TEMPERATURE HEATERS USING SAID MATERIAL

]54[

30.01.2001 ]22[ RU ]33[ 17.02.2000 ]32[ 2000103649 ]31[

Int. Cl.8 C04B 035/505, C22C 029/02, H05B 003/14 ]51[ INSTITUT FIZIKI TVERDOGO TELA

ROSSIISKOI AKADEMII NAUK, RUSSIA

]71[

BORIS ABRAMOVICH GNESIN, PAVEL ARTEMOVICH GURZGIYANTS

]72[



]74[


751

[57] A heat-resistant material comprising molybdenum and tungsten silicides Me5Si3 and MeSi2 and silicon carbide, characterized in that it comprises silicides in the form of solid solutions (Mo, W)5Si3, (Mo, W)5Si3C and (Mo, W)Si2 with the

following ratio of the components (in vol. %): (Mo, W)5Si3 and/or (Mo, W)5Si3C 5-98, (Mo, W) Si2 2-95, the ratio of molybdenum and tungsten in the total mass of the refractory metals in the heat-resistant material ranging within (in wt. %) Mo 2-90, W 10-98, the material comprising silicon carbide 0-55 vol %.

__________

151212 ]21][11[

ן מוקצףגליון עמיל

FOAMED STARCH SHEET

]54[

14.02.2001 ]22[ IT ]33[ 15.02.2000 ]32[ TO2000A000141 ]31[

Int. Cl.8 B32B 017/12, C08J 009/12, C08L 003/12 ]51[ NOVAMONT S.P.A., ITALY ]71[ WO/2001/060898 ]87[

,לוצאטו את לוצאטור בא, 5352. ד.ת, עומר , גן תעשייה

שבע


]74[

[57] A foamed article, in particular in the form of a foamed sheet useful as a partly-finished product adapted to be further processed into a finished article of manufacture, comprising destructured or complexed starch foamed as a continuous phase, having a density lying between 20 and 150 kg/m3, cell dimensions in a range

lying between 20 and 700 µm with a cell distribution such that at least 80% of them have, in the absence of stretching, a dimension lying between 20 and 400 µm, in which the material from which the foam is made has an intrinsic viscosity in DMSO at 30˚ lying between 1.5 and 0.3 dl/g.

__________


151314 ]21][11[

ן ותכשירי שיטות להכנתן ותכנת, מיצלות רוקחות המכילים אותן

MICELLES, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

]54[

20.02.2001 ]22[ US ]33[ 18.02.2000 ]32[ 60/183768 ]31[

Int. Cl.8 A61K 031/70, 038/00, A61P 043/00, C07D 407/12, C07F 009/00, 009/655, C07H 005/00, 019/00, 021/00

]51[

EISAI CO.,LTD., JAPAN ]71[ WO/2001/060382 ]87[



]74[

[57] A method for preparing at least one micelle comprising Compound (1), a pharmaceutically acceptable salt thereof, and/or a stereoisomer thereof, which method comprises: adding an amount of Compound (1), a pharmaceutically

acceptable salt thereof and/or a stereoisomer thereof to a first aqueous alkaline solution comprising at least one basic metal salt, at least one neutral salt, and a predetermined concentration of metal ion; wherein Compound (1) is:

thereby forming a second aqueous alkaline solution comprising at least one micelle having a preselected hydrodynamic diameter, wherein the at least one micelle

comprises Compound (1), a pharmaceutically acceptable salt thereof, and/or a stereoisomer thereof.

__________


753

151390 ]21][11[

, על סילאןהרכבי ציפויים המבוססים פריטים מצופים המופקים מהם ושיטות

לשימוש בהם

SILANE-BASED COATING COMPOSITIONS, COATED ARTICLES OBTAINED THEREFROM AND METHODS OF USING SAME

]54[

08.02.2001 ]22[ US ]33[ 28.02.2000 ]32[ 60/185354 ]31[ US 29.02.2000 60/185367 US 29.09.2000 60/236158

Int. Cl.8 C09D 183/06 ]51[ ADSIL, LC, U.S.A. ]71[ WO/2001/064804 ]87[ ',ר שלמה כהן ושות"ד

תל אביב, 11490. ד.ת , 124 אבן גבירול DR. SHLOMO COHEN & CO., 124 IBN GABIROL ST., P.O.B. 11490, TEL AVIV 62038

]74[

[57] An aqueous coating composition formed by admixing

(A) at least one silane of the formula

R1Si(OR2)3 wherein R1 is a C1-C6 alkyl group, a phenyl group or a functional group containing at least one of vinyl, acrylic, amino, mercapto, or vinyl chloride functional group; and R2 is a C1-C6 alkyl group;

(C) acid component comprising a member selected from the group consisting of water-soluble organic acids, H3BO3 and H3PO3; and (D) water and further comprising a silane compound of the formula

X[R1Si(OR2)3]2

wherein R1 and R2 are as defined above, and X represents an amino group or keto group

O || C<

__________


151586 ]21][11[

קרוטן–β–דיקטו–'4,4הכנת נגזרות

PREPARATION OF 4,4'-DIKETO-Β-CAROTENE DERIVATIVES

]54[

03.09.2002 ]22[ US ]33[ 13.09.2001 ]32[ 953007 ]31[

Int. Cl.8 C07C 403/24 ]51[ DSM IP ASSETS B.V., THE

NETHERLANDS ]71[



]74[

[57] A method of preparing 4,4'-diketo derivatives from β-carotene or β-carotene derivatives comprising contacting the β-carotene or β-carotene derivatives in an organic solvent with a solution of an oxidizing agent, wherein said oxidizing

agent is formed by mixing acidified aqueous solutions of the sodium or potassium salts of sulfite, hydrogen sulfite, or bisulfite solutions and sodium or potassium bromate solutions in water to produce 4,4'-diketo derivative products.

__________

151789 ]21][11[

ורידית–מיכל לתמיסת לינזוליד תוך

CONTAINER FOR LINEZOLID INTRAVENOUS SOLUTION

]54[

15.03.2001 ]22[ US ]33[ 22.03.2000 ]32[ 60/191383 ]31[

Int. Cl.8 A61J 001/00, A61L 002/16 ]51[ PHARMACIA & UPJOHN

COMPANY LLC, U.S.A. ]71[

WO/2001/070170 ]87[ ,לצר וכהן צדק, פרל, איתן הרצליה, 12688. ד.ת , 7חוב שנקר ר


]74[

[57] A container containing an IV aqueous solution of a Gram-positive oxazolidinone agent, wherein the container

surface that contacts the solution is made of at least 50% polyolefin.




__________


755

151825 ]21][11[

תחמוצות הניוביום מופחתות חמצן

OXYGEN REDUCED NIOBIUM OXIDES

]54[

22.03.2001 ]22[ US ]33[ 23.03.2000 ]32[ 09/533430 ]31[ US 01.09.2000 60/229668 US 11.01.2001 09/758705

Int. Cl.8 G01G 001/02, H01G 009/04 ]51[ CABOT CORPORATION, U.S.A. ]71[ WO/2001/071738 ]87[

',זליגסון גבריאלי ושות תל אביב, 1426. ד.ת , 31יבנה ' רח

SELIGSOHN GABRIELI & CO., 31 YAVNE ST. P.O.B. 1426 TEL AVIV 61013

]74[

[57] The method of forming an anode comprising the steps of pressing a mixture of niobium oxide powder with at least one binder or lubricant to form the pressed

anode, wherein the niobium oxide has an atomic ratio of niobium to oxygen of 1:less than 2.5.

__________

151953 ]21][11[

מחבר אביזרים עבור כלי נשק

ACCESSORY MOUNT FOR A FIREARM

]54[

26.09.2002 ]22[ Int. Cl.8 F41A 029/00 ]51[

]T.D.I. ARMS SYSTEMS LTD. ]71 יבנה, מ" נשק בעמערכות. אי.די.טי ',גדור ושות, ד בלום"דבורה גדור עו

גבעתיים, 23קומה , 53 דרך השלום DEBORAH GADOR, BLUM, GADOR & CO., 53 DERECH HASHALOM 23 RD FLOOR GIVATAYIM 53454

]74[

[57] An accessory mount for a hand held firearm having a barrel and a mounting rail coupled beneath the barrel, the accessory mount comprising: a frame, defining a substantially flattened bottom surface, and a track for mounting along the mounting

rail, the frame having a cavity for receiving a light, and a bipod mount coupled adjacent the track and behind the light cavity and arranged to hold a bipod having legs which can be folded substantially adjacent the barrel.


__________

152305 ]21][11[

שכבתי מחוזק ושיטה להכנתו–אריג רב

REINFORCED MULTILAYER FABRIC AND METHOD OF PREPARATION

]54[

12.04.2001 ]22[ IT ]33[ 17.04.2000 ]32[ MI2000A000860 ]31[

Int. Cl.8 B32B 005/08, D04H 003/04, F41H 005/04 ]51[ F. LLI CITTERIO S.P.A., ITALY ]71[ WO/2001/078975 ]87[

,לוצאטו את לוצאטובאר , 5352. ד.ת, עומר , גן תעשייה

שבע


]74[

[57] A finished reinforced multilayer fabric (18), comprising at least a first layer (12) of threads (13) parallel with each other, superimposed on at least one second layer (12) of threads also parallel with each other, the threads of said first layer being set in various directions as regards the threads of the second layer; a binding layer (14) interposed between said first and second layer to keep said layers together

and to prevent one layer sliding over the other, wherein the binding layer impregnates only a portion of a single thread which is placed on the upper layer and next to each thread of the lower layer, the remaining portion of said threads are made up of fibrils which are impregnated with a resin matrix which keeps said fibrils firmly together.


757

__________

152333 ]21][11[

תכשיר לציפוי

COATING COMPOSITION

]54[

20.04.2001 ]22[ AU ]33[ 20.04.2000 ]32[ PQ7079 ]31[

Int. Cl.8 C09D 005/00, 007/12 ]51[

WORLDWIDE THERMAL MANAGEMENT IP PTY LTD., AUSTRALIA WORLDWIDE FIRE RETARDANT IP PTY LTD., AUSTRALIA WORLDWIDE COATINGS IP PTY LTD, AUSTRALIA

]71[



]74[

[57] A coating composition comprising (i) a supporting medium, and (ii) a plurality of cellulose particles, having an average dry particle size of less than 10

µm, dispersed in the supporting medium in an amount of less than about 10 g/L, excluding aqueous coating compositions adapted for application to paper.

__________


152972 ]21][11[

קליע בעל קוטר מלא

FULL-CALIBER PROJECTILE

]54[

20.11.2002 ]22[ DE ]33[ 23.11.2001 ]32[ 10157563.7 ]31[

Int. Cl.8 F42B 014/00 ]51[ RHEINMETALL W & M GMBH,

GERMANY ]71[



]74[

[57] A full-caliber projectile (1) comprising: a projectile body having a cylindrical guide region (5) and an ogival projectile tip (7), connected to a front end of the guide region; a cylindrical guide ring (8), which is divided at its circumference into at least two shell-like guide-ring segments (9), mounted on an outer surface of the projectile tip, with an outer diameter of the ring being smaller than an inner diameter of a gun barrel (2) of the same caliber as the projectile; and

means (10) securing the guide ring to the outer surface of the projectile tip such that the guide-ring segments detach from the projectile and move rapidly outwardly when a predetermined firing acceleration is attained in the corresponding gun barrel, so that the guide-ring segments are pushed rearwardly toward the cylindrical guide region of the projectile in an axial direction until the guide ring segments rest against the inside wall of the gun barrel and against the projectile.

__________


759

153136 ]21][11[

חבק תיקון צינורות

PIPE REPAIR CLAMP

]54[

27.11.2002 ]22[ Int. Cl.8 F16L 021/06 ]51[

KRAUSZ METAL INDUSTRIES תל אביב, מ"קראוס תעשיות מתכת בעLTD.

]71[

ELIEZER KRAUSZ, AVI יפרוט'אבי צ, אליעזר קראוסCHIPROOT

]72[



]74[

[57] A wide-range pipe repair clamp (10) for temporary or permanent repair of pipes (12, 12') comprising: (a) a metal clamping band (14) to surround said pipe, said band being extended at both ends to form a hollow shape (16) including a flat base (18), a wedge-shaped section (20) and a convex rounded section (22), elongated apertures (24) being provided to allow passage for screw fasteners (26) through said hollow shape, narrow edges of said wedge-shaped sections being in contact with each other to form a substantially triangularly shaped space (28) between said formed ends; (b) a flexible inner sealing sleeve (30) disposed inside said clamping band; (c) a pair of profile strips (32) each having a major face for contacting the outer

surface of said convex rounded section, and an opposite seating face for shoulder support of a plurality of screw fasteners, said strips having apertures (40) to allow passage of said fasteners, said profile strips sliding over said convex rounded section when said fasteners are tightened or loosened to maintain said seating face perpendicular to the axes of said fasteners; and (d) said plurality of screw fasteners inserted into said apertures wherein the tightening of said screw fasteners reduces the size of said triangularly shaped space and tightens said metal clamping band to compress said flexible inner sleeve sealingly against the outer diameter of said pipes.


__________

153892 ]21][11[

ןערכה עבור הליחלוח של פני שטח העי

KIT FOR MOISTURIZING THE SURFACE OF THE EYE

]54[

06.07.2001 ]22[ US ]33[ 12.07.2000 ]32[ 09/614790 ]31[ US 30.03.2001 09/823385

Int. Cl.8 A61K 009/00, A61P 027/02, C07D 311/00 ]51[ ROGUE VALLEY NATURAL

SPRINGS, INC., U.S.A. ]71[



]74[

[57] A kit for moisturizing the surface of the eye comprising a sealed container, an aqueous fluid within said container, and an

actuator that sprays a mist of said fluid from said container.

__________


761

154133 ]21][11[

מקרר מדחס ותהליך הרכבתו

COMPRESSOR COOLER AND ITS ASSEMBLY PROCEDURE

]54[

26.01.2003 ]22[ NL ]33[ 29.01.2002 ]32[ 1019858 ]31[

Int. Cl.8 F04B 017/04 ]51[ THALES NEDERLAND B.V., THE

NETHERLANDS ]71[


רחובות


]74[

[57] Assembly procedure of a cooler compressor comprising the following steps: coating at least one piston with a material; placing each piston in a cylinder; and raising the temperature to a predetermined

temperature so that the coated piston expands to occupy substantially all the cylinder; wherein each piston is fixed in the cylinder in this position until the temperature returns to ambient temperature.

__________


154303 ]21][11[

תהליך רציף להכנת תרכיז סוספנסיה מימית קוטלת עשבים בצורת תכשיר

יציב

CONTINUOUS PROCESS FOR THE PREPARATION OF A STABLE HERBICIDAL AQUEOUS SUSPENSION CONCENTRATE COMPOSITION

]54[

24.08.2001 ]22[ US ]33[ 25.08.2000 ]32[ 60/228316 ]31[

Int. Cl.8 A01N 025/04, 033/18 ]51[ BASF AKTIENGESELLSCHAFT,

GERMANY ]71[


תל אביב, 4060. ד.ת , 21ב אחד העם רחוREINHOLD COHN AND PARTNERS, 21 AHAD HA'AM ST., P.O.B. 4060, TEL AVIV 61040

]74[

[57] A process for the preparation of a stable aqueous suspension concentrate composition which comprises mixing a molten pendimethalin stream having a temperature of about 57˚ to 75˚C with an

aqueous stream containing coformulants plus seed crystals of orange pendimethalin, said aqueous stream having a temperature of about -3˚C to 5˚C.

__________

154360 ]21][11[

ות התרחבות גז שיטה לשימוש של אנרגי ושימוש במתקן כח לממש שיטה זו

METHOD FOR UTILIZATION OF GAS EXPANSION ENERGY AND UTILIZATION OF POWER INSTALLATION FOR IMPLEMENTATION OF THIS METHOD

]54[

15.08.2001 ]22[ RU ]33[ 16.08.2000 ]32[ 2000121361 ]31[

Int. Cl.8 F02C 001/02, F25B 011/02 ]51[ ALLA PAVLOVNA TUZOVA,

RUSSIA ]71[

VLADIMIR YAROSLAVOVICH VASILEV, OLEG MICHAILOVICH KISELEV

]72[



]74[

[57] Method of utilization of the natural


763

gas expansion energy during the process of reduction of gas pressure from high to the required one by conversion of natural gas expansion energy to mechanical energy with the aid of the gas cooled down in the process of pressure reduction as a cooling agent characterized in that natural gas

pressure is reduced in two or more successive stages (1, 2) simultaneously, wherein at least a part of natural gas after the first and/or each successive stage of natural gas pressure drop is used as a cooling agent for generation of cold.

__________

154569 ]21][11[

שיטות לסינון אוויר למערכת טורבינת גז

METHODS FOR FILTERING AIR FOR A GAS TURBINE SYSTEM

]54[

10.08.2001 ]22[ US ]33[ 05.09.2000 ]32[ 60/230138 ]31[ US 31.05.2001 09/871169

Int. Cl.8 B01D 039/16, 046/24, 046/52 ]51[ DONALDSON COMPANY, INC.,

U.S.A. ]71[



]74[

[57] A filter structure for filtering air in a gas turbine intake system, the turbine operating at an intake air demand greater than 8000 cu.ft./min. the intake air having

an ambient temperature and a

humidity of at least 50% RH, the structure comprising, in an air intake of a gas turbine system, at least one filter element (242), the filter element having a media pack (260, 262) forming a tubular


construction defining a open filter interior (268, 276), the open filter interior being a clean air plenum, the media pack including a pleated construction of a media composite, the media composite including a substrate at least partially covered by a layer of fine fibers, the fine fibers

comprising a polymeric composition comprising an addition polymer or a condensation polymer other than a copolymer formed from a cyclic lactam and a C6-10 diamine monomer or a C6-10 diacid monomer combined with an additive material.

__________

154570 ]21][11[

או יותר שכבות מבנה מסנן בעל שתיים של סיב עדין בעל אורך חיים שימושי

משופר

FILTER STRUCTURE WITH TWO OR MORE LAYERS OF FINE FIBER HAVING EXTENDED USEFUL SERVICE LIFE

]54[

21.08.2001 ]22[ US ]33[ 05.09.2000 ]32[ 60/230138 ]31[ US 31.05.2001 09/871156

Int. Cl.8 B01D 039/00, 046/12 ]51[ DONALDSON COMPANY, INC.,

U.S.A. ]71[



]74[

[57] A fine filter media comprising a single layer of filter substrate, the substrate having a first surface and a second surface,

the substrate having a permeability of about 0.03 to 15 m/sec and an efficiency


765

greater than 10%, the first surface and the second surface each comprising a layer of fine fiber having a diameter of about 0.001 to 0.5 microns, the layer of fine fiber having a thickness of less than 5 microns, the layer of fine fiber formed in an amount effective to obtain a pore size of about

0.0001 to 5 microns, an overall efficiency under ASTM-1215-89 with monodisperse 0.78 micron polystyrene latex particles at 6.1 m/min velocity of about 50% to 90% in any one layer and to obtain an efficiency of greater than 90% in the layers combined.

__________

154653 ]21][11[

טים סטריליים מפולימרים הכנת פריהמכילים מייצב המבוסס על פולי

)אוקסיאלקילין(

PREPARATION OF STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE)

]54[

30.08.2001 ]22[ US ]33[ 01.09.2000 ]32[ 09/654359 ]31[

Int. Cl.8 A61L 002/14, C08K 005/12 ]51[ OCCIDENTAL CHEMICAL





]74[

[57] A method of preparing a sterile article comprising: (A) preparing a polymer having a halogen-containing repeating unit, where said polymer contains about 0.005 to about 65 phr (as defined in the specification) of a stabilizer having the general formula TGOT', where each T is independently selected from R-, R-CO-, -P(OR)2, -Si(OR)3 or –Si(OR)3, T' is T or A[GOT]n, each A is independently selected from LS-Sn(R)3-q(SLJ)q, L-O-Sn(R)3-q (OLJ)q, (CH2)pS-Sn(R)3-q(S(CH2)p-J)q, LCO2SN(R)3-q(OLCO-J)q, or LSn(Y)3-

q(LJ)q when n is 0, from CO, E, CO-E-CO, Si(R)2, Si(OR)2, (Si(R)2G)r, (CO-E-CO-G)r, or (E-G)r when n is 1, and from P, PO, and trimellitate when n is 2, Y

is –SLJ, -SLOR, -OLJ, -OLR, -S(CH2)p-J, -S(CH2)pR, OLCO-J, or OLCOOR, G is (O-CH2-R'CH)n, J is O-(CH2CR'HO)T, L is CO(CH2)p, each R is independently selected from R', aralkyl from C6 to C12, and alkaryl from C6 to C12 each R' is independently selected from hydrogen, alkyl from C1 to C12 and aryl from C6 to C12, E is alkylene from C1 to C12, aralkylene from C6 to C12, alkarylene from C6 to C12, arylene from C6 to C12, m is 1 to

20, n is 0 to 2, p is 0 to 10, q is 0 to 3 and r is 1 to 20; (B) making said article from said polymer; and (C) sterilizing said article with ionizing radiation.


__________

154957 ]21][11[

מערכת חיבור גמישה למצנחים אטומים מהסביבה ומתקני בטיחות אחרים

FLEXIBLE LINKAGE SYSTEM FOR ENVIRONMENTALLY SEALED PARACHUTES AND OTHER SAFETY DEVICES

]54[

21.09.2001 ]22[ US ]33[ 22.09.2000 ]32[ 09/667678 ]31[

Int. Cl.8 B64D 017/40 ]51[ SIMULA, INC., U.S.A. ]71[ WO/2002/024528 ]87[


רחובות


]74[

[57] A flexible linkage system for removably connecting an environmentally sealed apparatus (40) to an external apparatus, said flexible linkage system comprising: (a) a flexible internal link (10) attachable at a first end to the environmentally sealed apparatus, said flexible internal link comprising an internal loop at a second end; and

(b) a flexible external link (20) comprising an external loop (23) at a third end and a removable fastener (24) anchored to a mid-section of the external link, wherein said flexible external link is attachable to the external apparatus at a fourth end, and wherein the external loop is routed through the internal loop and removably connected to the removable fastener.

__________


767

155006 ]21][11[

הרכבים פולימריים בעלי יעילות משופרת למתן לאופרוליד

POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY

]54[

21.09.2001 ]22[ US ]33[ 21.09.2000 ]32[ 09/666174 ]31[ US 13.11.2000 09/711758

Int. Cl.8 A61K 009/00, 038/09, 047/34 ]51[ QLT USA, INC., U.S.A. ]71[ WO/2002/030393 ]87[



]74[

[57] A flowable composition suitable for use as a controlled release implant, the composition comprising: (a) a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid; (b) a biocompatible polar aprotic solvent

selected from the group consisting of an amide, an ester, a carbonate, a ketone, an ether, and a sulfonyl; wherein the biocompatible polar aprotic solvent is miscible to dispersible in aqueous medium or body fluid; and (c) leuprolide acetate.

__________

155138 ]21][11[

ל עבור אלקטרופורזיס'מלכודת ג

GEL TRAP FOR ELECTROPHORESIS

]54[

29.10.2001 ]22[ IL ]33[ 02.11.2000 ]32[ 139446 ]31[ IL 02.11.2000 139447

Int. Cl.8 G01N 027/447 ]51[ ]GENE BIO-APPLICATION LTD. ]71 מ"גן יישומים בביולוגיה בע



]74[

[57] Apparatus for electrophoresis comprising a suitable housing (100)

accommodating a first gel matrix

(38) adapted for performing an electrophoretic process on at least one sample of interest therein in a first


direction, characterized in comprising at least a first trap (90) comprising a second gel matrix (48) having at least one suitable absorption material capable of trapping and retaining therein at least one target substance migrating thereto from the first gel matrix in an opposite direction to said

first direction when an electrophoretic process is performed in said first matrix in said first direction, wherein said first gel matrix is in ionic communication with said second gel matrix, and wherein said target substance is different from said at least one sample of interest.

__________

155357 ]21][11[

יחידת העמסה

LOADING MEMBER

]54[

13.11.2001 ]22[ DK ]33[ 13.11.2000 ]32[ PA200001694 ]31[

Int. Cl.8 B65D 019/40, 071/00, B65G 001/00 ]51[ INTER IKEA SYSTEMS B.V., THE

NETHERLANDS ]71[

WO/2002/038471 ]87[ , וגולרברגמן, וולף



]74[

[57] A loading member (7), which is adapted to be handled by a fork lift truck, which further has a substantially L-shaped

cross section and which jointly with a corresponding loading member may be arranged at the bottom of a box


769

(3), each member being provided at one of two respective parallel lower edges (3a, 3b) of the box and retained in close abutment with the box by means of circumferential straps (5) or packaging film, whereby the members may form the feet of the box, one web (2) of the L-section being provided with at least two pressed hollow projections (7', 7'', 7''') on the surface intended to face a supporting surface of the loading member, characterized in that the two outermost of

these projections (7', 7''), which are arranged in one row, have an interspacing of at least half the length of the member and a width being less than or equal to half the width of the web and further that the projections substantially abut the edge (4), at which the web (2, 6) of the L-section converge, and that the interspacing between the projections is such as to allow the insertion therebetween of forks of a fork-lift truck.

__________

155372 ]21][11[

מכשיר פריפריאלי לרכישת מידע במיוחד להכנת , ביומטריו אישי מסמכים מזהים

PERIPHERAL DEVICE FOR ACQUIRING BIOMETRIC AND PERSONAL DATA, PARTICULARLY FOR PREPARING RECOGNITION DOCUMENTS

]54[

11.10.2001 ]22[ IT ]33[ 16.10.2000 ]32[ RM2000A000549 ]31[ IT 29.01.2001 RM2001U000012

Int. Cl.8 G07C 009/00 ]51[ ITALDATA INGEGNERIA DELL'IDEA

S.P.A., ITALY ]71[


באר , 5352. ד.ת, עומר , גן תעשייה שבע


]74[

[57] Peripheral device for acquiring biomertric and personal data, which, in


particular, acts as an interface device with a main computer for the preparation of recognition documents such as identity cards, comprising, in a single casing: a smart card reader/writer device (20); a first video camera (3) for the live photography of a person requesting the document; an external lighting unit (63) adjacent to the first video camera; a second video camera (4), acting as a scanner, located inside the casing, for the acquisition of personal characteristics shown on a backing card for video digitization, which can be inserted into a guide and support frame in front of the second camera, through an entry slot formed in the casing; an internal lighting

unit (69) adjacent to the second video camera, for illuminating the backing card; a video source switch (65), for switching the signals from the first video camera and the second video camera; a power supply unit (60) operated by a switch (61) and connected to a distributor of power (6) to the first and second video cameras; one USB data connector (1) for the connection to the main computer; characterized in that: said video source switch receives signals from said first video camera and said second video camera, said signals are sent to said USB data connector through a video digitizer (7).

__________

155408 ]21][11[

שלבית–מחסנית סינון דו

DUAL-STAGE FILTRATION CARTRIDGE

]54[

30.10.2001 ]22[ US ]33[ 30.10.2000 ]32[ 60/244317 ]31[ US 02.01.2001 60/259889

Int. Cl.8 A61M 001/34, B01D 061/14, 063/00 ]51[ NEPHROS, INC., U.S.A. ]71[ WO/2002/036246 ]87[


רחובות


]74[


771

[57] In a blood dialysis system including a source of substitution fluid and a blood dialysis machine, a hemodiafiltration cartridge (10) comprising: a housing (12) including a blood inlet (20) which receives blood, a blood outlet (60) which discharges diafiltered blood, a dialysate inlet (12) for receiving a dialysate fluid and a dialysate outlet (64) for discharging the dialysate fluid, the housing further including a plurality of semi-permeable filtering elements; a member for dividing the housing into a first hemodiafiltration stage (14) and a second hemodiafiltration stage (16) a first portion of the plurality of semi-permeable filtering elements being associated with the first stage and a second portion of the plurality of semi-permeable filtering elements being associated with the

second stage, the blood inlet being in fluid communication only with the first stage, while the blood outlet is in fluid communication only with the second stage; and an inter-stage section for providing fluid communication between the first and second stages, the inter-stage section including an inlet for receiving a substitution fluid, wherein blood entering the blood inlet is partially diafiltered as it flows within the semi-permeable filtering elements of the first stage before being discharged into the inter-stage section where it is mixed with substitution fluid to form a blood/substitution mixture which then flows within the semi-permeable filtering elements of the second stage where further diafiltration occurs, wherein the housing includes only one dialysate fluid compartment that is common to both the first and second stages.

__________


155700 ]21][11[

מיכל ואביזר למיכל

CONTAINER AND CONTAINER ACCESSORY

]54[

21.11.2001 ]22[ GB ]33[ 06.12.2000 ]32[ 0029752.3 ]31[ GB 10.08.2001 0119484.4 GB 28.08.2001 0120767.9

Int. Cl.8 B65D 023/08, 077/04 ]51[ ELI LILLY AND COMPANY, U.S.A. ]71[ WO/2002/064438 ]87[



]74[

[57] A protective container (1) for housing a fragile article (100) comprising: a container portion (3) and a base portion (5), said container portion comprising: an upper end, a lower end, and a generally cylindrical side surface extending lengthwise along a longitudinal axis from said upper end to said lower end, said cylindrical side surface forming a cavity therein for housing the fragile article, wherein said cylindrical side surface comprises an inner wall surface and an outer wall surface, said inner wall surface comprising a configuration of inner wall ribs and inner wall depressions, said outer wall surface comprising a configuration of

outer wall ribs (37) and outer wall depressions (39), wherein said outer wall depressions correspond with said inner wall ribs and said outer wall ribs correspond with said inner wall depressions, and wherein said container portion further comprises an upper end collar (45) and a lower end collar (47), both extending laterally beyond the outer wall ribs; wherein each collar is adapted to absorb impact energy in the event of an impact thereon to protect the fragile article from breakage; and wherein said base portion is releasably securable to said container portion.


773

__________

155711 ]21][11[

מכשיר להוצאה ופליטה של תרתיל של כדור מכלי ירי

DEVICE FOR EXTRACTING AND EJECTING A CARTRIDGE CASE AWAY FROM A FIREARM

]54[

01.05.2003 ]22[ IT ]33[ 13.05.2002 ]32[ MI2002A001016 ]31[

Int. Cl.8 F41A 015/12 ]51[ FABBRICA D'ARMI PIETRO BERETTA

S.P.A., ITALY ]71[

,לוצאטו את לוצאטובאר , 5352. ד.ת, עומר , גן תעשייה

שבע


]74[

[57] Device for extracting and ejecting a cartridge case in a firearm applied to a breechblock equipped with windows (17) on opposite sides, characterized in that it comprises an extraction element (19), equipped with an engagement means (28) suitable for holding a cartridge case (15), and an ejector element (20), equipped with

a thrusting plane (33) suitable for taking away said cartridge case from the firearm through one of said windows, as well as in that it comprises a removable retainer element (27) of said extraction and ejector element, said extraction and ejector elements being housed equally effectively


on opposite sides of a breechblock (12) in seats (18).

_________

156103 ]21][11[

מנגנון שסתום למערכות עירוי נוזלים

VALVE MECHANISM FOR INFUSION FLUID SYSTEMS

]54[

07.12.2001 ]22[ US ]33[ 08.12.2000 ]32[ 60/254230 ]31[

Int. Cl.8 A61L 002/24, B01D 012/00, 017/12, 061/24 ]51[ NEPHROS, INC., U.S.A. ]71[ WO/2002/045813 ]87[


רחובות


]74[

[57] A method of ensuring sterility and preventing contamination of a first fluid delivered through a first conduit (90) from a supply source that contains fresh, unused fluid to a point of use, wherein the first fluid is filtered before the point of use to produce sterile first fluid, the method comprising: disposing valve mechanism (110) along the first conduit, the valve mechanism being positionable between an open position in which the first fluid flows through the first conduit to the point of use and a closed position in which the first fluid is prevented from flowing through the valve mechanism to the point of use; sensing a first flow pressure of the fresh, unused first fluid in the first conduit at a location upstream of the valve mechanism; combining the first fluid with a second fluid to form a third fluid at a location

downstream of the valve mechanism; opening the valve mechanism when the first flow pressure exceeds a reference flow pressure by a predetermined value; and closing the valve mechanism under a preselected condition to prevent the first fluid from flowing to the point of use, the closing of the valve mechanism also preventing retrograde flow of the second and third fluids from the point of use to a location upstream of the valve mechanism, thereby ensuring that the first fluid is sterile and substantially free of contamination, wherein the fluid in the first conduit is divided into a first stream that delivers fresh, unused first fluid to a location where the first fluid is filtered and a second stream that delivers the first fluid directly to the point of use and the valve mechanism is disposed along the first


775

stream of the first conduit between a location where the first fluid is filtered and the point of use of the sterile first fluid such that the valve mechanism acts on and

controls flow of the sterile first fluid in the first conduit downstream of the location where the first fluid is filtered.

__________

156952 ]21][11[

ינוקותעגלת טיול מתקפלת עבור ת

FOLDABLE PUSHCHAIR FOR BABIES

]54[

16.07.2003 ]22[ ES ]33[ 10.09.2002 ]32[ 200202189 ]31[

Int. Cl.8 B62B 007/06 ]51[ JANE, S.A., SPAIN ]71[ ,פ"עו, ר יצחק הס ושותפיו"ד


]74[

[57] A foldable pushchair for babies comprising: a central front wheel (1) being


a castoring wheel, and a footrest (5) being formed by a plate, wherein said footrest is linked by a pin-jointed connection to a lower portion of converging front legs (3, 4) by a cross pin (8), said footrest comprising: a rearward portion of said footrest defining two recesses (6), the front legs being fitted to said recesses by the cross-pin, an extension (9) provided with a

cylindrical bore at a forward portion of said footrest to fit a fork (12) to which the castoring wheel is fitted, and means (15) for locking the footrest in a position when in use and allowing for folding said footrest, said means being gripped to a plate (26) being fixed to the lower portion of the front legs.

__________

157258 ]21][11[

שיטה להסרת מרכז כבל ממעטפתו

METHOD FOR REMOVING A CABLE CORE FROM A CABLE SHEATH

]54[

20.02.2002 ]22[ AT ]33[ 20.02.2001 ]32[ PCT/AT01/00041 ]31[ AT 28.06.2001 A 1010/2001

Int. Cl.8 H01B 015/00, H02G 001/08 ]51[ ALOIS PICHLER, AUSTRIA ]71[ WO/2002/067397 ]87[

,ריינהולד כהן ושותפיותל , 4060. ד.ת , 21 רחוב אחד העם

אביב


]74[

[57] A method for removing a cable core from a cable sheath of a cable, which cable core comprises an envelope, wherein, at an end of the cable – the so-called proximal cable end – a flowable medium is introduced under pressure into the cable

tube so as to reduce friction,and a tensile force is exerted on the cable core at an end of the cable, characterized in that the flowable medium is introduced precisely targeted into an annular space between the inner side of the cable sheath and the


777

envelope of the cable core. __________

157290 ]21][11[

עיבוד כימי מכני וגימור שטח פנים

CHEMICAL MECHANICAL MACHINING AND SURFACE FINISHING

]54[

07.02.2002 ]22[ US ]33[ 08.02.2001 ]32[ 60/267756 ]31[

Int. Cl.8 B24B 037/04 ]51[ REM TECHNOLOGIES, INC., U.S.A. ]71[ WO/2002/062528 ]87[



]74[

[57] A process comprising: (a) providing a tool; (b) introducing an active chemistry onto a workpiece, the active chemistry being capable of reacting with the workpiece to form a conversion coating on the workpiece, the conversion coating being insoluble in the active chemistry such that the conversion coating protects the workpiece from further reaction; and

(c) contacting the tool with the workpiece with a relative motion therebetween, until a desired surface property of the workpiece is reached; wherein the contact between the tool and the workpiece removes the conversion coating from the workpiece, thereby exposing the workpiece to further reaction with the active chemistry such that the conversion coating is allowed to re-form on the workpiece.


__________

157506 ]21][11[

שיטה לייצור שכבות דיאלקטריות עבור , בעלות מקדם דיאלקטרי נמוך

שהן בעלות , מוליכים על שבבי סיליקון אדהזיה משופרת וצפיפות פגמים נמוכה

METHOD OF FABRICATING LOW-DIELECTRIC CONSTANT INTERLEVEL DIELECTRIC FILMS FOR BEOL INTERCONNECTS WITH ENHANCED ADHESION AND LOW-DEFECT DENSITY

]54[

19.02.2002 ]22[ US ]33[ 21.02.2001 ]32[ 09/789422 ]31[

Int. Cl.8 H01L 021/312 ]51[ IBM CORPORATION, U.S.A. ]71[ WO/2002/069381 ]87[

,מעבדות יבמ חיפה, אוניברסיטת חיפה הר הכרמל

IBM LABORATORIES, HAIFA UNIVERSITY HAIFA 31905

]74[

[57] A method of fabricating an integrated circuit comprising the steps of: (a) applying a silane coupling agent containing at least one polymerizable group to a surface of a substrate to provide a substantially uniform coating of said silane-coupling agent on said substrate; (b) heating said substrate containing said coating of said silane-coupling agent at a temperature of about 90º or above to provide a modified surface layer to said substrate containing Si—O bonds, said

modified surface layer having a greater water contact angle than a non-heated substrate containing a coating of said silane-coupling agent; (c) rinsing said heated substrate with a suitable solvent that is effective in removing any unreacted silane-coupling agent to provide a modified surface that is substantially free of particular matter; and (d) applying a dielectric material to said rinsed surface containing said Si—O.

__________


779

157663 ]21][11[

התקן לזיהוי מיקום של גוף נע במערכת ניווט ושיטה לכך

APPARATUS FOR DETECTING LOCATION OF MOVABLE BODY IN NAVIGATION SYSTEM AND METHOD THEREOF

]54[

29.08.2003 ]22[ KR ]33[ 14.03.2003 ]32[ 16090/2003 ]31[

Int. Cl.8 G01C 021/26, G08G 001/0968 ]51[ SAMSUNG ELECTRONICS CO.,

LTD., REPUBLIC OF KOREA ]71[


רחובות


]74[

[57] An apparatus for detecting location of a movable body in a navigation system, the apparatus comprising: a map data detector (420) for detecting a width of a road, road linear information, and map information of a region corresponding to a location information in an external digital map storage on the basis of location information of the movable body, said location information being transmitted by sensors sensing location coordinates and traveling direction information of the movable body; a memory (430) for storing said width of the road, road linear information, and map information detected from the map data detector; a filter (440)

for computing an optimum location information of the movable body including the width of a road and the road linear information included in said map information on the basis of the location coordinates and traveling direction information of the movable body transmitted by said sensors; and a map-matching unit (450) for receiving the optimum location information of the movable body from the filter and correcting the optimum location information by matching the optimum location information and the map information stored in the memory.

__________


157691 ]21][11[

סימטרית של פרופיל קו בעזרת –מדידה א סקטרומטריה

LINE PROFILE ASYMMETRY MEASUREMENT USING SCATTEROMETRY

]54[

28.02.2002 ]22[ US ]33[ 02.03.2001 ]32[ 60/273039 ]31[

Int. Cl.8 G01B 011/02 ]51[ ACCENT OPTICAL

TECHNOLOGIES, INC., U.S.A. ]71[



]74[

[57] A method of measuring line profile asymmetries in microelectronic devices, the method comprising the steps of: directing light at an array of microelectronic features of a microelectronic device; detecting light scattered back from the array comprising

one or more features selected from the group consisting of one or more angles of reflection and one or more wavelengths; and comparing one or more characteristics of the back-scattered light by performing an operation comprising examining data from complementary angles of reflection.

__________


781

157789 ]21][11[

שיטות והתקן לעיבוד חומרים

METHODS AND APPARATUS FOR MATERIALS PROCESSING

]54[

21.02.2002 ]22[ US ]33[ 07.03.2001 ]32[ 802037 ]31[

Int. Cl.8 B01F 007/12, B01J 019/10 ]51[ KREIDO LABORATORIES, U.S.A. ]71[ WO/2002/072251 ]87[

,ריינהולד כהן ושותפיו תל אביב,4060. ד.ת , 21 רחוב אחד העם


]74[

[57] A method for processing materials, comprising: passing materials to be processed in a flow path through an annular processing passage (44) between two closely spaced smooth surfaces provided by respective cylindrical apparatus members (30), at least one rotating relative to the another; wherein the material forms material boundary layers

against both the surfaces; wherein the radial spacing between the two surfaces is equal to or less than the back-to-back radial thicknesses of the two boundary layers; and wherein the smoothnesses of the surfaces are such that formation of Taylor vortices in the processing passage is inhibited.

__________


158429 ]21][11[

שיטה לצילוב פריט פולימרי

METHOD FOR CROSS-LINKING A POLYMER ARTICLE

]54[

21.03.2002 ]22[ EP ]33[ 11.05.2001 ]32[ 01111570.6 ]31[

Int. Cl.8 C08F 008/42 ]51[ BOREALIS TECHNOLOGY OY,

FINLAND ]71[

WO/2002/096962 ]87[ ,וריינהולד כהן ושותפי


]74[

[57] Method for cross-linking a polymer article comprising a cross-linkable polymer which has been produced by the use of a single-site catalyst with hydrolysable silane groups and a

crystallinity level of at least 30% wherein the cross-linking is performed in the presence of a silanol condensation catalyst comprising a compound of the formula

ArSO3H

or a precursor thereof, Ar being a hydrocarbyl substituted aromatic group comprising at least 14 carbon atoms.

__________

158662 ]21][11[

מערכות תגובת קובץ מקטעי התפרצות אנוקסית מעורבים

SURGE ANOXIC MIX SEQUENCING BATCH REACTOR SYSTEMS

]54[

03.03.1999 ]22[ US ]33[ 04.03.1998 ]32[ 09/034512 ]31[ US 02.10.1998 60/102864

Int. Cl.8 C02F 003/12, 003/20, 003/30 ]51[ DIVISION FROM 138198 ]62[ MIKKEL G. MANDT, U.S.A. ]71[ WO/1999/044951 ]87[


רחובות


]74[


783

[57] A surge anoxic mix sequencing batch reaction method for treating wastewater to reduce its solids content, biological oxygen demand (BOD) and nitrogenous content in an overall sequencing batch-reaction treatment cycle time of less than 20 hours, comprising the steps of: providing an anaerobic pretreatment zone, an anoxic waste liquid treatment zone and one or more separate aerobic sequencing waste liquid treatment zones wherein the ratio of the volume of the anoxic waste liquid treatment zone to the volume of the one or more aerobic sequencing waste liquid treatment zones is in the range of from about 0.2: to about 1:1; and wherein the anaerobic treatment zone has a treatment volume in the range of from about 20 percent to about 300 percent of the treatment volume of the anoxic treatment zone; introducing influent wastewater containing wastewater solids content, BOD and nitrogenous content to be treated into the anaerobic pretreatment zone containing waste solids including treatment microorganisms under anaerobic conditions; introducing waste water from said anaerobic treatment zone into the anoxic waste liquid treatment zone containing waste solids including treatment microorganisms under anoxic conditions; introducing wastewater and treatment microorganisms from said anoxic waste liquid treatment zone in to the one or more aerobic sequencing waste liquid treatment zones containing waste solids including treatment microorganisms under aerobic conditions; mixing and aerating the waste liquid in the one or more aerobic sequencing batch aeration treatment zones to reduce the biological oxygen demand of the wastewater and to convert at least a portion of the nitrogenous wastewater content to inorganic nitrate or nitrite components; introducing and mixing waste liquid and treatment microorganisms from the one or more aerobic sequencing waste liquid treatment zones into the anoxic waste

liquid treatment zone at a rate of at least about 0.1 of the total volume of anoxic zone per hour during an interaction time period, to provide nitrate or nitrite oxidizing components from the one or more aerobic sequencing batch reaction treatment zones for the anoxic treatment microorganism metabolism and to convert the nitrate or nitrite components to nitrogen for removal from the wastewater in the anoxic mix treatment zone; subsequently to said mixing and aeration steps, maintaining the waste liquid in the one or more aerobic sequential batch wastewater treatment zones in a quiescent state without said mixing and aerating, to form in the respective one or more sequencing batch aeration zones, a clarified upper layer and a stratified lower waste liquor layer containing waste solids including treatment microorganisms; recycling waste solids from the stratified lower waste liquor layer including treatment microorganisms from said one or more aerobic sequential batch waste water treatment zones directly into the anaerobic pretreatment zones or indirectly into the anoxic zone and subsequently into the anaerobic pretreatment zone at a flow rate in the range of from about 50/1 to about 1/300 of the influent wastewater flow rate to the anaerobic treatment zone, wherein at least a portion of the total suspended solids of the influent wastewater to be treated is settled to an anaerobic settled solids zone in the lower portion of the anaerobic treatment zone, wherein at least 50 percent by weight of the microbial and other solids content (TSS) of the waste liquor directly or indirectly recycled to the anaerobic zone is settled to the anaerobic settled solids zone in the lower portion of the anaerobic treatment zone together with settled influent wastewater solids, wherein at least about 10 percent by weight of the organic solids which settle in the settled solids zone are anaerobically biologically digested to produce anaerobically digested solid, soluble and gas components,


wherein wastewater from the anaerobic treatment zone which includes both influent wastewater and recycled waste liquor wastewater, is conducted from the anaerobic zone to the anoxic zone, and wherein at least the soluble anaerobic digestion components produced by anaerobic digestion in the anaerobic treatment zone are conducted in the wastewater flow from the anaerobic treatment zone to the anoxic treatment

zone for anoxic biotreatment, and to the aerobic treatment zone for aerobic biotreatment; and removing a predetermined portion of the clarified upper layer from the respective one or more sequencing aeration treatment zones as a treated effluent stream having reduced solids content BOD and nitrogenous content with respect to said influent wastewater.




__________

159091 ]21][11[

הרכב חומר סיכה בטמפרטורה גבוהה

HIGH TEMPERATURE LUBRICANT COMPOSITION

]54[

31.05.2002 ]22[ US ]33[ 01.06.2001 ]32[ 09/872191 ]31[

Int. Cl.8 C10M 169/04 ]51[ ANDEROL, INC., U.S.A. ]71[ MICHAEL A. MCHENRY, DALE D.

CARR, JEFFREY A. HUTTER ]72[

WO/2002/099021 ]87[ ,מ"קניין רוחני בע',פנסטר ושות

. ד.ת, קרית אריה , 1 כניסה 12 בזל פתח תקוה, 10256

FENSTER & COMPANY, INTELLECTUAL PROPERTY LTD, 12 BASEL STREET ENTRANCE 1 P.O.BOX 10256 PETACH TIKVA

]74[

[57] A synthetic polyol ester based lubricant, comprising (A) a polyol ester base stock that is the reaction product of: (i) a polyol mixture including a major proportion of dipentaerythritol, and (ii) at least one C5 to C12 monocarboxylic acid, wherein the resulting mixture of

esters has a viscosity at 40˚C of at least about 120 cSt, and (B) an additive package including an effective amount of at least one oligomeric amine antioxidant, extreme pressure/anti-wear agents and a minor effective amount of a corrosion inhibitor.

__________


785

159109 ]21][11[

–4–אמינו–3(–7נגזרות של –A(טטרהידרואימידזו)ארילבוטנואיל

–3,4(פיראזין וטטרהידרוטריאזולו)2,1A( פיראזין כמעכבים של דיפפטידיל פפטידז

ותכשירי רוקחות המכילים אותן

DIPEPTIDYL PEPTIDASE INHIBITING 7-(3-AMINO-4-ARYLBUTANOYL)TETRAHYDROIMIDAZO (1,2-A) PYRAZINE AND TETRAHYDROTRIAZOLO (4,3-A) PYRAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

]54[

05.07.2002 ]22[ US ]33[ 06.07.2001 ]32[ 60/303474 ]31[

Int. Cl.8 A61K 031/4985, A61P 001/00, 003/00, 003/10, 005/00, 009/00, 015/16, 019/10, 025/00, 031/18, 035/00, 037/06, C07D 487/04, 519/00, C12P 017/18

]51[

MERCK & CO., INC., U.S.A. ]71[ WO/2003/004498 ]87[ ',ר שלמה כהן ושות"ד

תל , 11490. ד.ת , 124 אבן גבירול אביב

DR. SHLOMO COHEN & CO., 124 IBN GABIROL ST., P.O.B. 11490, TEL AVIV 62038

]74[


wherein: Ar is phenyl which is unsubstituted or substituted with 1-5 of R3, wherein R3 is independently selected from the group consisting of: (1) halogen, (2) C1-6 alkyl, which is linear or branched and is unsubstituted or substituted with 1-5 halogens, (3) OC1-6 alkyl, which is linear or branched and is unsubstituted or substituted with 1-6 halogens, and (4) CN; X is selected from the group consisting of: (1) N, and

(2) CR3;

R1 and R2 are independently selected from the group consisting of: (1) hydrogen, (2) CN, (3) C1-10 alkyl, which is linear or branched and which is unsubstituted or substituted with 1-5 halogens or phenyl, which is unsubstituted or substituted with 1-5 substituents independently selected from halogen, CN, OH, R4, OR4, NHSO2R4, SO2R4, CO2H, and CO2C1-6 alkyl, wherein the CO2C1-6 alkyl is linear or branched, (4) phenyl which is unsubstituted or substituted with 1-5 substituents independently selected from halogen, CN,


OH, R4, OR4, NHSO2R4, SO2R4, CO2H, and CO2C1-6 alkyl, wherein the CO2C1-6 alkyl is linear or branched, and (5) a 5- or 6-membered heterocycle which may be saturated or unsaturated comprising 1-4 heteroatoms independently selected from N, S and O, the heterocycle being unsubstituted or substituted with 1-3 substituents independently selected from oxo, OH, halogen, C1-6 alkyl, and OC1-6 alkyl, wherein the C1-6 alkyl and OC1-6

alkyl are linear or branched and optionally substituted with 1-5 halogens; R4 is C1-6 alkyl, which is linear or branched and which is unsubstituted or substituted with 1-5 groups independently selected from halogen, CO2H, and CO2C1-6

alkyl, wherein the CO2C1-6 alkyl, wherein the CO2C1-6 alkyl is linear or branched; and pharmaceutically acceptable salts thereof and individual diastereomers thereof.

לתקנות 35פירוט זה נבחן בהתאם לתקנה

1968 –ח "תשכ, הפטנטיםThis specification was examined in accordance with regulation 35 of the Patent Regulations, 5728 - 1968

בקשות חלוקה מבקשה .מוזו שטרם פורס


__________

160163 ]21][11[

קצה להב של טורבינה מיקרו מעגל לצינון

TURBINE BLADE TIP WITH MICROCIRCUIT COOLING

]54[

02.02.2004 ]22[ US ]33[ 05.02.2003 ]32[ 10/358646 ]31[

Int. Cl.8 F01D 005/18 ]51[ UNITED TECHNOLOGIES




]74[

[57] A turbine blade (24) comprising: a hollow airfoil (54) into which cooling flow is flowable from an end of said airfoil, said airfoil including pressure (42) and suction (44) sidewalls joined together at leading (46) and trailing (48) edges and extending from a root (50) to a tip (36); at least one micropassage (80) disposed within said tip, said micropassage includes an inlet (70) and an outlet (72), said inlet

and said outlet in flow communication with said micropassage; a means for providing cooling flow to said airfoil wherein said cooling flow enters said inlet from said airfoil, transitions through said micropassage and exits at said outlet into a region outside said airfoil; and at least one pedestal (88), said pedestal radially extends at least in part in the path of said cooling flow flowing in said micropassage.


787

__________

161371 ]21][11[

לוח עם שכבת בידוד קול ושיטת ייצור

PANEL WITH SOUND INSULATION LAYER AND PRODUCTION METHOD

]54[

28.06.2002 ]22[ DE ]33[ 23.10.2001 ]32[ 10151614.2 ]31[

Int. Cl.7 B32B 021/08, 025/04, E04F 015/20 ]51[ M. KAINDL, AUSTRIA ]71[ WO/2003/035396 ]87[


ירושלים


]74[

[57] A method for the production of a panel (P) having a sound insulation layer (5) mounted thereon, in which several

layers are pressed in a press by supplying pressure and heat, wherein single layers are made of wood, derived timber product


or paper, at least one layer being provided with aminoplast, characterized in that: the layers are pressed together with the sound insulation layer; wherein the sound

insulation layer is connected to the paper that is impregnated with aminoplast, and after pressing, the panel is provided with locking elements (6, 7).

__________

161917 ]21][11[

חום מפני קרינה עבור מערכת –מגן סולרית

RADIATION HEAT SHIELD FOR SOLAR SYSTEM

]54[

13.11.2002 ]22[ US ]33[ 13.11.2001 ]32[ 987106 ]31[

Int. Cl.8 F24J 002/05, 002/10 ]51[ ]SOLEL SOLAR SYSTEMS LTD. ]71 ירושלים, מ"ל מערכות סולריות בעסול



]74[

[57] A solar system (60) comprising a reflector and a heat collecting element (HCE) received at the focus of the reflector, said HCE having a longitudinal axis extending between a first end and a second end; the HCE comprising a coated tube (16) received within a coaxial evacuated enveloping glass tube (24); said enveloping glass tube being secured at respective ends thereof to the coated tube by a coaxially deformable connector element (30) having a distal end thereof

sealingly secured to the coated tube and a proximal end thereof sealingly attached to a respective end of the enveloping glass tube by a glass to metal connection (46) (GMC), wherein a radiation shield assembly (62, 64) extends over the connector element and over the GMC; said radiation shield assembly is secured to the connector element by support legs (70, 72) engaging the connector element adjacent the proximal end.


789

__________

163286 ]21][11[

–2–פירולידין)גליציל מותמר(–1הכנתם ותכשירי רוקחות , קרבוניטרילים

המכילים אותם

1-(SUBSTITUTED GLYCYL)PYRROLIDINE-2-CARBONITRILES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

]54[

04.03.2003 ]22[ HU ]33[ 06.03.2002 ]32[ P0200849 ]31[

Int. Cl.8 A61K 031/395, A61P 001/00, 003/00, 009/00, 015/06, 017/00, 025/00, 029/00, 035/00, 037/00, C07D 401/14, 413/14, 417/14, 451/04, 451/14

]51[

SANOFI AVENTIS, FRANCE ]71[ WO/2003/074500 ]87[ ,פ"עו, ר יצחק הס ושותפיו"ד


]74[

[57] Dipeptidyl peptidase –IV- enzyme inhibition compounds of the formula


wherein R1 means a nitrogen-containing aromatic moiety consisting of one or two aromatic rings, preferably a pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxidazolyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, benzimidazolyl, indazolyl, benzthiazolyl, benzisothiazolyl, benzoxazolyl or benzisoxazolyl, tetrazolyl, triazinyl ring; which is, in a given case, independently from each other mono- or disubstituted by one or two of the following groups: C1-4 alkyl groups, C1-4 alkoxy groups, halogen atom, trihalogenomethyl group, methylthio group, nitro group, cyano group, amino group or phenyl group; or thienyl, furyl or

benzyl group; or p-toluenesulfonyl group; or acyl group of formula R1a-CO, wherein R1a means C1-4 alkyl group, phenyl group; phenyl, pyridyl or phenylethenyl group substituted with one or more alkyl- and/or alkoxy- or nitro-group or halogen atom; phenylethenyl or phenylethyl group substituted with alkylene-dioxy group; piperidin-1-yl, 4-methylpiperazin-1-yl, pyrrolidin-l-yl group, B stands for a group of formula (1) or (2) or (3) or (4) or (5) or (6) or (7) as shown in the specification; R2 stands for hydrogen atom or fluorine atom; R3 stands for fluorine atom; and salts, isomers, tautomers, solvates and hydrates thereof.

__________

163398 ]21][11[

מערכת קירור עבור להב של טורבינה

MICROCIRCUIT COOLING FOR A TURBINE BLADE

]54[

05.08.2004 ]22[ US ]33[ 08.08.2003 ]32[ 637448 ]31[

Int. Cl.8 F01D 005/18 ]51[ UNITED TECHNOLOGIES




]74[

[57] A turbine rotor blade (27) comprising: an external wall (24), said external wall including an inner surface (65); an internal cavity (32a-c) into which cooling air is flowable; a first cooling circuit (22) embedded within said wall, said first cooling circuit including: a first inlet (61c), said first inlet connects said first cooling circuit with said cavity and provides a cooling air flow path into said

first cooling circuit; and an exit aperture (63), said exit aperture provides a cooling air flow path out of said first cooling circuit, said first cooling circuit configured to increase the temperature of the cooling air as it travels from said inlet to said exit aperture of said second cooling circuit; and a third cooling circuit (22) embedded within said wall, said third cooling circuit includes: a first inlet (61a), said first inlet


791

of said second cooling circuit connects said second cooling circuit with said cavity and provides a cooling air flow path into said second cooling circuit; and an exit aperture (63), said exit aperture of said third cooling circuit provides a cooling air flow path out of said third cooling circuit, said third cooling circuit configured to increase the temperature of the cooling air

as it travels from said inlet of said third cooling circuit to said exit aperture of said third cooling circuit; wherein said first inlets are aligned with the direction of counter-rotating flow circulations (104, 106) experienced by said inner surface of said wall of said cavity caused by Coriolis forces on the cooling air flow inside said cavity.

__________


163443 ]21][11[

התקן המונע סיבוב של אטם פנימי

INNER AIR SEAL ANTI-ROTATION DEVICE

]54[

10.08.2004 ]22[ US ]33[ 13.08.2003 ]32[ 10/640225 ]31[

Int. Cl.8 F01D 009/04, 011/00, F04B 017/00, F16B 039/00 ]51[ UNITED TECHNOLOGIES



ירושלים


]74[

[57] An anti-rotation device for preventing rotation of a damper spring and an inner air seal (1) in a stator assembly (10), said device comprising a lug (8) positioned within a slot at a center of an inner air seal arc segment, said lug

engaging a slot in said damper spring and a cutout (18) in a stator segment so as to prevent rotation of said damper spring and said inner air seal in either direction relative to the stator assembly.

__________


793

163624 ]21][11[

מנתק מהיק בעל קפיץ עוצר

QUICK DISCONNECT WITH RETAINING SPRING

]54[

19.08.2004 ]22[ US ]33[ 29.08.2003 ]32[ 60/499166 ]31[

Int. Cl.8 H01R 004/00, 004/50 ]51[ TRIUMPH BRANDS, INC., U.S.A. ]71[


ירושלים


]74[

[57] A quick disconnect (100), comprising: a front coupling (10, 70) and a rear coupling (10) each for connection to a respective cable end; a hinge latch (20) comprising at least one finger pivotally mounted at a first end (18) of the rear coupling, the finger having a retention

groove (24) disposed at a second end and having a coupling groove for receiving the front coupling; a compression sleeve (40) slidably disposed over the hinge latch; a biasing member disposed at a first end of the compression sleeve for engagement with the retention groove of the finger.

__________


164542 ]21][11[

חיבור שער חבילה ומבנה הסגר

BALER GATE LINKAGE AND LATCH STRUCTURE

]54[

13.10.2004 ]22[ US ]33[ 15.10.2003 ]32[ 687256 ]31[

Int. Cl.8 A01D 046/08 ]51[ DEERE & COMPANY, U.S.A. ]71[



]74[

[57] A baler having a bale forming chamber with first and second upright frame sections (46, 48), the second frame section movable relative to the first frame section for releasing a formed bale from the chamber, linkage structure (50) connecting the first and second frame sections including a control linkage having an upper link (82) connecting an upper portion of the first frame section with an upper portion of the second frame section, a second link (86) pivotally connected between first and second frame sections at a location below the upper link, and cylinder structure (76) connected between the frame sections and rocking the second frame section relative to the first frame section between a closed position for

forming a bale and an open position for releasing the bale, wherein in the closed position, the upper portions of the frame sections generally abut, wherein the upper link moves the second frame section over the upper portion of the first frame section as the cylinder rocks the second frame member towards the open position; and further including a latch member (100) connected to the second frame section and securing the second frame section to the first frame section in the closed position, wherein the operation of the cylinder structure with the frame sections in the closed position initially moves the first frame section to release the latch member without need for a separate unlatching mechanism.

__________


795

164842 ]21][11[

מבנה מגלל להזנת כותנה

COTTON FEEDING ROLLER STRUCTURE

]54[

26.10.2004 ]22[ US ]33[ 28.10.2003 ]32[ 695096 ]31[

Int. Cl.8 A01D 046/08 ]51[ DEERE & COMPANY, U.S.A. ]71[



]74[

[57] In a mobile cotton harvester having selectively operable processing structure connected to the harvester for processing harvested cotton in a field, accumulator structure comprising: an upright storage area having side walls (30g) and having a lower discharge area (124), the upright storage area receiving the harvested cotton and facilitating continuous harvester operation; a cotton metering structure (32) including upper and lower rotatable spaced rollers (92, 96), the metering structure defining an inclined accumulator floor

angling downwardly towards the lower discharge area; a drive (14) connected to the metering structure for rotating the spaced rollers in a same direction to urge the received cotton from the storage area towards the lower discharge area; and a discharge roller (120) located above the lower roller and discharge area, the discharge roller intercepting the cotton urged towards the lower discharge area to break up cotton clumps and meter cotton to the discharge area.

__________


164924 ]21][11[

מכלול נחיר הזרקת דיו הכולל דוחף דיו בר הזזה

INK JET NOZZLE ASSEMBLY INCLUDING DISPLACEABLE INK PUSHER

]54[

21.08.2002 ]22[ US ]33[ 28.06.2002 ]32[ 10/183175 ]31[

Int. Cl.8 B41J 002/05 ]51[ SILVERBROOK RESEARCH PTY.

LTD., AUSTRALIA ]71[



]74[

[57] An ink jet printhead chip that comprises a substrate (116); drive circuitry (156) positioned in the substrate; and a plurality of nozzle arrangements (122) positioned on the substrate, each nozzle arrangement comprising nozzle chamber walls (150) and a roof wall (130) that define a nozzle chamber and an ink ejection port in the roof wall in fluid communication with the nozzle chamber; an ink pusher that is operatively positioned

with respect to the nozzle chamber and is displaceable through a range of between 1 micron and 5 microns to eject ink from the ink ejection port; and an actuator (128) that is connected to the drive circuitry and the ink pusher to displace the ink pusher on receipt of an electrical signal from the drive circuitry, each nozzle arrangement being the product of a MEMS fabrication technique.

__________


797

165463 ]21][11[

שכבתי נטול פחם–מוצר דף רב

MULTI-LAYER CARBONLESS SHEET PRODUCT

]54[

19.05.2003 ]22[ GB ]33[ 29.05.2002 ]32[ 0212358.6 ]31[

Int. Cl.8 B41M 005/00 ]51[ ARJO WIGGINS LIMITED, UNITED

KINGDOM ]71[

DAVID JOHN TAYLOR, RICHARD DAVID SAUNDERS, MICHAEL ERIC HOBSON

]72[

WO/2003/101744 ]87[ ,מ"בע' דוד ושות-בן. ירמיהו מ



]74[

[57] A magnetically-activatable sheet product comprising a pair of laminated outer sheets between which is a magnetic layer comprising magnetically-activatable particles in a binder matrix, the outer sheets having sufficient opacity to mask the appearance of the magnetic layer; at least one of the outer sheets being provided on its outward facing surface with a

coating which comprises either microcapsules containing a solution of at least one chromogenic material, or dispersed droplets containing at least one chromogenic material in a pressure-rupturable matrix, or a colour developer composition, or both microcapsules containing at least one chromogenic material and also a colour developer.

__________


165884 ]21][11[

של משטחיםUVשיטה לטיהור

METHOD FOR PHOTOSENSITIZED ULTRAVIOLET DECONTAMINATION OF SURFACES

]54[

08.11.1999 ]22[ US ]33[ 09.11.1998 ]32[ 60/107617 ]31[

Int. Cl.8 A61L 002/10 ]51[ DIVISION FROM 143058 ]62[ CLEAN EARTH TECHNOLOGIES,

LLC, U.S.A. ]71[

WO/2000/028552 ]87[ , ושותפיוריינהולד כהן


]74[

[57] A method of decontaminating a contaminated surface, the method comprising: spraying a photosensitizer onto the contaminated surface, the photosensitizer comprising an aqueous

solution containing hydrogen peroxide and peracetic acid; and applying UV light in an intensity sufficient to destroy contaminants on the surface.

__________


799

165885 ]21][11[

לטיהור של משטחיםשיטה והתקן

METHOD FOR PHOTOSENSITIZED DECONTAMINATION OF SURFACES

]54[

08.11.1999 ]22[ US ]33[ 09.11.1998 ]32[ 60/107617 ]31[

Int. Cl.8 A61L 002/10 ]51[ DIVISION FROM 143058 ]62[ CLEAN EARTH TECHNOLOGIES,

LLC, U.S.A. ]71[



]74[

[57] A method of decontaminating the surface of a contaminated object, the method comprising: surrounding the contaminated object with a barrier having an entrance and an exit therein;

establishing an air flow into the exit and out of the entrance; spraying a photo sensitizer onto the surface of the object; and illuminating the sprayed surfaces of the object with light.

__________


165886 ]21][11[

שיטה לטיהור של משטחים

METHOD FOR PHOTOSENSITIZED DECONTAMINATION OF SURFACES

]54[

08.11.1999 ]22[ US ]33[ 09.11.1998 ]32[ 60/107617 ]31[

Int. Cl.8 A61F 002/10 ]51[ CLEAN EARTH TECHNOLOGIES,

LLC, U.S.A. ]71[



]74[

[57] A method of decontaminating a contaminated non-conducting surface, the method comprising: providing a conducting backing for the non-conducting surface; spraying photosensitizer onto the

contaminated surface, the photosensitizer being electrically charged so that it is attracted to the contaminated surface; and illuminating the sprayed surface with light.

__________


801

166724 ]21][11[

אלקטרומכני עם תכונות של –מפעיל מיקרו אבזם מתנגד

MICRO-ELECTROMECHANICAL ACTUATOR WITH BUCKLE-RESISTANT PROPERTIES

]54[

30.06.2000 ]22[ Int. Cl.8 B41J 002/45 ]51[

SILVERBROOK RESEARCH PTY. LTD., AUSTRALIA

]71[



]74[

[57] A micro-electromechanical actuator (7) that includes a substrate (2); drive circuitry positioned on the substrate; an active beam member (10) that is anchored to the substrate at one end and electrically connected to the drive circuitry, the active beam member defining an electrical heating circuit that is spaced from and overlies the substrate to heat resistively and expand when a current from the drive circuitry is set up in the active beam member; a passive beam member (12) that is also anchored to the substrate at one end

and electrically isolated from the drive circuitry, the active beam member being interposed between the substrate and the passive beam member; a longitudinally extending lever arm (6) that is fast at one end to an opposite end of the active and passive beam members, such that expansion and subsequent contraction of the active beam member causes reciprocal movement of the lever arm away from and towards the substrate; and a working member fast with an opposite end of the lever arm.

__________


167283 ]21][11[

ם וספרים מודפסים שיטות להדפסת ספרי בשיטות אלו

METHODS FOR PRINTING BOOKLETS AND BOOKLETS PRINTED THEREBY

]54[

07.03.2005 ]22[ Int. Cl.8 B42C 001/00, B42D 009/00 ]51[

אשדוד, ישראל מרמורשטיין אשדוד, אליעזר כץ

ISRAEL MARMORSTEIN ELIEZER KATZ

]71[

,ברגמן וגולר, וולף ירושלים, 1352. ד.ת' , ב19וב קרן היסוד רח


]74[

[57] A method for preparing a protable booklet of multi-column textual material, comprising reformatting the textual layout of said material in order to create substantial alignment between the lines of text I all of the columns in an area predetermined for horizontal subdivision of the sheet containing the same, creating at least one space horizontally extending across said predetermined area of said

sheet, thereby subdividing each of said respective columns to form at least two distinct areas of printed matter, and utilizing said subdivided sheets to form a booklet having pages of reduced height in the direction of its columns, while substantially maintaining the original font size of the letters of said multi-column textual material.

__________


803

PATENTS פטנטים

פטנטים שניתנוPATENTS GRANTED

132651 132101 131418 131275 131147 129561 129319 114982 146702 146664 146460 146384 146287 146254 132813 132793 146992 146977 146956 146917 146897 146872 146721 146705 148116 147944 147895 147703 147634 147614 147557 147413 148629 148551 148414 148355 148316 148290 148194 148128 149556 149499 149489 149338 148910 148816 148743 148637 151204 151192 150726 150715 150616 150512 150230 150023 151581 151536 151511 151504 151471 151293 151244 151241 127325 127193 125628 124977 124471 108316 106357 99435 142738 142570 142484 142457 142132 142112 127770 127769 143441 143370 143354 143112 142978 142954 142879 142868 143733 143694 143576 143495 143490 143487 143479 143457 144762 144747 144486 144358 144352 144106 144084 143797 145158 145157 145156 145121 145011 144905 144847 144775 145400 145350 145336 145318 145316 145305 145177 145159 145948 145799 145783 145767 145561 145554 145517 145437 134087 133078 123514 122832 121614 121402 146103 145986 135585 135499 135371 135295 135166 134980 134602 134224 152394 152222 152192 137096 136773 136768 136469 135945 154066 153673 153657 153630 153448 153396 153026 152986 156331 156236 155910 155255 155211 155187 154926 154765 158405 158305 158210 157711 157622 156918 156537 156403 138951 138647 138435 138425 116609 116398 158663 158409 140476 140368 140080 139849 139666 139252 139199 139035 141045 141039 140804 140702 140661 140636 140552 140491 159158 141848 141780 141727 141707 141501 141411 141183 162279 161466 160122 159760 159522 159400 159245 159213 164775 164505 164504 164448 164445 163503 163497 163265

165038 164931 164930 164834 164782

June 3, 2007 804– ז" בסיון התשסז"י

פטנטים שחודשו

PATENTS RENEWED

89428 89410 89399 89357 89311 89303 89277 89094 89602 89577 89545 89541 89477 89465 89461 89442 104829 104821 104800 104789 104776 104774 104506 99435 104891 104881 104880 104868 104853 104844 104835 104830 105017 105009 105003 104995 104970 104965 104930 104896 120249 120213 120157 120121 119944 119417 105048 105036 120325 120295 120280 120279 120260 120257 120255 120251 120380 120361 120354 120352 120351 120348 120345 120332 121790 121614 121218 120455 120442 120430 120425 120407 125214 124977 124850 124760 124572 122647 122315 121981 125598 125590 125504 125492 125483 125392 125361 125356 125748 125735 125711 125688 125649 125645 125622 125615 125856 125848 125841 125838 125822 125819 125805 125796 125975 125968 125954 125945 125926 125911 125909 125861 126153 126096 126086 126054 126050 126028 126022 125986 129319 128592 127325 126358 126331 126303 126180 126179 131716 130941 130447 130368 130229 130169 130168 129760 135499 134536 133610 133609 133469 132793 132651 132425 137548 136811 136773 136768 136469 136125 135893 135523 138690 138647 138577 138435 138277 138094 137970 137757 140476 140458 140423 140379 140080 139910 139387 139035 141591 141557 141522 141411 141320 141045 140933 140702 141848 141814 141763 141758 141752 141740 141672 141632 142570 142132 141989 141970 141964 141942 141939 141889 143354 143086 142978 142879 142784 142738 142687 142645 143645 143637 143602 143601 143590 143556 143495 143479 144199 144100 143998 143997 143739 143733 143698 143694 145158 145157 145156 145121 144847 144775 144465 144229 145767 145745 145606 145437 145393 145305 145219 145159 146664 146562 146219 146204 145993 145948 145799 145783 147089 146958 146956 146910 146897 146872 146759 146705 147668 147663 147634 147422 147413 147374 147339 147226 148743 148637 148414 148316 148128 148116 147895 147703 150512 150230 150023 149651 149556 149489 149485 148816 151416 151281 151107 151103 150989 150715 150647 150519 153026 152488 152286 151581 151549 151511 151504 151464 155934 155499 155498 154944 154926 154153 154013 153657 159222 159158 158305 158210 157622 156851 156476 156331 163497 163485 163484 162279 161466 159999 159522 159396 169917 168934 165038 164931 164930 164834 164775 163501


805

פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש

PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL FEES

123446


פטנטים שחודשו לעשרים שנהPATENTS RENEWED FOR 20 YEARS

146287 142068


807

NOTICE הודעה

, לחוק הפטנטים66לפי סעיף 1967-ז"תשכ

Under section 66 of the Patents Law, 5727-1967

מודע בזאת כי ניתנה רשות 'לבעלת בקשת הפטנט מס

133835 This is to notify that permission has been granted to the owner of Patent Application No.

Acceptance published in journal 7/2003 דבר הקיבול פורסם ביומןלתקן את הפירוט של בקשת

הפטנט האמורה To amend the specification of the

said Patent Application. כל אדם רשאי להתנגד למתן הרשות תוך שלושה חודשים

כפי , טים זהמתאריך יומן פטנ לחוק ובתקנה 67שנקבע בסעיף

-ח"התשכ, לתקנות הפטנטים991968.

Any person may oppose such grant of permission within three months from the date of this Patents Journal, as prescribed by section 67 of the Law and by regulation 99 of the Patent Regulations, 5728-1968.


NOTICE הודעה





Acceptance published in journal 5/2005 דבר הקיבול פורסם ביומןלתקן את הפירוט של בקשת



כפי , מתאריך יומן פטנטים זה לחוק ובתקנה 67ף שנקבע בסעי

-ח"התשכ, לתקנות הפטנטים991968.



809

NOTICE הודעה





Acceptance published in journal 8/2006 פורסם ביומןדבר הקיבוללתקן את הפירוט של בקשת



כפי , מתאריך יומן פטנטים זה לחוק ובתקנה 67שנקבע בסעיף

-ח"התשכ, קנות הפטנטים לת991968.



תיקון טעות

Corrigendum

Journal 10/2006יומן

P. 4206 Patent application No 76608 76608' בקשת פטנט מס4206' ע

Notice under section 64 of the Patents Law הפטנטים לחוק64הודעה לפי סעיף .Delete the notice מחק את ההודעה

The notice had been published earlier in 9/2006ורסמה קודם ביומן ההודעה פJournal 9/2006


811

קודים למדינת המופיעים ביומןCOUNTRY CODES APPEARING IN THIS JOURNAL

Code Country or Organization AR Argentina AT Austria AU Australia BA Herzegovina BE Belgium BR Brazil CA Canada CH Switzerland CN China CU Cuba CZ Czech Republic DE Germany DK Denmark EC Ecuador EP European Patent Office ES Spain FI Finland FR France GB United Kingdom GE Georgia GR Greece GT Guatemala HR Croatia HU Hungary IE Ireland IL Israel IN India IT Italy JP Japan KR Republic of Korea LK Sri Lanka LU Luxembourg LV Latvia MX Mexico MY Malaysia


NL The Netherlands NO Norway NZ New Zealand PL Poland PT Portugal RU Russian Federation SE Sweden SG Singapore SI Slovenia SK Slovakia TH Thailand TR Turkey TW Taiwan UA Ukraine US United States of America UY Uruguay UZ Uzbekistan WO World Intellectual Property Organization (W.I.P.O.) ZA South Africa


813

DESIGNS מדגמים מדגמים שנרשמו

DESIGNS REGISTERED

36120, 40378, 40379 Class 23(01) סוג 31.1.2002

MIGAN LTD. מ"מיגן בע Fast connector מחבר מהיר

39787 Class 6(01) סוג 15.8.2004

JESSICA COHEN סיקה כהן'ג Modular children's pouff פוף מודלרי לילדים

39943 Class 9(01) סוג 18.11.2004

TNUVA CENTRAL COOPERATIVE FOR THE MARKETING OF AGRICULTURAL PRODUCE IN ISRAEL LTD.

תנובה מרכז שתופי לשווק מ"אית בישראל בעתוצרת חקל

Bottle בקבוק

40022, 40024 Class 6(01) סוג 6.12.2004

RONEN YITZHAKI AND GLAMER DESIGN IN WOOD LTD.

רונן יצחקי וגלמר עיצוב בעץ מ"בע

Bed מיטה

40083 Class 3(01) סוג 21.12.2004

KETER PLASTIC LTD. מ"כתר פלסטיק בע Bucket for tools דלי לכלי עבודה


40340 Class 8(08) סוג 15.2.2005

MOSHE LAVI משה לביא Attachment assembly for road signs to a pole מערכת להצמדת תמרור לעמוד

40355 Class 22(04) סוג 20.2.2005

FAB MANUFACTURING & IMPORT OF INDUSTRIAL EQUIPMENT LTD.

פאב ייצור ויבוא ציוד תעשייתי מ"בע

Firearm grip ידית של כלי נשק 40404 Class 22(04) סוג 7.3.2005

FAB MANUFACTURING & IMPORT OF INDUSTRIAL EQUIPMENT LTD.

פאב ייצור ויבוא ציוד תעשייתי מ"בע

Accessory grip ידית עבור אביזרים

40448 Class 6(06) סוג 14.3.2005

L.B. ORLY LTD. מ"אורלי בע. ב.ל Profile פרופיל

40480 Class 11(01) סוג 20.3.2005

ELIYAHU RAM (FADIDA) פדידה(אליהו רם( Pendant תליון

40707 Class 23(01) סוג 1.5.2005

ODIS IRRIGATION EQUIPMENT (2002) LTD. AND ODIS FILTERING LTD.

) 2002(אודיס אביזרי השקיה מ"מ ואודיס מפעלי סינון בע"בע

Cover for filtering unit מכסה למסנן


815

40868 Class 3(01) סוג 20. 6.2005

NIRIT DRORI AND ANAT NEVO רית דרורי וענת נבוני Baby carrier מנשא לתינוק

41113 Class 11(01) סוג 25. 7.2005

H. STERN COMERCIO E INDUSTRIA S.A. Jewel תכשיט

41507 Class 21(02) סוג 12. 10.2005

TAL COHEN טל כהן Exercise bench ספסל להתעמלות 41522

Class 9(03) סוג 17.10.2005

N.V. NUTRICIA Container מיכל Convention date (OHIM) 26.11.2005 אוהיים(תאריך האמנה(

41645 Class 9(03) סוג 24. 11.2005

ORION CORPORATION Package אריזה

41677, 43553 Class 8(07) סוג 30. 11.2005

SHULAMIT MEIRA BITTON שולמית מאירה ביטון Key מפתח


41761 Class 19(06) סוג 20.12.2005

MERZ & KRELL GMBH & CO. KGAA Writing instrument כלי כתיבה Convention date (Germany) 15.7.2005 גרמניה(תאריך האמנה( 41862

Class 28(03) סוג 11.1.2006

UNILEVER PLC Bottle בקבוק Convention date (U.S.A.) 26.7.2005 ארצות הברית(תאריך האמנה( 41866

Class 9(01) סוג 17.1.2006

UNILEVER PLC Bottle בקבוק Convention date (U.S.A.) 26.7.2005 ארצות הברית(תאריך האמנה(

41924 Class 2(03) סוג 29. 1.2006

MOSHE HAREL AND GABRIEL BEN HAIM

משה הראל וגבריאל בן חיים

Headgear כיסוי ראש

41928 Class 15(09) סוג 30. 1.2006

B. VARTICOVSCHI LTD. מ"ורטיקובסקי בע. ב Key מכונה לליטוש יהלומים 42001

Class 4(02) סוג 10.2.2006

COLGATE-PALMOLIVE COMPANY Electric toothbrush handle ידית של מברשת שיניים חשמלית Convention date (U.S.A.) 17.8.2005 ארצות הברית(תאריך האמנה(


817

42271 Class 11(01) סוג 4. 4.2006

BEN ZIDEL בן זידל Bracelet צמיד

42294 Class 11(01) סוג 6. 4.2006


42303 Class 11(01) סוג 6. 4.2006

H. STERN COMERCIO E INDUSTRIA S.A. Jewelry תכשיטים

42412, 42413 Class 11(01) סוג 27. 4.2006

GERALDO LTD. מ"ראלדו בע'ג Jewel אבן חן 42452

Class 19(04) סוג 14.5.2006

KING JIM CO. LTD. Pocket folder אוגדן כיס Convention date (Japan) 15.11.2005 יפן(תאריך האמנה(

42520, 42521 Class 21(02) סוג 25. 5.2006

GREENFIELD B.G LTD. מ"בע. ג.גרינפלד ב Gymnastic apparatus מתקן להתעמלות


42594 Class 11(01) סוג 12. 6.2006

DIAMINTANGIBLES INTERNATIONAL, LTD. Diamond יהלום

42597, 42598 Class 11(01) סוג 13. 6.2006

DIAMINTANGIBLES INTERNATIONAL, LTD. Diamond יהלום

42606 Class 8(08) סוג 14. 6.2006

AMISHAY MARKETING COMPANY LTD.

) 1980(עמישי חברה לשיווק מ"בע

Door stop מעצור דלת

42662 Class 11(01) סוג 3. 7.2006

JAFA SHAVIT יפה שביט Ornament קישוט

42679, 42680, 42681, 42682, 42683

Class 6(06) סוג 4. 7.2006

XI MODULAR DESIGN LTD. מ"קסאי עיצוב מודולארי בע Profile פרופיל 42698, 42699

Class 6(01) סוג 5.7.2006

NICOLETTI S.P.A. Sofa ספה Convention date (Italy) 13.1.2006 איטליה(תאריך האמנה(


819

42797, 42800, 42801, 42802

Class 11(01) סוג 23. 7.2006


42806 Class 9(03) סוג 25. 7.2006

HISHTIL LTD. מ"חישתיל בע Form for seedling ידול שתיליםתבנית לג

42808, 42809, 42812, 42813

Class 25(01) סוג 25. 7.2006

EXTAL LTD. מ"אקסטל בע Profile פרופיל

42832 Class 6(03) סוג 1. 8.2006

KETER PLASTIC LTD. מ"כתר פלסטיק בע Collapsible table שולחן מתקפל

42836 Class 11(01) סוג 2. 8.2006

JACOB SIMAN-TOV AND ITZHAK SIMAN-TOV

טוב-טוב ויצחק סימן-יעקב סימן

Gemstone אבן חן

42861 Class 2(02) סוג 9. 8.2006

DIGRIS IMPORT LTD. מ"דיגריס יבוא בע Pants מכנסיים


42922, 42923, 42924 Class 2(04) סוג 20. 8.2006

PAPAYA FASHION LTD. מ"פאפאיה אופנה בע Sole סוליה

42935 Class 19(06) סוג 27. 8.2006

OMEGA CREATIVE INDUSTRIES KFAR GLICKSON, (1975) LIMITED PARTNERSHIP

אומגה תעשיות כפר גליקסון שותפות מוגבלת, )1975(

Painting assembly ערכת צביעה

42984, 42986 Class 23(01) סוג 3. 9.2006

ELGO IRRIGATION LTD. מ"אלגו השקייה בע Irrigator מתקן להשקיה

42989, 42990, 42991, 42992, 42993

Class 8(06) סוג 3. 9.2006

ARBRAHAM COHEN-HANDLES &PROFILES LTD.

ידיות ופרופילים -אברהם כהןמ"בע

Handle ידית 42994 Class 8(07) סוג 4. 9.2006

MUL-T-LOCK TECHNOLOGIES LTD.

מ"מולטילוק טכנולוגיות בע

Key head ראש מפתח

42998 Class 25(01) סוג 4. 9.2006

KOL CHEN LTD AND HAIM AZOULAY

מ וחיים אזולאי"כל חן בע

Profile פרופיל


821

43037, 43042 Class 11(01) סוג 10. 9.2006


43073 Class 24(04) סוג 17. 9.2006

ILANIT SCHWAIZER PELEG אילנית שוויצר פלג Pacifier מוצץ

43077 Class 7(01) סוג 18. 9.2006

FORMASTER S.A.

Jug water filter קנקן מסנן מים

43094 Class 20(03) סוג 21. 9.2006

AVIV ZAGURI ADVERTISEMENT מ"אביב זגורי פרסומאים בע Advertisement device םמתקן פרסו

43157, 43158 Class 9(03) סוג 5. 10.2006

SHAHAM Y. ARICHA AND SONS LTD.

מ"אריכא ובניו בע. שחם י

Trash container אשפתון

43159 Class 25(03) סוג 5. 10.2006




Guard cabin ה לשומרמבנ

43160 Class 23(01) סוג 5. 10.2006



Drinking fountain ברזיה

43161 Class 20(03) סוג 5. 10.2006



Bulletin board לוח מודעות

43162, 43163, 43683 Class 6(01) סוג 5. 10.2006



Sitting set מערכת ישיבה

43164, 43165 Class 25(02) סוג 5. 10.2006


מ"ובניו בעאריכא . שחם י

Barrier מחסום

43166, 43169 Class 25(03) סוג 5. 10.2006



Pergola פרגולה

43168, 43171 Class 6(01) סוג


823

5. 10.2006 SHAHAM Y. ARICHA AND SONS LTD.

מ"ו בעאריכא ובני. שחם י

Bench ספסל

43172 Class 12(11) סוג 5. 10.2006



Bike device מתקן לאופניים

43174, 43175, 43176, 43177

Class 23(01) סוג 15. 10.2006

FORMASTER S.A.

Water filter cartridge מחסנית למסנן מים

43198, 43200 Class 11(01) סוג 15.10.2006

H. STERN COMERCIO E INDUSTRIA S.A.

Jewel תכשיט

43222, 43223 Class 11(01) סוג 22.10.2006


Jewel תכשיט

43244, 43245, 43246, 43247, 43248

Class 11(01) סוג 23.10.2006



Jewel טתכשי

43271, 43272, 43273, 43274, 43275, 43276, 43277, 43278, 43279,

43280

Class 27(03) סוג 2. 11.2006

UNIQUE COMFORT ACCESSORIES LTD.

מ"יוניק אביזרי נוחות בע

Cigarette extinguisher חונק סיגריות

43290, 43291, 43292, 43293 Class 2(04) סוג 7. 11.2006

GAZIT SHOES T. VINER LTD. מ"וינר ובניו בע. נעלי גזית ט Shoe נעל


825

מדגמים שחודשו

DESIGNS RENEWED

27715 27714 27713 27712 27711 27710 27581 27443 36366 36305 36172 36158 36155 36089 36088 34794 36429 36424 36405 36404 36403 36402 36401 36368 36495


מדגמים שבוטלוDESIGNS VOID

26575 26569 26558 19128 19126 19103 19102 19072 26644 26639 26638 26633 26604 26603 26590 26589 35464 35454 35453 35445 35440 35438 35436 27252 35481 35480 35479 35474 35473 35472 35470 35465 35505 35502 35501 35493 35492 35491 35488 35482 36853 36852 36851

Dr. Meir Noam Commissioner of Patents, Designs and Trade Marks

ר מאיר נועם"ד המדגמים, רשם הפטנטים וסימני מסחר


i

שינויים בפרטים רשומים בפנקס

CHANGES IN PARTICULARS ENTERED IN REGISTER

מפתחות לבקשות שקובלוINDICES OF APPLICATIONS ACCEPTED

NAME INDEX מפתח שמי

116223מ "מערכות בע. וי. די3

הרשות , גוריון בנגב-אוניברסיטת בן 147199למחקר ופיתוח

140429מ "ישומים בעאוריקל י 149324מ "טלקום בע. איי.סי.אי 147169מ "קוד בע. סי.איי

167283אליעזר כץ מ "סיסטמס פלאש דיסק פיונירס בע-אם

148619 145572אנה ברמן

140367בינימין רון

150880מ "ינג בע'גיוון אימג

155138מ "גן יישומים בביולוגיה בע 133693מ "פארם בע-די

137455מ "זולי החזקות בע

148375מ "טויטופלסט בע 151953מ "מערכות נשק בע. אי.די.טי

143014מ "טראנספארמה מדיקל בע

, 143202מ "ידע חברה למחקר ופיתוח בע

150301 151000יצחק גוילי

144966ישראל אליעזרוב 167283ישראל מרמורשטיין

150855מ "ת בעניטי טכנולוגיות רפואיו

161917מ "סולל מערכות סולריות בע

125855מ "סלריס בע 149823, 149822מ "ספידביט בע

150251מ "יק בע'ספייסלוג

149439מ "פוליקום ישראל בע

135332מ "קלוקוייז טכנולוגיות בע 153136מ "קראוס תעשיות מתכת בע

מ "בע) טכנולוגיות קרמיקה(קראל 143780

145572ראובן ברמן

רשות לפיתוח אמצעי לחימה -רפאל 141710מ "בע

June 3, 2007 ii– ז" בסיון התשסז"י

3DV SYSTEMS LIMITED 116223

ABBOTT GMBH & CO. KG 146232 ACCENT OPTICAL TECHNOLOGIES, INC. 157691 ADSIL, LC 151390 AKZO NOBEL N.V. 145483 ALEXANDER BECKMANN 145362 ALLA PAVLOVNA TUZOVA 154360 ALOIS PICHLER 157258 ALZA CORPORATION 144756 ANDEROL, INC. 159091 ANGIOTECH INTERNATIONAL AG. 145069 ANGIOTECH PHARMACEUTICALS, INC. 145069 ANNA BERMAN 145572 APPLIED VISION SYSTEMS, INC. 147672 ARJO WIGGINS LIMITED 165463 ASAT AG APPLIED SCIENCE & TECHNOLOGY 142876 ASK 141761 ASTRAZENECA AB 139297 ASTRAZENECA AB 141410, 150403 ATHEROS COMMUNICATIONS, INC. 147916 AVENTIS PHARMA S.A. 136647

BANDSPEED, INC. 145090 BASF AKTIENGESELLSCHAFT 147767 BASF AKTIENGESELLSCHAFT 150173, 154303 BAYER AKTIENGESELLSCHAFT 149748 BAYER CROPSCIENCE S.A. 148162 BELDEN WIRE & CABLE COMPANY 146993 BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY 147199 BENYAMIN RON 140367 BIOFRONTERA BIOSCIENCE GMBH 142876 Biogen Idec MA Inc. 126918

BIOPHYSICA, INC. 143709 BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 151011 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG 149984 BOREALIS TECHNOLOGY OY 158429

CABOT CORPORATION 151825 CELGENE CORPORATION 135288 CELLARIS LTD. 125855 CENTAUR PHARMACEUTICALS, INC. 150403 CEREL (CERAMIC TECHNOLOGIES) LTD. 143780 CHUGAI SEIYAKU KABUSHIKI KAISHA 136310 CLEAN EARTH TECHNOLOGIES, LLC 165884, 165885, 165886 CLOCKWISE TECHNOLOGIES LTD. 135332 COLEY PHARMACEUTICALS, INC. 139813 COMPUTER ASSOCIATES THINK, INC. 142572, 143693, 143940 COMPUTER ASSOCIATES THINK, INC. 144067, 145325 COULTER PHARMACEUTICAL INC. 140028 CV THERAPEUTICS, INC. 146471

DEERE & COMPANY 164542, 164842 DERMATRENDS, INC. 150177 DONALDSON COMPANY, INC. 154569, 154570 D-PHARM LIMITED 133693 DSM IP ASSETS B.V. 151586

ECI TELECOM LTD. 149324 EGIS GYOGYSZERGYAR RT. 146420 EISAI CO.,LTD. 151314 ELI LILLY AND COMPANY 146810, 155700 ELIEZER KATZ 167283 ENZO THERAPEUTICS, INC. 137292


iii

ETHYPHARM 142787

F. HOFFMANN-LA ROCHE AG 150549 F. LLI CITTERIO S.P.A. 152305 FABBRICA D'ARMI PIETRO BERETTA S.P.A. 155711 FIDELINE 137257 FUMAKILLA LIMITED 150888

GALENIX DEVELOPPEMENT 148003 GALMED INTERNATIONAL LIMITED 142650 GE MEDICAL SYSTEMS GLOBAL TECHNOLOGY COMPANY, LLC 150811 GENE BIO-APPLICATION LTD. 155138 GENENTECH, INC. 135345 GENZYME CORPORATION 146211 GIVAUDAN SA 137893 GIVEN IMAGING LTD. 150880 GLAXOSMITHKLINE S.P.A. 147012 GPI NIL HOLDINGS, INC. 128792 GRUNENTHAL GMBH 148406

HARRIS CORPORATION 145125 HARRY CONNICK, JR. 149816 HONEYWELL INC. 149730

I.C. CODE LTD. 147169 IBM CORPORATION 141458, 143013 IBM CORPORATION 157506 IHARA CHEMICAL INDUSTRY CO., LTD. 146758 IMMUGEN PHARMACEUTICALS, INC. 145470 INNOVAPARK, LLC 149880 INSTITUT FIZIKI TVERDOGO TELA ROSSIISKOI AKADEMII NAUK 151182 INTEL CORPORATION 149538 INTER IKEA SYSTEMS B.V. 155357 INTERNATIONAL BUSINESS MACHINES CORPORATION 142265, 147118 INTROGENE B.V. 133032 ISRAEL ELIEZEROV 144966

ISRAEL MARMORSTEIN 167283 ITALDATA INGEGNERIA DELL'IDEA S.P.A. 155372 ITZHAK GVILI 151000

JANE, S.A. 156952 JANSSEN PHARMACEUTICA N.V. 147327, 147328 JONATHAN DALLAS TOYE 129912

KIRIN-AMGEN INC. 140669 KRAUSZ METAL INDUSTRIES LTD. 153136 KREIDO LABORATORIES 157789

LABORATOIRE L. LAFON 148042 LABORATOIRE THERAMEX 148953 LIFESCAN, INC. 150669 LILLY ICOS LLC 146098 LOEB HEALTH RESEARCH INSTITUTE AT THE OTTAWA HOSPITAL 139813 LONZA AG 143229 LOOK DYNAMICS, INC. 146688 LTS LOHMANN THERAPIE-SYSTEME AG 148568 LTS LOHMANN THERAPIE-SYSTEME AG 149812

M. KAINDL 161371 MASSACHUSETTS INSTITUTE OF TECHNOLOGY 137299 MASSACHUSETTS INSTITUTE OF TECHNOLOGY 148137 MEDA PHARMA GMBH & CO. KG 148068 MERCK & CO., INC. 159109 MERCK PATENT GMBH 146707 MIKKEL G. MANDT 158662 MILKHAUS LABORATORY, INC. 131478, 138336 MOELLER GEBAUDEAUTOMATION KG 146058 M-SYSTEMS FLASH DISK PIONEERS LTD. 148619

N.V. ORGANON 145483

June 3, 2007 iv– ז" בסיון התשסז"י

NAGRACARD S.A. 148521 NDS LIMITED 126552 NEOTHERMIA CORPORATION 150159 NEPHROS, INC. 155408, 156103 NEWMAT, S.A. 148683 NEXMED HOLDINGS, INC. 150306 NIKEM RESEARCH S.R.L. 147012 NITI MEDICAL TECHNOLOGIES LTD. 150855 NORTH CAROLINA STATE UNIVERSITY 150560 NOVAMONT S.P.A. 151212 NOVEXEL 136647 NOVO NORDISK A/S 124939

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIJU "KLINIKA INSTITUTA BIOREGUL YATSII I GERONTOLOGII" 146432 OCCIDENTAL CHEMICAL CORPORATION 154653 OLIVER BRUESTLE 136833 ORTHOFIX INTERNATIONAL B.V. 145553 ORTHO-MCNEIL PHARMACEUTICAL, INC. 137954, 147510 ORYCLE APPLICATIONS LTD. 140429

PHARMACIA & UPJOHN COMPANY LLC 151789 POLYCOM ISRAEL LTD. 149439 POWDERJECT RESEARCH LIMITED 145668 PRODEMEX, S.A. DE C.V. 151586

QLT USA, INC. 155006 QUALCOMM INCORPORATED 138090, 147418, 147761, 147791, 147795 QUALCOMM INCORPORATED 147628

RAFAEL-ARMAMENT DEVELOPMENT AUTHORITY LTD. 141710 RECORDATI IRELAND LIMITED

147441 RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY 147441 REM TECHNOLOGIES, INC. 157290 RESEARCH CORPORATION TECHNOLOGIES, INC. 140553 REUBEN BERMAN 145572 RHEINMETALL W & M GMBH 152972 ROGER DE LATHOUWER 143886 ROGUE VALLEY NATURAL SPRINGS, INC. 153892 RTP PHARMA INC. 138767

SAMSUNG ELECTRONICS CO., LTD. 141743 SAMSUNG ELECTRONICS CO., LTD. 157663 SANOFI AVENTIS 145150 SANOFI AVENTIS 163286 SANOFI-AVENTIS DEUTSCHLAND GMBH 146276, 149209 SCANNEX TECHNOLOGIES, LLC 147319 SCHERING AKTIENGESELLSCHAFT 136455 SECURELOGIC LTD. 150251 SILVERBROOK RESEARCH PTY. LTD. 146619, 164924, 166724 SIMULA, INC. 154957 SMITHKLINE BEECHAM CORPORATION 140028 SMITHKLINE BEECHAM CORPORATION 148325 SNECMA MOTEURS 149738 SOCIETE DES PRODUITS NESTLE S.A. 143270 SOLEL SOLAR SYSTEMS LTD. 161917 SPEEDBIT LTD. 149822, 149823 SPS VERPACKUNGS-SYSTEM GMBH 149898 SUGEN, INC. 124728

T.D.I. ARMS SYSTEMS LTD. 151953 TECHNISCHE UNIVERSITAT DRESDEN 143952 THALES 149659


v

THALES NEDERLAND B.V. 154133 THE MOWER FAMILY CHF TREATMENT IRREVOCABLE TRUST 144290 THE OTTAWA HEALTH RESEARCH INSTITUTE 139813 THE PROCTER & GAMBLE COMPANY 147265 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 128058 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 143202 THE REGENTS OF THE UNIVERSITY OF MICHIGAN 140028 TOSHIO KITAMURA 136310 TRANSPHARMA MEDICAL LTD. 143014 TRIUMPH BRANDS, INC. 163624 T-SYSTEMS INTERNATIONAL, INC. 143253 TWITOPLAST LTD. 148375

UNITED TECHNOLOGIES CORPORATION 147091, 160163, 163398 UNITED TECHNOLOGIES CORPORATION 163443 UNIVERSITY OF BRITISH COLUMBIA 145069 UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 144411

VACUUMSCHELZE GMBH 138199

WARCOP INVESTMENT LTD. 140367 WAYPORT, INC. 149356 WISCONSIN ALUMNI RESEARCH FOUNDATION 146923 WORLDWIDE COATINGS IP PTY LTD 152333 WORLDWIDE FIRE RETARDANT IP PTY LTD. 152333 WORLDWIDE THERMAL MANAGEMENT IP PTY LTD. 152333 WYETH HOLDINGS CORPORATION 137617

YEDA RESEARCH AND DEVELOPMENT CO. LTD. 143202, 150301

ZULI HOLDINGS LTD. 137455

June 1, 2007– ז"ו בסיון התשס"ט

vi

מפתח ענייניSUBJECT MATTER INDEX

A01G – 144701

A01J – 145605

A01H – 149773, 150925, 152186

A23N – 146356, 163176

A23J – 158263

A23K – 128541

A61B – 137514, 149645 A61F – 140059, 141980, 145629, 148121, 150112

A61K – 123509, 130842, 131346, 134163, 136804, 140667, 140670, 140745, 140899, 143012, 143093, 143234, 143294, 143580, 145112, 145580, 146578, 146974, 147212, 147559, 149085, 149580, 150628, 154975, 154976

A61J – 143119

A61M – 140475, 148609, 148636, 150960, 151120, 160450 A62B – 172238

A63B – 141219, 166971

A63H – 159934

B01D – 139539, 154033, 154244, 157906

B01F – 155267

B01J – 148287, 154390, 160321

B05B – 143319

B32B – 162235

B41J – 149952, 150382, 164954

B60N – 154444

B61L – 158815 B65D – 147222, 154878, 156431

C03B – 154708

C07C – 132518, 137964, 139922, 140744, 146032, 146372, 148111, 148407, 148761, 148870, 149527, 154974

C07D – 134787, 136717, 136827, 137828, 139946, 140032, 140062, 141324, 144026, 145375, 145814, 147898, 148218, 148318, 148782, 149063, 149164, 149289, 156943, 157457

C07F – 145280, 145925, 150490, 158110

C07H – 144274 C07J – 149424, 150082, 153703

C07K– 110367, 123815, 127155, 128941, 134968

C08F – 149332, 152174, 157798, 161973, 164466

C08G – 158290

C08J – 150465, 157910


vii

C09D – 153090 C12N– 107822, 127363, 128578, 129164, 131171, 132259, 134700, 138353 C12P – 141645

C23C– 143076

D04H – 150139

D06B – 162231

E04C – 148699

F02K – 160696, 162142

F03B – 156993

F04B – 156196

F15D – 131589

F16J –146687

F16K – 166167

F24F – 159601

F25B – 152951

F25D – 159602

F41F – 156013

F42B – 145097, 148248, 154056

G01c – 145593, 149934

G01D – 157311

G01N – 145970, 154961

G01R – 143927

G01S – 156156

G02B – 128950, 156159, 156855

G03F – 154504 G06F – 135448, 146048, 147754, 147844

G06K –145905, 146673

G07B – 156675

G08B – 158270

G08G – 151258

H01L – 150784, 153153, 153156, 156319, 156321, 156523

H01R – 138621, 142552

H01T – 124696

H02G – 145847

H02H – 149861

H03F – 140564

H04B – 144258, 147792, 148207

H04H – 135184

H04J – 137058

H04L – 141464, 147513, 148037

H04N – 148356

H04Q– 135907, 147142, 147577

H05H – 152119

June 1, 2007– ז"ו בסיון התשס"ט 8

ירושלים, משרד המשפטים, י רשות הפטנטים"נערך ע ירושלים, הופק והודפס במדפיס הממשלתי

EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM

PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER


9

patents and designs journal - nevo.co.il · government publications, 29 b-street, ... matan digital...

Documents